A O O
52 O O
year O O
old O O
male O O
patient O O
was O O
referred O O
to O O
our O O
institute O O
as O O
a O O
massive O O
tumor O B-C0027651
of O O
right O O
thigh O O
for O O
further O O
management O O
. O O

there O O
was O O
no O O
history O O
of O O
fever O B-C0015967
or O O
loss O B-C1971624
of O I-C1971624
appetite O I-C1971624
; O O
however O O
history O O
for O O
night O B-C0028081
sweats O I-C0028081
and O O
weight O B-C1262477
loss O I-C1262477
and O O
low O B-C0024031
back O I-C0024031
pain O I-C0024031
was O O
positive O O
. O O

he O O
denied O O
any O O
history O O
of O O
cough O B-C0010200
, O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
, O O
hemoptysis O B-C0019079
or O O
history O O
of O O
contact O O
with O O
a O O
tuberculous O O
patient O O
or O O
relative O O
. O O

there O O
were O O
no O O
other O O
medical O O
illnesses O O
. O O

physical O O
examination O O
revealed O O
normal O O
vital O O
signs O O
. O O

the O O
right O O
thigh O O
was O O
massively O O
swollen O O
and O O
was O O
non O O
tender O O
and O O
was O O
not O O
associated O O
with O O
any O O
inflammation O O
. O O

the O O
patient O O
looked O O
ill O O
and O O
underweight O B-C0041667
, O O
but O O
there O O
was O O
no O O
lymph O O
node O O
enlargement O O
or O O
clubbing O O
. O O

chest O O
and O O
cardiovascular O O
examination O O
was O O
unremarkable O O
. O O

abdominal O O
examination O O
revealed O O
soft O O
, O O
non-tender O O
abdomen O O
and O O
no O O
organomegaly O B-C4054315
. O O

palpation O O
of O O
lumbar O O
spine O O
revealed O O
tenderness O O
. O O

laboratory O O
investigations O O
revealed O O
normal O O
full O O
blood O O
count O O
, O O
liver O O
enzymes O O
, O O
electrolytes O O
, O O
urea O O
and O O
creatinine O O
. O O

ESR O O
was O O
85 O O
and O O
HIV O O
serology O O
was O O
negative O O
. O O

x-rays O O
of O O
the O O
chest O O
, O O
pelvis O O
and O O
thigh O O
was O O
normal O O
. O O

x-rays O O
of O O
the O O
lumbar O O
spine O O
revealed O O
decreased O O
disc O O
space O O
between O O
L1 O O
and O O
L2 O O
vertebra O O
along O O
with O O
collapse O O
of O O
L2 O O
. O O

magnetic O O
resonance O O
imaging O O
of O O
thigh O O
revealed O O
large O O
well O O
encapsulated O O
abscess O B-C0000833
in O O
the O O
back O O
of O O
thigh O O
extending O O
upto O O
popliteal O O
fossa O O
, O O
in O O
continuation O O
with O O
ilio-psoas O O
abscess O B-C0000833
. O O

the O O
abscess O B-C0000833
was O O
aspirated O O
under O O
ultrasound O O
guidance O O
. O O

ziehl-neelsen O O
stain O O
of O O
the O O
aspirate O O
was O O
positive O O
for O O
acid-fast O O
bacilli O O
. O O

culture O O
of O O
the O O
aspirate O O
revealed O O
mycobacterium O B-C0026918
tuberculosis O B-C0041296
resistant O O
to O O
isoniazid O O
, O O
and O O
rifampicin O O
, O O
but O O
sensitive O O
to O O
ethambutol O O
, O O
pyrazinamide O O
, O O
streptomycin O O
, O O
capreomycin O O
, O O
ofloxacin O O
and O O
amikacin O O
. O O

he O O
was O O
started O O
on O O
pyrazinamide O O
, O O
ethambutol O O
, O O
streptomycin O O
, O O
ofloxacin O O
and O O
amikacin O O
. O O

isoniazid O O
and O O
rifampicin O O
were O O
discontinued O O
. O O

the O O
abscess O B-C0000833
was O O
then O O
drained O O
under O O
ultrasound O O
guidance O O
and O O
650 O O
ml O O
of O O
purulent O O
fluid O O
was O O
obtained O O
. O O

streptomycin O O
was O O
locally O O
instilled O O
and O O
the O O
drain O O
was O O
kept O O
in O O
place O O
for O O
seven O O
days O O
. O O

A O O
period O O
of O O
18 O O
months O O
of O O
therapy O O
was O O
completed O O
. O O

at O O
the O O
end O O
of O O
the O O
treatment O O
course O O
, O O
the O O
swelling O B-C0038999
resolved O O
completely O O
, O O
the O O
patient O O
improved O O
clinically O O
, O O
gained O O
weight O O
and O O
was O O
walking O O
normally O O
. O O

A O O
56 O O
- O O
year-old O O
female O O
was O O
bitten O O
by O O
a O O
snake O O
on O O
her O O
left O O
foot O O
. O O

soon O O
after O O
, O O
she O O
was O O
taken O O
to O O
our O O
hospital O O
. O O

the O O
patient O O
was O O
conscious O O
and O O
without O O
any O O
neurological O O
deficits O O
. O O

her O O
vital O O
signs O O
were O O
stable O O
on O O
arrival O O
and O O
during O O
in O O
hospital O O
period O O
. O O

her O O
left O O
foot O O
showed O O
swelling O B-C0038999
, O O
which O O
gradually O O
worsened O O
over O O
the O O
next O O
few O O
days O O
and O O
progressed O O
to O O
the O O
left O O
thigh O O
. O O

the O O
laboratory O O
exams O O
showed O O
elevations O O
of O O
creatine O O
kinase O O
( O O
maximum O O
37340 O O
IU O O
/ O O
L O O
on O O
day O O
3 O O
) O O
and O O
white O O
cell O O
count O O
( O O
maximum O O
14520 O O
/ O O
micro O O
L O O
on O O
day O O
2 O O
) O O
. O O

creatine O O
kinase-mb O O
fraction O O
( O O
4% O O
) O O
remained O O
within O O
normal O O
range O O
. O O

antibiotics O O
and O O
tetanus O B-C0039614
vaccine O O
as O O
well O O
as O O
intravenous O O
fluid O O
were O O
administered O O
. O O

anti O O
snake O O
venom O O
was O O
not O O
administered O O
. O O

cepharanthine O O
was O O
administered O O
intravenously O O
. O O

cepharanthine O O
is O O
a O O
biscoclaurine O O
( O O
bisbenzylisoquinoline O O
) O O
amphipathic O O
alkaloid O O
isolated O O
from O O
stephania O O
cepharantha O O
hayata O O
and O O
is O O
widely O O
used O O
in O O
japan O O
to O O
treat O O
a O O
variety O O
of O O
diseases O O
including O O
alopecia O B-C0002171
areata O I-C0002171
, O O
radiotherapy-induced O O
leucopenia O O
, O O
and O O
, O O
septic O B-C0036983
shock O I-C0036983
[ O O
3 O O
] O O
. O O

the O O
electrocardiogram O O
, O O
which O O
is O O
routinely O O
recorded O O
in O O
admitted O O
patient O O
in O O
our O O
hospital O O
, O O
revealed O O
negative O O
T O O
waves O O
in O O
various O O
leads O O
. O O

therefore O O
we O O
undertook O O
echocardiogram O O
and O O
observed O O
abnormal O O
left O O
ventricular O O
systolic O O
function O O
with O O
apical O O
akinesis O O
and O O
a O O
hyperdynamic O O
basal O O
segment O O
of O O
the O O
left O O
ventricle O O
, O O
which O O
is O O
typical O O
in O O
takotsubo O B-C1739395
cardiomyopathy O I-C1739395
. O O

abnormalities O O
in O O
electrocardiogram O O
and O O
echocardiogram O O
resolved O O
four O O
days O O
after O O
snake O B-C0037379
bite O I-C0037379
. O O

hemodynamic O O
complications O O
including O O
heart O B-C0018801
failure O I-C0018801
and O O
severe O O
arrhythmia O B-C0003811
did O O
not O O
occur O O
. O O

multi-detector O O
CT O O
scanning O O
undertaken O O
later O O
on O O
revealed O O
no O O
stenotic O O
lesions O B-C0221198
in O O
her O O
coronary O O
arteries O O
. O O

she O O
was O O
discharged O O
without O O
any O O
disabilities O O
after O O
two O O
months O O
of O O
rehabilitation O O
. O O

the O O
victim O O
could O O
not O O
identify O O
the O O
snake O O
, O O
however O O
, O O
we O O
assume O O
that O O
the O O
snake O O
was O O
gloydius O O
blomhoffii O O
, O O
since O O
there O O
are O O
only O O
two O O
species O O
of O O
venomous O O
snake O O
, O O
G O O
. O O
blomhoffii O O
and O O
rhabdophis O O
tigrinus O O
, O O
in O O
the O O
patient's O O
habitation O O
, O O
and O O
the O O
fang O O
site O O
was O O
likely O O
due O O
to O O
G O O
. O O
blomhoffii O O
. O O

A O O
54 O O
years O O
old O O
female O O
patient O O
( O O
weight O O
108 O O
kg O O
height O O
162 O O
cm O O
, O O
body O O
mass O O
index O O
( O O
BMI O O
) O O
= O O
41.2 O O
kg O O
/ O O
cm O O
² O O
) O O
was O O
submitted O O
for O O
laparoscopic O O
adjustable O O
gastric O O
band O O
in O O
september O O
2001 O O
. O O

her O O
comorbidities O O
include O O
non-insulin O O
dependent O O
diabetes O O
and O O
hypertension O B-C0020538
. O O

the O O
post-operative O O
course O O
reported O O
to O O
be O O
straightforward O O
with O O
no O O
immediate O O
complications O O
. O O

however O O
she O O
started O O
to O O
be O O
followed O O
up O O
in O O
other O O
hospital O O
with O O
no O O
available O O
documented O O
data O O
about O O
reduction O O
in O O
weight O O
in O O
the O O
few O O
years O O
after O O
the O O
surgery O O
. O O

at O O
september O O
2009 O O
, O O
she O O
presented O O
to O O
the O O
emergency O O
department O O
complaining O O
of O O
fever O B-C0015967
, O O
periumblical O O
pain O B-C0030193
and O O
swelling O B-C0038999
. O O

on O O
examination O O
there O O
is O O
superficial O O
periumblical O O
swelling O B-C0038999
and O O
tenderness O O
. O O

blood O O
tests O O
revealed O O
leukocytosis O B-C0023518
. O O

abdominal O O
contrast O O
enhanced O O
CT O O
scan O O
showed O O
6.5 O O
X O O
4.5cm O O
fluid O O
collection O O
surrounding O O
the O O
access O O
port O O
. O O

under O O
general O O
anesthesia O B-C0278134
, O O
incisional O O
drainage O O
and O O
access-port O O
removal O O
was O O
performed O O
. O O

the O O
remaining O O
part O O
of O O
connecting O O
tube O O
left O O
in O O
the O O
abdominal O O
cavity O O
. O O

the O O
patient O O
covered O O
with O O
antibiotic O O
regimen O O
and O O
released O O
from O O
the O O
hospital O O
few O O
days O O
later O O
doing O O
well O O
. O O

three O O
months O O
later O O
, O O
the O O
patient O O
presented O O
again O O
to O O
the O O
emergency O O
department O O
with O O
colicky O B-C3888418
abdominal O I-C3888418
pain O I-C3888418
and O O
abdominal O B-C0000731
distention O I-C0000731
. O O

supine O O
and O O
erect O O
abdomen O O
x-ray O O
revealed O O
small O B-C2749237
bowel O I-C2749237
dilatation O I-C2749237
and O O
multiple O O
air-fluid O O
levels O O
. O O

interestingly O O
, O O
the O O
gastric O O
band O O
and O O
its O O
connecting O O
tube O O
seen O O
in O O
the O O
lower O O
abdomen O O
at O O
midline O O
probably O O
in O O
the O O
distal O O
ilial O O
loops O O
. O O

the O O
patient O O
was O O
given O O
oral O O
contrast O O
( O O
gastrografin O O
® O O
) O O
and O O
contrast O O
enhanced O O
abdomen O O
CT O O
scan O O
performed O O
later O O
. O O

it O O
showed O O
resolution O O
of O O
bowel O O
dilatation O O
with O O
the O O
band O O
and O O
its O O
connecting O O
tube O O
noted O O
at O O
transverse O O
/ O O
descending O O
colon O O
. O O

few O O
hours O O
later O O
the O O
patient O O
started O O
to O O
have O O
rectal O B-C0034886
pain O I-C0034886
and O O
x-ray O O
requested O O
. O O

it O O
showed O O
that O O
the O O
gastric O O
band O O
at O O
rectal O O
area O O
. O O

per O O
rectal O O
examination O O
performed O O
and O O
the O O
gastric O O
band O O
removed O O
with O O
no O O
difficulties O O
. O O

repeated O O
abdominal O O
x-ray O O
confirms O O
complete O O
removal O O
of O O
gastric O O
band O O
and O O
its O O
connecting O O
tube O O
. O O

the O O
patient O O
symptoms O O
relieved O O
and O O
she O O
was O O
discharged O O
in O O
good O O
condition O O
. O O

the O O
patient O O
followed O O
up O O
in O O
the O O
surgery O O
outpatient O O
clinic O O
and O O
she O O
was O O
doing O O
fine O O
with O O
no O O
GIT O O
symptoms O O
. O O

A O O
78 O O
- O O
year-old O O
man O O
, O O
without O O
medication O O
coexisting O O
diseases O O
, O O
body O O
weight O O
50 O O
kg O O
, O O
underwent O O
transurethral O O
resection O O
of O O
prostate O O
under O O
spinal O O
anesthesia O B-C0278134
, O O
with O O
2.5 O O
ml O O
of O O
hyperbaric O O
bupivacaine O O
( O O
0.5% O O
) O O
. O O

that O O
extended O O
to O O
the O O
T10 O O
level O O
, O O
as O O
tested O O
by O O
pin O O
prick O O
. O O

the O O
heart O O
rate O O
at O O
the O O
start O O
of O O
the O O
operation O O
was O O
85 O O
bpm O O
, O O
blood O O
pressure O O
140 O O
/ O O
80 O O
mmhg O O
, O O
electrocardiogram O O
normal O O
and O O
spo2 O O
was O O
98% O O
. O O

the O O
patient O O
was O O
positioned O O
in O O
lithotomy O O
posture O O
. O O

and O O
the O O
TURP O O
surgery O O
was O O
started O O
. O O

the O O
preoperative O O
values O O
of O O
serum O O
sodium O O
was O O
145 O O
mmol O O
/ O O
L O O
, O O
potassium O O
4.1 O O
mmol O O
/ O O
L O O
, O O
creatinine O O
14 O O
mg O O
/ O O
L O O
and O O
urea O O
0.4g O O
/ O O
L O O
. O O

A O O
routine O O
monitoring O O
of O O
fluid O O
absorption O O
by O O
expired O O
breath O O
tests O O
is O O
not O O
practiced O O
in O O
our O O
hospital O O
. O O

the O O
irrigation O O
fluid O O
used O O
by O O
urologist O O
was O O
glycine O O
1.5% O O
. O O

TURP O O
was O O
performed O O
by O O
monopolar O O
instrument O O
. O O

the O O
height O O
of O O
the O O
irrigating O O
fluid O O
reservoir O O
was O O
fixed O O
at O O
60 O O
cm O O
height O O
from O O
patient's O O
bed O O
. O O

the O O
total O O
intraoperative O B-C0079027
bleeding O I-C0079027
was O O
estimed O O
at O O
500 O O
ml O O
. O O

the O O
average O O
peroperative O O
blood O O
pressure O O
was O O
145 O O
/ O O
85 O O
mmhg O O
and O O
heart O O
rate O O
85 O O
bpm O O
. O O

during O O
surgery O O
, O O
which O O
lasted O O
for O O
120 O O
min O O
, O O
the O O
patient O O
had O O
been O O
given O O
1500 O O
ml O O
normal O O
saline O O
solution O O
by O O
intravenous O O
infusion O O
. O O
30 O O
min O O
after O O
the O O
end O O
of O O
operation O O
, O O
patient O O
suddenly O O
was O O
developed O O
in O O
recovery O O
room O O
, O O
nausea O B-C0027497
, O O
vomiting O B-C0042963
, O O
agitation O B-C0085631
then O O
rapidly O O
coma O O
, O O
hypoxemia O B-C0700292
( O O
spo2 O O
70% O O
) O O
, O O
hypotension O B-C0020649
( O O
70 O O
/ O O
40 O O
mmhg O O
) O O
and O O
bradycardia O B-C0428977
( O O
45 O O
bpm O O
) O O
. O O

the O O
abdomen O O
and O O
lung O O
auscultation O O
were O O
normal O O
. O O

he O O
was O O
intubated O O
and O O
ventilated O O
with O O
an O O
FIO2 O O
of O O
1 O O
. O O

he O O
was O O
loaded O O
with O O
500 O O
ml O O
of O O
hydroxyethyl O O
starch O O
and O O
500 O O
ml O O
of O O
saline O O
0.9% O O
, O O
a O O
central O O
venous O O
line O O
was O O
inserted O O
, O O
the O O
inotopic O O
support O O
( O O
norepinephrine O O
) O O
was O O
administred O O
, O O
inducing O O
normalization O O
hemodynamic O O
. O O

the O O
TURP O O
syndrome O O
was O O
subsequently O O
confirmed O O
by O O
an O O
immediately O O
electrolyte O O
analysis O O
revealed O O
a O O
decrease O O
in O O
serum O O
sodium O O
concentration O O
from O O
145 O O
mmhg O O
to O O
125 O O
mmhg O O
. O O

hypertonic O O
saline O O
solution O O
3% O O
at O O
a O O
rate O O
of O O
50 O O
ml O O
/ O O
h O O
was O O
started O O
. O O

the O O
patient O O
was O O
transfused O O
with O O
2 O O
units O O
blood O O
. O O

furosemide O O
wasn't O O
given O O
. O O

the O O
measurement O O
of O O
all O O
irrigating O O
fluids O O
showed O O
that O O
four O O
litres O O
had O O
been O O
absorbed O O
. O O

blood O O
ammonemia O O
and O O
glycinemia O B-C0268559
concentrations O O
weren't O O
measured O O
. O O

the O O
patient O O
was O O
transferred O O
sedated O O
and O O
ventilated O O
to O O
the O O
intensive O O
care O O
unit O O
. O O

the O O
blood O O
pressure O O
and O O
heart O O
rate O O
were O O
gradually O O
stabilized O O
at O O
120 O O
/ O O
70 O O
and O O
80 O O
bpm O O
. O O

A O O
chest O O
x-ray O O
of O O
the O O
lungs O O
and O O
ECG O O
were O O
normal O O
. O O

three O O
hours O O
later O O
, O O
the O O
sodium O O
concentration O O
was O O
129 O O
mmhg O O
, O O
potassium O O
3.2 O O
mmhg O O
, O O
glucose O O
level O O
2.31g O O
/ O O
l O O
, O O
cardiac O O
troponin O O
0.2ng O O
/ O O
ml O O
, O O
creatinine O O
10mg O O
/ O O
l O O
and O O
hemoglobin O O
9.7g O O
/ O O
dl O O
. O O

the O O
second O O
postoperative O O
day O O
, O O
sodium O O
concentration O O
was O O
increased O O
to O O
134 O O
mmol O O
/ O O
L O O
, O O
potassium O O
4.7 O O
mmol O O
/ O O
L O O
, O O
hemoglobin O O
12.7g O O
/ O O
l O O
and O O
troponin O O
3.132 O O
ng O O
/ O O
ml O O
. O O

the O O
patient O O
was O O
extubated O O
2 O O
days O O
later O O
. O O

the O O
concentration O O
sodium O O
level O O
stabilized O O
at O O
135 O O
mmol O O
/ O O
L O O
, O O
potassium O O
3.5 O O
mmol O O
/ O O
L O O
and O O
troponin O O
0.15 O O
ng O O
/ O O
ml O O
. O O

he O O
was O O
returned O O
to O O
the O O
urologic O O
clinic O O
six O O
days O O
later O O
and O O
he O O
was O O
discharged O O
from O O
the O O
hospital O O
10 O O
days O O
later O O
in O O
good O O
condition O O
. O O

OT O O
, O O
a O O
15 O O
year-old O O
final O O
year O O
secondary O O
school O O
student O O
was O O
taken O O
to O O
the O O
village O O
health O O
centre O O
by O O
the O O
school O O
principal O O
because O O
of O O
a O O
persistent O O
discomfort O B-C2364135
from O O
a O O
moving O O
object O O
in O O
the O O
chest O O
that O O
prevented O O
her O O
from O O
attending O O
the O O
secondary O O
school O O
leaving O O
certificate O O
examination O O
. O O

the O O
symptoms O O
had O O
been O O
on O O
for O O
about O O
a O O
year O O
but O O
just O O
got O O
worsened O O
. O O

there O O
was O O
no O O
other O O
associated O O
symptom O O
nor O O
abnormal O O
finding O B-C0037088
on O O
examination O O
though O O
xray O O
machine O O
was O O
not O O
available O O
at O O
the O O
centre O O
. O O

he O O
reassured O O
and O O
placed O O
on O O
multivitamins O O
and O O
analgesic O O
but O O
reffered O O
to O O
a O O
psychiatrist O O
after O O
six O O
weeks O O
because O O
there O O
was O O
no O O
improvement O O
. O O

the O O
psychiatrist O O
assessed O O
and O O
made O O
a O O
diagnosis O O
of O O
generalized O O
anxiety O B-C0003469
disorder O I-C0003469
, O O
requested O O
for O O
a O O
chest O O
radiograph O O
and O O
full O O
blood O O
count O O
. O O

she O O
defaulted O O
from O O
the O O
clinic O O
and O O
was O O
not O O
able O O
to O O
do O O
the O O
tests O O
for O O
" O O
financial O O
reasons O O
" O O
. O O

she O O
re-presented O O
about O O
fourteen O O
months O O
later O O
with O O
additional O O
six O O
months O O
history O O
of O O
recurrent O O
, O O
productive O B-C0239134
cough O I-C0239134
, O O
fever O B-C0015967
, O O
weight O B-C1262477
loss O I-C1262477
and O O
bilaterally O O
swollen O O
nail-bedth O O
. O O

clinical O O
examination O O
revealed O O
a O O
young O O
girl O O
, O O
mildly O O
pale O O
, O O
anicteric O O
, O O
febrile O B-C0015967
but O O
not O O
in O O
any O O
obvious O O
respiratory O B-C0476273
distress O I-C0476273
with O O
grade O O
IV O O
finger O B-C0009080
clubbing O I-C0009080
. O O

she O O
was O O
not O O
tachypnoiec O O
but O O
there O O
was O O
stone O O
dullness O O
and O O
reduced O O
air O O
entry O O
in O O
the O O
right O O
middle O O
lung O O
zone O O
. O O

she O O
was O O
financially O O
assisted O O
to O O
do O O
chest O O
radiograph O O
, O O
full O O
blood O O
count O O
\ O O
( O O
FBC O O
) O O
, O O
fasting O B-C0015663
blood O O
sugar O O
\ O O
( O O
FBS O O
) O O
and O O
sputum O O
alcohol O O
acid O O
fast O O
bacilli O O
\ O O
( O O
AAFB O O
) O O
. O O

the O O
FBC O O
and O O
FBS O O
were O O
normal O O
; O O
the O O
sputum O O
AAFB O O
was O O
negative O O
on O O
three O O
occasions O O
but O O
the O O
chest O O
radiograph O O
showed O O
a O O
rounded O O
, O O
well-defined-lobulated O O
peripherally O O
located O O
mass O O
in O O
the O O
( O O
RT O O
) O O
middle O O
lung O O
zone O O
, O O
measuring O O
about O O
6x5cm O O
and O O
forming O O
an O O
acute O O
angle O O
with O O
the O O
lateral O O
chest O O
wall O O
. O O

there O O
was O O
no O O
calcification O O
, O O
satellite O O
pulmonary O O
lesion O B-C0221198
, O O
periosteal O B-C2674853
reaction O I-C2674853
, O O
or O O
bony O O
erosion O O
. O O

A O O
diagnosis O O
solitary O B-C2350019
pulmonary O I-C2350019
nodule O I-C2350019
" O O
chest O O
coin O O
" O O
: O O
encysted O O
pleural O B-C0032227
effusion O I-C0032227
secondary O O
to O O
tuberculosis O B-C0041296
was O O
made O O
; O O
to O O
rule O O
out O O
pleural O O
fibroma O B-C0016045
and O O
lipoma O B-C0023798
. O O

she O O
couldn't O O
afford O O
the O O
requested O O
chest O O
CT O O
and O O
was O O
placed O O
on O O
the O O
free O O
anti O O
tuberculosis O B-C0041296
regime O O
for O O
few O O
months O O
. O O

evaluation O O
clinically O O
and O O
with O O
radiograph O O
showed O O
there O O
was O O
no O O
improvement O O
; O O
fund O O
was O O
sourced O O
for O O
her O O
for O O
a O O
chest O O
CT O O
. O O

enhanced O O
CT O O
scan O O
revealed O O
a O O
well O O
defined O O
rounded O O
, O O
peripherally O O
located O O
soft O O
tissue O O
density O O
mass O O
in O O
the O O
right O O
middle O O
lung O O
zone O O
on O O
the O O
scannogram O O
. O O

serial O O
cuts O O
showed O O
a O O
fairly O O
homogenous O O
, O O
well O O
defined O O
soft O O
tissue O O
density O O
mass O O
with O O
no O O
calcific O O
nor O O
cystic O O
area O O
within O O
it O O
. O O

there O O
was O O
minimal O O
enhancement O O
post O O
intravenous O O
contrast O O
. O O

there O O
was O O
no O O
pleural O B-C0032227
effusion O I-C0032227
nor O O
invasion O O
of O O
the O O
surrounding O O
lung O O
tissue O O
, O O
mediastinum O O
and O O
ribs O O
. O O

the O O
diagnosis O O
of O O
pleural O O
fibrous O O
tumor O B-C0027651
was O O
confirmed O O
. O O

at O O
surgery O O
, O O
a O O
fibrocystic O O
mass O O
of O O
about O O
6x7cm O O
with O O
stalk O O
on O O
the O O
( O O
rt O O
) O O
lower O O
lung O O
lobe O O
and O O
adhering O O
to O O
the O O
lateral O O
chest O O
wall O O
was O O
found O O
. O O

histology O O
confirmed O O
a O O
diagnosis O O
of O O
benign O O
solitary O B-C1266119
fibrous O I-C1266119
tumor O I-C1266119
. O O

the O O
patient O O
was O O
discharged O O
two O O
weeks O O
after O O
surgery O O
. O O

the O O
post O O
op O O
chest O O
radiograph O O
did O O
not O O
reveal O O
any O O
residual O O
mass O O
, O O
initial O O
six O O
monthly O O
and O O
later O O
yearly O O
review O O
for O O
the O O
past O O
five O O
years O O
did O O
not O O
show O O
any O O
evidence O O
of O O
recurrence O O
. O O

A O O
72 O O
- O O
year O O
old O O
man O O
was O O
admitted O O
in O O
our O O
department O O
on O O
april O O
2009 O O
, O O
with O O
a O O
history O O
of O O
left O O
testicular O B-C4314664
enlargement O I-C4314664
. O O

there O O
was O O
no O O
history O O
of O O
bone O B-C0151825
pain O I-C0151825
, O O
weight O B-C1262477
loss O I-C1262477
, O O
fatigue O B-C0015672
, O O
fever O B-C0015967
or O O
other O O
systemic O O
complaints O O
. O O

physical O O
examination O O
revealed O O
only O O
a O O
mass O O
in O O
the O O
left O O
side O O
of O O
the O O
scrotum O O
at O O
5cm O O
. O O

full O O
examination O O
revealed O O
no O O
other O O
abnormalities O O
. O O

A O O
scrotal O O
ultrasonography O O
and O O
abdominal O O
CT O O
scan O O
showed O O
a O O
testis O O
tumor O B-C0027651
with O O
some O O
small O O
abdominal O O
mesenteric O O
lymph O O
nodes O O
. O O

ultrasonography O O
of O O
the O O
liver O O
, O O
gallbladder O O
, O O
pancreas O O
, O O
spleen O O
, O O
kidneys O O
, O O
ureters O O
, O O
and O O
bladder O O
were O O
normal O O
. O O

the O O
laboratory O O
findings O O
were O O
normal O O
, O O
including O O
routine O O
blood O O
tests O O
, O O
urine O O
tests O O
, O O
biochemical O O
markers O O
and O O
LDH O O
value O O
. O O

so O O
the O O
radical O O
left O O
orchidectomy O O
was O O
performed O O
and O O
the O O
microscopic O O
examination O O
showed O O
a O O
plasmacytic O O
infiltration O O
with O O
mature O O
plasma O O
cell O O
and O O
some O O
plasmablasts O O
; O O
in O O
the O O
immunohistochemical O O
assay O O
, O O
the O O
tumor O B-C0027651
cells O O
were O O
diffusely O O
and O O
strongly O O
positive O O
for O O
CD138 O O
and O O
lambda O O
chains O O
but O O
negative O O
for O O
kappa O O
chains O O
and O O
CD20 O O
. O O

the O O
pathological O O
report O O
concluded O O
the O O
diagnosis O O
of O O
plasmocytoma O B-C0032131
with O O
clear O O
surgical O O
margins O O
of O O
the O O
tumor O B-C0027651
. O O

after O O
this O O
diagnosis O O
, O O
immunoelectrophoresis O O
showed O O
no O O
evidence O O
for O O
hyperproteinemia O B-C0267988
or O O
paraproteinemia O B-C0030489
. O O

whole O O
body O O
bone O O
scan O O
was O O
negative O O
and O O
a O O
bone O O
marrow O O
biopsy O O
revealed O O
less O O
than O O
5% O O
of O O
polyclonal O O
plasma O O
cells O O
. O O

no O O
bence O O
jones O O
or O O
other O O
M O O
components O O
were O O
detected O O
in O O
the O O
urine O O
. O O

therefore O O
, O O
multiple O B-C0026764
myeloma O I-C0026764
was O O
excluded O O
by O O
nuclear O O
medicine O O
, O O
laboratory O O
and O O
histology O O
studies O O
. O O

the O O
therapeutic O O
decision O O
for O O
this O O
patient O O
was O O
the O O
monitoring O O
without O O
any O O
chemotherapy O O
and O O
radiotherapy O O
. O O

sixteen O O
months O O
after O O
surgery O O
, O O
the O O
patient O O
presented O O
a O O
subcutaneous O O
nodule O B-C0028259
at O O
right O O
iliac O O
fossa O O
, O O
approximately O O
4cm O O
in O O
size O O
. O O

the O O
aspiration O O
cytology O O
of O O
the O O
skin O O
lesion O B-C0221198
showed O O
a O O
multiple O O
dystrophic O O
plasma O O
cells O O
, O O
and O O
cutaneous O O
biopsy O O
confirmed O O
the O O
diagnosis O O
of O O
plasmocytoma O B-C0032131
. O O

the O O
serological O O
examination O O
showed O O
an O O
increase O O
of O O
the O O
levels O O
of O O
free O O
light O O
lambda O O
chains O O
66.25mg O O
/ O O
l O O
, O O
and O O
in O O
immunoelectrophoresis O O
we O O
had O O
a O O
hypergammaglobunemia O O
iga O O
at O O
15,3g O O
/ O O
l O O
. O O

however O O
bone O O
marrow O O
aspiration O O
revealed O O
normal O O
patterns O O
of O O
cell O O
distribution O O
, O O
with O O
absence O O
of O O
hypercalcemia O B-C0020437
, O O
renal O B-C1565489
insufficiency O I-C1565489
and O O
anemia O B-C0002871
. O O

the O O
patient O O
was O O
started O O
on O O
chemotherapy O O
by O O
thalidomide O O
100mg O O
/ O O
day O O
with O O
dexamethasone O O
. O O

two O O
months O O
later O O
he O O
complained O O
an O O
irregular O O
mass O O
occupying O O
the O O
left O O
side O O
of O O
abdomen O O
; O O
thoraco-abdominal O O
CT O O
scan O O
showed O O
two O O
other O O
localizations O O
: O O
mediastinal O O
at O O
70x30mm O O
and O O
retroperitoneal O O
90x60mm O O
. O O

the O O
histological O O
examination O O
showed O O
similar O O
morphology O O
to O O
the O O
testicular O B-C0039590
tumor O I-C0039590
. O O

hence O O
, O O
the O O
histological O O
diagnosis O O
of O O
recurrent O O
plasmacytoma O B-C0032131
was O O
made O O
. O O

skeletal O O
surveys O O
did O O
not O O
show O O
any O O
pathological O O
changes O O
. O O

there O O
was O O
no O O
evidence O O
of O O
anemia O B-C0002871
, O O
hypercalcemia O B-C0020437
or O O
renal O B-C1565489
insufficiency O I-C1565489
. O O

the O O
second O O
bone O O
marrow O O
biopsy O O
was O O
normal O O
. O O

following O O
this O O
evolution O O
and O O
poor O O
response O O
the O O
patient O O
was O O
retreated O O
by O O
polychemotherapy O O
VTD O O
( O O
bortezomib O O
1,3 O O
mg O O
/ O O
m O O
2 O O
, O O
thalidomide100mg O O
/ O O
j O O
, O O
dexamethasone O O
20 O O
mg O O
/ O O
m O O
2 O O
) O O
. O O

on O O
follow O O
up O O
, O O
he O O
was O O
asymptomatic O O
but O O
the O O
retroperitoneal O O
mass O O
still O O
presented O O
after O O
2 O O
cycles O O
of O O
chemotherapy O O
, O O
and O O
he O O
developed O O
another O O
skin O O
lesion O B-C0221198
at O O
4cm O O
in O O
his O O
back O O
. O O

electrophoresis O O
of O O
proteins O O
found O O
a O O
peak O O
gamma O O
globulin O O
49.5 O O
g O O
/ O O
l O O
with O O
increasing O O
of O O
light O O
chain O O
lambda O O
285mg O O
/ O O
l O O
, O O
and O O
bone O O
marrow O O
biopsy O O
was O O
still O O
normal O O
. O O

the O O
patient O O
was O O
treated O O
at O O
this O O
time O O
by O O
CTD O O
( O O
cyclophosphamide O O
, O O
thalidomide O O
and O O
dexamethasone O O
) O O
. O O

evaluation O O
after O O
three O O
cycles O O
showed O O
a O O
good O O
response O O
, O O
and O O
the O O
CT O O
scan O O
confirmed O O
the O O
disappearance O O
of O O
all O O
masses O O
with O O
normalization O O
of O O
electrophoresis O O
of O O
protein O O
. O O

because O O
of O O
the O O
frequent O O
recurrence O O
and O O
possibility O O
of O O
transformation O O
into O O
MM O O
, O O
the O O
patient O O
is O O
still O O
on O O
follow O O
up O O
at O O
long O O
term O O
. O O

A O O
66 O O
- O O
year-old O O
female O O
patient O O
known O O
case O O
of O O
hypertension O B-C0020538
and O O
diabetic O B-C0011847
mellitus O O
presented O O
to O O
our O O
institute O O
with O O
palpable O O
mass O O
in O O
the O O
left O O
breast O O
associated O O
with O O
pain O B-C0030193
of O O
long O O
duration O O
. O O

there O O
was O O
no O O
nipple O B-C0149741
discharge O I-C0149741
, O O
or O O
fever O B-C0015967
. O O

no O O
history O O
of O O
breast O O
trauma O O
, O O
hormone O O
replacement O O
therapy O O
, O O
or O O
family O B-C0241889
history O I-C0241889
of O O
breast O B-C0006142
cancer O I-C0006142
. O O

on O O
physical O O
examination O O
, O O
large O O
palpable O O
mass O O
is O O
identified O O
within O O
the O O
left O O
breast O O
with O O
regular O O
borders O O
. O O

the O O
nipple O O
, O O
areola O O
, O O
and O O
skin O O
are O O
unremarkable O O
. O O

there O O
was O O
no O O
palpable O O
lymph O O
node O O
in O O
the O O
left O O
axilla O O
. O O

the O O
right O O
breast O O
and O O
axilla O O
were O O
normal O O
and O O
systemic O O
examination O O
did O O
not O O
show O O
any O O
abnormality O O
. O O

investigations O O
showed O O
normal O O
complete O O
blood O O
count O O
, O O
and O O
chemistry O O
apart O O
from O O
raised O O
serum O O
glucose O O
level O O
. O O

liver O O
function O O
test O O
is O O
within O O
normal O O
limits O O
. O O

chest O O
x-ray O O
is O O
grossly O O
unremarkable O O
. O O

on O O
her O O
mammograms O O
, O O
large O O
oval O O
and O O
dense O O
mass O O
is O O
identified O O
within O O
upper O O
outer O O
quadrant O O
of O O
the O O
left O O
breast O O
. O O

the O O
mass O O
is O O
multilobulated O O
and O O
well O O
circumscribed O O
in O O
its O O
contours O O
. O O

it O O
measures O O
about O O
9.2x7.5 O O
cm O O
. O O

there O O
was O O
no O O
associated O O
microcalcifications O B-C0521174
. O O

the O O
nipple-areola O O
and O O
skin O O
complex O O
are O O
grossly O O
unremarkable O O
. O O

no O O
significant O O
enlarged O O
axillary O O
lymph O O
nodes O O
are O O
seen O O
. O O

the O O
right O O
breast O O
is O O
within O O
normal O O
limits O O
. O O

our O O
impression O O
based O O
on O O
the O O
mammograms O O
is O O
unusual O O
large O O
dense O O
mass O O
of O O
the O O
left O O
breast O O
coded O O
as O O
BIRAD O O
4A O O
taking O O
into O O
consideration O O
the O O
patient O O
age O O
for O O
further O O
evaluation O O
by O O
target O O
ultrasound O O
. O O

the O O
differential O O
diagnosis O O
would O O
include O O
phyllodes O B-C0010701
tumor O I-C0010701
, O O
PASH O O
( O O
pseudoangiomatous O B-C2931031
stromal O I-C2931031
hyperplasia O I-C2931031
) O O
, O O
and O O
well O O
circumscribed O O
carcinoma O O
. O O

ultrasound O O
was O O
performed O O
in O O
same O O
sitting O O
for O O
further O O
characterization O O
using O O
philips O O
IU22 O O
ultrasound O O
machine O O
. O O

the O O
ultrasound O O
revealed O O
a O O
large O O
heterogeneous O O
and O O
lobulated O O
mass O O
seen O O
in O O
the O O
left O O
breast O O
upper O O
outer O O
quadrant O O
corresponding O O
to O O
the O O
mammographic O B-C1268717
density O I-C1268717
. O O

few O O
internal O O
anechoic O O
cysts O B-C0010709
are O O
seen O O
at O O
the O O
peripheral O O
aspect O O
of O O
the O O
lesion O B-C0221198
. O O

doppler O O
interrogated O O
images O O
were O O
also O O
obtained O O
which O O
revealed O O
no O O
internal O O
vascularity O O
within O O
the O O
mass O O
. O O

there O O
was O O
no O O
associated O O
enlarged O O
axillary O O
lymph O O
nodes O O
. O O

plan O O
was O O
made O O
for O O
histological O O
confirmation O O
by O O
biopsy O O
. O O

the O O
procedure O O
risks O O
, O O
and O O
benefits O O
were O O
completely O O
explained O O
to O O
the O O
patient O O
. O O

procedure O O
consent O O
form O O
was O O
obtained O O
from O O
the O O
patient O O
. O O

ultrasound O O
guided O O
core O O
needle O O
biopsy O O
was O O
performed O O
. O O

the O O
specimen O O
was O O
sent O O
to O O
the O O
pathology O O
department O O
for O O
analysis O O
. O O

the O O
procedure O O
was O O
uneventful O O
. O O

no O O
complications O O
were O O
reported O O
. O O

CT O O
scan O O
was O O
performed O O
for O O
further O O
assessment O O
which O O
showed O O
a O O
large O O
oval O O
hypodense O O
mass O O
in O O
the O O
left O O
breast O O
. O O

very O O
tiny O O
and O O
thin O O
internal O O
septations O O
were O O
also O O
evident O O
. O O

peripheral O O
enhancement O O
was O O
seen O O
. O O

no O O
internal O O
enhancement O O
within O O
the O O
mass O O
was O O
identified O O
. O O

the O O
mass O O
measured O O
about O O
6.8x6.2x9 O O
cm O O
in O O
maximum O O
dimensions O O
. O O

no O O
axillary O O
lymph O O
nodes O O
were O O
noted O O
. O O

the O O
rest O O
of O O
intra O O
thoracic O B-C0729233
and O O
abdominal O O
structures O O
were O O
within O O
normal O O
limits O O
. O O

the O O
pathology O O
report O O
revealed O O
scanty O O
material O O
formed O O
of O O
fragmented O O
eosinophilic O O
membranes O O
with O O
laminated O O
appearance O O
in O O
keeping O O
with O O
hydatid O B-C4553297
cyst O I-C4553297
. O O

the O O
final O O
diagnosis O O
was O O
made O O
to O O
be O O
hydatid O B-C4553297
cyst O I-C4553297
of O O
the O O
breast O O
. O O

the O O
patient O O
was O O
referred O O
to O O
the O O
surgery O O
department O O
for O O
surgical O O
resection O O
. O O

A O O
30 O O
- O O
year-old O O
saudi O O
gentleman O O
who O O
was O O
admitted O O
to O O
the O O
hospital O O
for O O
rehabilitation O O
. O O

patient O O
had O O
a O O
motor O O
vehicle O O
accident O O
one O O
month O O
before O O
admission O O
which O O
resulted O O
in O O
multiple O B-C0026771
injuries O I-C0026771
( O O
including O O
spinal O B-C0037929
cord O I-C0037929
injury O I-C0037929
and O O
mild O B-C3508472
traumatic O I-C3508472
brain O I-C3508472
injury O I-C3508472
) O O
. O O

he O O
did O O
not O O
manifest O O
behavioral O O
or O O
psychological O O
problems O O
during O O
the O O
initial O O
four O O
months O O
stay O O
at O O
the O O
hospital O O
. O O

patient O O
was O O
supposed O O
to O O
be O O
discharged O O
from O O
the O O
hospital O O
after O O
achieving O O
the O O
rehabilitation O O
goals O O
. O O

neuroleptic O B-C0027849
malignant O I-C0027849
syndrome O I-C0027849
and O O
patient O O
behavior O O
in O O
the O O
beginning O O
of O O
the O O
fourth O O
month O O
, O O
the O O
patient O O
was O O
referred O O
to O O
our O O
psychiatric O O
services O O
from O O
the O O
spinal O B-C0037929
cord O I-C0037929
injury O I-C0037929
rehabilitation O O
unit O O
for O O
evaluation O O
and O O
management O O
of O O
agitated O O
combative O O
behavior O O
, O O
he O O
started O O
to O O
manifest O O
abruptly O O
one O O
day O O
after O O
he O O
was O O
informed O O
of O O
imminent O O
discharge O O
. O O

physician O O
in O O
the O O
ward O O
, O O
thought O O
that O O
this O O
frustrated O O
angry O O
behavior O O
was O O
due O O
to O O
patient O O
` O O
s O O
dissatisfaction O O
of O O
rehabilitation O O
achievements O O
. O O

detailed O O
review O O
found O O
no O O
prior O O
psychiatric O O
history O O
, O O
history O O
of O O
substance O B-C0740858
abuse O I-C0740858
and O O
known O O
exposure O O
to O O
neuroleptics O O
. O O

patient O O
had O O
one O O
previous O O
episode O O
of O O
urinary O B-C0042029
tract O I-C0042029
infections O I-C0042029
( O O
UTI O O
) O O
during O O
his O O
hospital O O
stay O O
that O O
required O O
treatment O O
with O O
oral O O
antibiotics O O
. O O

on O O
the O O
first O O
day O O
of O O
assessment O O
, O O
the O O
patient O O
` O O
s O O
initial O O
signs O B-C0037088
and O I-C0037088
symptoms O I-C0037088
included O O
a O O
temperature O O
of O O
38.4 O O
° O O
C O O
, O O
agitated O O
and O O
combative O O
behavior O O
, O O
refusing O O
medication O O
( O O
including O O
muscle O O
relaxants O O
) O O
and O O
oral O O
intake O O
and O O
progressively O O
deteriorating O O
sleep O O
. O O

the O O
provisional O O
diagnosis O O
was O O
delirium O B-C0011206
due O O
to O O
a O O
recurrent O O
UTI O O
. O O

olanzapine O O
10 O O
mg O O
IM O O
stat O O
was O O
given O O
and O O
urinalysis O O
( O O
UA O O
) O O
was O O
ordered O O
. O O

on O O
the O O
following O O
day O O
, O O
( O O
UA O O
) O O
revealed O O
evidence O O
of O O
urinary O O
tract O O
bacterial O B-C0004623
infection O I-C0004623
for O O
which O O
an O O
intravenous O O
antibiotic O O
was O O
commenced O O
. O O

on O O
the O O
same O O
day O O
the O O
patient O O
continued O O
to O O
have O O
agitated O O
combative O O
behavior O O
for O O
which O O
he O O
received O O
haloperidol O O
10 O O
mg O O
IM O O
in O O
the O O
afternoon O O
( O O
which O O
calmed O O
him O O
down O O
) O O
. O O

on O O
the O O
third O O
day O O
the O O
patient O O
demonstrated O O
a O O
clear O O
change O O
in O O
his O O
mental O O
state O O
. O O

his O O
agitation O B-C0085631
decreased O O
, O O
however O O
he O O
began O O
to O O
show O O
perplexed O O
affect O O
, O O
distractibility O B-C0233415
and O O
poor O O
initiation O O
of O O
purposeful O O
behavior O O
. O O

he O O
was O O
immobile O O
and O O
unresponsive O O
, O O
staring O B-C0423086
and O O
not O O
responding O O
to O O
verbal O O
commands O O
but O O
responding O O
to O O
pain O B-C0030193
with O O
purposeful O O
withdrawal O B-C2825032
. O O

assessment O O
of O O
central O O
nervous O B-C0027769
system O O
( O O
CNS O O
) O O
was O O
difficult O O
as O O
the O O
patient O O
was O O
constantly O O
moving O O
and O O
had O O
generalized O O
spasticity O B-C0026838
. O O

he O O
responded O O
to O O
questions O O
by O O
uttering O O
a O O
few O B-C5233700
words O I-C5233700
and O O
became O O
very O O
agitated O O
, O O
shouting O O
obscenities O O
. O O

laboratory O O
results O O
done O O
on O O
the O O
same O O
day O O
showed O O
the O O
following O O
results O O
: O O
white O O
blood O O
cell O O
count O O
: O O
18.2 O O
cells O O
/ O O
ml O O
, O O
serum O O
creatinine O O
: O O
93 O O
µmol O O
/ O O
L O O
, O O
fasting O B-C0015663
blood O O
glucose O O
: O O
8.37 O O
mmol O O
/ O O
l O O
, O O
calcium O O
: O O
2.59 O O
mmol O O
/ O O
l O O
, O O
phosphorus O O
: O O
1.79 O O
mmol O O
/ O O
l O O
, O O
alkaline O O
phosphatase O O
( O O
ALP O O
) O O
: O O
162 O O
IU O O
/ O O
L O O
, O O
aspartate O O
aminotransferase O O
( O O
AST O O
) O O
: O O
76 O O
U O O
/ O O
L O O
, O O
gamma-glutamyltranspeptidase O O
( O O
GGT O O
) O O
: O O
157 O O
U O O
/ O O
L O O
, O O
and O O
creatinine O O
phosphokinase O O
( O O
CPK O O
) O O
level O O
: O O
4731 O O
IU O O
/ O O
L O O
. O O

the O O
urine O O
output O O
was O O
low O O
at O O
350ml O O
/ O O
12h O O
. O O

the O O
patient O O
was O O
started O O
on O O
hydration O O
and O O
immediately O O
transferred O O
to O O
ICU O O
with O O
differential O O
diagnoses O O
that O O
included O O
NMS O O
and O O
meningitis O B-C0025289
. O O

early O O
the O O
next O O
morning O O
the O O
patient O O
had O O
a O O
complex O B-C0149958
partial O I-C0149958
seizure O I-C0149958
which O O
ceased O O
after O O
IV O O
diazepam O O
administration O O
. O O

lumbar O O
puncture O O
( O O
LP O O
) O O
, O O
computerized O O
tomography O O
( O O
CT O O
) O O
of O O
the O O
head O O
and O O
electroencephalogram O O
( O O
EEG O O
) O O
did O O
not O O
indicate O O
any O O
significant O O
findings O O
. O O

the O O
diagnosis O O
of O O
NMS O O
was O O
retained O O
, O O
and O O
the O O
patient O O
was O O
started O O
on O O
bromocriptine O O
7.5 O O
mg O O
three O O
times O O
daily O O
and O O
lorazepam O O
1 O O
mg O O
at O O
bedtime O O
. O O

on O O
the O O
5th O O
day O O
after O O
the O O
( O O
ICU O O
) O O
admission O O
the O O
patient O O
demonstrated O O
decreased O O
rigidity O B-C0026837
and O O
agitation O B-C0085631
and O O
increased O O
periods O O
of O O
wakefulness O O
. O O

on O O
the O O
6th O O
day O O
patient O O
regained O O
a O O
full O O
level O O
of O O
orientation O O
and O O
cooperation O O
. O O

liver O O
function O O
tests O O
and O O
CPK O O
normalized O O
and O O
patient O O
was O O
transferred O O
to O O
the O O
general O O
ward O O
. O O

A O O
27 O O
- O O
year O O
old O O
nigerian O O
male O O
student O O
requiring O O
surgical O O
consultation O O
for O O
possible O O
diagnosis O O
of O O
primary O B-C0221002
hyperparathyroidism O I-C0221002
. O O

he O O
had O O
serial O O
fracture O O
of O O
five O O
long O O
bones O O
on O O
four O O
separate O O
occasions O O
, O O
over O O
a O O
period O O
of O O
three O O
and O O
half O O
years O O
. O O

the O O
first O O
was O O
fracture O O
of O O
the O O
right O O
humerus O O
which O O
was O O
sustained O O
from O O
a O O
fall O B-C0085639
while O O
climbing O O
a O O
stairway O O
in O O
the O O
dark O O
. O O

the O O
second O O
was O O
fracture O O
of O O
the O O
left O O
femur O O
which O O
was O O
sustained O O
after O O
a O O
trivial O O
unprovoked O O
fall O B-C0085639
while O O
walking O O
a O O
leveled O O
ground O O
( O O
the O O
first O O
fracture O O
had O O
not O O
healed O O
on O O
non-operative O O
treatment O O
before O O
the O O
second O O
fracture O O
despite O O
an O O
interval O O
of O O
about O O
6 O O
months O O
) O O
. O O

the O O
third O O
was O O
fracture O O
of O O
the O O
left O O
humerus O O
, O O
sustained O O
while O O
rehabilitating O O
with O O
a O O
walking O O
frame O O
after O O
surgery O O
for O O
the O O
left O O
femoral O O
and O O
right O O
humeral O B-C0020162
fractures O I-C0020162
. O O

the O O
forth O O
was O O
a O O
combination O O
of O O
right O O
femoral O O
and O O
tibia O O
fractures O B-C0016658
sustained O O
simultaneously O O
while O O
bearing O O
weight O O
on O O
the O O
right O O
lower O O
limb O O
as O O
the O O
leading O O
limb O O
to O O
board O O
a O O
vehicle O O
. O O

hyperparathyroidism O B-C0020502
was O O
considered O O
upon O O
the O O
forth O O
occasion O O
. O O

the O O
history O O
of O O
weakness O B-C3714552
, O O
generalized O O
bone O O
and O O
joint O B-C0003862
pains O I-C0003862
preceded O O
the O O
first O O
episode O O
of O O
fracture O O
by O O
about O O
1 O O
year O O
. O O

he O O
also O O
had O O
production O O
of O O
cloudy O O
urine O O
and O O
history O O
of O O
epigastric O B-C0232493
pain O I-C0232493
diagnosed O O
informally O O
as O O
gastritis O B-C0017152
from O O
chronic O O
ingestion O O
of O O
nonsteroidal O O
anti-inflammatory O O
he O O
had O O
previously O O
had O O
open O O
reduction O O
and O O
internal O O
fixation O O
for O O
the O O
initial O O
two O O
fractures O B-C0016658
under O O
general O O
anesthesia O B-C0278134
he O O
sustained O O
mandibular O B-C0024692
fracture O I-C0024692
at O O
intubation O O
. O O

he O O
had O O
been O O
transfused O O
6 O O
pints O O
of O O
blood O O
on O O
separate O O
occasions O O
. O O

his O O
genotype O O
was O O
AS O O
, O O
he O O
was O O
neither O O
hypertensive O B-C0020538
nor O O
diabetic O B-C0011847
. O O

he O O
was O O
on O O
chronic O O
ingestion O O
of O O
calcium O O
and O O
vitamin O O
D O O
supplements O O
. O O

there O O
was O O
no O O
history O O
suggestive O O
of O O
associated O O
thyroid O B-C0040128
disease O I-C0040128
and O O
no O O
family O B-C0241889
history O I-C0241889
suggestive O O
of O O
multiple O O
endocrine O O
neoplastic O B-C1882062
syndrome O I-C1882062
or O O
primary O O
hyperparathryrodism O O
. O O

at O O
first O O
consultation O O
by O O
the O O
general O O
surgeon O O
, O O
physical O O
examination O O
revealed O O
a O O
young O O
man O O
, O O
conscious O O
and O O
alert O O
, O O
in O O
pains O O
, O O
wasted O O
, O O
with O O
a O O
global O O
reduction O O
in O O
muscle O O
bulk O O
. O O

there O O
was O O
frontal O O
bursing O O
and O O
multiple O O
bony O O
swellings O O
on O O
the O O
lower O O
jaw O O
, O O
there O O
was O O
no O O
clinical O O
obvious O O
neck O O
mass O O
. O O

there O O
were O O
healed O O
scars O B-C2004491
on O O
the O O
right O O
arm O O
and O O
left O O
thigh O O
with O O
reduced O O
range O O
of O O
movement O O
at O O
both O O
shoulders O O
and O O
both O O
hip O O
joints O O
. O O

on O O
the O O
right O O
lower O O
limb O O
, O O
the O O
junction O O
between O O
the O O
upper O O
and O O
middle O O
third O O
of O O
the O O
thigh O O
was O O
swollen O O
, O O
abnormally O O
positioned O O
and O O
tender O O
. O O

there O O
was O O
midshaft O O
swelling O B-C0038999
of O O
the O O
leg O O
on O O
the O O
same O O
limb O O
, O O
the O O
swelling O B-C0038999
was O O
soft O O
and O O
tender O O
. O O

there O O
were O O
no O O
bruises O B-C0009938
or O O
abrasions O O
, O O
and O O
no O O
external O O
bleeding O B-C0019080
. O O

serum O O
calcium O O
and O O
alkaline O O
phosphatase O O
were O O
markedly O O
elevated O O
( O O
3.17mmol O O
/ O O
l O O
and O O
260 O O
I.U O O
/ O O
l O O
respectively O O
) O O
. O O

all O O
other O O
electrolytes O O
and O O
haemogram O O
were O O
within O O
normal O O
limits O O
. O O

scouting O O
x-rays O O
revealed O O
evidence O O
of O O
healed O O
and O O
healing O O
fractures O B-C0016658
of O O
the O O
jaw O O
and O O
ribs O O
in O O
addition O O
to O O
the O O
clinically O O
obvious O O
long O B-C0240231
bone O I-C0240231
fractures O I-C0240231
. O O

urinalysis O O
showed O O
2 O O
+ O O
haematuria O B-C0018965
. O O

neck O O
ultrasound O O
revealed O O
an O O
enlarged O O
left O O
lower O O
parathyroid O O
gland O O
and O O
the O O
abdominal O O
ultrasound O O
scan O O
showed O O
multiple O O
kidney O B-C0022650
stones O I-C0022650
. O O

the O O
serum O O
parathyroid O O
hormone O O
level O O
was O O
202.8 O O
pmol O O
/ O O
l O O
( O O
normal O O
is O O
1.6 O O
- O O
6.9 O O
pmol O O
/ O O
l O O
) O O
. O O
99mtc O O
sestamibi O O
parathyroid O O
scintigraphy O O
revealed O O
an O O
increased O O
focal O O
uptake O O
. O O
. O O

he O O
subsequently O O
had O O
excision O O
of O O
the O O
parathyroid O O
mass O O
( O O
left O O
inferior O O
parathyroid O O
) O O
under O O
cervical O O
block O O
and O O
minimal O O
sedation O O
. O O

the O O
mass O O
was O O
grayish-black O O
, O O
measuring O O
7 O O
by O O
4cm O O
and O O
weighed O O
32g O O
. O O

histology O O
revealed O O
a O O
parathyroid O B-C0262587
adenoma O I-C0262587
. O O

postoperatively O O
he O O
had O O
sudden O O
and O O
persistent O O
symptomatic O O
drop O O
in O O
serum O O
calcium O O
necessitating O O
continuous O O
infusion O O
of O O
calcium O O
gluconate O O
. O O

he O O
is O O
currently O O
15 O O
months O O
post-surgery O O
, O O
he O O
is O O
being O O
rehabilitated O O
as O O
an O O
outpatient O O
, O O
he O O
is O O
pain O B-C0030193
free O O
, O O
more O O
mobile O O
and O O
the O O
serum O O
calcium O O
has O O
remained O O
normal O O
. O O

miss O O
EJ O O
, O O
a O O
28 O O
year O O
old O O
, O O
single O O
, O O
was O O
received O O
in O O
our O O
emergency O O
unit O O
for O O
pelvic O B-C0030794
pain O I-C0030794
at O O
9 O O
weeks O O
and O O
5 O O
days O O
of O O
pregnancy O O
. O O

the O O
pain O B-C0030193
started O O
five O O
days O O
prior O O
to O O
consultation O O
and O O
was O O
associated O O
with O O
dark O O
and O O
light O O
vaginal O B-C2979982
bleeding O I-C2979982
. O O

she O O
first O O
consulted O O
in O O
a O O
health O O
center O O
where O O
she O O
received O O
antispasmodics O O
without O O
success O O
. O O

she O O
was O O
then O O
referred O O
to O O
our O O
emergency O O
unit O O
for O O
better O O
management O O
. O O

in O O
past O O
history O O
, O O
the O O
patient O O
had O O
her O O
first O O
menses O O
at O O
13 O O
and O O
the O O
first O O
sexual O O
intercourse O O
at O O
19 O O
. O O

her O O
menstrual O O
cycle O O
is O O
regular O O
lasting O O
30 O O
days O O
and O O
she O O
bleeds O O
for O O
5 O O
days O O
. O O

she O O
has O O
no O O
history O O
of O O
sexually O B-C0036916
transmitted O I-C0036916
infection O I-C0036916
. O O

as O O
contraception O O
, O O
she O O
has O O
always O O
used O O
male O O
condom O O
and O O
practiced O O
interrupted O O
coïtus O O
. O O

her O O
first O O
pregnancy O O
resulted O O
in O O
a O O
normal O O
vaginal O O
delivery O O
at O O
term O O
. O O

the O O
ongoing O O
pregnancy O O
was O O
the O O
second O O
and O O
was O O
at O O
9 O O
weeks O O
and O O
5 O O
days O O
. O O

she O O
is O O
a O O
dizygotic O O
twin O O
. O O

she O O
was O O
successfully O O
treated O O
for O O
pulmonary O B-C0041327
tuberculosis O I-C0041327
four O O
years O O
ago O O
. O O

on O O
admission O O
she O O
had O O
a O O
good O O
general O O
condition O O
and O O
the O O
vital O O
parameters O O
were O O
normal O O
. O O

gynecological O B-C0302487
examination O I-C0302487
revealed O O
an O O
enlarged O O
uterus O O
consistent O O
with O O
a O O
10 O O
weeks O O
pregnancy O O
, O O
a O O
painful O O
left O O
adnexal O O
mass O O
of O O
10 O O
centimeters O O
of O O
diameters O O
and O O
cervical O O
motion O O
tenderness O O
. O O

there O O
was O O
no O O
vaginal O B-C2979982
bleeding O I-C2979982
. O O

we O O
suspected O O
an O O
ectopic O B-C0032987
pregnancy O I-C0032987
associated O O
to O O
uterine O B-C0042133
fibroids O I-C0042133
. O O

differential O O
diagnoses O O
were O O
a O O
complicated O O
ovarian O B-C0029927
cyst O I-C0029927
in O O
pregnancy O O
and O O
pelvic O B-C0242172
inflammatory O I-C0242172
disease O I-C0242172
in O O
pregnancy O O
. O O

one O O
hour O O
after O O
admission O O
, O O
while O O
being O O
in O O
the O O
imaging O O
unit O O
for O O
emergency O O
pelvic O O
ultrasonography O O
, O O
she O O
felt O O
a O O
sudden O O
, O O
intense O O
and O O
cramp-like O O
pelvic O B-C0030794
pain O I-C0030794
associated O O
with O O
vomiting O B-C0042963
. O O

the O O
pain O B-C0030193
then O O
diffused O O
progressively O O
to O O
the O O
whole O O
abdomen O O
. O O

the O O
findings O O
of O O
the O O
ultrasonography O O
were O O
: O O
an O O
evolving O O
singleton O O
intrauterine O O
pregnancy O O
of O O
7 O O
weeks O O
and O O
6 O O
days O O
, O O
a O O
gestational O O
sac O O
in O O
the O O
right O O
uterine O O
adnexae O O
containing O O
a O O
non O O
living O O
embryo O O
of O O
8 O O
weeks O O
and O O
2 O O
days O O
and O O
300 O O
milliliters O O
of O O
hemoperitoneum O B-C0019065
. O O

on O O
reevaluation O O
, O O
vital O O
parameters O O
remained O O
normal O O
. O O

on O O
abdominal O O
palpation O O
, O O
we O O
noted O O
a O O
slight O O
pelvic O O
tenderness O O
. O O

on O O
vaginal O O
digital O O
exploration O O
the O O
cervix O O
was O O
long O O
and O O
closed O O
, O O
and O O
adnexae O O
were O O
tender O O
and O O
difficult O O
to O O
palpate O O
. O O

the O O
pouch O O
of O O
douglas O O
was O O
painful O O
and O O
bulging O O
. O O

culdocentesis O O
brought O O
back O O
4 O O
milliliters O O
of O O
non O O
clotting O O
blood O O
. O O

we O O
concluded O O
that O O
the O O
extra-uterine O O
pregnancy O O
was O O
ruptured O O
. O O

after O O
an O O
intramuscular O O
injection O O
of O O
500 O O
milligrammes O O
of O O
long O O
acting O O
progesterone O O
, O O
we O O
carried O O
out O O
an O O
emergency O O
laparotomy O O
. O O

we O O
found O O
a O O
left O O
tubal O O
ruptured O O
pregnancy O O
, O O
a O O
homolateral O O
corpus O O
luteum O O
, O O
a O O
globular O O
and O O
soft O O
uterus O O
consistent O O
with O O
a O O
pregnancy O O
of O O
9 O O
weeks O O
, O O
1,300 O O
milliliters O O
of O O
hemoperitoneum O B-C0019065
and O O
left O O
adnexae O O
embedded O O
in O O
type O O
B O O
adhesions O O
. O O

we O O
did O O
a O O
total O O
left O O
salpingectomy O O
. O O

postoperative O O
course O O
was O O
uneventful O O
and O O
the O O
patient O O
was O O
discharged O O
five O O
days O O
after O O
surgery O O
. O O

every O O
week O O
she O O
received O O
an O O
intramuscular O O
dose O O
of O O
500 O O
milligrammes O O
of O O
long O O
acting O O
progesterone O O
till O O
the O O
eighteenth O O
gestational O O
week O O
. O O

the O O
course O O
of O O
the O O
pregnancy O O
was O O
normal O O
and O O
our O O
patient O O
gave O O
birth O O
at O O
term O O
to O O
a O O
live O O
girl O O
weighing O O
3.1 O O
kilogrammes O O
. O O

A O O
36 O O
year O O
old O O
male O O
from O O
asian O O
origin O O
presented O O
on O O
13 O O
/ O O
10 O O
/ O O
2009 O O
with O O
hyperpigmentation O B-C0162834
and O O
darkening O O
of O O
the O O
skin O O
that O O
had O O
been O O
developed O O
for O O
previous O O
5 O O
months O O
accompanied O O
by O O
fatigue O B-C0015672
for O O
a O O
period O O
of O O
more O O
than O O
a O O
year O O
with O O
lumbar O B-C0024031
back O I-C0024031
pain O I-C0024031
. O O

during O O
his O O
physical O O
examination O O
, O O
he O O
had O O
a O O
core O O
body O O
temperature O O
of O O
36 O O
° O O
C O O
, O O
a O O
pulse O O
84 O O
beats O O
per O O
minute O O
, O O
a O O
respiratory O O
rate O O
20 O O
breaths O O
per O O
minute O O
and O O
a O O
blood O O
pressure O O
of O O
100 O O
/ O O
60 O O
mmhg O O
. O O

he O O
had O O
mild O O
pallor O B-C0030232
, O O
but O O
no O O
jaundice O O
or O O
cyanosis O B-C0010520
. O O

skin O O
showed O O
generalized O O
hyperpigmentation O B-C0162834
with O O
prominent O O
gingival O O
and O O
buccal O O
mucosa O O
darkening O O
. O O

there O O
was O O
no O O
significant O O
peripheral O O
lymphadenopathy O B-C0497156
. O O

thyroid O O
gland O O
was O O
not O O
enlarged O O
. O O

his O O
abdomen O O
was O O
soft O O
and O O
flat O O
with O O
no O O
organomegaly O B-C4054315
. O O

chest O O
and O O
cardiac O O
examinations O O
revealed O O
no O B-C3809765
abnormalities O I-C3809765
. O O

laboratory O O
findings O O
included O O
a O O
red O O
blood O O
cell O O
count O O
of O O
4.51 O O
× O O
10 O O
12 O O
/ O O
L O O
; O O
hemoglobin O O
11.1 O O
g O O
/ O O
dl O O
; O O
white O O
blood O O
cell O O
count O O
16.31 O O
× O O
10 O O
9 O O
/ O O
L O O
; O O
( O O
neutrophils O O
61.6% O O
; O O
lymphocytes O O
13.1% O O
; O O
monocytes O O
, O O
7.0% O O
; O O
eosinophils O O
, O O
0.1% O O
; O O
basophils O O
, O O
0.7% O O
) O O
; O O
platelet O O
count O O
308 O O
× O O
10 O O
9 O O
/ O O
L O O
; O O
high O O
erythrocyte O O
sedimentation O O
rate O O
( O O
42 O O
mm O O
/ O O
h O O
) O O
, O O
high O O
c-reactive O O
protein O O
( O O
14.88mg O O
/ O O
L O O
) O O
, O O
low-serum O O
sodium O O
( O O
129 O O
mmol O O
/ O O
L O O
) O O
, O O
high-serum O O
potassium O O
( O O
5.4 O O
mmol O O
/ O O
L O O
) O O
, O O
low O O
serum O O
chloride O O
( O O
92 O O
mmol O O
/ O O
L O O
) O O
, O O
blood O O
glucose O O
level O O
( O O
118 O O
mg O O
/ O O
dl O O
) O O
, O O
normal O O
kidney O O
function O O
, O O
normal O B-C1848676
liver O I-C1848676
function O I-C1848676
, O O
low-serum O O
cortisol O O
8 O O
am O O
( O O
2.9 O O
µg O O
/ O O
dl O O
) O O
, O O
4 O O
pm O O
( O O
2.6 O O
µg O O
/ O O
dl O O
) O O
, O O
TB O O
igm O O
antibody O O
( O O
? O O

ve O O
) O O
, O O
TB O O
igg O O
antibody O O
( O O
+ O O
ve O O
) O O
and O O
positive O O
purified O O
protein O O
derivative O O
test O O
( O O
PPD O O
) O O
. O O

A O O
chest O O
x-ray O O
revealed O O
no O B-C3809765
abnormalities O I-C3809765
. O O

A O O
thoracic O B-C0729233
lumbar O O
plain O O
film O O
revealed O O
narrowing O O
of O O
the O O
L1 O O
- O O
L2 O O
space O O
with O O
irregularity O O
and O O
osteolysis O B-C4721411
of O O
the O O
endplates O O
suggesting O O
the O O
possibility O O
of O O
lumbar O O
spine O O
TB O O
. O O

an O O
abdominal O O
CT O O
imaging O O
revealed O O
bilateral O O
adrenal O B-C0342500
mass O I-C0342500
like O O
enlargement O O
with O O
irregular O O
enhancement O O
and O O
lesion O B-C0221198
like O O
changes O O
without O O
calcification O O
. O O

based O O
on O O
the O O
clinical O O
presentation O O
, O O
laboratory O O
findings O O
of O O
positive O O
igg O O
anti-tb O O
antibodies O O
, O O
positive O O
PPD O O
test O O
, O O
high O O
ESR O O
, O O
low O B-C3809994
serum O I-C3809994
cortisol O I-C3809994
, O O
low O O
sodium O O
level O O
and O O
high O O
potassium O O
level O O
, O O
beside O O
the O O
radiological O O
findings O O
of O O
spinal O O
and O O
adrenal O O
involvement O O
, O O
the O O
diagnosis O O
of O O
combined O O
primary O O
adrenal O O
and O O
spinal O O
TB O O
with O O
adrenal O B-C0001623
insufficiency O I-C0001623
was O O
highly O O
suggested O O
. O O

based O O
on O O
this O O
diagnosis O O
, O O
the O O
patient O O
started O O
anti-tb O O
drugs O O
in O O
the O O
form O O
of O O
( O O
isoniazid O O
, O O
rifampicin O O
, O O
ethambutol O O
, O O
pyrazinamide O O
) O O
in O O
combination O O
with O O
vitamin O O
B6 O O
tablets O O
and O O
steroid O O
therapy O O
in O O
the O O
form O O
of O O
prednisolone O O
( O O
7.5 O O
mg O O
/ O O
day O O
) O O
in O O
two O O
divided O O
dose O O
of O O
5 O O
mg O O
in O O
the O O
morning O O
8 O O
am O O
and O O
2.5 O O
mg O O
afternoon O O
at O O
4 O O
pm O O
. O O

he O O
was O O
called O O
for O O
clinical O O
follow O O
up O O
every O O
6 O O
months O O
and O O
all O O
the O O
necessary O O
investigations O O
were O O
performed O O
each O O
time O O
. O O

in O O
the O O
recent O O
follow O O
up O O
of O O
our O O
patient O O
in O O
2012 O O
, O O
he O O
was O O
without O O
clinical O O
symptoms O O
and O O
all O O
the O O
laboratory O O
investigations O O
were O O
nearly O O
normalized O O
. O O

the O O
anti O O
TB O O
drugs O O
were O O
stopped O O
but O O
steroid O O
therapy O O
in O O
the O O
form O O
of O O
prednisolone O O
is O O
continued O O
with O O
same O O
dose O O
as O O
earlier O O
. O O

the O O
thoracic O B-C0729233
lumbar O O
plain O O
film O O
taken O O
later O O
in O O
2012 O O
, O O
that O O
we O O
have O O
presented O O
in O O
the O O
article O O
demonstrated O O
nearly O O
the O O
same O O
finding O B-C0037088
as O O
shown O O
in O O
the O O
earlier O O
film O O
taken O O
during O O
the O O
initial O O
presentation O O
. O O

A O O
CT O O
scan O O
of O O
his O O
adrenal O O
glands O O
documented O O
a O O
relevant O O
reduction O O
of O O
the O O
bilateral O O
adrenal O O
masses O O
and O O
the O O
adrenal O O
lesions O B-C0221198
were O O
significantly O O
reduced O O
than O O
the O O
earlier O O
CT O O
film O O
along O O
with O O
diminished O O
degree O O
of O O
enhancement O O
, O O
however O O
it O O
is O O
not O O
conclusive O O
about O O
the O O
restoration O O
of O O
its O O
normal O B-C3275461
adrenal O I-C3275461
function O I-C3275461
. O O

referring O O
us O O
to O O
a O O
60 O O
year O O
old O O
male O O
patient O O
, O O
without O O
pathological O O
antecedents O O
, O O
accident O O
victim O O
of O O
the O O
highway O O
with O O
the O O
point O O
of O O
abdominal O O
impact O O
, O O
admitted O O
to O O
the O O
ICU O O
for O O
monitoring O O
, O O
review O O
the O O
admission O O
showed O O
a O O
well O O
oriented O O
in O O
space O O
and O O
time O O
, O O
personality O O
anxious O O
, O O
the O O
palpebral O O
conjunctivae O O
were O O
not O O
pale O O
, O O
stable O O
blood O O
pressure O O
with O O
120 O O
/ O O
70 O O
mm O O
hg O O
, O O
painful O O
on O O
palpation O O
of O O
the O O
abdomen O O
in O O
the O O
right O O
upper O O
quadrant O O
, O O
the O O
examination O O
of O O
the O O
chest O O
is O O
normal O O
without O O
pain O B-C0030193
, O O
cardiac O O
examination O O
is O O
completely O O
normal O O
except O O
for O O
a O O
slight O O
bradycardia O B-C0428977
to O O
54 O O
beat O O
/ O O
min O O
. O O
ultrasound O O
abdominal O O
showed O O
a O O
perihepatic O O
effusion O O
of O O
low O O
abundance O O
with O O
contusion O B-C0009938
of O O
the O O
lower O O
edge O O
of O O
the O O
liver O O
, O O
echocardiography O O
bedside O O
was O O
systematically O O
whatever O O
reason O O
in O O
any O O
patient O O
admitted O O
to O O
the O O
ICU O O
, O O
showed O O
in O O
our O O
patient O O
: O O
a O O
bollonisation O O
with O O
akinesia O B-C0085623
( O O
lack O O
of O O
mobility O O
and O O
thickening O O
myocardial O O
) O O
apical O O
with O O
hyper O O
kinesis O O
basal O O
, O O
the O O
fraction O O
ejection O O
estimated O O
at O O
45 O O
% O O
, O O
no O O
valvulopathy O B-C0018824
associated O O
, O O
dry O O
pericardium O O
, O O
the O O
ascending O O
and O O
abdominal O O
aorta O O
without O O
abnormality O O
, O O
size O O
and O O
respiratory O O
compliance O O
of O O
the O O
inferior O O
vena O O
cava O O
were O O
normal O O
. O O

this O O
prompted O O
us O O
to O O
do O O
an O O
electrocardiogram O O
outside O O
any O O
chest O B-C0008031
pain O I-C0008031
showed O O
that O O
: O O
ST O O
segment O O
elevation O O
in O O
DIII O O
V2 O O
V3 O O
V4 O O
V5 O O
V6 O O
and O O
- O O
avr O O
, O O
the O O
troponin O O
ic O O
showed O O
a O O
moderate O O
increase O O
of O O
2 O O
µg O O
/ O O
L O O
, O O
the O O
blood O O
electrolytes O O
and O O
blood O O
count O O
without O O
any O O
special O O
, O O
before O O
the O O
clinical O O
and O O
biological O O
aspect O O
asked O O
cardiac O O
MRI O O
outpatient O O
near O O
hospital O O
( O O
because O O
of O O
the O O
unavailability O O
of O O
technical O O
trays O O
for O O
coronary O O
angiography O O
) O O
showed O O
that O O
left O O
ventricular O O
ballooning O O
with O O
myocardial O O
edema O O
without O O
necrosis O O
or O O
fibrosis O B-C0016059
and O O
therefore O O
diagnosis O O
of O O
TC O O
syndrome O O
was O O
retained O O
. O O

the O O
patient O O
was O O
put O O
on O O
analgesic O O
, O O
diuretic O O
and O O
platelet O O
aggregation O O
inhibitors O O
without O O
anticoagulants O O
as O O
because O O
of O O
the O O
risk O O
of O O
worsening O O
liver O O
bleeding O B-C0019080
in O O
a O O
traumatic O O
context O O
. O O

A O O
second O O
echocardiogram O O
after O O
one O O
week O O
showed O O
a O O
total O O
resolution O O
of O O
apical O O
akinesia O B-C0085623
formally O O
illustrating O O
the O O
TC O O
syndrome O O
. O O

consent O O
statement O O
: O O
written O O
informed O O
consent O O
was O O
obtained O O
from O O
the O O
patient's O O
legal O O
guardian O O
\ O O
( O O
s O O
) O O
for O O
publication O O
of O O
this O O
case O O
report O O
and O O
any O O
accompanying O O
images O O
. O O

A O O
copy O O
of O O
the O O
written O O
consent O O
is O O
available O O
for O O
review O O
by O O
the O O
editor-in-chief O O
of O O
this O O
journal O O
. O O

A O O
20 O O
- O O
year-old O O
, O O
divorced O B-C0086170
africain O O
female O O
patient O O
, O O
with O O
multiple O B-C0558265
sexual O I-C0558265
partners O I-C0558265
, O O
low O O
socio-economic O O
status O O
, O O
G1P0 O O
, O O
28 O O
weeks O O
pregnant O O
woman O O
. O O

her O O
past O O
history O O
was O O
marked O O
by O O
offensive O O
yellow O O
vaginal O B-C0227791
discharge O I-C0227791
one O O
month O O
before O O
she O O
was O O
admitted O O
to O O
hospital O O
with O O
a O O
2 O O
day O O
history O O
of O O
fever O B-C0015967
and O O
asymmetric O O
joint O O
swollen O O
affecting O O
the O O
hands O O
, O O
wrists O O
, O O
left O O
ankle O O
, O O
and O O
right O O
sternoclavicular O O
joint O O
. O O

the O O
physical O O
examination O O
showed O O
a O O
temperature O O
of O O
40 O O
° O O
, O O
painful O O
swelling O B-C0038999
of O O
the O O
right O O
sternoclavicular O O
joint O O
, O O
the O O
wrists O O
, O O
right O O
knee O O
, O O
tenosynovitis O B-C0039520
of O O
extensor O O
areas O O
of O O
the O O
hand O O
, O O
and O O
hemorrhagic O O
pustules O B-C0241157
over O O
the O O
dorsum O O
of O O
the O O
feet O O
. O O

complete O O
blood O O
count O O
showed O O
leukocytosis O B-C0023518
( O O
white O O
blood O O
cell O O
count O O
of O O
10360 O O
cells O O
/ O O
mm O O
3 O O
with O O
80% O O
neutrophils O O
) O O
. O O

erythrocyte O O
sedimentation O O
rate O O
was O O
117 O O
mm O O
1hour O O
, O O
the O O
serum O O
c-reactive O O
protein O O
level O O
was O O
152 O O
mg O O
/ O O
L O O
, O O
A O O
urine O O
sample O O
contained O O
1 O O
930 O O
000 O O
leukocytes O O
/ O O
mm O O
3 O O
with O O
trichomonas O O
vaginalis O O
in O O
culture O O
. O O

vaginal O O
swab O O
was O O
positive O O
for O O
neisseria O O
gonorrhoea O O
. O O

complement O O
concentrations O O
were O O
normal O O
, O O
TPHA-VDRL O O
was O O
non-reactive O O
, O O
B O O
hepatitis O O
antigen O O
. O O

human O O
immunodeficiency O B-C0021051
virus O O
( O O
HIV O O
) O O
antibody O O
was O O
negatif O O
. O O

ultrasound O O
of O O
swelling O B-C0038999
joint O O
showed O O
: O O
power O O
doppler O O
enhanced O O
tenosynovitis O B-C0039520
of O O
extensor O O
pollicis O O
brevis O O
and O O
abductor O O
pollicis O O
longus O O
, O O
active O O
synovitis O B-C0039103
of O O
radio O O
carpal O O
joint O O
and O O
metacarpophalangeal O O
joint O O
. O O

active O O
synovitis O B-C0039103
in O O
doppler O O
with O O
erosion O O
of O O
right O O
sternoclavicular O O
joint O O
. O O

antibiotic O O
treatment O O
was O O
started O O
with O O
intravenous O O
cephalosporin O O
( O O
ceftriaxone O O
: O O
1g O O
/ O O
day O O
) O O
during O O
two O O
days O O
. O O

oral O O
therapy O O
by O O
cefixime O O
400 O O
mg O O
twice O O
a O O
day O O
over O O
7 O O
days O O
, O O
ténonitrozole O O
250 O O
twice O O
a O O
day O O
to O O
treat O O
trichomonas O O
vaginalis O O
and O O
azithromycin O O
( O O
a O O
single O O
1 O O
g O O
oral O O
dose O O
) O O
for O O
chlamydia O B-C0008149
. O O

improvement O O
in O O
fever O B-C0015967
and O O
joint O O
involvement O O
obtained O O
within O O
a O O
few O O
days O O
( O O
CRP O O
6 O O
) O O
. O O

the O O
outcome O O
of O O
pregnancy O O
was O O
timely O O
and O O
uneventful O O
. O O

A O O
52 O O
- O O
year O O
old O O
previously O O
healthy O O
man O O
was O O
referred O O
from O O
a O O
pneumology O O
hospital O O
in O O
the O O
capital O O
city O O
of O O
cameroon O O
, O O
yaoundé O O
, O O
for O O
the O O
evaluation O O
of O O
suspected O O
heart O B-C0018801
failure O I-C0018801
. O O

he O O
consulted O O
for O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
on O O
moderate O O
exertion O O
associated O O
with O O
a O O
dry O O
cough O B-C0010200
of O O
two O O
days O O
duration O O
. O O

the O O
cough O B-C0010200
was O O
worse O O
at O O
night O O
. O O

there O O
was O O
no O O
associated O O
fever O B-C0015967
, O O
no O O
weight O B-C1262477
loss O I-C1262477
; O O
no O O
excessive O B-C0700590
sweating O I-C0700590
at O O
night O O
, O O
no O O
chest O B-C0008031
pain O I-C0008031
, O O
no O O
lower O O
extremity O O
swelling O B-C0038999
and O O
no O O
hemoptysis O B-C0019079
. O O

he O O
had O O
no O O
significant O O
medical O O
or O O
family O B-C0241889
history O I-C0241889
of O O
a O O
cardiovascular O O
or O O
thromboembolic O O
disease O O
. O O

his O O
past O O
history O O
was O O
only O O
remarkable O O
for O O
exposure O O
to O O
a O O
patient O O
with O O
tuberculosis O B-C0041296
ten O O
years O O
ago O O
. O O

he O O
was O O
not O O
a O O
current O B-C3241966
smoker O I-C3241966
and O O
did O O
not O O
consume O O
alcohol O O
. O O

physical O O
examination O O
revealed O O
a O O
well O O
build O O
up O O
patient O O
in O O
no O O
acute O O
distress O O
, O O
a O O
blood O O
pressure O O
of O O
110 O O
/ O O
70 O O
mmhg O O
, O O
pulse O O
rate O O
of O O
70 O O
/ O O
min O O
, O O
respiratory O O
rate O O
of O O
19 O O
cycles O O
/ O O
min O O
, O O
temperature O O
of O O
36.9 O O
° O O
C O O
. O O

his O O
weight O O
was O O
71kg O O
and O O
BMI O O
of O O
25.15kg O O
/ O O
m O O
2 O O
. O O

on O O
the O O
examination O O
of O O
the O O
respiratory O O
system O O
, O O
auscultation O O
revealed O O
clear O O
breath O O
sounds O O
without O O
wheezes O O
nor O O
crackles O B-C0034642
. O O

on O O
examination O O
of O O
the O O
cardiovascular O O
system O O
, O O
he O O
had O O
a O O
regular O O
heart O O
beat O O
without O O
murmurs O O
, O O
no O O
accentuation O O
of O O
the O O
pulmonary O O
component O O
of O O
the O O
second O O
heart O O
sound O O
, O O
no O O
jugular O O
venous O O
distension O O
and O O
no O O
lower O B-C0239340
extremity O I-C0239340
edema O I-C0239340
. O O

chest O O
radiograph O O
revealed O O
an O O
enlarged O O
cardiac O O
silhouette O O
, O O
a O O
right O O
middle O O
lung O O
lobe O O
cavitary O O
lesion O B-C0221198
with O O
regional O O
lymphadenopathy O B-C0497156
. O O

ECG O O
showed O O
normal O O
sinus O O
rhythm O O
, O O
incomplete O B-C0262525
right O I-C0262525
bundle O I-C0262525
branch O I-C0262525
block O I-C0262525
and O O
T O O
wave O O
inversions O O
in O O
V1 O O
, O O
V2 O O
and O O
V3 O O
. O O
echocardiography O O
showed O O
dilated O B-C0344709
right O I-C0344709
atrium O I-C0344709
, O O
dilated O O
right O O
ventricle O O
, O O
severe O O
tricuspid O B-C0040961
regurgitation O I-C0040961
and O O
severe O O
pulmonary O B-C2973725
artery O I-C2973725
hypertension O I-C2973725
; O O
pulmonary O O
artery O O
systolic O O
pressure O O
( O O
PASP O O
) O O
: O O
80mmhg O O
. O O

ejection O O
fraction O O
of O O
the O O
left O O
ventricle O O
was O O
70% O O
. O O
following O O
the O O
results O O
of O O
the O O
echocardiography O O
, O O
a O O
thoracic O B-C0729233
computed O O
tomographic O O
scan O O
with O O
contrast O O
was O O
performed O O
which O O
showed O O
bilateral O O
proximal O O
pulmonary O O
emboli O O
\ O O
( O O
figure O O
1 O O
, O O
figure O O
2 O O
, O O
figure O O
3 O O
, O O
figure O O
4 O O
) O O
, O O
and O O
a O O
cavitary O O
lesion O B-C0221198
in O O
the O O
upper O O
lobe O O
of O O
the O O
right O O
lung O O
. O O

the O O
cavitation O O
of O O
the O O
right O O
lung O O
prompted O O
bronchial O O
fibroscopy O O
with O O
aspiration O O
of O O
bronchial O O
secretions O O
. O O

sputum O O
was O O
found O O
to O O
contain O O
numerous O O
acid-fast O O
bacilli O O
on O O
direct O O
microscopy O O
( O O
> O O
15 O O
bacilli O O
/ O O
field O O
) O O
. O O
culture O O
results O O
was O O
positive O O
for O O
mycobacterium O B-C0026918
tuberculosis O B-C0041296
. O O

brochial O O
biopsy O O
showed O O
severe O O
dysplasia O O
of O O
bronchial O O
epithelium O O
with O O
absence O O
of O O
carcinoma O O
. O O

ultrasound O O
studies O O
did O O
not O O
show O O
evidence O O
of O O
deep O B-C0149871
venous O I-C0149871
thrombosis O I-C0149871
. O O

other O O
laboratory O O
findings O O
revealed O O
a O O
WBC O O
of O O
4300 O O
/ O O
mm O O
3 O O
, O O
hemoglobin O O
13.8 O O
g O O
/ O O
dl O O
, O O
platelet O O
count O O
315,000 O O
/ O O
mm O O
3 O O
, O O
serum O O
creatinine O O
11.92mg O O
/ O O
l O O
, O O
c-reactive O O
protein O O
54.4mg O O
/ O O
l O O
, O O
erythrocyte O O
sedimentation O O
rates O O
at O O
46mm O O
and O O
59mm O O
, O O
fasting O B-C0015663
blood O O
sugar O O
1g O O
/ O O
l O O
, O O
aspartate O O
aminotransferase O O
19.9 O O
IU O O
/ O O
l O O
, O O
alanine O O
aminotransferase O O
15.6IU O O
/ O O
l O O
, O O
negative O O
HIV O O
serology O O
, O O
INR O O
1.10 O O
. O O

he O O
was O O
put O O
on O O
enoxaparin O O
that O O
was O O
overlapped O O
with O O
acenocoumarol O O
. O O

anti-tuberculosis O O
treatment O O
including O O
isoniazid O O
, O O
pyrazinamid O O
, O O
ethambutol O O
and O O
rifampicin O O
was O O
started O O
immediately O O
. O O

he O O
was O O
discharged O O
with O O
referral O O
to O O
the O O
pneumology O O
hospital O O
for O O
continuation O O
of O O
treatment O O
when O O
the O O
therapeutic O O
INR O O
was O O
reached O O
. O O

A O O
62 O O
year O O
old O O
male O O
farmer O O
was O O
attacked O O
by O O
a O O
swarm O O
of O O
bees O O
2hours O O
prior O O
to O O
presentation O O
on O O
account O O
of O O
severe O O
pains O O
. O O

there O O
were O O
no O O
previous O O
trauma O O
to O O
the O O
affected O O
left O O
eye O O
or O O
surgery O O
, O O
but O O
had O O
occasional O O
itchy O O
eyes O O
. O O

he O O
is O O
a O O
known O O
hypertensive O B-C0020538
with O O
good O O
control O O
on O O
medications O O
, O O
and O O
not O O
a O O
known O O
diabetic O B-C0011847
. O O

he O O
denied O O
any O O
history O O
of O O
harmful O O
traditional O O
eye O O
medications O O
\ O O
( O O
HTEM O O
) O O
. O O

examination O O
revealed O O
tender O O
swollen O O
upper O O
and O O
lower O O
lids O O
, O O
moderate O O
to O O
severe O O
mechanical O O
ptosis O B-C0033377
and O O
purulent O O
eye O B-C0423006
discharge O I-C0423006
. O O

after O O
eye O O
toileting O O
with O O
normal O O
saline O O
, O O
visual O O
acuity O O
, O O
cornea O O
, O O
anterior O O
chamber O O
and O O
pupillary O O
reactions O O
were O O
normal O O
but O O
there O O
was O O
severe O O
bulbar O O
chemosis O B-C0271298
figure O O
2 O O
. O O

A O O
swab O O
of O O
the O O
discharge O O
was O O
sent O O
for O O
microscopy O O
, O O
culture O O
and O O
sensitivity O O
( O O
m O O
/ O O
c O O
/ O O
s O O
) O O
. O O

treatment O O
was O O
thereafter O O
instituted O O
with O O
guttae O O
ciprofloxacin O O
and O O
flurbiprofen O O
, O O
and O O
oral O O
tramadol O O
and O O
NSAID O O
. O O

eighteen O O
hours O O
after O O
, O O
all O O
the O O
symptoms O O
had O O
subsided O O
. O O

further O O
examination O O
of O O
the O O
eye O O
revealed O O
a O O
stab O O
partial-thickness O O
entry O O
point O O
of O O
about O O
1 O O
- O O
1.5mm O O
in O O
diameter O O
in O O
the O O
sclera O O
at O O
6 O O
o O O
' O O
clock O O
position O O
, O O
3.5 O O
mm O O
from O O
the O O
limbus O O
and O O
normal O O
IOP O O
. O O

dilated O O
fundoscopy O O
using O O
binocular O O
indirect O O
ophthalmoscope O O
, O O
and O O
slit O O
lamp O O
examination O O
revealed O O
normal O O
posterior O O
segment O O
. O O

there O O
was O O
complete O O
resolution O O
of O O
the O O
lid O O
swelling O B-C0038999
, O O
and O O
chemosis O B-C0271298
within O O
72 O O
hours O O
apart O O
from O O
the O O
conjunctival O O
and O O
episcleral O O
hyperaemia O O
. O O

the O O
purulent O O
eye O B-C0423006
discharge O I-C0423006
stopped O O
after O O
6 O O
days O O
and O O
a O O
tapered O O
low O O
dose O O
oral O O
prednisolone O O
was O O
commenced O O
. O O

four O O
weeks O O
follow O O
up O O
showed O O
a O O
self O O
healing O O
wound O O
site O O
in O O
form O O
of O O
ciliary O O
staphyloma O B-C0155359
and O O
mild O O
scleritis O B-C0036416
, O O
with O O
no O O
evidence O O
of O O
erosion O O
or O O
irritation O O
from O O
a O O
retained O O
or O O
migrated O O
bee O O
stinger O O
. O O

the O O
result O O
of O O
the O O
m O O
/ O O
c O O
/ O O
s O O
showed O O
growths O O
of O O
staphylococcus O B-C1318973
aureus O I-C1318973
, O O
and O O
staphyloccoccus O O
epidermidis O O
sensitive O O
to O O
ciprofloxacin O O
, O O
ceftazidine O O
and O O
erythromycin O O
, O O
which O O
the O O
topical O O
antibiotics O O
had O O
taken O O
care O O
of O O
. O O

A O O
thirteen O O
month-old O O
male O O
patient O O
was O O
referred O O
to O O
department O O
of O O
pediatric O O
gastroenterology O O
of O O
rabat O O
children's O O
hospital O O
with O O
the O O
chief O O
complaint O O
of O O
hepatosplenomegaly O B-C0019214
associated O O
with O O
hydrocephalus O B-C0020255
. O O

he O O
was O O
born O O
at O O
term O O
by O O
normal O O
vaginal O O
delivery O O
without O O
complications O O
and O O
his O O
birth O O
weight O O
was O O
3200g O O
. O O

parents O O
were O O
non O O
consanguineous O O
, O O
one O O
brother O O
died O B-C1546956
at O O
the O O
same O O
age O O
of O O
unknown O O
etiology O O
( O O
with O O
similar O O
symptoms O O
) O O
. O O
according O O
to O O
his O O
past O O
medical O O
history O O
, O O
spleen O O
and O O
liver O O
enlargement O O
was O O
first O O
observed O O
at O O
the O O
age O O
of O O
four O O
months O O
by O O
a O O
physician O O
, O O
blood O O
investigations O O
were O O
performed O O
. O O

the O O
patient O O
was O O
lost O B-C1302313
to O I-C1302313
follow-up O I-C1302313
until O O
the O O
age O O
of O O
13 O O
months O O
when O O
parents O O
consulted O O
a O O
pediatrician O O
for O O
macrocephaly O B-C0221355
and O O
abdominal O O
overdistension O O
. O O

the O O
patient O O
was O O
referred O O
to O O
our O O
department O O
for O O
etiological O O
investigations O O
of O O
hepatosplenomegaly O B-C0019214
and O O
hydrocephalus O B-C0020255
. O O

on O O
general O O
physical O O
examination O O
, O O
the O O
patient O O
was O O
short O O
statured O O
( O O
his O O
length O O
and O O
weight O O
were O O
both O O
< O O
3 O O
rd O O
percentile O O
) O O
, O O
his O O
cranial O O
perimeter O O
was O O
between O O
the O O
75th O O
' O O
90th O O
percentiles O O
with O O
a O O
bulging O O
anterior O O
fontanel O O
. O O

delayed O O
physical O O
developmental O O
milestones O O
were O O
noted O O
. O O

patient O O
was O O
pale O O
and O O
was O O
not O O
icteric O O
. O O

abdomen O O
was O O
distended O O
with O O
hepatomegaly O B-C0019209
with O O
the O O
liver O O
noted O O
to O O
be O O
4cm O O
and O O
splenomegaly O B-C0038002
with O O
the O O
spleen O O
noted O O
to O O
be O O
7cm O O
. O O

intraoral O O
examination O O
showed O O
delayed O B-C0239174
tooth O I-C0239174
eruption O I-C0239174
. O O

skeletal O O
exam O O
revealed O O
frontal O B-C0221354
bossing O I-C0221354
, O O
palpable O O
costochondral O O
beading O O
and O O
bowlegs O O
. O O

ophtalmic O O
exam O O
showed O O
convergent O B-C0014877
squint O I-C0014877
with O O
loss O B-C4747726
of O I-C4747726
visual O I-C4747726
fixation O I-C4747726
and O O
pursuit O O
, O O
fundoscopic O O
examination O O
disclosed O O
bilateral O O
optic O B-C0029124
atrophy O I-C0029124
. O O

blood O O
investigations O O
revealed O O
microcytic O O
, O O
hypochromic O B-C0002884
anemia O I-C0002884
with O O
hemoglobin O O
9.4 O O
g O O
/ O O
dl O O
; O O
white O O
blood O O
cell O O
count O O
20800 O O
cells O O
/ O O
mm O O
3 O O
; O O
platelet O O
count O O
130.000 O O
/ O O
mm O O
3 O O
. O O

biochemical O O
analysis O O
showed O O
the O O
following O O
abnormalities O O
: O O
calcaemia O O
76mg O O
/ O O
l O O
; O O
alkaline O O
phosphatase O O
328 O O
IU O O
/ O O
l O O
; O O
parathyroid O O
hormone O O
135 O O
pg O O
/ O O
ml O O
. O O

serology O O
for O O
toxoplasma O O
, O O
hepatitis O O
virus O O
, O O
cytomegalovirus O O
and O O
rubella O B-C0035920
was O O
negative O O
. O O

immunoglobulin O O
( O O
G O O
, O O
A O O
, O O
M O O
) O O
levels O O
were O O
normal O O
. O O

chest O O
, O O
skull O O
and O O
vertebrae O O
radiographs O O
detected O O
generalized O O
dense O O
bone O O
particularly O O
in O O
the O O
skull O O
base O O
and O O
the O O
vertebrae O O
with O O
″ O O
bone-in-bone O O
″ O O
appearance O O
and O O
bone O O
modelling O O
affecting O O
the O O
metaphyses O O
of O O
long O O
bones O O
, O O
radiographic O O
features O O
of O O
superimposed O O
rickets O B-C0035579
was O O
also O O
noted O O
\ O O
( O O
figure O O
5 O O
, O O
figure O O
6 O O
) O O
. O O

abdominal O O
ultrasonography O O
disclosed O O
pronounced O O
hepatosplenomegaly O B-C0019214
. O O

CT O O
scan O O
revealed O O
triventricular O O
hydrocephalus O B-C0020255
due O O
to O O
aqueductal O B-C2936786
stenosis O I-C2936786
. O O

bone O O
marrow O O
aspiration O O
showed O O
hypocellularity O O
. O O

osteo-medullary O O
biopsy O O
demonstrated O O
hypoplastic O B-C1855710
bone O I-C1855710
marrow O I-C1855710
, O O
rare O O
osteoclasts O O
were O O
noted O O
. O O

liver O O
biopsy O O
revealed O O
extra-medullary O O
hematopoeisis O O
with O O
ballooned O O
and O O
clarified O O
hepatocytes O O
. O O

storage O O
disease O O
( O O
such O O
as O O
mucopolysaccharidosis O B-C0026703
) O O
and O O
congenital O O
infectious O O
disorders O O
( O O
TORCH O O
) O O
were O O
considered O O
in O O
the O O
differential O O
diagnosis O O
. O O

urine O O
ph O O
was O O
alkaline O O
, O O
metabolic O B-C0220981
acidosis O I-C0220981
and O O
intracerebral O B-C0270685
calcifications O I-C0270685
were O O
absent O O
, O O
therefore O O
carbonic O B-C0345407
anhydrase O I-C0345407
II O I-C0345407
deficiency O I-C0345407
syndrome O O
was O O
eliminated O O
. O O

however O O
, O O
correlating O O
the O O
radiographic O O
features O O
with O O
the O O
clinical O O
features O O
, O O
the O O
case O O
was O O
diagnosed O O
as O O
infantile O O
malignant O O
OP O O
. O O

diagnosis O O
was O O
confirmed O O
by O O
genetic O O
testing O O
which O O
revealed O O
two O O
heterozygote O O
mutations O O
( O O
c O O
. O O
196 O O
+ O O
1G O O
> O O
T O O
) O O
; O O
( O O
2236 O O
+ O O
1G O O
> O O
A O O
) O O
within O O
the O O
TCIRG1 O O
gene O O
. O O

the O O
patient O O
received O O
symptomatic O O
and O O
supportive O O
treatment O O
including O O
antibiotic O O
therapy O O
, O O
rhinopharyngeal O O
disinfection O O
, O O
respiratory O O
kinesitherapy O O
, O O
calcium O O
and O O
vitamin O O
D O O
supplementation O O
. O O

patient O O
was O O
advised O O
for O O
bone O O
marrow O O
transplantation O O
( O O
BMT O O
) O O
which O O
was O O
not O O
done O O
due O O
to O O
cost O O
. O O

patient O O
was O O
finally O O
referred O O
for O O
ventriculoperitoneal O O
shunt O O
. O O

he O O
died O B-C1546956
from O O
an O O
acute O B-C0748355
respiratory O I-C0748355
distress O I-C0748355
. O O

42 O O
- O O
year-old O O
woman O O
, O O
single O O
, O O
with O O
no O O
significant O O
personal O O
or O O
family O B-C0241889
history O I-C0241889
. O O

she O O
consulted O O
for O O
pelvic O B-C0030794
pain O I-C0030794
with O O
pelvic O B-C0347944
mass O I-C0347944
that O O
lasting O O
for O O
a O O
month O O
prior O O
toconsultation O O
. O O

the O O
clinical O O
assessment O O
of O O
the O O
patient O O
revealed O O
an O O
abdomino-pelvic O O
mass O O
of O O
hard O O
consistency O O
, O O
measuring O O
three O O
inches O O
, O O
not O O
mobilized O O
from O O
the O O
uterus O O
. O O

on O O
ultrasound O O
of O O
the O O
abdomen O O
and O O
pelvis O O
, O O
the O O
mass O O
appeared O O
tissue O O
and O O
vascular O O
on O O
color O O
doppler O O
, O O
measuring O O
112 O O
/ O O
85 O O
mm O O
. O O

abdomino-pelvic O O
CT O O
scan O O
showed O O
a O O
pelvi-abdominal O O
tissue O O
necrosis O O
in O O
places O O
, O O
slightly O O
enhanced O O
by O O
injection O O
of O O
contrast O O
, O O
measuring O O
100 O O
/ O O
70 O O
/ O O
60 O O
mm O O
. O O

they O O
were O O
multiple O O
peritoneal O O
nodules O O
with O O
an O O
overdensity O O
of O O
mesenteric O O
fat O O
, O O
pelvic O O
lymph O O
nodes O O
, O O
para-aortic O O
and O O
aorto-caval O O
arteries O O
. O O

the O O
liver O O
and O O
spleen O O
were O O
homogeneous O O
with O O
focal O O
lesion O B-C0221198
. O O

the O O
CA O O
125 O O
was O O
increased O O
to O O
708 O O
IU O O
/ O O
ml O O
. O O

an O O
exploratory O O
laparotomy O O
showed O O
a O O
solid O O
vegetating O O
tumor O B-C0027651
of O O
the O O
right O O
tube O O
, O O
measuring O O
100 O O
/ O O
80 O O
mm O O
. O O

both O O
ovaries O O
and O O
the O O
contralateral O O
horn O O
were O O
free O O
of O O
any O O
gross O O
lesions O B-C0221198
. O O

the O O
tumor O B-C0027651
invaded O O
the O O
bladder O O
and O O
a O O
vermiform O O
appendix O O
. O O
150 O O
ml O O
of O O
ascites O B-C0003962
fluid O O
was O O
aspirated O O
. O O

A O O
tumor O B-C0027651
biopsy O O
of O O
80 O O
/ O O
70 O O
/ O O
20 O O
mm O O
was O O
collected O O
and O O
sent O O
to O O
frozen O O
section O O
for O O
histology O O
. O O

the O O
result O O
of O O
the O O
biopsy O O
showed O O
a O O
poorly O O
differentiated O O
and O O
invasive O O
malignant O B-C0006826
tumor O I-C0006826
proliferation O O
. O O

A O O
total O O
hysterectomy O O
with O O
adnexal O O
conservation O O
without O O
appendectomy O O
, O O
with O O
omentectomy O O
and O O
partial O O
resection O O
of O O
the O O
bladder O O
was O O
performed O O
. O O

parietal O O
and O O
peritoneal O O
biopsies O O
were O O
done O O
. O O

the O O
postoperative O O
course O O
was O O
uneventful O O
. O O

the O O
patient O O
was O O
discharged O O
on O O
day O O
15 O O
post-op O O
. O O

the O O
pathological O O
diagnosis O O
showed O O
a O O
solid O B-C0280100
tumor O I-C0280100
proliferation O O
, O O
whitish O O
, O O
infiltrating O O
, O O
with O O
mesotubular O O
extension O O
, O O
adhering O O
to O O
the O O
front O O
right O O
side O O
of O O
the O O
uterus O O
and O O
measuring O O
12 O O
centimeters O O
in O O
diameter O O
. O O

the O O
microscopic O O
aspect O O
was O O
consistent O O
with O O
adenocarcinoma O B-C0001418
, O O
poorly O O
differentiated O O
, O O
infiltrating O O
, O O
necrotic O O
, O O
with O O
mesotubular O O
and O O
meso O O
appendix O O
extension O O
. O O

A O O
chest O O
radiograph O O
was O O
normal O O
. O O

no O O
recurrence O O
was O O
noted O O
at O O
6 O O
months O O
post-op O O
. O O

analytical O O
cross O B-C2936910
sectional O O
research O O
design O O
was O O
used O O
. O O

study O O
variables O O
were O O
hospital O O
equipment O O
, O O
hospital O O
infrastructure O O
, O O
the O O
surrounding O O
hospital O O
environment O O
, O O
training O O
, O O
drills O O
, O O
staff O O
knowledge O O
and O O
staff O O
capability O O
. O O

the O O
hypothesis O O
in O O
this O O
study O O
was O O
‘ O O
mean O O
score O O
capacity O O
does O O
not O O
differ O O
significantly O O
between O O
public O O
and O O
private O O
hospitals O O
in O O
nairobi O B-C0027345
county O O
, O O
kenya O O
‘ O O
. O O

the O O
study O O
setting O O
was O O
hospitals O O
in O O
nairobi O B-C0027345
county O O
, O O
kenya O O
. O O
32 O O
hospitals O O
cooperated O O
during O O
the O O
research O O
, O O
9 O O
of O O
them O O
public O O
and O O
23 O O
private O O
hospitals O O
. O O

study O O
respondents O O
were O O
the O O
hospital O O
workforce O O
categorised O O
as O O
either O O
clinical O O
or O O
administrative O O
staffs O O
. O O

clinical O O
staffs O O
comprised O O
those O O
whose O O
primary O O
responsibility O O
was O O
to O O
save O O
lives O O
and O O
doctors O O
and O O
nurses O O
were O O
the O O
main O O
respondents O O
. O O

administrative O O
staff O O
comprised O O
those O O
responsible O O
for O O
coordinating O O
the O O
HS O O
processes O O
within O O
the O O
hospitals O O
. O O

they O O
comprised O O
; O O
the O O
chief O O
medical O O
officer O O
, O O
financial O O
controller O O
, O O
the O O
disaster O O
management O O
committee O O
chair O O
, O O
the O O
communications O O
department O O
chair O O
and O O
the O O
human O O
resources O O
director O O
. O O

based O O
on O O
information O O
by O O
ndetei O O
, O O
khasakhala O O
and O O
omolo O O
, O O
[ O O
5 O O
] O O
, O O
the O O
number O O
of O O
administrative O O
and O O
clinical O O
staffs O O
in O O
nairobi O B-C0027345
county O O
was O O
obtained O O
to O O
be O O
18707 O O
. O O

slovin's O O
formula O O
for O O
random O O
sampling O O
[ O O
6 O O
] O O
was O O
used O O
to O O
get O O
the O O
representative O O
sample O O
at O O
95% O O
level O O
of O O
confidence O O
. O O

the O O
estimated O O
sample O O
size O O
obtained O O
was O O
391.6 O O
and O O
this O O
was O O
adjusted O O
to O O
400 O O
. O O

upon O O
field O O
work O O
, O O
263 O O
respondents O O
participated O O
which O O
was O O
65 O O
. O O
7 O O
5% O O
participation O O
. O O

research O O
instruments O O
were O O
questionnaires O O
, O O
participant O O
observation O O
checklist O O
and O O
key O O
informant O O
interviews O O
. O O

ethical O O
consideration O O
was O O
obtained O O
from O O
the O O
national O O
council O O
of O O
science O O
and O O
technology O O
, O O
kenya O O
and O O
the O O
hospital O O
ethical O O
committees O O
. O O

A O O
confidentiality O O
clause O O
was O O
also O O
included O O
on O O
the O O
questionnaire O O
form O O
. O O

field O O
work O O
was O O
executed O O
between O O
the O O
months O O
of O O
june O O
to O O
august O O
2012 O O
. O O

research O O
assistants O O
took O O
time O O
to O O
fill O O
the O O
observers O O
' O O
checklist O O
and O O
used O O
the O O
key O O
informant O O
interview O O
form O O
to O O
interview O O
administrative O O
staff O O
. O O

questionnaires O O
were O O
self O O
administered O O
on O O
the O O
clinical O O
staff O O
. O O

statistical O O
significance O O
was O O
considered O O
at O O
p O O
value O O
< O O
0.05 O O
. O O

data O O
obtained O O
after O O
fieldwork O O
was O O
filtered O O
, O O
coded O O
and O O
keyed O O
into O O
statistical O O
packages O O
for O O
social O O
scientists O O
( O O
SPSS O O
) O O
version O O
10 O O
. O O

A O O
detailed O O
description O O
of O O
study O O
results O O
obtained O O
is O O
tabulated O O
in O O
. O O

A O O
2.5 O O
year-old O O
girl O O
applied O O
to O O
our O O
clinic O O
with O O
the O O
complaints O O
of O O
abasia O B-C0877217
and O O
deformity O B-C0000768
in O O
knees O O
and O O
feet O O
. O O

she O O
was O O
the O O
third O O
child O O
of O O
a O O
diabetic O B-C0011847
mother O O
according O O
to O O
her O O
medical O O
history O O
and O O
consanguineous O O
marriage O B-C0024841
was O O
not O O
the O O
case O O
for O O
her O O
parents O O
. O O

it O O
was O O
understood O O
during O O
the O O
antenatal O O
follow-up O O
that O O
the O O
diagnosis O O
has O O
been O O
made O O
during O O
28th-gestational O O
week O O
and O O
caesarean O O
delivery O O
has O O
been O O
performed O O
at O O
34th-gestational O O
week O O
. O O

there O O
were O O
no O O
history O O
of O O
drug O O
use O O
, O O
radiation O B-C0015333
exposure O I-C0015333
and O O
serious O O
disease O O
for O O
the O O
mother O O
, O O
for O O
whom O O
the O O
blood O O
glucose O O
has O O
not O O
been O O
regulated O O
during O O
pregnancy O O
. O O

it O O
was O O
ascertained O O
that O O
there O O
were O O
no O O
similar O O
congenital O O
deformities O B-C0000768
in O O
other O O
family O O
members O O
including O O
the O O
healthy O O
siblings O O
of O O
patient O O
. O O

in O O
locomotor O O
system O O
examination O O
, O O
lower O O
extremities O O
of O O
patient O O
were O O
hypoplasic O O
and O O
there O O
were O O
no O O
activity O O
in O O
all O O
key O O
muscles O O
of O O
lower O O
extremities O O
including O O
quadriceps O O
. O O

her O O
hips O O
were O O
in O O
flexion O O
and O O
abduction O O
position O O
when O O
patient O O
was O O
in O O
supine O O
position O O
but O O
there O O
were O O
no O O
contracture O B-C0009917
. O O

flexion O O
contracture O B-C0009917
of O O
75 O O
degree O O
accompanied O O
by O O
popliteal O O
web O O
was O O
observed O O
in O O
the O O
knees O O
of O O
patient O O
. O O

equinovarus O B-C4551566
deformity O I-C4551566
has O O
been O O
observed O O
in O O
both O O
feet O O
. O O

hypoplasia O B-C0566899
of O I-C0566899
the O I-C0566899
labia O I-C0566899
majora O I-C0566899
has O O
been O O
determined O O
in O O
genital O O
area O O
. O O

no O O
deformities O B-C0000768
were O O
detected O O
in O O
upper O O
extremities O O
, O O
but O O
she O O
had O O
frog O O
abdomen O O
due O O
to O O
weakness O B-C3714552
of O O
the O O
abdominal O O
muscles O O
. O O

other O O
system O O
examinations O O
were O O
normal O O
. O O

total O O
sacral O B-C0344490
agenesis O I-C0344490
and O O
partial O O
lumbar O O
vertebrae O O
agenesis O B-C0000846
were O O
observed O O
in O O
voiding O O
cystourethrography O O
performed O O
due O O
to O O
repeated O O
urinary O B-C0042029
tract O I-C0042029
infections O I-C0042029
and O O
spinal O O
cord O O
was O O
observed O O
to O O
be O O
terminated O O
at O O
T6 O O
vertebral O O
corpus O O
level O O
according O O
to O O
lumbar O O
MRI O O
. O O

vertebrae O O
were O O
observed O O
to O O
the O O
T10 O O
vertebra O O
level O O
and O O
lower O O
thoracic O B-C0729233
and O O
lumbar O O
vertebrae O O
and O O
sacrum O O
couldn't O O
be O O
observed O O
. O O

tethered O B-C0080218
cord O I-C0080218
and O O
other O O
anomalies O O
of O O
vertebrae O O
such O O
as O O
hemivertebrae O B-C0265677
were O O
not O O
detected O O
in O O
patient O O
. O O

in O O
the O O
urinary O O
ultrasonography O O
, O O
horseshoe O B-C0221353
kidney O I-C0221353
with O O
the O O
fusion O O
abnormality O O
of O O
both O O
kidneys O O
at O O
lower O O
pole O O
and O O
bilateral O O
grade O O
2 O O
hydronephrosis O B-C0020295
were O O
observed O O
. O O

in O O
the O O
urodynamic O O
evaluation O O
, O O
detrusor O O
overactivity O O
and O O
grade O O
2 O O
vesicoureteral O B-C0042580
reflux O I-C0042580
( O O
VUR O O
) O O
were O O
determined O O
consistent O O
with O O
the O O
neurogenic O B-C0005697
bladder O I-C0005697
. O O

it O O
was O O
understood O O
that O O
the O O
patient O O
has O O
been O O
administered O O
with O O
clean O O
intermittent O O
catheterization O O
with O O
the O O
urologic O O
follow-up O O
. O O

cervical O O
MRI O O
and O O
transfontanelle O O
USG O O
results O O
of O O
the O O
patient O O
were O O
normal O O
and O O
result O O
of O O
cytogenetic O O
analysis O O
was O O
46 O O
, O O
XX O O
normal O O
female O O
karyotype O O
. O O

deformities O B-C0000768
of O O
lower O O
extremities O O
were O O
considered O O
for O O
surgery O O
by O O
consulting O O
to O O
orthopaedics O O
department O O
. O O

however O O
, O O
the O O
surgery O O
was O O
not O O
found O O
to O O
be O O
appropriate O O
as O O
the O O
flexion O B-C0333068
contractures O I-C0333068
in O O
the O O
knees O O
considered O O
to O O
help O O
the O O
sitting O O
stability O O
of O O
the O O
patient O O
having O O
no O B-C5394127
ambulation O I-C5394127
potential O O
due O O
to O O
spinal-pelvic O O
instability O O
. O O

family O O
has O O
been O O
informed O O
on O O
prognosis O O
and O O
treatment O O
options O O
, O O
upper O O
extremity O O
strengthening O O
exercises O O
, O O
good O O
skin O O
care O O
and O O
positioning O O
, O O
and O O
follow-up O O
procedures O O
have O O
been O O
initiated O O
for O O
patient O O
. O O

A O O
25 O O
years O O
old O O
, O O
multiparaous O O
widow O O
female O O
patient O O
with O O
loss O B-C0041657
of O I-C0041657
consciousness O I-C0041657
and O O
generalyzed O O
convulsion O B-C4048158
was O O
admitted O O
to O O
a O O
hospital O O
. O O

she O O
was O O
hospitalized O O
for O O
the O O
diagnosis O O
and O O
treatment O O
. O O

her O O
arterial O B-C1272641
blood O I-C1272641
pressure O I-C1272641
was O O
180 O O
/ O O
100 O O
mmhg O O
on O O
admission O O
. O O

hypoalbunemia O O
and O O
anemia O B-C0002871
were O O
detected O O
in O O
her O O
laboratory O O
findings O O
and O O
she O O
was O O
given O O
albumin O O
and O O
erythrocyte O O
suspensions O O
. O O

amlodipine O O
10 O O
mg O O
/ O O
day O O
was O O
started O O
for O O
hypertension O B-C0020538
. O O

the O O
patient O O
was O O
referred O O
to O O
us O O
for O O
further O O
examination O O
and O O
treatment O O
. O O

she O O
was O O
concious O O
when O O
admitted O O
to O O
the O O
emergency O O
clinic O O
. O O

the O O
patient O O
was O O
hospitalized O O
by O O
the O O
neurology O O
clinic O O
with O O
a O O
diagnosis O O
of O O
hypertensive O B-C0151620
encephalopathy O I-C0151620
. O O

hyperintensity O O
in O O
bilateral O O
parieto-occipital O O
region O O
and O O
was O O
observed O O
in O O
magnetic O O
resonance O O
imaging O O
that O O
was O O
compatible O O
with O O
PRES O O
. O O

initial O O
medical O O
history O O
did O O
not O O
reveal O O
a O O
delayed O O
menstruation O O
or O O
pregnancy O O
. O O

the O O
laboratory O O
findings O O
showed O O
serum O O
aspartate O O
aminotransaminase O O
( O O
AST O O
) O O
: O O
115 O O
U O O
/ O O
L O O
( O O
N O O
: O O
0 O O
- O O
35 O O
) O O
, O O
serum O O
alanine O O
aminotransaminase O O
( O O
ALT O O
) O O
: O O
26 O O
IU O O
/ O O
L O O
( O O
N O O
: O O
0 O O
- O O
45 O O
) O O
, O O
serum O O
urea O O
and O O
creatine O O
to O O
be O O
normal O O
, O O
white O O
blood O O
cell O O
( O O
WBC O O
) O O
: O O
6100 O O
/ O O
mm O O
3 O O
( O O
N O O
: O O
4400 O O
- O O
11300 O O
) O O
, O O
hemoglobin O O
( O O
hb O O
) O O
: O O
10.5mg O O
/ O O
dl O O
( O O
N O O
: O O
11.5 O O
- O O
16.0 O O
) O O
, O O
and O O
platelet O O
count O O
( O O
plt O O
) O O
: O O
165.000 O O
/ O O
mm O O
3 O O
( O O
N O O
: O O
150.000 O O
- O O
; O O
450000 O O
) O O
and O O
a O O
catheterized O O
urine O O
specimen O O
demonstrated O O
proteinuria O B-C0033687
( O O
+ O O
+ O O
+ O O
) O O
. O O

to O O
investigate O O
the O O
etiology O O
of O O
hypertension O B-C0020538
, O O
renal O O
ultrasound O O
examination O O
was O O
performed O O
. O O

during O O
ultrasonography O O
a O O
live O O
fetus O O
in O O
the O O
uterine O O
cavity O O
was O O
detected O O
. O O

she O O
was O O
admitted O O
to O O
the O O
neurology O O
department O O
with O O
an O O
initial O O
diagnosis O O
hypertension O B-C0020538
, O O
eclampsia O B-C0013537
and O O
HELLP O O
. O O

there O O
was O O
a O O
live O O
fetus O O
with O O
olygohydroamnios O O
compatible O O
with O O
21 O O
weeks O O
of O O
gestation O O
in O O
her O O
obstetrical O O
ultrasonography O O
. O O

arterial O B-C1272641
blood O I-C1272641
pressure O I-C1272641
was O O
150 O O
/ O O
90 O O
and O O
repeated O O
laboratory O O
findings O O
revealed O O
serum O O
aspartate O O
aminotransaminase O O
( O O
AST O O
) O O
: O O
66 O O
U O O
/ O O
L O O
( O O
N O O
: O O
0 O O
- O O
35 O O
) O O
, O O
serum O O
alanine O O
aminotransaminase O O
( O O
ALT O O
) O O
: O O
25 O O
IU O O
/ O O
L O O
( O O
N O O
: O O
0 O O
- O O
45 O O
) O O
, O O
serum O O
lactate O O
dehydrogenase O O
( O O
LDH O O
) O O
: O O
359 O O
IU O O
/ O O
L O O
( O O
N O O
: O O
25 O O
- O O
247 O O
) O O
, O O
serum O O
urea O O
and O O
creatine O O
to O O
be O O
normal O O
, O O
white O O
blood O O
cell O O
( O O
WBC O O
) O O
: O O
5700 O O
/ O O
mm O O
3 O O
( O O
N O O
: O O
4400 O O
- O O
11300 O O
) O O
, O O
hemoglobin O O
( O O
hb O O
) O O
: O O
9.7mg O O
/ O O
dl O O
( O O
N O O
: O O
11.5 O O
- O O
16.0 O O
) O O
, O O
and O O
platelet O O
count O O
( O O
plt O O
) O O
: O O
118.000 O O
/ O O
mm O O
3 O O
( O O
N O O
: O O
150.000 O O
- O O
450000 O O
) O O
and O O
a O O
catheterized O O
urine O O
specimen O O
demonstrated O O
proteinuria O B-C0033687
( O O
+ O O
+ O O
) O O
. O O

she O O
stated O O
that O O
she O O
concealed O O
the O O
pregnancy O O
as O O
it O O
was O O
out O O
of O O
wedlock O O
. O O

she O O
was O O
G2P1 O O
, O O
and O O
she O O
did O O
not O O
remember O O
the O O
last O O
menstruel O O
period O O
. O O

no O B-C1856553
seizures O I-C1856553
took O O
place O O
after O O
hospitalization O O
. O O

arterial O B-C1272641
blood O I-C1272641
pressure O I-C1272641
was O O
controlled O O
with O O
antihypertensive O O
( O O
alpha O O
metyl O O
dopa O O
) O O
. O O

magnesium O O
sulphate O O
was O O
started O O
. O O

after O O
24 O O
- O O
hours O O
, O O
urine O O
protein O O
increased O O
to O O
5791 O O
mg O O
, O O
arterial O B-C1272641
blood O I-C1272641
pressure O I-C1272641
elevated O O
( O O
160 O O
/ O O
100 O O
) O O
and O O
due O O
to O O
the O O
onset O O
of O O
symptoms O O
suggestive O O
of O O
severe O B-C0341950
preeclampsia O I-C0341950
such O O
as O O
olyguria O O
, O O
visual O B-C0422943
symptoms O I-C0422943
, O O
upper O O
abdominal O B-C0000737
pain O I-C0000737
, O O
she O O
was O O
taken O O
to O O
operating O O
room O O
for O O
an O O
emergency O O
cesarean O O
section O O
and O O
one O O
alive O O
female O O
baby O O
in O O
vertex O O
presentation O O
was O O
delivered O O
. O O

with O O
these O O
findings O O
, O O
the O O
patient O O
was O O
diagnosed O O
as O O
having O O
HELLP O B-C0162739
syndrome O I-C0162739
and O O
eclampsia O B-C0013537
. O O

although O O
latency O O
in O O
the O O
diagnosis O O
due O O
to O O
concealment O O
of O O
pregnancy O O
, O O
she O O
was O O
treated O O
successfully O O
and O O
unfortunately O O
, O O
the O O
fetus O O
died O B-C1546956
in O O
the O O
third O O
day O O
of O O
delivery O O
. O O

mrs O O
XY O O
. O O
is O O
23 O O
year O O
old O O
, O O
nulliparous O O
woman O O
who O O
was O O
wheeled O O
to O O
the O O
emergency O O
service O O
of O O
the O O
gynaeco-obstetrical O O
unit O O
of O O
the O O
hospital O O
for O O
severe O O
abdominal O B-C0000737
pains O I-C0000737
of O O
sudden O O
unset O O
followed O O
by O O
dizziness O B-C0012833
and O O
loss O O
of O O
stability O O
leading O O
to O O
a O O
fall O B-C0085639
and O O
collapsed O O
. O O

she O O
has O O
no O O
amenorrhea O B-C0002453
and O O
her O O
hemoglobin O O
electrophoresis O O
is O O
AA O O
. O O

she O O
has O O
no O O
particular O O
medical O O
or O O
surgical O O
past O O
history O O
. O O

interrogation O O
reveals O O
her O O
last O O
coitus O O
some O O
minutes O O
before O O
onset O O
of O O
symptoms O O
after O O
2years O O
of O O
forced O O
abstinence O O
( O O
fiancé O O
abroad O O
) O O
, O O
no O O
accident O O
or O O
fall O B-C0085639
, O O
and O O
no O O
fight O O
. O O

physical O O
examination O O
reveals O O
conserved O O
general O O
state O O
, O O
unstable O O
hemodynamic O O
parameters O O
( O O
BP O O
70 O O
/ O O
50mmhg O O
, O O
pulse O O
100bpm O O
, O O
temperature O O
37.3 O O
° O O
C O O
) O O
. O O

her O O
conjunctivae O O
were O O
coloured O O
with O O
a O O
distended O B-C0000731
abdomen O I-C0000731
especially O O
in O O
the O O
pelvic O O
region O O
of O O
hemoperitoneum O B-C0019065
confirmed O O
by O O
an O O
abdominal O O
tap O O
( O O
7milliliters O O
of O O
unclotted O O
blood O O
) O O
. O O

vaginal O O
exams O O
( O O
digital O O
and O O
speculum O O
) O O
reveal O O
no O O
bleeding O B-C0019080
, O O
no O O
pelvic O B-C0347944
mass O I-C0347944
but O O
tender O O
with O O
bulging O O
pouch O O
of O O
douglas O O
. O O

A O O
presumptive O O
working O O
diagnosis O O
of O O
a O O
ruptured O O
hemorrhagic O O
ovarian O B-C0029927
cyst O I-C0029927
was O O
considered O O
. O O

an O O
emergency O O
pre-operative O O
work-up O O
( O O
FBC O O
, O O
PT O O
, O O
and O O
CKT O O
) O O
was O O
performed O O
as O O
routine O O
and O O
she O O
was O O
prepared O O
for O O
exploratory O O
laparotomy O O
under O O
general O O
anesthesia O B-C0278134
. O O

two O O
units O O
( O O
500 O O
milliliters O O
/ O O
unit O O
) O O
of O O
blood O O
were O O
also O O
reserved O O
. O O

during O O
surgery O O
, O O
we O O
found O O
hemoperitoneum O B-C0019065
of O O
about O O
2500 O O
milliliters O O
of O O
fresh O O
blood O O
, O O
a O O
clean O O
pelvis O O
with O O
neither O O
adhesions O O
nor O O
a O O
pathologic O O
tube O O
or O O
ovary O O
. O O

extension O O
of O O
the O O
incision O O
anteriorly O O
for O O
abdominal O O
exploration O O
reveals O O
a O O
macroscopically O O
healthy O O
liver O O
but O O
the O O
spleen O O
presents O O
lacerations O B-C0043246
at O O
3 O O
points O O
posteriorly O O
( O O
2 O O
- O O
4cm O O
) O O
that O O
were O O
actively O O
bleeding O B-C0019080
( O O
grade O O
3 O O
) O O
. O O

total O O
splenectomy O O
was O O
done O O
with O O
the O O
help O O
of O O
abdominal O O
surgeons O O
. O O

peritoneal O O
toileting O O
with O O
closure O O
of O O
the O O
abdominal O O
wall O O
followed O O
. O O

her O O
post-operative O O
period O O
was O O
uneventful O O
on O O
antibiotics O O
and O O
antalgics O O
until O O
her O O
discharge O O
after O O
7days O O
of O O
hospitalization O O
. O O

neither O O
pathological O O
examination O O
of O O
the O O
splenectomy O O
material O O
nor O O
postoperative O O
consultations O O
with O O
the O O
hematology O O
and O O
infectious O B-C0009450
diseases O I-C0009450
departments O O
showed O O
any O O
pathology O O
to O O
explain O O
the O O
rupture O O
. O O

vaccination O O
against O O
certain O O
predisposed O O
infections O O
( O O
like O O
pneumococcus O O
infection O B-C3714514
was O O
also O O
advised O O
. O O

A O O
46 O O
year O O
old O O
namibian O O
male O O
was O O
referred O O
to O O
our O O
hospital O O
from O O
a O O
district O O
hospital O O
with O O
complaints O O
of O O
legs O O
weakness O B-C3714552
for O O
3 O O
weeks O O
. O O

the O O
patient O O
was O O
in O O
his O O
usual O O
state O O
of O O
health O O
until O O
3 O O
weeks O O
prior O O
, O O
when O O
he O O
developed O O
progressive O O
leg O B-C0427068
weakness O I-C0427068
associated O O
with O O
dull O O
back O B-C0004604
pain O I-C0004604
localized O O
to O O
thoracic O B-C0729233
area O O
. O O

he O O
also O O
noticed O O
inability O O
to O O
pass O O
urine O O
and O O
stool O O
. O O

there O O
was O O
no O O
history O O
of O O
trauma O O
to O O
the O O
back O O
preceding O O
this O O
presentation O O
. O O

there O O
were O O
no O O
complaints O O
related O O
to O O
other O O
body O O
systems O O
except O O
general O O
malaise O B-C0231218
and O O
weight O B-C1262477
loss O I-C1262477
. O O

his O O
past O O
medical O O
history O O
was O O
significant O O
for O O
being O O
on O O
treatment O O
for O O
schizophrenia O B-C0036341
which O O
was O O
well O O
controlled O O
on O O
haloperidol O O
. O O

in O O
addition O O
he O O
had O O
been O O
treated O O
several O O
times O O
for O O
alcohol O B-C0001973
dependence O I-C0001973
. O O

on O O
physical O O
examination O O
we O O
found O O
a O O
middle O O
aged O O
man O O
, O O
sick O O
looking O O
and O O
markedly O O
wasted O O
. O O

he O O
was O O
apyrexial O O
with O O
finger O B-C0009080
clubbing O I-C0009080
and O O
below O O
knee O O
bilateral O O
pitting O O
edema O O
. O O

his O O
vital O O
signs O O
were O O
normal O O
. O O

he O O
had O O
reduced O B-C2750540
muscle O I-C2750540
bulk O I-C2750540
in O O
all O O
limbs O O
reflecting O O
generalized O O
wasting O O
. O O

the O O
tone O O
in O O
the O O
lower O O
limbs O O
was O O
reduced O O
, O O
with O O
power O O
of O O
0 O O
/ O O
5 O O
bilaterally O O
and O O
absent O O
knee O O
and O O
ankle O O
reflexes O O
. O O

the O O
babinski O B-C0034935
sign O I-C0034935
was O O
present O O
and O O
he O O
had O O
a O O
sensory O O
level O O
at O O
T12 O O
. O O

the O O
upper O O
limbs O O
were O O
normal O O
with O O
power O O
of O O
5 O O
/ O O
5 O O
. O O
the O O
abdomen O O
was O O
mildly O O
distended O O
, O O
with O O
a O O
firm O O
non O O
tender O O
hepatomegaly O B-C0019209
4cm O O
below O O
costal O O
margin O O
. O O

there O O
was O O
no O B-C1856555
splenomegaly O I-C1856555
and O O
the O O
kidneys O O
were O O
not O O
palpable O O
. O O

the O O
lungs O O
were O O
clear O O
on O O
auscultation O O
. O O

the O O
patient O O
liver O O
function O O
tests O O
were O O
consistent O O
alcoholic O B-C0019187
hepatitis O I-C0019187
with O O
a O O
ratio O O
of O O
aspartate O O
transaminase O O
( O O
AST O O
) O O
180 O O
IU O O
/ O O
l O O
to O O
alanine O O
transaminase O O
( O O
ALT O O
) O O
70 O O
IU O O
/ O O
l O O
greater O O
than O O
2 O O
: O O
1 O O
. O O

the O O
alkaline O O
phosphatase O O
( O O
ALP O O
) O O
and O O
gamma-glutamyltransferase O O
( O O
GGT O O
) O O
were O O
high O O
269 O O
IU O O
/ O O
l O O
and O O
223 O O
IU O O
/ O O
l O O
respectively O O
. O O

he O O
had O O
hypoalbuminemia O B-C0239981
of O O
25g O O
/ O O
l O O
and O O
the O O
serology O O
for O O
hepatitis O B-C0019163
B O I-C0019163
was O O
consistent O O
with O O
chronic O B-C0524909
hepatitis O I-C0524909
B O I-C0524909
infection O B-C3714514
and O O
hepatitis O B-C0019196
C O I-C0019196
serology O O
was O O
unreactive O O
. O O

his O O
alphafeto O O
protein O O
was O O
elevated O O
2000 O O
ng O O
/ O O
ml O O
and O O
the O O
international O O
normalized O O
ratio O O
( O O
INR O O
) O O
was O O
normal O O
at O O
0.98 O O
. O O

the O O
abdominal O O
ultrasound O O
revealed O O
the O O
liver O O
to O O
be O O
enlarged O O
with O O
multiple O O
hyperechoic O O
masses O O
biggest O O
measuring O O
4x4 O O
cm O O
in O O
diameter O O
and O O
ascites O B-C0003962
. O O

the O O
chest O O
X O O
ray O O
and O O
chest O O
computed O O
tomography O O
( O O
CT O O
) O O
scan O O
showed O O
bilateral O O
nodular O B-C1518345
lesions O I-C1518345
in O O
keeping O O
with O O
pulmonary O O
metastatic O B-C2939419
disease O I-C2939419
. O O
. O O

spinal O O
X O O
ray O O
and O O
CT O O
scan O O
showed O O
lumbar O O
1 O O
( O O
L1 O O
) O O
osteolytic O O
vertebra O O
body O O
lesions O B-C0221198
with O O
left O O
pedicle O O
destruction O O
and O O
L4 O O
osteopenia O B-C0029453
without O O
anterior O B-C1856599
wedging O I-C1856599
, O O
kyphosis O B-C0022821
or O O
destruction O O
of O O
the O O
adjacent O O
intervertebral O O
disk O O
spaces O O
. O O

A O O
liver O O
biopsy O O
was O O
done O O
which O O
showed O O
features O O
of O O
liver O B-C0023890
cirrhosis O I-C0023890
and O O
hepatocellular O B-C2239176
carcinoma O I-C2239176
. O O

computed O O
tomography O O
guided O O
biopsy O O
and O O
histology O O
of O O
the O O
paravertebral O O
mass O O
showed O O
features O O
consistent O O
with O O
a O O
metastatic O O
hepatocellular O B-C2239176
carcinoma O I-C2239176
and O O
the O O
abnormal O B-C1510715
cells O I-C1510715
were O O
positive O O
to O O
immunostains O O
for O O
hep O O
par O O
1 O O
. O O

the O O
patient O O
was O O
not O O
offered O O
palliative O O
radiotherapy O O
for O O
his O O
spine O O
metastases O B-C0027627
because O O
the O O
spinal O B-C0037926
cord O I-C0037926
compression O I-C0037926
had O O
lasted O O
over O O
3 O O
weeks O O
. O O

he O O
was O O
offered O O
tramadol O O
and O O
was O O
discharged O O
on O O
morphine O O
and O O
lactulose O O
for O O
his O O
pain O B-C0030193
control O O
and O O
supportive O O
nursing O O
care O O
. O O

he O O
expired O O
after O O
one O O
month O O
hospital O O
stay O O
. O O

Z.Z O O
, O O
an O O
18 O O
months O O
old O O
boy O O
, O O
the O O
child O O
of O O
related O O
parents O O
, O O
presented O O
with O O
respiratory O O
disorders O O
associated O O
with O O
the O O
fever O B-C0015967
and O O
cough O B-C0010200
. O O

there O O
was O O
a O O
history O O
of O O
recurrent O O
episodes O O
of O O
cough O B-C0010200
and O O
breathlessness O B-C0013404
since O O
age O O
of O O
4 O O
months O O
, O O
with O O
an O O
increase O O
in O O
the O O
frequency O O
and O O
severity O O
of O O
the O O
episodes O O
in O O
the O O
few O O
past O O
weeks O O
. O O

he O O
was O O
receiving O O
treatment O O
from O O
his O O
practitioner O O
, O O
but O O
was O O
referred O O
for O O
increasing O O
breathlessness O B-C0013404
. O O

early O O
development O O
was O O
normal O O
, O O
except O O
language O O
and O O
dentition O O
delayed O O
. O O

there O O
was O O
no O O
family O B-C0241889
history O I-C0241889
. O O

on O O
examination O O
, O O
the O O
child O O
was O O
febrile O B-C0015967
and O O
had O O
respiratory O B-C0476273
distress O I-C0476273
with O O
intercostal O O
and O O
subcostal O O
retractions O O
. O O

the O O
respiratory O O
rate O O
was O O
60 O O
/ O O
min O O
, O O
heart O O
rate O O
110 O O
/ O O
min O O
, O O
and O O
blood O O
pressure O O
100 O O
/ O O
70 O O
mmhg O O
, O O
sao O O
2 O O
was O O
60% O O
in O O
the O O
ambient O O
air O O
and O O
then O O
increased O O
up O O
to O O
94% O O
using O O
2l O O
of O O
oxygen O O
. O O

the O O
weight O O
and O O
height O O
were O O
10 O O
kg O O
( O O
under O O
2DS O O
) O O
and O O
70 O O
cm O O
( O O
normal O O
for O O
that O O
age O O
) O O
respectively O O
. O O

the O O
face O O
had O O
a O O
senile O O
appearance O O
with O O
pendulous O O
ear O O
lobes O O
and O O
lax O B-C0010495
skin O I-C0010495
. O O

his O O
thorax O O
is O O
deformed O O
with O O
scoliosis O B-C0036439
. O O

there O O
was O O
a O O
right-sided O O
, O O
reducible O O
, O O
inguinal O B-C0019294
hernia O I-C0019294
. O O

there O O
was O O
no O O
laxity O O
of O O
joints O O
. O O

chest O O
examination O O
revealed O O
the O O
bilaterally O O
creptations O O
. O O

cardiovascular O O
examination O O
was O O
normal O O
with O O
first O O
and O O
second O O
heart O O
sounds O O
were O O
heard O O
normally O O
. O O

examination O O
of O O
the O O
abdomen O O
was O O
normal O O
with O O
no O O
palpable O B-C0577045
liver O I-C0577045
and O O
spleen O O
. O O

others O O
systems O O
were O O
normal O O
. O O

test O O
showed O O
hemoglobin O O
of O O
8.7 O O
g O O
/ O O
dl O O
, O O
a O O
total O O
WBC O O
count O O
of O O
17270 O O
/ O O
mm O O
3 O O
with O O
a O O
differential O O
count O O
of O O
polymorphs O O
of O O
42% O O
, O O
lymphocytes O O
of O O
56% O O
. O O

routine O O
biochemical O O
investigations O O
yielded O O
normal O O
results O O
. O O

CRP O O
was O O
26 O O
mg O O
/ O O
l O O
TORSH O O
( O O
toxoplasmosis O B-C0040558
, O O
rubella O B-C0035920
, O O
syphilis O B-C0039128
, O O
herpes O B-C0019340
) O O
serologies O O
were O O
negatives O O
. O O

A O O
chest O O
x-ray O O
showed O O
emphysema O B-C0034067
in O O
the O O
left O O
lung O O
, O O
opacities O O
in O O
the O O
right O O
lung O O
and O O
cadiomegaly O O
with O O
a O O
cardiothoracic O O
ratio O O
of O O
0.6 O O
. O O

electrocardiography O O
showed O O
aortic O B-C0265004
dilatation O I-C0265004
, O O
mitral O O
valve O O
prolapsed O O
and O O
sign O O
of O O
pulmonary O B-C2973725
arterial O I-C2973725
hypertension O I-C2973725
. O O

thoracic O B-C0729233
computed O O
tomography O O
revealed O O
alveolar O O
condensations O O
and O O
localizations O O
of O O
emphysema O B-C0034067
. O O

gastric O O
fibroscopy O O
was O O
normal O O
the O O
child O O
was O O
treated O O
with O O
bronchodilators O O
and O O
antibiotics O O
. O O

A O O
78 O O
- O O
year-old O O
moroccan O O
woman O O
with O O
past O O
medical O O
history O O
of O O
parkinson's O B-C0030567
disease O I-C0030567
presented O O
to O O
our O O
hospital O O
with O O
an O O
umbilical O O
mass O O
with O O
loss O B-C1262477
of O I-C1262477
weight O I-C1262477
and O O
impairment O O
of O O
the O O
performance O O
status O O
( O O
PS O O
) O O
in O O
the O O
last O O
two O O
months O O
. O O

the O O
physical O O
examination O O
revealed O O
an O O
abdominal O B-C0000731
distension O I-C0000731
with O O
purplish O O
nodules O O
infiltrating O O
the O O
para O O
umbilical O O
skin O O
and O O
the O O
PS O O
was O O
scored O O
2 O O
. O O

nodule O B-C0028259
biopsy O O
has O O
been O O
performed O O
and O O
revealed O O
a O O
cutaneous O O
localization O O
of O O
moderately O O
differentiated O O
adenocarcinoma O B-C0001418
and O O
pelvic O O
ultrasonography O O
noted O O
the O O
presence O O
of O O
a O O
tumoral O O
right O O
adnexal O O
mass O O
. O O

her O O
serum O O
carbohydrate O O
antigen O O
125 O O
( O O
CA125 O O
) O O
level O O
was O O
100 O O
U O O
/ O O
ml O O
( O O
normal O O
< O O
35 O O
U O O
/ O O
ml O O
) O O
and O O
her O O
serum O O
AFP O O
concentration O O
was O O
150 O O
ng O O
/ O O
ml O O
( O O
normal O O
< O O
7.0 O O
ng O O
/ O O
ml O O
) O O
. O O

her O O
serum O O
levels O O
of O O
carcinoembryonic O O
antigen O O
and O O
CA O O
- O O
199 O O
were O O
within O O
normal O O
ranges O O
. O O

an O O
exploratory O O
laparoscopy O O
was O O
undertaken O O
and O O
found O O
peritoneal O B-C0346990
carcinomatosis O I-C0346990
with O O
pelvic O B-C1386453
adhesions O I-C1386453
allowing O O
only O O
peritoneal O O
biopsies O O
and O O
there O O
were O O
no O O
visible O O
liver O O
lesions O B-C0221198
with O O
homogeneous O O
appearance O O
. O O

histologic O O
sections O O
of O O
the O O
biopsied O O
peritoneal O B-C0346990
carcinomatosis O I-C0346990
showed O O
polyhedral O O
tumor O B-C0027651
cells O O
with O O
abundant O O
eosinophilic O O
cytoplasm O O
, O O
central O O
round O O
vesicular O O
nuclei O O
with O O
variably O O
prominent O B-C3280497
nucleoli O I-C3280497
in O O
nests O O
and O O
trabeculae O O
with O O
a O O
sinusoidal O O
arrangement O O
of O O
vascular O O
channels O O
resembling O O
liver O O
without O O
bile O O
. O O

the O O
tumor O B-C0027651
was O O
relatively O O
homogeneous O O
with O O
no O O
evidence O O
of O O
ovarian O O
surface O O
epithelial O O
tumor O B-C0027651
morphology O O
or O O
germ-cell O O
component O O
. O O

paraffin O O
tissue O O
blocks O O
were O O
prepared O O
and O O
stained O O
with O O
antibodies O O
to O O
hepatocyte O O
paraffin O O
- O O
1 O O
, O O
AFP O O
, O O
cytokeratin O O
7 O O
( O O
CK7 O O
) O O
, O O
CK20 O O
, O O
CK O O
8 O O
/ O O
18 O O
, O O
S O O
- O O
100 O O
protein O O
, O O
synaptophysin O O
, O O
inhibin O O
, O O
calretinin O O
and O O
epithelial O O
membrane O O
antigen O O
. O O

the O O
results O O
showed O O
that O O
tumor O B-C0027651
cells O O
were O O
positive O O
for O O
hepatocyte O O
paraffin O O
- O O
1 O O
which O O
was O O
diffusely O O
and O O
overwhelmingly O O
expressed O O
. O O

these O O
hepatoid O O
cells O O
were O O
positive O O
for O O
CK7 O O
and O O
CK8 O O
/ O O
18 O O
but O O
negative O O
for O O
CK20 O O
. O O

also O O
, O O
AFP O O
, O O
S O O
- O O
100 O O
protein O O
, O O
synaptophysin O O
, O O
inhibin O O
, O O
calretinin O O
and O O
epithelial O O
membrane O O
antigen O O
were O O
all O O
negative O O
. O O

A O O
computed O O
tomography O O
( O O
CT O O
) O O
scan O O
of O O
the O O
pelvis O O
showed O O
an O O
extensive O O
omental O O
peritoneal O O
implants O O
and O O
bilateral O O
adnexal O O
masses O O
with O O
6.8 O O
× O O
9.9 O O
cm O O
on O O
right O O
and O O
3.9 O O
× O O
4.1cm O O
on O O
left O O
. O O

the O O
patient O O
got O O
then O O
after O O
a O O
positron O O
emission O O
tomography O O
scan O O
( O O
PET O O
/ O O
CT O O
) O O
with O O
fludeoxyglucose O O
( O O
FDG O O
) O O
which O O
revealed O O
a O O
metastatic O B-C2939419
disease O I-C2939419
with O O
an O O
intense O O
hypermetabolisme O O
in O O
the O O
pelvic O O
with O O
standard O O
uptake O O
value O O
SUV O O
max O O
: O O
3.3 O O
with O O
no O O
uptake O O
in O O
the O O
liver O O
. O O

it O O
revealed O O
also O O
an O O
intense O O
hypermetabolisme O O
in O O
the O O
eighth O O
dorsal O O
vertebra O O
with O O
pulmonary O O
hilar O O
nodes O O
. O O

the O O
diagnosis O O
of O O
primary O O
HCO O O
was O O
established O O
on O O
the O O
basis O O
of O O
classic O O
histopathologic O O
findings O O
, O O
immunohistochemical O O
staining O O
and O O
marked O O
elevation O O
in O O
serum O O
of O O
α-fetoprotein O O
more O O
than O O
the O O
carbohydrate O O
antigen O O
125 O O
. O O

the O O
disease O O
was O O
metastatic O O
and O O
the O O
patient O O
got O O
a O O
palliative O O
chemotherapy O O
with O O
paclitaxel O O
175 O O
mg O O
/ O O
m2 O O
and O O
carboplatin O O
with O O
an O O
area O O
under O O
the O O
curve O O
of O O
5 O O
every O O
3 O O
weeks O O
. O O

evaluation O O
after O O
3 O O
cycles O O
revealed O O
the O O
drop O O
of O O
patient's O O
performance O O
status O O
to O O
3 O O
versus O O
2 O O
with O O
an O O
increase O O
in O O
the O O
AFP O O
level O O
to O O
350 O O
versus O O
150 O O
ng O O
/ O O
ml O O
and O O
radiologic O O
stability O O
according O O
to O O
RECIST O O
1.1 O O
( O O
figure O O
6 O O
) O O
. O O

the O O
patient O O
was O O
not O O
legible O O
for O O
receiving O O
a O O
second O O
line O O
of O O
treatment O O
. O O

she O O
died O B-C1546956
one O O
month O O
later O O
. O O

A O O
66 O O
year O O
old O O
patient O O
with O O
a O O
history O O
of O O
UC O O
treated O O
by O O
mesalazine O O
since O O
5 O O
years O O
consulted O O
in O O
july O O
2012 O O
for O O
a O O
painful O O
erythematous O O
swelling O B-C0038999
of O O
the O O
back O O
of O O
the O O
right O O
hand O O
. O O

the O O
bacteriological O O
samples O O
were O O
negative O O
, O O
the O O
lesion O B-C0221198
was O O
considered O O
as O O
an O O
abscesses O B-C0000833
and O O
the O O
patient O O
was O O
treated O O
with O O
antibiotics O O
and O O
local O O
antiseptics O O
without O O
improvement O O
. O O

the O O
evolution O O
was O O
characterized O O
by O O
the O O
appearance O O
of O O
an O O
erythematous O O
vesiculobullous O O
centrifugal O O
expansion O O
taking O O
the O O
whole O O
back O O
of O O
the O O
right O O
hand O O
treated O O
several O O
times O O
by O O
various O O
antibiotics O O
unsuccessfully O O
. O O

biopsy O O
of O O
this O O
lesion O B-C0221198
was O O
initially O O
not O O
specific O O
. O O

in O O
october O O
2012 O O
, O O
the O O
patient O O
was O O
hospitalized O O
for O O
fever O B-C0015967
and O O
polyarthralgia O B-C0162296
in O O
the O O
context O O
of O O
impaired O O
general O O
condition O O
. O O

he O O
had O O
a O O
quiescent O O
UC O O
disease O O
. O O

the O O
skin O O
examination O O
found O O
an O O
erythematous O O
plaque O O
of O O
10 O O
cm O O
of O O
diameter O O
, O O
with O O
a O O
raised O O
border O O
and O O
vesicules O O
, O O
taking O O
the O O
back O O
of O O
the O O
right O O
hand O O
and O O
wrist O O
. O O

there O O
was O O
also O O
an O O
infiltrated O O
erythematous O O
plaque O O
on O O
the O O
right O O
leg O O
and O O
another O O
topped O O
with O O
a O O
large O O
pustule O B-C0241157
at O O
the O O
left O O
ankle O O
. O O

in O O
biology O O
, O O
there O O
was O O
a O O
biological O O
inflammatory O O
syndrome O O
and O O
high O O
leukocytosis O B-C0023518
with O O
neutrophils O O
. O O

hepatic O O
and O O
renal O O
functions O O
were O O
normal O O
. O O

skin O O
biopsy O O
showed O O
at O O
the O O
edge O O
of O O
the O O
back O O
of O O
the O O
closet O O
right O O
hand O O
ulcerated O O
epidermis O O
and O O
the O O
dermis O O
infiltrate O B-C0332448
rich O O
in O O
neutrophils O O
with O O
leukocytoclastic O B-C2973529
vasculitis O I-C2973529
finding O B-C0037088
a O O
PG O O
. O O

other O O
biopsies O O
taken O O
at O O
infiltrated O O
erythematous O B-C0332477
plaques O I-C0332477
of O O
the O O
ankle O O
showed O O
a O O
normal O O
appearance O O
of O O
skin O O
, O O
edema O O
of O O
the O O
superficial O O
dermis O O
based O O
on O O
an O O
infiltrate O B-C0332448
rich O O
in O O
neutrophils O O
without O O
vasculitis O B-C0042384
confirming O O
the O O
diagnosis O O
of O O
SS O O
. O O

corticosteroid O O
treatment O O
was O O
then O O
started O O
with O O
prednisolone O O
at O O
a O O
dose O O
of O O
1mg O O
/ O O
kg O O
/ O O
j O O
. O O

the O O
evolution O O
was O O
marked O O
since O O
day O O
7 O O
of O O
treatment O O
by O O
the O O
desinfiltration O O
of O O
the O O
plaques O O
, O O
the O O
recovery O O
of O O
the O O
general O O
condition O O
and O O
disappearance O O
of O O
biological O O
inflammatory O O
syndrome O O
. O O

A O O
56 O O
- O O
year-old O O
female O O
without O O
any O O
pathological O O
history O O
presented O O
to O O
the O O
emergency O O
department O O
of O O
plastic O O
and O O
hand O O
surgery O O
of O O
la O O
rabta O O
hospital O O
in O O
tunis O O
with O O
a O O
painful O O
swollen O O
right O O
hand O O
evolving O O
for O O
48 O O
hours O O
. O O

during O O
anamnesis O O
, O O
the O O
patient O O
did O O
not O O
report O O
any O O
recent O O
trauma O O
or O O
inoculation O O
in O O
the O O
hand O O
. O O

but O O
she O O
mentioned O O
that O O
six O O
days O O
earlier O O
, O O
her O O
cat O O
bit O O
her O O
in O O
the O O
thumb O O
. O O

physical O O
examination O O
showed O O
a O O
significant O O
edema O O
of O O
the O O
right O O
hand O O
with O O
a O O
flessum O O
of O O
the O O
fingers O O
associated O O
to O O
paresthesia O B-C0030554
in O O
the O O
territory O O
of O O
the O O
median O O
nerve O O
. O O

passive O O
finger O O
extension O O
was O O
impossible O O
and O O
extremely O O
painful O O
. O O

there O O
was O O
no O O
apparent O O
infection O B-C3714514
or O O
necrosis O O
of O O
the O O
skin O O
but O O
we O O
noted O O
a O O
high O O
local O O
temperature O O
. O O

biology O O
showed O O
an O O
elevated O O
rate O O
of O O
white O O
blood O O
cells O O
and O O
a O O
slightly O O
elevated O O
rate O O
of O O
c-reactive O O
protein O O
. O O

the O O
diagnosis O O
of O O
an O O
acute O O
carpal O B-C0007286
tunnel O I-C0007286
syndrome O I-C0007286
associated O O
to O O
a O O
compartment O B-C0009492
syndrome O I-C0009492
of O O
the O O
hand O O
was O O
clinically O O
obvious O O
. O O

the O O
patient O O
was O O
immediately O O
operated O O
with O O
a O O
large O O
incision O O
of O O
the O O
carpal O O
tunnel O O
that O O
evacuated O O
high O O
pressure O O
viscous O O
yellowish O O
substance O O
from O O
which O O
a O O
sample O O
was O O
taken O O
for O O
microbiology O O
tests O O
. O O

we O O
noticed O O
that O O
the O O
median O O
nerve O O
presented O O
signs O O
of O O
vascular O O
suffering O O
. O O

on O O
the O O
posterior O O
side O O
of O O
the O O
hand O O
, O O
two O O
incisions O O
allowed O O
us O O
to O O
perform O O
fasciotomy O O
of O O
the O O
four O O
muscular O O
compartments O O
of O O
the O O
hand O O
. O O

immediately O O
, O O
finger O O
extension O O
was O O
easily O O
obtained O O
. O O

the O O
carpal O O
tunnel O O
and O O
the O O
posterior O O
incisions O O
were O O
completely O O
irrigated O O
with O O
saline O O
solution O O
. O O

after O O
surgery O O
, O O
the O O
patient O O
reported O O
that O O
paresthesia O B-C0030554
disappeared O O
. O O

A O O
splint O O
was O O
crafted O O
to O O
maintain O O
the O O
hand O O
and O O
wrist O O
in O O
a O O
functional O O
position O O
and O O
limb O O
elevation O O
was O O
advised O O
to O O
limit O O
the O O
edema O O
. O O

the O O
patient O O
was O O
placed O O
under O O
doxycycline O O
and O O
started O O
rehabilitation O O
. O O

after O O
two O O
months O O
of O O
follow O O
up O O
, O O
we O O
noticed O O
a O O
regression O B-C1836830
of O O
edema O O
, O O
good O O
functional O O
outcome O O
with O O
good O O
finger O O
mobility O O
and O O
a O O
disappearance O O
of O O
paresthesia O B-C0030554
. O O

A O O
25 O O
- O O
year-old O O
female O O
presenting O O
with O O
3 O O
months O O
history O O
of O O
cauda O B-C0392548
equina O I-C0392548
syndrome O I-C0392548
progressively O O
worsening O O
. O O

lumbar O O
spine O O
medical O O
imaging O O
revealed O O
in O O
MRI O O
scan O O
a O O
low O O
signal O O
intensity O O
process O O
on O O
T1 O O
a O O
high O O
signal O O
intensity O O
on O O
T2 O O
and O O
in O O
CT O O
scan O O
a O O
hypodense O O
process O O
extending O O
on O O
a O O
height O O
of O O
7cm O O
and O O
developing O O
in O O
the O O
left O O
posterior O O
lumbar O O
soft O O
tissues O O
at O O
the O O
height O O
of O O
L5 O O
extending O O
in O O
the O O
left O O
sacral O O
region O O
with O O
infiltration O O
and O O
osteolysis O B-C4721411
of O O
the O O
sacroiliac O O
joint O O
and O O
the O O
left O O
sacral O O
foramina O O
with O O
nerve O B-C0751463
root O I-C0751463
compression O I-C0751463
at O O
this O O
level O O
. O O

the O O
patient O O
underwent O O
surgery O O
with O O
resection O O
of O O
a O O
left O O
paravertebral O O
lesion O B-C0221198
+ O O
L5 O O
and O O
S1 O O
laminectomy O O
+ O O
partial O O
resection O O
of O O
the O O
intraductal O O
portion O O
of O O
the O O
tumor O B-C0027651
. O O

histopathological O O
study O O
showed O O
that O O
the O O
tumor O B-C0027651
is O O
characterized O O
by O O
multilobular O O
structures O O
divided O O
by O O
fibrous O O
septa O O
, O O
and O O
disposed O O
in O O
an O O
abundant O O
myxoid O O
matrix O O
. O O
tumoral O O
cells O O
are O O
isolated O O
or O O
grouped O O
in O O
cords O O
, O O
mitoses O O
are O O
rare O O
. O O

cells O O
express O O
the O O
protein O O
S100 O O
and O O
NSE O O
and O O
do O O
not O O
express O O
cytokeratin O O
AE1 O O
/ O O
AE3 O O
and O O
desmin O O
. O O

based O O
on O O
these O O
findings O O
, O O
the O O
patient O O
was O O
diagnosed O O
with O O
EMC O O
. O O

postoperative O O
spinal O O
MRI O O
showed O O
the O O
persistence O O
of O O
a O O
large O O
tumor O B-C3273930
mass O I-C3273930
of O O
the O O
erector O O
muscles O O
of O O
the O O
lumbar O O
spine O O
68x12mm O O
extending O O
to O O
the O O
gluteal O O
muscles O O
, O O
with O O
persistence O O
of O O
the O O
anterior O O
epidural O O
tumoral O O
component O O
and O O
extension O O
at O O
lumbosacral O O
spinal O O
. O O

at O O
his O O
admission O O
to O O
the O O
department O O
of O O
radiotherapy O O
, O O
4 O O
weeks O O
later O O
, O O
clinical O O
examination O O
found O O
a O O
huge O O
mass O O
in O O
the O O
left O O
buttock O O
and O O
posterior O O
lumbar O O
region O O
. O O

planning O O
CT O O
and O O
CT O O
scanner O O
found O O
an O O
increase O O
in O O
tumor O B-C0027651
volume O O
with O O
the O O
same O O
extensions O O
described O O
in O O
the O O
postoperative O O
imaging O O
in O O
addition O O
to O O
extension O O
at O O
the O O
left O O
iliac O O
bone O O
and O O
at O O
the O O
left O O
iliac O O
psoas O O
muscle O O
protruding O O
at O O
the O O
left O O
lateral O O
pelvic O O
region O O
. O O

from O O
these O O
results O O
, O O
a O O
palliative O O
radiotherapy O O
was O O
delivered O O
in O O
the O O
total O O
dose O O
of O O
20 O O
gy O O
in O O
5 O O
fractions O O
of O O
4gy O O
. O O

the O O
patient O O
was O O
referred O O
for O O
chemotherapy O O
thereafter O O
. O O

we O O
report O O
a O O
case O O
of O O
a O O
30 O O
- O O
year-old O O
man O O
who O O
presented O O
electively O O
in O O
our O O
clinic O O
with O O
a O O
history O O
of O O
intermittent O O
high O O
grade O O
fever O B-C0015967
and O O
right O O
lower O O
quadrant O O
non-radiating O O
abdominal O B-C0000737
pain O I-C0000737
for O O
1 O O
year O O
+ O O
6 O O
months O O
duration O O
, O O
for O O
which O O
he O O
consulted O O
and O O
treated O O
in O O
5 O O
different O O
health O O
facilities O O
with O O
no O O
favourable O O
evolution O O
. O O

on O O
review O O
of O O
his O O
systems O O
; O O
presence O O
of O O
non-productive O B-C0850149
cough O I-C0850149
, O O
intermittent O O
night O O
sweat O O
, O O
loss O B-C1971624
of O I-C1971624
appetite O I-C1971624
, O O
nausea O B-C0027497
but O O
neither O O
vomiting O B-C0042963
nor O O
altered O O
bowel O O
habit O O
. O O

his O O
past O O
history O O
is O O
remarkable O O
for O O
appendicectomy O O
10 O O
months O O
ago O O
after O O
he O O
consulted O O
for O O
similar O O
complaints O O
. O O

also O O
, O O
there O O
is O O
a O O
history O O
of O O
contact O O
with O O
relative O O
diagnose O O
with O O
pulmonary O B-C0041327
tuberculosis O I-C0041327
( O O
TB O O
) O O
2 O O
years O O
ago O O
. O O

on O O
examination O O
; O O
our O O
patient O O
was O O
normotensive O B-C2712122
( O O
BP O O
= O O
110 O O
\ O O
70mmhg O O
) O O
febrile O B-C0015967
to O O
touch O O
( O O
temp O O
= O O
38 O O
° O O
c O O
) O O
, O O
lost O O
10% O O
body O O
weight O O
within O O
6 O O
months O O
, O O
ill-looking O O
, O O
asthenic O O
with O O
moderately O O
pink O O
conjunctivae O O
and O O
anicteric O O
sclera O O
. O O

head O O
and O O
neck O O
exam O O
revealed O O
palpable O O
submental O O
, O O
right O O
and O O
left O O
anterior O O
and O O
posterior O O
superficial O O
cervical O O
lymph O O
nodes O O
and O O
right O O
and O O
left O O
axillary O O
lymph O O
nodes O O
. O O

nodes O O
were O O
mobile O O
, O O
non-tender O O
with O O
the O O
left O O
cervical O O
node O O
having O O
the O O
largest O O
diameter O O
of O O
4cm O O
. O O

presence O O
of O O
fine O O
inspiratory O B-C0577961
crackles O I-C0577961
on O O
chest O O
examination O O
. O O

abdominal O O
examination O O
revealed O O
grid-iron O O
incision O O
mark O O
and O O
mild O O
tenderness O O
around O O
the O O
right O O
lower O O
abdominal O O
quadrant O O
. O O

A O O
working O O
diagnosis O O
of O O
mesenteric O B-C0025469
adenitis O I-C0025469
+ O O
lymph O B-C0041316
node O I-C0041316
tuberculosis O I-C0041316
was O O
made O O
. O O

A O O
full O O
blood O O
count O O
( O O
microcytic O O
hypochromic O O
anaemia O B-C0002871
with O O
hb O O
= O O
11g O O
\ O O
dl O O
, O O
lymphocytosis O B-C0024282
) O O
, O O
chest O O
x-ray O O
( O O
showed O O
parahila O O
nodes O O
) O O
, O O
normal O O
abdominal O O
ultrasound O O
, O O
lymph O O
node O O
biopsy O O
and O O
histopathology O O
( O O
showed O O
granulomas O B-C0018188
with O O
langham O O
giant O O
cells O O
and O O
central O O
caseation O O
) O O
. O O

patient O O
was O O
then O O
placed O O
on O O
a O O
6 O O
month O O
anti-tb O O
regiment O O
under O O
direct O O
observational O O
therapy O O
. O O

two O O
weeks O O
after O O
onset O O
of O O
treatment O O
evolution O O
was O O
favourable O O
with O O
normal O O
body O O
temperature O O
and O O
gain O O
of O O
appetite O O
. O O

three O O
months O O
later O O
, O O
patient O O
gained O O
4kg O O
body O O
weight O O
, O O
no O O
palpable O O
submental O O
and O O
axillary O O
lymph O O
node O O
; O O
there O O
is O O
mark O O
reduction O O
in O O
size O O
of O O
cervical O O
lymph O O
nodes O O
. O O

patient O O
is O O
fine O O
now O O
, O O
has O O
no O O
complaint O O
and O O
has O O
resume O O
work O O
. O O

A O O
45 O O
year-old O O
unmarried O B-C0087136
female O O
, O O
presented O O
in O O
the O O
department O O
of O O
otorhinolaryngology O O
with O O
chief O O
compliant O O
of O O
slow O O
growing O O
swelling O B-C0038999
over O O
palate O O
since O O
last O O
6 O O
months O O
. O O

the O O
lady O O
also O O
complained O O
of O O
pain O B-C0030193
over O O
swelling O B-C0038999
while O O
swallowing O O
along O O
with O O
difficulty O O
in O O
deglutition O O
because O O
of O O
swelling O B-C0038999
. O O

there O O
was O O
no O O
history O O
of O O
headache O B-C0018681
, O O
vertigo O B-C0042571
, O O
ear O B-C0155540
discharge O I-C0155540
, O O
trauma O O
or O O
any O O
other O O
associated O O
symptoms O O
. O O

there O O
was O O
no O O
history O O
of O O
fever O B-C0015967
, O O
weight O B-C1262477
loss O I-C1262477
, O O
bleeding O B-C0019080
, O O
pus O O
discharge O O
or O O
any O O
other O O
type O O
of O O
discharge O O
from O O
the O O
swelling O B-C0038999
. O O

the O O
personal O O
history O O
of O O
the O O
patient O O
did O O
not O O
reveal O O
any O O
history O O
of O O
smoking O O
, O O
or O O
any O O
other O O
addiction O O
. O O

on O O
past O O
history O O
there O O
was O O
no O O
history O O
of O O
similar O O
illness O O
in O O
past O O
neither O O
there O O
was O O
any O O
past O O
history O O
of O O
significant O O
medical O O
or O O
surgical O O
illness O O
. O O

there O O
was O O
no O O
family O B-C0241889
history O I-C0241889
of O O
similar O O
complaints O O
. O O

the O O
patient O O
did O O
not O O
take O O
any O O
treatment O O
for O O
the O O
above O O
complaints O O
and O O
presented O O
for O O
the O O
first O O
time O O
in O O
our O O
hospital O O
for O O
the O O
similar O O
complaints O O
. O O

general O O
examination O O
reveals O O
normal O O
and O O
stable O O
vital O O
parameters O O
. O O

there O O
was O O
no O O
icterus O B-C0022346
or O O
pallor O B-C0030232
. O O

the O O
examination O O
of O O
remaining O O
body O O
did O O
not O O
reveal O O
any O O
other O O
swelling O B-C0038999
. O O

the O O
systemic O O
examination O O
of O O
other O O
systems O O
was O O
within O O
normal O O
limits O O
. O O

on O O
local O O
examination O O
there O O
was O O
a O O
globular O O
mass O O
on O O
right O O
side O O
of O O
palate O O
with O O
normal O O
overlying O O
mucosa O O
was O O
seen O O
. O O

the O O
lesion O B-C0221198
appeared O O
to O O
arise O O
from O O
mid O O
part O O
of O O
palate O O
, O O
extending O O
up O O
to O O
the O O
posterior O O
border O O
of O O
hard O O
palate O O
. O O

it O O
was O O
non-tender O O
, O O
firm O O
, O O
and O O
non O O
compressible O O
and O O
had O O
well O O
defined O O
margins O O
. O O

posteriorly O O
it O O
was O O
limited O O
by O O
the O O
posterior O O
margin O O
of O O
soft O O
palate O O
and O O
anteriorly O O
merging O O
with O O
the O O
soft O O
palate O O
. O O

superiorly O O
it O O
was O O
extending O O
into O O
nasopharyngeal O O
region O O
. O O

the O O
transillumination O O
test O O
was O O
negative O O
. O O

rest O O
of O O
otorhinolaryngological O O
examination O O
did O O
not O O
reveal O O
any O O
other O O
significant O O
abnormality O O
. O O

on O O
the O O
basis O O
of O O
history O O
and O O
clinical O O
examination O O
a O O
diagnosis O O
of O O
solid O O
non O O
infectious O O
mass O O
of O O
soft O O
palate O O
likely O O
of O O
benign O O
etiology O O
was O O
made O O
. O O

the O O
possibility O O
of O O
infective O O
etiology O O
( O O
palatal O O
abscess O B-C0000833
) O O
was O O
less O O
likely O O
as O O
there O O
no O O
fever O B-C0015967
neither O O
there O O
was O O
any O O
tenderness O O
or O O
erythema O O
. O O

she O O
was O O
then O O
advised O O
a O O
contrast O O
enhanced O O
computed O O
tomography O O
scan O O
of O O
paranasal O O
sinuses O B-C0016169
. O O

CT O O
scan O O
was O O
performed O O
on O O
a O O
dual O O
source O O
128 O O
slice O O
spiral O O
CT O O
with O O
coronal O O
and O O
saggital O O
reformations O O
. O O

the O O
CT O O
scan O O
revealed O O
a O O
well O O
defined O O
homogeneously O O
enhancing O O
hypodense O O
soft O O
tissue O O
les O O
ion O O
of O O
size O O
4,27 O O
cm O O
X O O
4cm O O
X O O
4,5 O O
cm O O
arising O O
from O O
right O O
side O O
of O O
soft O O
palate O O
and O O
abutting O O
the O O
hard O O
palate O O
anteriorly O O
, O O
uvula O O
posteriorly O O
, O O
tongue O O
inferiorly O O
and O O
nasopharyngeal O O
wall O O
superiorly O O
. O O

laterally O O
it O O
was O O
seen O O
to O O
be O O
abutting O O
the O O
right O O
lateral O O
nasopharyngeal O O
wall O O
. O O

there O O
was O O
no O O
infiltration O O
of O O
the O O
surrounding O O
structures O O
with O O
well O O
defined O O
surrounding O O
planes O O
. O O

there O O
was O O
no O O
non O O
enhancing O O
area O O
within O O
to O O
suggest O O
central O O
necrosis O O
of O O
secondary O B-C0442886
infection O I-C0442886
. O O

the O O
radiological O O
features O O
were O O
suggestive O O
of O O
a O O
benign O O
etiology O O
neoplastic O O
mass O O
. O O

the O O
possibility O O
of O O
other O O
clinical O O
diagnosis O O
of O O
palatal O O
abscess O B-C0000833
was O O
completely O O
ruled O O
out O O
. O O

the O O
patient O O
was O O
then O O
advised O O
surgical O O
excision O O
of O O
the O O
lesion O B-C0221198
. O O

A O O
biopsy O O
was O O
performed O O
, O O
which O O
was O O
suggestive O O
of O O
PA O O
. O O

all O O
preoperative O O
blood O O
and O O
urine O O
investigations O O
were O O
done O O
, O O
which O O
were O O
within O O
normal O O
limits O O
. O O

the O O
patient O O
underwent O O
surgery O O
under O O
general O O
anesthesia O B-C0278134
. O O

the O O
excised O O
mass O O
was O O
5 O O
× O O
4 O O
cm O O
and O O
surgical O B-C0332803
wound O I-C0332803
was O O
closed O O
with O O
advancement O O
of O O
adjacent O O
mucosa O O
. O O

histopathological O O
examination O O
revealed O O
epithelial O O
and O O
mesenchymal O O
cells O O
and O O
along O O
with O O
other O O
features O O
was O O
suggestive O O
of O O
pleomorphic O B-C0026277
adenoma O I-C0026277
. O O

the O O
patient's O O
postoperative O O
course O O
was O O
uneventful O O
. O O

the O O
healing O O
was O O
satisfactory O O
. O O

no O O
recurrence O O
was O O
observed O O
after O O
a O O
follow-up O O
period O O
of O O
1 O O
year O O
. O O

A O O
13 O O
year-old O O
tunisian O O
male O O
was O O
admitted O O
in O O
our O O
department O O
of O O
paediatric O O
nephrology O O
on O O
october O O
2009 O O
with O O
a O O
week-history O O
of O O
fever O B-C0015967
and O O
asthenia O B-C0004093
. O O

he O O
was O O
suffering O O
from O O
end-stage O B-C0022661
renal O I-C0022661
failure O I-C0022661
attributed O O
to O O
a O O
vesico-ureteral O B-C0042580
reflux O I-C0042580
discovered O O
in O O
2003 O O
. O O

in O O
2007 O O
, O O
the O O
patient O O
had O O
a O O
pre-emptive O O
renal O O
transplant O B-C0478647
from O O
a O O
living O O
donor O O
. O O

the O O
post-operative O O
course O O
was O O
characterised O O
by O O
an O O
acute O O
ischemia O B-C0022116
of O O
the O O
transplant O B-C0478647
due O O
to O O
a O O
venous O O
renal O B-C0866188
thrombosis O I-C0866188
that O O
lead O O
to O O
a O O
detransplantation O O
. O O

A O O
regular O O
peritoneal O O
dialysis O O
was O O
initiated O O
on O O
june O O
2007 O O
. O O

A O O
second O O
renal O O
transplantation O O
was O O
performed O O
on O O
june O O
2009 O O
from O O
a O O
27 O O
year-old O O
deceased O O
donor O O
. O O

the O O
post O O
operative O O
course O O
was O O
uneventful O O
. O O

the O O
patient O O
was O O
maintained O O
on O O
prednisone O O
10 O O
mg O O
/ O O
day O O
, O O
mycophenolate O O
mofetil O O
1500 O O
mg O O
/ O O
day O O
, O O
and O O
cyclosporine O O
75 O O
mg O O
twice O O
per O O
day O O
with O O
adequate O O
renal O O
function O O
. O O

three O O
months O O
after O O
transplantation O O
, O O
the O O
patient O O
was O O
hospitalized O O
in O O
our O O
department O O
for O O
fever O B-C0015967
with O O
asthenia O B-C0004093
. O O

the O O
physical O O
examination O O
on O O
admission O O
revealed O O
asthenic O O
patient O O
, O O
with O O
temperature O O
of O O
38.5 O O
° O O
C O O
, O O
blood O O
pressure O O
of O O
110 O O
/ O O
70 O O
mm O O
hg O O
, O O
pulse O O
rate O O
of O O
90 O O
/ O O
min O O
, O O
and O O
inspiratory O O
rhonchi O B-C0035508
with O O
decreased O O
breath O O
sound O O
over O O
both O O
bases O O
. O O

there O O
were O O
no O O
peripheral O O
lymph O O
nodes O O
or O O
hepatosplenomegaly O B-C0019214
. O O

laboratory O O
investigations O O
revealed O O
hematocrit O O
of O O
38% O O
, O O
white O O
blood O O
cell O O
count O O
of O O
8300 O O
/ O O
mm O O
3 O O
, O O
platelet O O
count O O
of O O
220.000 O O
/ O O
mm O O
3 O O
, O O
blood O O
urea O O
nitrogen O O
of O O
6.8 O O
mmol O O
/ O O
l O O
, O O
serum O O
creatinine O O
level O O
of O O
75 O O
µmol O O
/ O O
l O O
, O O
C O O
reactive O O
protein O O
serum O O
level O O
of O O
88.5mg O O
/ O O
l O O
and O O
erythrocyte O O
sedimentation O O
rate O O
of O O
51 O O
mm O O
/ O O
hour O O
. O O

liver O O
function O O
tests O O
and O O
lipid O O
profile O O
were O O
normal O O
. O O

the O O
protein O O
electrophoresis O O
showed O O
a O O
total O O
protein O O
serum O O
level O O
of O O
65g O O
/ O O
l O O
, O O
( O O
albumin O O
33.9g O O
/ O O
l O O
, O O
α1 O O
globulin O O
5.8g O O
/ O O
l O O
, O O
α2 O O
globulin O O
9.6g O O
/ O O
l O O
, O O
β1 O O
globulin O O
3.9g O O
/ O O
l O O
, O O
β2 O O
globulin O O
3.4g O O
/ O O
l O O
, O O
γ O O
globulin O O
8.3g O O
/ O O
l O O
) O O
. O O

the O O
chest O O
x-ray O O
revealed O O
opacity O O
in O O
the O O
right O O
middle O O
zone O O
and O O
superior O O
mediastinal O O
enlargement O O
. O O

A O O
thoracic O B-C0729233
CT O O
scan O O
showed O O
cavitatory O O
pneumonia O B-C0032285
of O O
the O O
right O O
lower O O
lobe O O
and O O
anterior O O
mediastinal O O
mass O O
on O O
right O O
and O O
left O O
main O O
stem O O
bronchi O O
corresponding O O
to O O
lymph O O
nodes O O
. O O

regarding O O
the O O
clinical O O
, O O
biological O O
and O O
radiological O O
findings O O
, O O
three O O
diagnoses O O
were O O
suspected O O
: O O
pneumonia O B-C0032285
, O O
pulmonary O B-C0041327
tuberculosis O I-C0041327
and O O
pulmonary O B-C2350529
aspergillosis O I-C2350529
. O O

by O O
considering O O
the O O
history O O
of O O
the O O
patient O O
and O O
the O O
fact O O
that O O
our O O
country O O
is O O
endemic O O
, O O
our O O
diagnosis O O
was O O
quickly O O
directed O O
towards O O
pulmonary O B-C0041327
tuberculosis O I-C0041327
despite O O
the O O
negativity O O
of O O
tuberculin O O
skin O O
test O O
. O O

the O O
search O O
of O O
mycobacterium O B-C0026918
tuberculosis O B-C0041296
by O O
gastric O O
tubing O O
was O O
negative O O
but O O
the O O
diagnosis O O
was O O
made O O
by O O
the O O
study O O
of O O
sputum O O
specimens O O
aspirated O O
during O O
bronchoalveolar O O
lavage O O
that O O
revealed O O
the O O
presence O O
of O O
mycobacterium O B-C0026918
tuberculosis O B-C0041296
. O O

in O O
vitro O O
studies O O
showed O O
the O O
organisms O O
to O O
be O O
fully O O
susceptible O O
to O O
all O O
antituberculosis O O
drugs O O
. O O

four O O
drugs O O
, O O
isoniazid O O
( O O
INH O O
) O O
, O O
rifadine O O
( O O
RIF O O
) O O
, O O
ethambutol O O
\ O O
( O O
EMB O O
) O O
and O O
pyazolin O O
\ O O
( O O
PZA O O
) O O
were O O
administered O O
orally O O
with O O
the O O
usual O O
doses O O
. O O

the O O
dose O O
of O O
corticosteroids O O
was O O
increased O O
and O O
that O O
of O O
cyclosporine O O
was O O
adjusted O O
to O O
maintain O O
trough O O
plasma O O
levels O O
in O O
recommended O O
therapeutic O O
range O O
. O O

to O O
prevent O O
the O O
neurological O O
side O O
effects O O
of O O
INH O O
we O O
prescribed O O
a O O
pyridoxine O O
in O O
dose O O
of O O
50 O O
mg O O
per O O
day O O
. O O

the O O
outcome O O
under O O
antitubercular O O
therapy O O
has O O
so O O
far O O
been O O
favourable O O
, O O
with O O
prolonged O O
apyrexia O O
and O O
regression O B-C1836830
of O O
the O O
pulmonary O O
abnormalities O O
. O O

this O O
regimen O O
, O O
maintained O O
during O O
18 O O
months O O
, O O
was O O
well O O
tolerated O O
without O O
any O O
modification O O
in O O
liver O O
tests O O
and O O
graft O O
function O O
. O O

patient O O
1 O O
A O O
two-month-old O O
boy O O
had O O
been O O
hospitalized O O
in O O
pediatric O O
surgery O O
unit O O
for O O
suspected O O
tracheo-osefageal O O
fistula O B-C0016169
. O O

he O O
was O O
referred O O
from O O
another O O
hospital O O
with O O
the O O
diagnosis O O
of O O
recurrent O B-C0747651
aspiration O I-C0747651
pneumonia O I-C0747651
unresponsive O O
to O O
antibiotic O O
therapy O O
. O O

on O O
the O O
admission O O
, O O
he O O
had O O
tachypnea O B-C0231835
and O O
subfebrile O O
fever O B-C0015967
on O O
physical O O
examination O O
. O O

laboratory O O
tests O O
showed O O
a O O
white O O
blood O O
cell O O
( O O
WBC O O
) O O
of O O
10900 O O
/ O O
µl O O
, O O
c-reactive O O
protein O O
( O O
CRP O O
) O O
of O O
11.8 O O
mg O O
/ O O
L O O
and O O
normal O O
biochemistry O O
values O O
. O O

peripheral O O
blood O O
culture O O
wasobtained O O
. O O

twelve O O
hours O O
later O O
, O O
the O O
bact O O
/ O O
alert O O
device O O
( O O
biomerièux O O
, O O
marseille O O
, O O
france O O
) O O
gave O O
a O O
signal O O
indicating O O
a O O
growth O O
of O O
microorganism O O
. O O

gram O O
staining O O
was O O
positive O O
forgram-negative O O
coccobacilli O O
. O O

the O O
microorganism O O
was O O
nonmotile O O
, O O
strictly O O
aerobic O O
, O O
catalase-positive O O
and O O
oxidase-negative O O
. O O

empirical O O
antibiotic O O
treatment O O
with O O
meropenem O O
and O O
amikacin O O
was O O
started O O
. O O

the O O
next O O
day O O
, O O
vitek O O
MS O O
( O O
biomerièux O O
, O O
marseille O O
, O O
france O O
) O O
identified O O
the O O
microorganism O O
as O O
acinetobacterursingii O O
and O O
reliability O O
was O O
99.9% O O
. O O

the O O
e-test O O
used O O
to O O
describe O O
antimicrobiological O O
susceptibility O O
showed O O
that O O
the O O
microorganism O O
was O O
susceptible O O
to O O
ampicillin-sulbactam O O
, O O
gentamicin O O
, O O
ciprofloxacin O O
and O O
imipenem O O
. O O

the O O
antibiotic O O
therapy O O
was O O
de-escalated O O
to O O
ampicillin-sulbactam O O
. O O

on O O
the O O
third O O
day O O
of O O
the O O
treatment O O
, O O
control O O
peripheral O O
blood O O
culture O O
was O O
taken O O
and O O
remainedsterile O O
. O O

he O O
was O O
successfully O O
treated O O
with O O
ampicillin-sulbactam O O
. O O

patient O O
2 O O
A O O
fourteen-month-old O O
boy O O
with O O
the O O
diagnosis O O
of O O
gastroesophageal O B-C0017168
reflux O I-C0017168
disease O I-C0017168
was O O
admitted O O
to O O
our O O
hospital O O
with O O
complaints O O
of O O
vomiting O B-C0042963
and O O
diarrhea O B-C0011991
for O O
amonth O O
. O O

on O O
admission O O
, O O
his O O
physical O O
examination O O
revealed O O
fever O B-C0015967
( O O
38.4 O O
° O O
C O O
) O O
. O O

because O O
of O O
the O O
prolonged O O
diarrhea O B-C0011991
and O O
vomiting O B-C0042963
, O O
patient O O
was O O
hospitalized O O
and O O
further O O
investigated O O
. O O

laboratory O O
tests O O
showed O O
a O O
WBC O O
of O O
5800 O O
/ O O
µl O O
, O O
CRP O O
of O O
3.2 O O
mg O O
/ O O
L O O
and O O
normal O O
biochemistry O O
values O O
. O O

peripheral O O
blood O O
culture O O
was O O
obtainedand O O
signaled O O
growth O O
for O O
gram-negative O O
bacilli O O
. O O

empirical O O
antibiotic O O
treatment O O
with O O
meropenem O O
and O O
amikacin O O
was O O
started O O
. O O

microorganism O O
was O O
identified O O
as O O
acinetobacterursingii O O
by O O
vitek O O
MS O O
( O O
biomerièux O O
) O O
with O O
a O O
reliability O O
of O O
99.9% O O
. O O

the O O
e-test O O
showed O O
that O O
A O O
. O O
ursingii O O
was O O
susceptible O O
to O O
ampicilin-sulbactam O O
, O O
gentamicin O O
, O O
ciprofloxacin O O
and O O
imipenem O O
. O O

the O O
antibiotic O O
therapy O O
was O O
deescalated O O
to O O
ampicin-sulbactam O O
. O O

on O O
the O O
third O O
day O O
of O O
the O O
treatment O O
, O O
control O O
peripheral O O
blood O O
culture O O
remained O O
sterile O O
. O O

he O O
was O O
successfully O O
treated O O
with O O
ampicillin-sulbactam O O
. O O

this O O
is O O
a O O
girl O O
aged O O
24 O O
, O O
without O O
specific O O
medical O O
history O O
, O O
which O O
arose O O
in O O
consultation O O
for O O
a O O
right O O
axillary O O
mass O O
gradually O O
increasing O O
volume O O
for O O
two O O
years O O
without O O
inflammatory O O
signs O O
operating O O
in O O
a O O
context O O
of O O
conservation O O
general O O
condition O O
. O O

physical O O
examination O O
revealed O O
a O O
hard O O
mass O O
axillary O O
measuring O O
about O O
12 O O
cm O O
, O O
attached O O
to O O
the O O
deep O O
plane O O
, O O
associated O O
with O O
muscle O B-C0151786
weakness O I-C0151786
throughout O O
the O O
right O O
upper O O
limb O O
and O O
a O O
deficit O O
of O O
the O O
radial O O
nerve O O
realizing O O
the O O
hand O O
drooping O O
appearance O O
. O O

additional O O
tests O O
in O O
search O O
of O O
the O O
original O O
has O O
been O O
made O O
, O O
a O O
mammo-ultrasound O O
found O O
a O O
mass O O
the O O
axilla O O
without O O
significant O O
abnormality O O
of O O
both O O
breasts O O
, O O
axillary O O
MRI O O
objectified O O
a O O
heterogeneous O O
mass O O
right O O
axillary O O
irregular O O
contours O O
measuring O O
171 O O
/ O O
88 O O
/ O O
115 O O
mm O O
embracing O O
and O O
delivering O O
the O O
right O O
axillary O O
artery O O
. O O

thoraco-abdominal O O
pelvic O O
CT O O
showed O O
no O O
secondary O O
locations O O
. O O

histological O O
study O O
with O O
immunohistochemistry O O
on O O
biopsy O O
of O O
the O O
mass O O
was O O
in O O
favor O O
of O O
apocrine O O
carcinoma O O
: O O
tumor O B-C0027651
cells O O
expressed O O
CK7 O O
and O O
CK20 O O
weakly O O
. O O

CD138 O O
, O O
CD30 O O
, O O
CD3 O O
, O O
melan O O
A O O
, O O
hormone O O
receptors O O
and O O
hercep O O
test O O
were O O
negative O O
. O O

the O O
first O O
surgery O O
could O O
not O O
be O O
performed O O
given O O
the O O
involvement O O
of O O
the O O
axillary O O
pedicle O O
. O O

the O O
patient O O
was O O
put O O
on O O
chemotherapy O O
FEC O O
100 O O
. O O

A O O
breast O O
MRI O O
scan O O
done O O
after O O
6 O O
cycles O O
of O O
chemotherapy O O
objectified O O
axillary O O
mass O O
measuring O O
161 O O
/ O O
90 O O
mm O O
coming O O
in O O
contact O O
with O O
the O O
right O O
axillary O O
pedicle O O
remained O O
permeable O O
. O O

surgery O O
was O O
discussed O O
at O O
this O O
stage O O
but O O
challenged O O
seen O O
the O O
intimate O O
contact O O
of O O
the O O
tumor O B-C3273930
mass O I-C3273930
with O O
large O O
axillary O O
vessels O O
. O O

the O O
patient O O
was O O
then O O
put O O
under O O
a O O
kind O O
weekly O O
docetaxel O O
chemotherapy O O
at O O
a O O
dose O O
of O O
24mg O O
/ O O
m O O
2 O O
/ O O
week O O
. O O

CONSENT O O
: O O
written O O
informed O O
consent O O
was O O
obtained O O
from O O
the O O
patient O O
’ O O
s O O
legal O O
guardians O O
for O O
publication O O
of O O
this O O
case O O
report O O
and O O
any O O
accompanying O O
images O O
. O O

A O O
copy O O
of O O
the O O
written O O
consent O O
is O O
available O O
of O O
review O O
by O O
the O O
editor O O
in O O
chief O O
of O O
this O O
journal O O
. O O

the O O
patient O O
was O O
a O O
19 O O
- O O
year O O
old O O
female O O
primigravida O O
who O O
presented O O
with O O
labour-like O O
pains O O
to O O
her O O
local O O
health O O
centre O O
. O O

she O O
was O O
thought O O
to O O
be O O
at O O
term O O
based O O
on O O
her O O
last O O
menstrual O O
period O O
, O O
and O O
had O O
attended O O
one O O
antenatal O O
appointment O O
( O O
of O O
the O O
usual O O
four O O
that O O
are O O
offered O O
) O O
. O O

she O O
reported O O
no O O
previous O O
medical O O
or O O
surgical O O
history O O
and O O
screening O O
test O O
showed O O
she O O
was O O
HIV O B-C0481430
negative O I-C0481430
. O O

she O O
is O O
reported O O
to O O
have O O
told O O
staff O O
that O O
she O O
took O O
" O O
herbs O O
" O O
to O O
start O O
( O O
or O O
induce O O
) O O
her O O
labour O O
. O O

following O O
a O O
vaginal O O
delivery O O
of O O
a O O
live O O
baby O O
of O O
normal O B-C2712185
weight O I-C2712185
she O O
had O O
a O O
post-partum O O
haemorrhage O B-C0019080
and O O
complained O O
of O O
abdominal O B-C0000737
pain O I-C0000737
, O O
but O O
initially O O
this O O
was O O
managed O O
in O O
the O O
local O O
health O O
centre O O
. O O

however O O
, O O
after O O
24 O O
hours O O
she O O
was O O
seen O O
to O O
be O O
deteriorating O O
with O O
confusion O O
and O O
decreased O O
conscious O O
level O O
so O O
was O O
transferred O O
to O O
our O O
unit O O
, O O
the O O
referral O O
hospital O O
for O O
the O O
region O O
. O O

here O O
an O O
intern O O
doctor O O
assessed O O
her O O
and O O
made O O
a O O
provisional O O
diagnosis O O
of O O
sepsis O B-C0243026
of O O
unknown O O
origin O O
and O O
started O O
the O O
patient O O
on O O
broad-spectrum O O
intravenous O O
( O O
IV O O
) O O
antibiotics O O
and O O
fluids O O
. O O

at O O
this O O
stage O O
no O O
observations O O
were O O
recorded O O
and O O
no O O
formal O O
scale O O
was O O
used O O
to O O
assess O O
her O O
conscious O O
level O O
, O O
although O O
it O O
was O O
commented O O
on O O
that O O
she O O
" O O
unresponsive O O
" O O
. O O

again O O
, O O
no O O
documentation O O
was O O
made O O
as O O
to O O
whether O O
she O O
was O O
given O O
the O O
treatment O O
prescribed O O
. O O

the O O
following O O
morning O O
she O O
was O O
reviewed O O
by O O
the O O
author O O
, O O
now O O
more O O
than O O
48 O O
hours O O
since O O
delivery O O
. O O

the O O
patient's O O
observations O O
were O O
pulse O O
rate O O
110 O O
beats O O
per O O
minute O O
, O O
respiratory O O
rate O O
50 O O
breaths O O
per O O
minute O O
, O O
blood O O
pressure O O
110 O O
/ O O
75 O O
mmhg O O
and O O
oxygen O O
saturations O O
were O O
82% O O
on O O
air O O
. O O

no O O
temperature O O
was O O
recorded O O
as O O
no O O
thermometer O O
was O O
available O O
in O O
the O O
unit O O
. O O

she O O
appeared O O
clinically O O
dehydrated O B-C0011175
, O O
with O O
concentrated O O
urine O O
, O O
and O O
her O O
GCS O O
was O O
7 O O
. O O

on O O
examination O O
the O O
chest O O
had O O
bilateral O O
basal O O
crepitations O O
, O O
heart O O
sounds O O
were O O
normal O O
and O O
there O O
was O O
a O O
distended O B-C0000731
abdomen O I-C0000731
. O O

on O O
vaginal O O
examination O O
there O O
was O O
minimal O O
lochia O O
and O O
it O O
was O O
non-offensive O O
. O O

she O O
was O O
given O O
oxygen O O
therapy O O
at O O
the O O
highest O O
concentration O O
available O O
( O O
4L O O
/ O O
min O O
via O O
nasal O O
prongs O O
) O O
and O O
saturations O O
improved O O
to O O
92% O O
. O O

the O O
patient O O
was O O
given O O
IV O O
antibiotics O O
, O O
2 O O
litres O O
of O O
IV O O
normal O O
saline O O
and O O
a O O
decision O O
was O O
made O O
to O O
perform O O
an O O
abdominal O O
ultrasound O O
scan O O
. O O

this O O
was O O
done O O
quickly O O
and O O
the O O
only O O
positive O O
findings O O
were O O
of O O
significant O O
free O O
fluid O O
/ O O
haemoperitoneum O O
. O O

at O O
this O O
point O O
the O O
diagnosis O O
was O O
sepsis O B-C0243026
with O O
possible O O
uterine O B-C0042143
rupture O I-C0042143
. O O

A O O
decision O O
was O O
made O O
for O O
exploratory O O
laparotomy O O
. O O

A O O
sub-umbilical O O
midline O O
incision O O
was O O
performed O O
and O O
at O O
laparotomy O O
there O O
were O O
findings O O
of O O
2 O O
- O O
3L O O
of O O
blood O O
stained O O
ascites O B-C0003962
, O O
sloughy O O
exudate O O
all O O
over O O
the O O
intra-abdominal O O
organs O O
, O O
and O O
a O O
posterior O O
uterine O B-C0042143
rupture O I-C0042143
in O O
a O O
transverse O O
direction O O
approximately O O
7cm O O
in O O
width O O
. O O

the O O
site O O
of O O
the O O
rupture O O
was O O
very O O
low O O
1 O O
- O O
2cm O O
above O O
the O O
internal O O
os O O
of O O
the O O
cervix O O
, O O
although O O
it O O
had O O
not O O
extended O O
into O O
the O O
cervix O O
, O O
vagina O O
or O O
laterally O O
. O O

in O O
view O O
of O O
the O O
viability O O
of O O
the O O
uterine O O
tissue O O
and O O
site O O
of O O
rupture O O
a O O
sub-total O O
hysterectomy O O
was O O
performed O O
and O O
the O O
abdomen O O
washed-out O O
and O O
closed O O
. O O

in O O
the O O
following O O
24 O O
hours O O
the O O
patient's O O
condition O O
continued O O
to O O
deteriorate O O
and O O
although O O
her O O
urine O O
output O O
improved O O
with O O
the O O
IV O O
fluids O O
, O O
her O O
conscious O O
level O O
did O O
not O O
improve O O
, O O
and O O
in-fact O O
deteriorated O O
to O O
a O O
GCS O O
of O O
5 O O
and O O
then O O
3 O O
. O O

treatment O O
was O O
mainly O O
palliative O O
from O O
then O O
on O O
and O O
the O O
patient O O
died O B-C1546956
a O O
few O O
days O O
later O O
. O O

we O O
report O O
a O O
case O O
of O O
38 O O
year O O
old O O
, O O
housewife O O
without O O
past O O
medical O O
history O O
. O O

there O O
was O O
no O O
history O O
of O O
steroid O O
usage O O
, O O
alcohol O O
drinking O O
, O O
or O O
trauma O O
. O O

she O O
presented O O
in O O
2009 O O
, O O
during O O
the O O
third O O
trimester O O
of O O
pregnancy O O
, O O
mechanical O O
pain O B-C0030193
in O O
the O O
left O O
hip O O
, O O
persistent O O
postpartum O O
, O O
causing O O
walking O O
discomfort O B-C2364135
. O O

blood O O
analysis O O
was O O
normal O O
in O O
postpartum O O
, O O
and O O
radiographs O O
showed O O
the O O
femoral O O
head O O
subtle O O
loss O O
of O O
sphericity O O
. O O

T2 O O
- O O
weighted O O
sequence O O
MRI O O
of O O
the O O
femoral O O
heads O O
showed O O
bilateral O O
joint O B-C1253936
effusion O I-C1253936
with O O
focal O O
lesion O B-C0221198
at O O
the O O
anterior O O
part O O
of O O
the O O
left O O
hip O O
. O O

symptomatic O O
treatment O O
was O O
introduced O O
to O O
avoid O O
complications O O
and O O
elective O O
caesarean O O
section O O
was O O
indicated O O
. O O

by O O
the O O
way O O
, O O
she O O
consulted O O
five O O
years O O
ago O O
in O O
our O O
department O O
for O O
the O O
same O O
but O O
bilateral O O
symptoms O O
, O O
and O O
pain O B-C0030193
became O O
more O O
severe O O
at O O
left O O
without O O
extra-articular O O
sign O O
. O O

physical O O
examination O O
revealed O O
a O O
walking O O
limp O O
, O O
weight O O
at O O
65 O O
kg O O
, O O
and O O
167.5 O O
cm O O
for O O
size O O
. O O

there O O
was O O
a O O
pain O B-C0030193
in O O
left O O
hip O B-C2237371
flexion O I-C2237371
with O O
limitation O O
at O O
100 O O
degrees O O
. O O

key O O
sign O O
was O O
positive O O
with O O
positive O O
patrick's O O
( O O
flexion O O
abduction O O
external O O
rotation O O
) O O
tests O O
especially O O
at O O
left O O
hip O O
. O O

radiographs O O
showed O O
prominent O O
osteoarthritis O B-C0029408
, O O
which O O
is O O
espacially O O
at O O
right O O
, O O
with O O
collapse O O
of O O
the O O
articular O O
surface O O
and O O
minimal O O
loss O O
of O O
sphericity O O
at O O
the O O
left O O
femoral O O
head O O
, O O
compared O O
to O O
the O O
radio O O
after O O
pregnancy O O
. O O

laboratory O O
tests O O
were O O
normal O O
( O O
ESR O O
at O O
26 O O
mm O O
/ O O
first O O
hour O O
, O O
rhumatoid O O
factor O O
and O O
antinuclear O O
antibodies O O
were O O
negative O O
, O O
hemoglobin O O
electrophoresis O O
showed O O
; O O
A1 O O
at O O
97 O O
and O O
A2 O O
at O O
3 O O
, O O
antiphospholipid O O
antibodies O O
were O O
negative O O
, O O
and O O
normal O O
lipidic O O
analysis O O
) O O
. O O

there O O
wasn't O O
any O O
abdominal O O
ultrasound O O
abnormalies O O
. O O

retained O O
diagnosis O O
was O O
aseptic O O
osteonecrosis O B-C0029445
of O O
the O O
left O O
femoral O O
head O O
and O O
secondary O O
osteoarthritis O B-C0029408
at O O
right O O
by O O
hyperpression O O
. O O

core O O
decompression O O
surgical O O
treatment O O
was O O
suggested O O
, O O
but O O
the O O
patient O O
wished O O
to O O
receive O O
medical O O
treatment O O
only O O
to O O
date O O
( O O
symptomatic O O
treatment O O
, O O
oral O O
bisphosphonate O O
) O O
, O O
associeted O O
to O O
shockwaves O O
. O O

the O O
outcome O O
marked O O
clinical O O
improvement O O
( O O
walk O O
without O O
limping O B-C0311395
and O O
pain O B-C0030193
) O O
, O O
the O O
radiographs O O
are O O
expected O O
six O O
months O O
after O O
starting O O
treatment O O
. O O

A O O
34 O O
year O O
old O O
pimigravida O O
presented O O
in O O
our O O
hospital O O
on O O
20 O O
october O O
2015 O O
at O O
period O O
of O O
gestation O O
13 O O
weeks O O
2days O O
for O O
routine O O
antenatal O O
examination O O
. O O

on O O
examination O O
her O O
height O O
of O O
uterus O O
was O O
found O O
to O O
be O O
30 O O
- O O
32 O O
weeks O O
gestational O O
size O O
. O O

on O O
vaginal O O
examination O O
we O O
could O O
feel O O
the O O
uterus O O
separately O O
of O O
about O O
12 O O
- O O
14 O O
weeks O O
gestational O O
size O O
, O O
beside O O
this O O
a O O
huge O O
mass O O
of O O
about O O
15 O O
cm O O
diameter O O
filling O O
whole O O
abdomen O O
was O O
felt O O
separately O O
. O O

ultrasonography O O
showed O O
an O O
intrauterine O O
viable O O
fetus O O
of O O
14 O O
weeks O O
2 O O
days O O
gestation O O
with O O
a O O
large O O
well O O
defined O O
hypoechoic O O
abdominopelvic O O
mass O O
measuring O O
16x10 O O
cm O O
with O O
minimum O O
vascularity O O
seen O O
which O O
was O O
extending O O
from O O
right O O
adenexa O O
to O O
right O O
side O O
of O O
abdominal O O
cavity O O
upto O O
right O O
hypochondrium O O
. O O

A O O
bridging O O
vessel O O
was O O
seen O O
extending O O
from O O
fundus O O
of O O
uterus O O
to O O
the O O
mass O O
lesion O B-C0221198
so O O
1st O O
possibility O O
of O O
degenerated O O
pedunculated O O
fibroid O B-C0023267
was O O
kept O O
however O O
right O O
ovary O O
was O O
not O O
seen O O
separately O O
from O O
the O O
mass O O
lesion O B-C0221198
so O O
the O O
possibility O O
of O O
ovarian O B-C0240611
mass O I-C0240611
was O O
also O O
not O O
ruled O O
out O O
. O O

patient O O
was O O
counselled O O
regarding O O
all O O
possible O O
outcomes O O
of O O
pregnancy O O
along O O
with O O
this O O
mass O O
and O O
she O O
agreed O O
to O O
undergo O O
exploratory O O
laparotomy O O
. O O

on O O
laparotomy O O
a O O
huge O O
subserosal O O
pedunculated O O
fibroid O B-C0023267
arising O O
from O O
right O O
fundic O O
region O O
of O O
size O O
16x12x10 O O
cm O O
was O O
found O O
and O O
removed O O
. O O

following O O
leiomyoma O B-C0023267
removal O O
haemostasis O O
was O O
carefully O O
achieved O O
. O O

fetal O O
monitoring O O
by O O
ultrasonography O O
was O O
carried O O
out O O
immediately O O
after O O
surgery O O
and O O
fetus O O
was O O
found O O
viable O O
. O O

postoperative O O
period O O
was O O
uneventful O O
and O O
patient O O
was O O
given O O
tocolysis O O
for O O
3 O O
days O O
with O O
uterine O O
relaxants O O
and O O
micronized O O
progesterone O O
was O O
continued O O
for O O
4 O O
weeks O O
. O O

patient O O
was O O
discharged O O
on O O
10thpost O O
operative O O
day O O
and O O
followed O O
up O O
using O O
ultrasonography O O
4 O O
weekly O O
till O O
38 O O
weeks O O
at O O
which O O
patient O O
was O O
admitted O O
in O O
hospital O O
. O O

patient O O
went O O
into O O
spontaneous O O
labour O O
at O O
39 O O
weeks O O
1 O O
day O O
and O O
delivered O O
vaginally O O
a O O
male O O
child O O
weighing O O
3 O O
kg O O
with O O
apgar O O
score O O
of O O
8 O O
and O O
10 O O
. O O
mother O O
and O O
baby O O
was O O
discharged O O
after O O
48 O O
hours O O
from O O
the O O
hospital O O
. O O

this O O
is O O
the O O
case O O
of O O
an O O
11 O O
year O O
old O O
girl O O
suffering O O
from O O
right O O
hip O B-C4551516
pain O I-C4551516
, O O
examined O O
over O O
the O O
past O O
four O O
months O O
in O O
a O O
context O O
of O O
apyrexia O O
. O O

the O O
child O O
neither O O
has O O
any O O
significant O O
medical O O
historynor O O
takes O O
any O O
drug O O
treatment O O
. O O

she O O
does O O
not O O
practice O O
sport O O
regularly O O
. O O

the O O
pain O B-C0030193
is O O
present O O
both O O
during O O
activity O O
and O O
occasionally O O
at O O
rest O O
. O O

it O O
begins O O
at O O
the O O
groin O O
and O O
radiates O O
in O O
the O O
anterior O O
aspect O O
of O O
the O O
thigh O O
. O O

on O O
clinical O O
examination O O
, O O
hips O O
were O O
normalwithsymmetricalmobility O O
. O O

the O O
monopodal O O
support O O
and O O
jump O O
were O O
painful O O
and O O
unstable O O
. O O

direct O O
axial O O
impaction O B-C0333124
of O O
the O O
hip O O
joint O O
elicited O O
no O O
pain O B-C0030193
. O O

standard O O
radiographs O O
and O O
CT O O
scan O O
of O O
the O O
pelvis O O
were O O
normal O O
. O O

magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
was O O
prescribed O O
, O O
it O O
showed O O
isosignal O O
on O O
T1 O O
and O O
hyperintense O O
signal O O
on O O
T2 O O
sequence O O
of O O
the O O
acetabular O O
roof O O
, O O
without O O
bone O O
destruction O O
or O O
invasion O O
of O O
the O O
hip O O
joint O O
. O O

this O O
abnormalsignal O O
can O O
not O O
be O O
associated O O
with O O
a O O
particular O O
pathology O O
. O O

the O O
bone O O
scintigraphy O O
shows O O
increased O O
uptake O O
at O O
the O O
right O O
acetabulum O O
. O O

laboratory O O
tests O O
especially O O
markers O O
of O O
infection O B-C3714514
were O O
normal O O
. O O

the O O
duration O O
of O O
the O O
development O O
and O O
the O O
absence O O
of O O
bone O O
destruction O O
makes O O
the O O
tumoral O O
etiology O O
unlikely O O
. O O

diagnosis O O
of O O
stress O B-C0016664
fracture O I-C0016664
of O O
acetabulum O O
roof O O
was O O
retained O O
. O O

conservative O O
treatment O O
consisting O O
of O O
discharge O O
of O O
the O O
right O O
leg O O
was O O
followed O O
for O O
3 O O
month O O
, O O
walking O O
with O O
cane O O
one O O
the O O
healthy O O
limb O O
was O O
allowed O O
. O O

after O O
this O O
period O O
, O O
the O O
pain O B-C0030193
decreased O O
remarkably O O
andmrishowed O O
a O O
diminution O O
of O O
oedema O B-C0013604
in O O
the O O
roof O O
of O O
acetabulum O O
. O O

after O O
6 O O
months O O
the O O
child O O
was O O
completely O O
free O O
of O O
pain O B-C0030193
and O O
the O O
physical O O
exam O O
was O O
perfectly O O
normal O O
. O O

MRI O O
showed O O
a O O
complete O O
regression O B-C1836830
of O O
the O O
oedema O B-C0013604
and O O
the O O
signal O O
of O O
the O O
acetabulum O O
was O O
normal O O
corresponding O O
to O O
the O O
healing O O
stage O O
of O O
the O O
stress O B-C0016664
fracture O I-C0016664
. O O

follow O O
up O O
was O O
during O O
a O O
year O O
. O O

during O O
this O O
year O O
, O O
the O O
patient O O
did O O
not O O
complain O O
of O O
any O O
sort O O
of O O
pain O B-C0030193
. O O

she O O
goes O O
through O O
full O B-C5142828
recovery O I-C5142828
activity O O
and O O
sport O O
. O O

A O O
male O O
infant O O
aged O O
2 O O
years O O
old O O
, O O
was O O
brought O O
to O O
the O O
pediatric O O
emergency O O
department O O
in O O
an O O
acute O B-C0000727
abdomen O I-C0000727
table O O
with O O
vivid O O
abdominal O B-C0000737
pain O I-C0000737
associated O O
with O O
vomiting O B-C0042963
and O O
severe O O
constipation O B-C0009806
but O O
without O O
real O O
interruption O O
of O O
bowel O O
movement O O
. O O

clinical O O
examination O O
revealed O O
an O O
infant O O
11 O O
kg O O
, O O
tired O O
, O O
pale O O
but O O
with O O
good O O
hemodynamic O O
constants O O
, O O
no O O
dehydrated O B-C0011175
, O O
no O O
fever O B-C0015967
( O O
T O O
: O O
36.4 O O
° O O
) O O
. O O

the O O
physical O O
examination O O
of O O
the O O
abdomen O O
showed O O
widespread O O
defense O O
and O O
sensitivity O O
without O O
contracture O B-C0009917
, O O
the O O
remaining O O
of O O
the O O
physical O O
examination O O
was O O
normal O O
. O O

A O O
plain O O
x-ray O O
of O O
the O O
abdomen O O
showed O O
irregular O O
punctate O O
opacities O O
mainly O O
colic O B-C0232488
seat O O
. O O

abdominal O O
ultrasound O O
showed O O
no O B-C3809765
abnormalities O I-C3809765
; O O
a O O
surgical O O
emergency O O
was O O
then O O
discarded O O
. O O

the O O
child O O
was O O
referred O O
to O O
our O O
medical O O
facility O O
for O O
additional O O
support O O
anamnestic O O
investigations O O
revealed O O
a O O
notion O O
of O O
pica O B-C0031873
with O O
ingestion O O
of O O
flaking O O
paint O O
and O O
pencil O O
leads O O
; O O
knowing O O
that O O
the O O
child O O
is O O
living O O
in O O
an O O
old O O
home O O
built O O
in O O
1960 O O
and O O
repainted O O
in O O
2009 O O
. O O

no O O
consumption O O
of O O
traditional O O
medicine O O
products O O
or O O
use O O
of O O
" O O
kohl O O
" O O
by O O
the O O
baby O O
was O O
found O O
. O O

further O O
exploration O O
revealed O O
hypochromic O O
microcytic O B-C5194182
anemia O I-C5194182
( O O
7.5g O O
/ O O
dl O O
; O O
normal O O
11.0 O O
- O O
14.5g O O
/ O O
dl O O
) O O
; O O
a O O
blood O O
smear O O
revealed O O
the O O
presence O O
of O O
basophilic O O
inclusions O O
in O O
erythrocytes O O
; O O
the O O
liver O O
and O O
kidney O O
function O O
were O O
normal O O
; O O
elevated O O
BLL O O
to O O
22.8 O O
µg O O
/ O O
dl O O
and O O
the O O
rate O O
of O O
vitamin O O
D3 O O
was O O
low O O
at O O
28ng O O
/ O O
l O O
. O O

examination O O
of O O
the O O
eye O O
fundus O O
did O O
not O O
show O O
greyish O O
studded O O
macula O O
aspect O O
called O O
sonkin O O
seedlings O O
specific O O
of O O
this O O
intoxication O O
. O O

there O O
was O O
no O O
clear O O
metaphyseal O O
bands O O
on O O
tibial O O
radiographies O O
. O O

determination O O
of O O
lead O O
in O O
potable O O
water O O
used O O
by O O
this O O
family O O
was O O
within O O
normal O O
limits O O
at O O
8 O O
µg O O
/ O O
dl O O
; O O
the O O
same O O
test O O
was O O
done O O
on O O
paint O O
chips O O
removed O O
from O O
his O O
home O O
that O O
showed O O
a O O
rate O O
of O O
40 O O
µg O O
/ O O
g O O
. O O

treatment O O
with O O
lactulose-based O O
laxative O O
lifted O O
the O O
constipation O B-C0009806
and O O
allowed O O
disappearance O O
of O O
abdominal O B-C0000737
pain O I-C0000737
. O O

diarrhea O B-C0011991
debacle O O
cleaned O O
the O O
colon O O
from O O
its O O
metal O O
content O O
. O O

chelation O O
therapy O O
was O O
not O O
indicated O O
as O O
the O O
blood O O
lead O O
level O O
was O O
not O O
too O O
high O O
. O O

A O O
45 O O
- O O
year-old O O
women O O
with O O
ssc O O
was O O
referred O O
to O O
the O O
unit O O
of O O
orofacial O B-C0178782
pain O I-C0178782
and O O
temporomandibular O O
dysfunction O O
of O O
the O O
university O O
medical O O
dental O O
clinic O O
of O O
monastir O O
, O O
tunisia O O
, O O
with O O
a O O
progressive O O
limited O B-C1848474
mouth O I-C1848474
opening O I-C1848474
and O O
facial O B-C0015468
pain O I-C0015468
since O O
2 O O
years O O
. O O

A O O
history O O
of O O
pain O B-C0030193
in O O
the O O
right O O
and O O
left O O
pre-auricular O O
regions O O
and O O
masticatory O O
myalgia O B-C0231528
more O O
pronounced O O
in O O
masseter O O
muscles O O
with O O
a O O
morning O O
stiffness O B-C0427008
of O O
jaws O O
was O O
depicted O O
. O O

these O O
symptoms O O
are O O
aggravated O O
by O O
function O O
. O O

A O O
sounds O O
in O O
the O O
right O O
TMJ O O
were O O
also O O
reported O O
. O O

she O O
had O O
no O O
history O O
of O O
trauma O O
or O O
infection O B-C3714514
of O O
the O O
TMJ O O
. O O

the O O
patient O O
had O O
a O O
medical O O
history O O
of O O
limited O O
cutanous O O
systemic O B-C0036421
sclerosis O I-C0036421
diagnosed O O
by O O
an O O
internal O O
medicine O O
specialist O O
since O O
3 O O
years O O
and O O
treated O O
by O O
methotrexate O O
, O O
colchicine O O
, O O
amlodipine O O
, O O
methylprednisolone O O
, O O
cholecalciferol O O
, O O
sulodexide O O
, O O
acidumfolicum O O
and O O
lysinacetylsalicylas O O
. O O

the O O
TMJ O O
and O O
muscle O O
symptoms O O
was O O
noted O O
since O O
1 O O
year O O
after O O
her O O
diagnosis O O
. O O

these O O
symptoms O O
have O O
slowly O O
worsened O O
prompting O O
the O O
patient O O
to O O
run O O
our O O
specializing O O
consultation O O
. O O

physical O O
examination O O
of O O
the O O
patient O O
revealed O O
that O O
ssc O O
affected O O
mainly O O
her O O
hands O O
with O O
a O O
fingers O O
movementlimitation O O
, O O
associated O O
with O O
sclerodactyly O B-C0150988
complicated O O
by O O
digital O O
ulcers O B-C0041582
, O O
moderate O O
lung O B-C0034069
fibrosis O I-C0034069
with O O
a O O
flexion O O
contracture O B-C0009917
and O O
a O O
claw-like O O
deformity O B-C0000768
. O O

the O O
clinical O O
examination O O
of O O
the O O
orofacial O O
region O O
revealed O O
a O O
masklike O B-C0424448
facies O I-C0424448
with O O
a O O
smooth O O
and O O
tight O O
facial O O
skin O O
with O O
a O O
loss O O
of O O
normal O O
animation O O
lines O O
and O O
a O O
bilateral O O
stiffness O B-C0427008
in O O
masticatory O O
muscles O O
at O O
palpation O O
and O O
movements O O
. O O

the O O
mouth O O
opening O O
was O O
limited O O
to O O
23 O O
mm O O
and O O
the O O
mandible O O
deviated O O
to O O
the O O
right O O
side O O
. O O

the O O
other O O
mandibular O O
movements O O
such O O
as O O
propulsion O O
and O O
deductionare O O
also O O
restricted O O
. O O

the O O
palpation O O
of O O
TMJ O O
region O O
causes O O
severe O O
pain O B-C0030193
more O O
pronounced O O
in O O
the O O
right O O
side O O
and O O
a O O
restricted O O
condylar O O
movement O O
. O O

no O O
joint O O
sounds O O
and O O
no O O
malocclusion O B-C0024636
are O O
depicted O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
, O O
in O O
open-and O O
closed-mouth O O
positions O O
, O O
was O O
performed O O
to O O
evaluate O O
the O O
TMJ O O
and O O
to O O
check O O
an O O
eventual O O
masticatory O O
muscles O O
fibrosis O B-C0016059
. O O

the O O
MRI O O
showed O O
internal O O
derangement O O
of O O
TMJ O O
, O O
bilateral O O
mandibular O O
condylar O O
process O O
resorption O O
, O O
and O O
disk O O
deformations O O
with O O
heterogeneous O O
appearance O O
. O O

the O O
bilateral O O
mandibular O O
condylar O O
process O O
containssubchondral O O
geodes O O
and O O
thinned O O
cortical O O
on O O
sagittal O O
and O O
coronal O O
views O O
of O O
MRI O O
and O O
hypomobility O O
in O O
open O B-C0240379
mouth O I-C0240379
. O O

there O O
was O O
no O O
fibrosis O B-C0016059
in O O
masticatory O O
muscles O O
. O O

the O O
diagnosis O O
of O O
temporomandibular O B-C0039494
disorder O I-C0039494
( O O
TMD O O
) O O
with O O
arthralgia O B-C0003862
and O O
myalgia O B-C0231528
related O O
to O O
ssc O O
was O O
made O O
. O O

the O O
patient O O
was O O
treated O O
by O O
an O O
association O O
of O O
conservative O O
techniques O O
including O O
rest O O
, O O
reassurance O O
and O O
jaw-opening O O
exercises O O
for O O
painful O O
joint O O
. O O

A O O
myorelaxant O O
was O O
prescribed O O
for O O
10 O O
days O O
to O O
managing O O
myofascial O O
pain O B-C0030193
and O O
aphysical O O
therapy O O
was O O
indicated O O
for O O
6 O O
months O O
including O O
massage O O
treatment O O
on O O
the O O
bilateral O O
masseter O O
and O O
temporal O O
muscles O O
, O O
exercises O O
, O O
ultrasound O O
, O O
for O O
improve O O
jaw O O
movements O O
, O O
managing O O
musculoskeletal O O
and O O
myofacial O B-C0751138
pain O I-C0751138
. O O

the O O
patient O O
was O O
regularly O O
reviewed O O
monthly O O
to O O
evaluate O O
pain O B-C0030193
and O O
jaw O O
movements O O
. O O

A O O
great O O
improvement O O
in O O
TMD O O
symptoms O O
was O O
reported O O
. O O

after O O
2 O O
months O O
of O O
physical O O
therapy O O
, O O
the O O
mouth O O
opening O O
increased O O
from O O
23 O O
to O O
33 O O
mm O O
and O O
a O O
reduction O O
in O O
muscle O B-C0231528
pain O I-C0231528
was O O
noted O O
. O O

the O O
preauricular O O
and O O
muscle O B-C0231528
pain O I-C0231528
was O O
gradually O O
disappeared O O
. O O

the O O
muscle O O
flexibility O O
has O O
been O O
partially O O
improved O O
by O O
physiotherapy O O
. O O

however O O
, O O
a O O
certain O O
rigidity O B-C0026837
in O O
the O O
area O O
of O O
masseter O O
muscles O O
is O O
still O O
, O O
due O O
to O O
its O O
ssc O O
and O O
skin O O
fibrosis O B-C0016059
. O O

A O O
relaxant O O
nocturnal O O
occlusal O O
appliance O O
was O O
indicated O O
to O O
stabilize O O
the O O
resultsand O O
was O O
very O O
supported O O
by O O
the O O
patient O O
. O O

A O O
51 O O
year-old O O
women O O
came O O
to O O
the O O
emergency O O
department O O
with O O
right O O
abdominal O B-C0000737
pain O I-C0000737
, O O
nausea O B-C0027497
, O O
vomiting O B-C0042963
and O O
fever O B-C0015967
at O O
( O O
38 O O
° O O
C O O
) O O
. O O

the O O
pain O B-C0030193
did O O
not O O
radiate O O
to O O
any O O
other O O
site O O
and O O
did O O
not O O
change O O
with O O
various O O
positions O O
. O O

the O O
physical O O
examination O O
revealed O O
a O O
mcburney's O O
point O O
, O O
without O O
psoas O O
signs O O
. O O

the O O
biological O O
assessment O O
showed O O
leukocytosis O B-C0023518
at O O
16200 O O
/ O O
m O O
3 O O
. O O

the O O
ultrasound O O
study O O
showed O O
a O O
free O O
fluid O O
in O O
the O O
right O O
lower O O
quadrant O O
with O O
a O O
non-compressible O O
structure O O
over O O
the O O
iliac O O
vessels O O
suggesting O O
an O O
acute O B-C0085693
appendicitis O I-C0085693
. O O

an O O
appendectomy O O
was O O
performed O O
by O O
mcburney's O O
incision O O
. O O

the O O
patient O O
was O O
discharged O O
two O O
days O O
later O O
without O O
any O O
complications O O
. O O

pathology O O
report O O
showed O O
an O O
acute O B-C0085693
appendicitis O I-C0085693
with O O
periappendicular O O
reaction O O
. O O
12 O O
days O O
later O O
, O O
the O O
patient O O
came O O
back O O
with O O
lump O B-C0424844
in O O
the O O
right O O
iliac O O
fossa O O
with O O
pain O B-C0030193
and O O
high O O
grade O O
fever O B-C0015967
. O O

the O O
physical O O
exam O O
found O O
localized O O
fixed O O
mass O O
in O O
the O O
right O O
iliac O O
fossa O O
. O O

blood O O
exams O O
revealed O O
14,000 O O
white O O
blood O O
cells O O
with O O
80% O O
neutrophiles O O
. O O

A O O
c-reactive O O
protein O O
level O O
was O O
at O O
112 O O
mg O O
/ O O
L O O
. O O

the O O
ultrasonography O O
was O O
showing O O
localized O O
collection O O
in O O
right O O
iliac O O
fossa O O
. O O

computed O O
tomography O O
( O O
CT O O
) O O
scan O O
revealed O O
a O O
10cm O O
× O O
4.7 O O
cm O O
fluid O O
collection O O
in O O
the O O
psoas O O
, O O
associated O O
with O O
inflammatory O O
changes O O
in O O
the O O
local O O
fat O O
and O O
a O O
small O O
amount O O
of O O
free O O
liquid O O
in O O
the O O
right O O
parietocolic O O
area O O
. O O

A O O
computer O O
tomography O O
( O O
CT O O
) O O
scan-guided O O
percutaneous O O
aspiration O O
of O O
the O O
abscess O B-C0000833
has O O
been O O
performed O O
and O O
a O O
catheter O O
to O O
drain O O
the O O
abscess O B-C0000833
was O O
placed O O
. O O

on O O
the O O
third O O
day O O
, O O
an O O
enterocutaneous O B-C0341318
fistula O I-C0341318
was O O
observed O O
and O O
a O O
long O O
tapeworm O B-C0007894
emerged O O
from O O
the O O
mcburney's O O
incision O O
. O O

the O O
cestode O O
was O O
removed O O
attentively O O
in O O
a O O
single O O
piece O O
. O O

the O O
fistula O B-C0016169
was O O
managed O O
conservatively O O
and O O
the O O
patient O O
was O O
discharged O O
on O O
15 O O
th O O
post-operative O O
day O O
after O O
she O O
received O O
a O O
single O O
dose O O
of O O
niclosamide O O
( O O
4x500 O O
mg O O
) O O
. O O

two O O
weeks O O
later O O
, O O
she O O
returned O O
without O O
any O O
pain O B-C0030193
or O O
fever O B-C0015967
. O O

the O O
fistula O B-C0016169
was O O
dried O O
out O O
and O O
the O O
wound O O
was O O
properly O O
healed O O
without O O
any O O
signs O O
of O O
ongoing O O
infection O B-C3714514
. O O

the O O
parasitological O O
exam O O
revealed O O
teania O O
saginata O O
. O O

A O O
20 O O
years O O
old O O
female O O
patient O O
, O O
the O O
sixth O O
of O O
a O O
family O O
of O O
8 O O
children O O
is O O
treated O O
since O O
2010 O O
for O O
edematous-ascitic O O
syndrome O O
related O O
to O O
a O O
primary O O
intestinal O B-C0024215
lymphangiectasia O I-C0024215
( O O
or O O
wildmann O O
’ O O
s O O
disease O O
) O O
suspected O O
by O O
hypoalbuminemia O B-C0239981
, O O
lymphopenia O O
and O O
hypogammmaglobulinemia O O
. O O

the O O
disease O O
was O O
confirmed O O
by O O
an O O
intestinal O O
biopsy O O
indicating O O
dilated O O
lymphatic O O
ducts O O
figure O O
1 O O
, O O
figure O O
2 O O
. O O

the O O
patient O O
followed O O
a O O
low-fat O O
diet O O
associated O O
with O O
medium-chain O O
triglycerides O O
, O O
vit O O
A O O
and O O
K O O
supplementations O O
. O O

the O O
evolution O O
was O O
good O O
with O O
effusions O O
resorption O O
. O O

however O O
, O O
6 O O
months O O
ago O O
, O O
the O O
patient O O
presented O O
MRC O O
grade O O
3 O O
dyspnea O B-C0013404
with O O
alternated O O
fever O B-C0015967
and O O
apyrexia O O
. O O

it O O
appeared O O
after O O
she O O
chose O O
to O O
stop O O
, O O
8 O O
months O O
ago O O
, O O
the O O
low O O
fat O O
diet O O
that O O
was O O
prescribed O O
by O O
her O O
pediatrician O O
. O O

the O O
physical O O
exam O O
revealed O O
a O O
cachectic O O
, O O
apyretic O O
patient O O
with O O
BMI O O
of O O
17kg O O
/ O O
m O O
2 O O
, O O
WHO O O
performance O O
index O O
of O O
1 O O
, O O
a O O
minor O O
conjunctivial O O
discoloration O O
and O O
a O O
RR O O
of O O
22 O O
B O O
/ O O
min O O
. O O

the O O
lung O O
exam O O
showed O O
a O O
bilateral O O
fluid O O
effusion O O
syndrome O O
. O O

the O O
cardiovascular O O
exam O O
indicated O O
a O O
pericardial O O
rub O O
with O O
a O O
systolic O B-C0232257
murmur O I-C0232257
at O O
the O O
mitral O O
area O O
. O O

the O O
abdominal O O
exam O O
found O O
a O O
shifting O O
dullness O O
with O O
a O O
smoothed O O
umbilicus O O
. O O

the O O
skin O O
exam O O
showed O O
a O O
thin O B-C0423757
skin O I-C0423757
with O O
no O O
dehydration O B-C0011175
signs O O
, O O
skin O B-C0037284
lesions O I-C0037284
or O O
edema O O
. O O

suspected O O
diagnoses O O
were O O
: O O
tuberculosis O B-C0041296
, O O
type O O
B O O
lymphoma O O
, O O
disseminated O B-C0024141
lupus O I-C0024141
erythematosus O I-C0024141
. O O

paraclinical O O
tests O O
showed O O
a O O
moderate O O
inflammatory O O
syndrome O O
. O O

the O O
AFB O O
sputum O O
examination O O
by O O
direct O O
microscopy O O
, O O
the O O
tuberculin O O
skin O O
test O O
, O O
the O O
24h O O
proteinuria O B-C0033687
and O O
the O O
immunological O O
tests O O
were O O
negative O O
. O O

the O O
thoracentesis O O
revealed O O
a O O
lymphocytic O O
exudative O O
fluid O O
with O O
no O O
MTB O O
in O O
the O O
pleural O O
fluid O O
( O O
direct O O
microscopy O O
) O O
and O O
a O O
negative O O
ADA O O
level O O
. O O

the O O
abdominal O O
ultrasound O O
showed O O
medium-abundance O O
ascites O B-C0003962
associated O O
with O O
an O O
abundant O O
pleurisy O B-C0032231
and O O
a O O
renal O B-C3887499
cyst O I-C3887499
. O O

heart O O
ultrasound O O
reveals O O
a O O
pericardial O B-C0031039
effusion O I-C0031039
with O O
a O O
normal O O
ejection O O
fraction O O
. O O

however O O
, O O
no O O
causal O O
factor O O
has O O
been O O
found O O
in O O
either O O
thoracoabdominal O O
CT O O
scan O O
, O O
bronchoscopy O O
or O O
thoracoscopy O O
. O O

patient O O
was O O
born O O
as O O
preterm O O
36WA O O
male O O
baby O O
with O O
body O O
weight O O
of O O
1700g O O
, O O
during O O
the O O
perinatal O O
period O O
the O O
newborn O O
presented O O
an O O
intrauterine O B-C0015934
growth O I-C0015934
retardation O I-C0015934
and O O
alteration O O
of O O
cerebral O O
vascularization O O
, O O
indicating O O
a O O
caesarean O O
section O O
( O O
c-section O O
) O O
birth O O
and O O
delivery O O
with O O
good O O
adaptation O O
to O O
extra-uterine O O
life O O
. O O

the O O
newborn O O
was O O
admitted O O
in O O
our O O
department O O
at O O
day O O
one O O
of O O
life O O
for O O
prematurity O B-C0021294
of O O
36 O O
SA O O
, O O
with O O
intrauterine O B-C0015934
growth O I-C0015934
retardation O I-C0015934
, O O
diffuse O O
jaundice O O
and O O
petechiae O B-C0031256
were O O
found O O
on O O
face O O
, O O
trunk O O
and O O
limbs O O
with O O
hepatosplenomegaly O B-C0019214
. O O

laboratory O O
data O O
showed O O
; O O
anaemia O B-C0002871
hb O O
12,2g O O
/ O O
dl O O
, O O
leukopenia O B-C0023530
8510 O O
/ O O
µl O O
, O O
platelet O O
was O O
markedly O O
decreased O O
to O O
18,000 O O
/ O O
µl O O
, O O
hepatic O B-C0151763
cytolysis O I-C0151763
; O O
ALAT O O
159U O O
/ O O
L O O
; O O
ASAT O O
140U O O
/ O O
L O O
; O O
total O O
bilirubin O O
151mg O O
/ O O
l O O
; O O
direct O O
bilirubin O O
109mg O O
/ O O
l O O
; O O
and O O
biological O O
cholestasis O B-C0008370
; O O
alkaline O O
phosphatase O O
( O O
ALP O O
) O O
of O O
174 O O
; O O
gamma O O
glutamyltransferase O O
of O O
252UI O O
/ O O
L O O
activated O O
partial O O
thromboplastin O O
time O O
( O O
PTT O O
) O O
was O O
normal O O
; O O
prothrombin O O
time O O
( O O
PT O O
) O O
of O O
50% O O
. O O

abdominal O O
ultrasound O O
has O O
noticed O O
hepatosplenomegaly O B-C0019214
while O O
the O O
brain O O
CT O O
revealed O O
no O O
calcification O O
or O O
other O O
abnormal O O
findings O O
such O O
as O O
ventricular O B-C2675972
enlargement O I-C2675972
. O O

because O O
of O O
CMV O O
PCR O O
was O O
very O O
positive O O
( O O
54305UI O O
/ O O
ml O O
) O O
in O O
the O O
peripheral O O
blood O O
, O O
intravenous O O
ganciclovir O O
administration O O
( O O
15 O O
mg O O
/ O O
kg O O
/ O O
day O O
) O O
was O O
started O O
and O O
blood O O
transfusion O O
was O O
given O O
for O O
his O O
anaemia O B-C0002871
. O O

after O O
4 O O
weeks O O
of O O
treatment O O
, O O
the O O
evolution O O
was O O
marked O O
by O O
a O O
good O O
clinical O O
and O O
biological O O
improvement O O
with O O
regression O B-C1836830
of O O
jaundice O O
( O O
direct O O
bilirubin O O
at O O
47mg O O
/ O O
ml O O
; O O
total O O
bilirubin O O
at O O
63mg O O
/ O O
l O O
) O O
and O O
petechiae O B-C0031256
, O O
betterment O O
of O O
liver O O
function O O
( O O
ALAT O O
56UI O O
/ O O
L O O
; O O
ASAT O O
83UI O O
/ O O
L O O
, O O
platelet O O
count O O
was O O
increased O O
rapidly O O
to O O
normal O O
level O O
( O O
platelet O O
at O O
165000 O O
/ O O
µl O O
) O O
while O O
viral O B-C0376705
load O I-C0376705
of O O
CMV O O
was O O
decreased O O
to O O
572UI O O
/ O O
ml O O
. O O

the O O
newbornhas O O
subsequently O O
presented O O
a O O
reappearance O O
of O O
jaundice O O
and O O
petechiae O B-C0031256
, O O
laboratory O O
data O O
showed O O
: O O
hb O O
10g O O
/ O O
dl O O
, O O
leukopenia O B-C0023530
2750 O O
/ O O
µl O O
, O O
platelet O O
at O O
73000 O O
/ O O
µl O O
, O O
ALAT O O
91U O O
/ O O
L O O
; O O
ASAT O O
123U O O
/ O O
L O O
; O O
total O O
bilirubin O O
101mg O O
/ O O
l O O
; O O
direct O O
bilirubin O O
77mg O O
/ O O
l O O
, O O
with O O
a O O
rescinding O O
of O O
the O O
viral O B-C0376705
load O I-C0376705
( O O
54305UI O O
/ O O
ml O O
\ O O
) O O
making O O
suspected O O
a O O
resistanceto O O
ganciclovir O O
or O O
a O O
reactivation O O
of O O
CMV O O
in O O
relation O O
with O O
breastfeedingtherefore O O
we O O
had O O
switched O O
to O O
an O O
oral O O
antiviral O O
drug O O
( O O
valganciclovir O O
30 O O
mg O O
/ O O
kg O O
/ O O
day O O
) O O
for O O
fourth O O
week O O
. O O

unfortunately O O
the O O
newborn O O
died O B-C1546956
as O O
a O O
result O O
of O O
a O O
lightning O B-C0023702
hemorrhage O B-C0019080
\ O O
( O O
hematemesis O B-C0018926
, O O
epistaxis O B-C0014591
, O O
otorrhagia O B-C0271412
) O O
. O O

57 O O
- O O
year O O
old O O
male O O
patient O O
was O O
admitted O O
to O O
emergency O O
department O O
with O O
dyspnea O B-C0013404
and O O
tachypnea O B-C0231835
. O O

thorax O O
computed O O
tomography O O
( O O
CT O O
) O O
examination O O
was O O
performed O O
with O O
the O O
initial O O
diagnosis O O
of O O
pulmonary O B-C0034065
embolism O I-C0034065
, O O
which O O
revealeda O O
3x2 O O
cm O O
sized O O
mass O O
located O O
lateral O O
to O O
sternum O O
in O O
the O O
left O O
side O O
of O O
anterior O O
mediastinum O O
. O O

the O O
mediastinal O O
mass O O
was O O
thoracoscopically O O
removed O O
by O O
en O O
bloc O O
excision O O
. O O

since O O
histopathological O O
examination O O
revealed O O
parathyroid O B-C0687150
carcinoma O I-C0687150
, O O
general O O
surgery O O
consultation O O
was O O
made O O
. O O

on O O
physical O O
examination O O
, O O
there O O
was O O
no O O
palpable O O
mass O O
in O O
both O O
thyroid O O
lobes O O
and O O
no O O
cervical O O
lymph O O
nodes O O
. O O

review O O
of O O
organ O O
systems O O
revealed O O
nothing O O
pathological O O
. O O

he O O
had O O
no O O
history O O
of O O
previous O O
surgical O O
operation O O
and O O
regular O O
drug O O
treatment O O
. O O

laboratory O O
parameters O O
were O O
as O O
follows O O
; O O
calcium O O
: O O
11.4 O O
mg O O
/ O O
dl O O
, O O
phosphorus O O
: O O
1.79 O O
mg O O
/ O O
dl O O
, O O
parathyroid O O
hormone O O
: O O
118.7 O O
pg O O
/ O O
ml O O
, O O
calcitonin O O
: O O
< O O
2 O O
pg O O
/ O O
ml O O
and O O
25 O O
hydroxy O O
vitamin O O
D O O
: O O
21.84 O O
ug O O
/ O O
l O O
. O O

neck O O
ultrasonography O O
( O O
USG O O
) O O
detected O O
a O O
25x11 O O
mm O O
sized O O
lesion O B-C0221198
which O O
was O O
adjacent O O
to O O
left O O
thyroid O O
lobe O O
inferoposteriorly O O
, O O
extending O O
caudally O O
and O O
had O O
cystic O O
areas O O
. O O

this O O
lesion O B-C0221198
had O O
moderate O O
level O O
vascularity O O
on O O
doppler O O
ultrasonography O O
. O O

the O O
remaining O O
of O O
thyroid O O
tissue O O
was O O
normal O O
and O O
no O O
pathological O O
lymph O O
node O O
was O O
detected O O
. O O

neck O O
and O O
thorax O O
diffusion O O
MR O O
examinations O O
demonstrated O O
a O O
21x11 O O
mm O O
sized O O
cystic O B-C1511606
lesion O I-C1511606
in O O
parathyroid O O
region O O
, O O
which O O
was O O
located O O
posterior O O
to O O
lower O O
part O O
of O O
left O O
thyroid O O
lobe O O
and O O
had O O
clear O O
margins O O
. O O

there O O
was O O
no O O
suspicious O O
appearance O O
in O O
the O O
region O O
of O O
previous O O
operation O O
. O O

technetium O O
- O O
99m O O
methoxy-isobutylisonitrile O O
\ O O
( O O
tc O O
- O O
99m O O
MIBI O O
) O O
parathyroid O O
scintigraphic O O
examination O O
was O O
performed O O
which O O
showed O O
early O O
and O O
late O O
phase O O
focal O O
activity O O
increase O O
adjacent O O
to O O
lower O O
pole O O
of O O
left O O
lobe O O
. O O

on O O
whole O O
body O O
bone O O
densitometry O O
, O O
AP O O
spine O O
bone O O
mineral O O
density O O
values O O
( O O
T O O
score O O
) O O
and O O
age O O
matched O O
( O O
Z O O
score O O
) O O
value O O
revealed O O
osteopenia O B-C0029453
, O O
while O O
right O O
proximal O O
femoral O O
neck O O
bone O O
mineral O O
density O O
values O O
( O O
T O O
score O O
) O O
showed O O
osteopenia O B-C0029453
and O O
age O O
matched O O
value O O
( O O
Z O O
score O O
) O O
was O O
normal O O
. O O

laboratory O O
parameters O O
on O O
the O O
day O O
before O O
the O O
operation O O
were O O
as O O
follows O O
; O O
calcium O O
: O O
11.1 O O
mg O O
/ O O
dl O O
, O O
phosphorus O O
: O O
2.39 O O
mg O O
/ O O
dl O O
, O O
PTH O O
: O O
184 O O
pg O O
/ O O
ml O O
, O O
thyroid O O
function O O
tests O O
and O O
thyroglobulin O O
levels O O
: O O
normal O O
. O O

left O O
inferior O O
parathyroid O O
gland O O
peroperatively O O
appeared O O
bigger O O
than O O
normal O O
and O O
connected O O
to O O
superior O O
parathyroid O O
gland O O
by O O
a O O
band O O
. O O

both O O
parathyroid O O
tissues O O
were O O
excised O O
and O O
it O O
was O O
confirmed O O
by O O
frozen O O
that O O
the O O
excised O O
tissues O O
were O O
parathyroid O O
glands O O
. O O

intact O O
PTH O O
values O O
measured O O
15 O O
and O O
30 O O
minutes O O
after O O
parathyroid O O
excision O O
were O O
78 O O
and O O
52 O O
pg O O
/ O O
ml O O
, O O
respectively O O
. O O

since O O
intact O O
PTH O O
( O O
ipth O O
) O O
levels O O
decreased O O
by O O
70% O O
of O O
pre-operative O O
values O O
and O O
the O O
appearance O O
of O O
other O O
parathyroid O O
glands O O
were O O
not O O
pathological O O
, O O
the O O
operation O O
was O O
terminated O O
after O O
left O O
thyroid O O
lobectomy O O
, O O
isthmectomy O O
+ O O
unilateral O O
central O O
lymph O O
node O O
dissection O O
were O O
performed O O
. O O

serum O O
calcium O O
and O O
PTH O O
values O O
measured O O
24 O O
hours O O
after O O
the O O
operation O O
were O O
9.2 O O
mg O O
/ O O
dl O O
and O O
63 O O
pg O O
/ O O
ml O O
, O O
respectively O O
. O O

histopathological O O
evaluation O O
90% O O
of O O
the O O
tumors O O
had O O
fibrous O O
bands O O
and O O
trabecular O O
structures O O
seen O O
in O O
microscopic O O
examination O O
. O O
67% O O
of O O
them O O
had O O
capsular O O
invasion O O
, O O
12% O O
showed O O
vascular O O
invasion O O
, O O
while O O
mitosis O O
and O O
fusiform O O
tumoral O O
cells O O
were O O
present O O
in O O
81% O O
. O O

extra-parathyroidal O O
lesion O B-C0221198
was O O
immunohistochemically O O
excluded O O
by O O
means O O
of O O
PTH O O
, O O
TTF O O
- O O
1 O O
, O O
PAX O O
- O O
8 O O
, O O
HMB45 O O
, O O
melan-a O O
, O O
CD117 O O
, O O
desmin O O
and O O
vimentin O O
. O O

we O O
detected O O
a O O
strong O O
staining O O
by O O
galectin O O
- O O
3 O O
and O O
cyclin-d1 O O
, O O
which O O
were O O
used O O
to O O
differentiate O O
parathyroid O B-C0262587
adenoma O I-C0262587
and O O
carcinoma O O
. O O
2% O O
increase O O
in O O
proliferation O O
was O O
observed O O
by O O
ki O O
- O O
67 O O
. O O

A O O
40 O O
- O O
year-old O O
man O O
presented O O
to O O
the O O
orthopaedic O O
out-patient O O
clinic O O
on O O
account O O
of O O
a O O
month O O
history O O
of O O
right O O
sided O O
pelvic O B-C0030794
pain O I-C0030794
and O O
a O O
limp O O
following O O
a O O
trivial O O
fall O B-C0085639
at O O
home O O
. O O

there O O
was O O
no O O
preceding O O
history O O
of O O
similar O O
symptoms O O
, O O
haematuria O B-C0018965
, O O
loin O B-C0235632
pain O I-C0235632
or O O
loin O O
mass O O
. O O

there O O
was O O
no O O
weight O B-C1262477
loss O I-C1262477
. O O

initial O O
clinical O O
evaluation O O
was O O
unremarkable O O
. O O

an O O
abdominopelvic O O
contrast O O
computerized O O
tomography O O
scan O O
( O O
CT O O
scan O O
) O O
revealed O O
an O O
expansile O O
lytic O O
mass O O
in O O
the O O
right O O
iliac O O
bone O O
, O O
eroding O O
it O O
and O O
invading O O
the O O
contiguous O O
iliacus O O
and O O
gluteal O O
muscles O O
. O O

it O O
also O O
showed O O
a O O
large O O
hypodense O O
mass O O
in O O
the O O
central O O
portion O O
of O O
the O O
right O O
kidney O O
, O O
adjacent O O
to O O
the O O
renal O O
hilum O O
with O O
peri-hilar O O
lymph O O
node O O
enlargement O O
. O O

the O O
renal O O
vein O O
and O O
inferior O O
vena O O
cava O O
were O O
however O O
not O O
involved O O
. O O

there O O
were O O
no O O
other O O
areas O O
of O O
metastasis O B-C0027627
. O O

based O O
on O O
the O O
above O O
findings O O
, O O
a O O
diagnosis O O
of O O
right O O
RCC O O
( O O
clinical O O
stage O O
T3 O O
, O O
N1 O O
, O O
M1 O O
( O O
stage O O
4 O O
) O O
was O O
made O O
. O O

he O O
was O O
subsequently O O
scheduled O O
for O O
right O O
radical O O
nephrectomy O O
via O O
a O O
right O O
subcoastal O O
transperitoneal O O
approach O O
. O O

intra-operatively O O
, O O
we O O
found O O
a O O
solid O O
right O O
renal O O
mass O O
which O O
had O O
invaded O O
the O O
gerota's O O
fascia O O
in O O
some O O
areas O O
measuring O O
7 O O
by O O
8 O O
centimeters O O
. O O

it O O
was O O
resected O O
en O O
bloc O O
with O O
adjoining O O
peri-hilar O O
lymph O O
nodes O O
. O O

following O O
recuperation O O
, O O
he O O
had O O
wide O O
local O O
excision O O
of O O
the O O
right O O
pelvic O B-C0347944
mass O I-C0347944
along O O
with O O
the O O
diseased O O
iliac O O
bone O O
and O O
iliacus O O
muscle O O
through O O
a O O
right O O
ilio-inguinal O O
approach O O
. O O

both O O
specimen O O
had O O
negative O O
resection O O
margins O O
. O O

histopathologic O O
evaluation O O
of O O
the O O
resected O O
kidney O O
specimen O O
revealed O O
proliferation O O
of O O
malignant O O
epithelial O O
cells O O
forming O O
tubules O O
which O O
are O O
cystically O O
dilated O O
. O O

the O O
renal O O
stroma O O
was O O
desmoblastic O O
and O O
infiltrated O O
by O O
some O O
of O O
these O O
malignant O O
cells O O
. O O

tumour O B-C0027651
was O O
confined O O
to O O
the O O
gerota's O O
fascia O O
. O O

the O O
findings O O
were O O
consistent O O
with O O
a O O
tubulocystic O O
variant O O
of O O
BDC O O
. O O

evaluation O O
of O O
the O O
iliac O O
bone O O
specimen O O
was O O
in O O
keeping O O
with O O
a O O
metastasis O B-C0027627
from O O
BDC O O
of O O
the O O
kidney O O
. O O

the O O
patient O O
made O O
a O O
smooth O O
post-operative O O
recovery O O
and O O
is O O
being O O
planned O O
for O O
commencement O O
of O O
immunotherapy O O
with O O
sunitinib O O
. O O

we O O
present O O
a O O
case O O
of O O
a O O
43 O O
- O O
year-old O O
female O O
who O O
presented O O
at O O
the O O
accident O O
and O O
emergency O O
department O O
of O O
princess O O
marina O O
hospital O O
, O O
gaborone O O
, O O
botswana O O
. O O

she O O
was O O
referred O O
from O O
a O O
peripheral O O
hospital O O
. O O

she O O
reported O O
a O O
deep O O
dull O O
aching O O
pain O B-C0030193
in O O
the O O
right O O
iliac O O
fossa O O
that O O
has O O
been O O
progressively O O
becoming O O
worse O O
. O O

she O O
had O O
no O O
associated O O
vomiting O B-C0042963
or O O
change O B-C0278008
in O I-C0278008
bowel O I-C0278008
habits O I-C0278008
. O O

she O O
reported O O
no O O
weight O B-C1262477
loss O I-C1262477
. O O

the O O
pain O B-C0030193
was O O
of O O
two O O
years O O
duration O O
and O O
has O O
been O O
in O O
and O O
out O O
of O O
hospital O O
on O O
antibiotics O O
and O O
analgesia O O
. O O

she O O
was O O
referred O O
to O O
princess O O
marina O O
hospital O O
after O O
having O O
been O O
found O O
to O O
have O O
a O O
large O O
sausage O O
like O O
cystic O O
mass O O
extending O O
from O O
the O O
pelvis O O
up O O
to O O
the O O
medial O O
aspect O O
of O O
the O O
ascending O O
colon O O
on O O
ultrasound O O
. O O

its O O
origins O O
were O O
unclear O O
. O O

there O O
was O O
no O O
free O O
fluid O O
seen O O
on O O
ultrasound O O
. O O

the O O
patient O O
was O O
otherwise O O
afebrile O O
and O O
hemodynamically O O
stable O O
. O O

she O O
had O O
normal O O
full O O
blood O O
count O O
, O O
urea O O
and O O
electrolytes O O
, O O
liver O O
function O O
tests O O
and O O
pregnancy O O
was O O
negative O O
. O O

she O O
was O O
admitted O O
to O O
the O O
ward O O
on O O
analgesia O O
and O O
an O O
abdomino-pelvic O O
CT O O
scan O O
was O O
performed O O
the O O
next O O
day O O
, O O
which O O
showed O O
a O O
sausage O O
like O O
cystic O O
mass O O
extending O O
from O O
the O O
pelvis O O
up O O
to O O
the O O
hepatic O O
flexure O O
of O O
the O O
colon O O
with O O
the O O
cecum O O
displaced O O
and O O
ante-flexed O O
over O O
the O O
ascending O O
colon O O
. O O

there O O
were O O
no O O
liver O O
lesions O B-C0221198
or O O
lymphadenopathy O B-C0497156
noted O O
. O O

the O O
length O O
of O O
the O O
mass O O
was O O
17.27 O O
cm O O
and O O
the O O
maximum O O
diameter O O
was O O
5.28cm O O
. O O

there O O
was O O
no O O
free O O
fluid O O
in O O
the O O
abdomen O O
. O O

an O O
impression O O
of O O
appendiceal O O
mucocele O B-C0026683
was O O
made O O
after O O
the O O
surgeon O O
and O O
the O O
radiologist O O
carefully O O
analysed O O
the O O
CT O O
scan O O
. O O

A O O
semi-elective O O
right O O
hemi-colectomy O O
was O O
planned O O
. O O

intraoperative O O
findings O O
: O O
a O O
distended O O
massive O O
appendix O O
pushing O O
the O O
redundant O O
cecal O O
end O O
up O O
to O O
the O O
hepatic O O
flexure O O
of O O
the O O
colon O O
and O O
the O O
tip O O
of O O
the O O
appendix O O
into O O
the O O
right O O
iliac O O
fossa O O
was O O
found O O
. O O

exploration O O
of O O
the O O
abdomen O O
revealed O O
no O O
metastatic O O
processes O O
, O O
no O O
lymphadenopathy O B-C0497156
and O O
no O O
other O O
malignancies O B-C0006826
. O O

the O O
pelvic O O
organs O O
were O O
all O O
normal O O
. O O

there O O
was O O
no O O
leak O O
of O O
appendicular O O
contents O O
and O O
the O O
appendix O O
was O O
not O O
adherent O O
to O O
surrounding O O
structures O O
. O O

the O O
distended O O
appendix O O
was O O
isolated O O
carefully O O
and O O
delivered O O
from O O
the O O
abdomen O O
. O O

A O O
right O O
hemicolectomy O O
was O O
performed O O
making O O
sure O O
not O O
to O O
rupture O O
the O O
appendix O O
or O O
cause O O
any O O
leakage O O
of O O
its O O
contents O O
. O O

A O O
stapled O O
functional O O
end-to-end O O
ileo-colic O O
anastomosis O O
was O O
performed O O
. O O

the O O
patient O O
recovery O O
was O O
uneventful O O
and O O
was O O
discharged O O
day O O
6 O O
post-operation O O
. O O

she O O
was O O
seen O O
at O O
the O O
outpatient O O
clinic O O
6 O O
weeks O O
later O O
and O O
had O O
uneventful O O
postoperative O O
course O O
. O O

histology O O
results O O
revealed O O
a O O
low-grade O O
appendicular O O
mucinous O O
neoplasm O O
with O O
negative O O
margins O O
and O O
no O O
involved O O
mesenteric O O
lymph O O
nodes O O
. O O

histopathology O O
report O O
* O O
all O O
slide O O
sections O O
are O O
stained O O
with O O
haematoxylin O O
& O O
eosin O O
( O O
H O O
/ O O
E O O
) O O
X50 O O
: O O
low O O
power O O
viewing O O
) O O
: O O
the O O
appendiceal O O
wall O O
shows O O
a O O
flattened O O
and O O
misplaced O O
epithelium O O
( O O
on O O
top O O
) O O
as O O
well O O
as O O
marked O O
fibrosis O B-C0016059
surrounding O O
a O O
focus O O
of O O
dystrophic O B-C0333582
calcification O I-C0333582
( O O
blue O O
stained O O
material O O
in O O
the O O
centre O O
of O O
the O O
image O O
) O O
X100 O O
and O O
x400 O O
: O O
medium O O
and O O
high O O
power O O
viewing O O
) O O
: O O
the O O
appendiceal O O
wall O O
shows O O
an O O
intestinal O O
type O O
covering O O
epithelium O O
( O O
right O O
side O O
) O O
comprising O O
of O O
crowded O O
columnar O O
cells O O
with O O
basal O O
, O O
hyperchromatic O B-C3553776
nuclei O I-C3553776
and O O
large O O
amounts O O
of O O
apical O O
mucin O O
as O O
well O O
as O O
minimal O O
dysplastic O O
changes O O
. O O

marked O O
fibrosis O B-C0016059
beneath O O
the O O
epithelial O O
lining O O
is O O
readily O O
apparent O O
. O O

* O O
fibrosis O B-C0016059
and O O
chronic O B-C0021376
inflammation O I-C0021376
are O O
secondary O O
changes O O
due O O
to O O
luminal O O
compression O O
in O O
a O O
long-standing O O
disease O O
. O O

case O O
1 O O
: O O
a O O
50 O O
- O O
year-old O O
woman O O
proceeded O O
to O O
the O O
emergency O O
department O O
with O O
lower O O
left O O
abdominal O B-C0000737
pain O I-C0000737
, O O
anorexia O B-C0003123
, O O
weight O B-C1262477
loss O I-C1262477
( O O
10kg O O
in O O
1 O O
month O O
) O O
and O O
constipation O B-C0009806
. O O

on O O
examination O O
, O O
her O O
vital O O
signs O O
were O O
normal O O
but O O
she O O
complained O O
with O O
lower O O
left O O
abdominal O B-C0000737
pain O I-C0000737
and O O
a O O
palpable O O
mass O O
in O O
the O O
same O O
region O O
. O O

the O O
laboratory O O
results O O
of O O
the O O
patient O O
showed O O
anemia O B-C0002871
. O O

computerized O O
tomography O O
( O O
CT O O
) O O
and O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
scans O O
revealed O O
a O O
66 O O
x O O
33mm O O
mass O O
attached O O
to O O
the O O
left O O
adnexa O O
and O O
sigmoid O O
colon O O
causing O O
proximal O O
colonic O O
distention O O
and O O
a O O
dilated O B-C4748583
ureter O I-C4748583
on O O
that O O
side O O
. O O

at O O
laparotomy O O
, O O
an O O
inflammatory O O
abscessed O O
mass O O
of O O
the O O
sigmoid O O
colon O O
was O O
found O O
and O O
a O O
sigmoid O O
resection O O
with O O
primary O O
anastomosis O O
was O O
carried O O
out O O
. O O

histology O O
showed O O
an O O
inflammatory O O
mass O O
with O O
multiple O O
abscesses O B-C0000833
containing O O
colonies O O
of O O
actinomyces O O
spp O O
. O O

as O O
soon O O
as O O
pathology O O
report O O
became O O
available O O
, O O
intramuscular O O
penicillin O O
treatment O O
was O O
initiated O O
followed O O
by O O
oral O O
penicillin O O
. O O

in O O
the O O
meantime O O
, O O
the O O
IUD O O
was O O
removed O O
but O O
the O O
follow-up O O
exams O O
revealed O O
a O O
cervix O O
inflammatory O O
process O O
. O O

A O O
total O O
abdominal O O
hysterectomy O O
and O O
salpingo-ophorectomy O O
was O O
performed O O
and O O
histology O O
specimen O O
revealed O O
uterine O O
actinomycosis O B-C0001261
. O O

no O O
postoperative O B-C0032787
complications O I-C0032787
were O O
observed O O
and O O
the O O
patient O O
was O O
discharged O O
to O O
complete O O
12 O O
months O O
of O O
oral O O
treatment O O
. O O

case O O
2 O O
: O O
a O O
68 O O
- O O
year-old O O
man O O
presented O O
with O O
a O O
2 O O
- O O
month O O
history O O
of O O
left O O
iliac O B-C0423647
fossa O I-C0423647
pain O I-C0423647
without O O
altered O O
bowel O O
habits O O
or O O
fever O B-C0015967
. O O

on O O
physical O O
examination O O
, O O
he O O
had O O
pain O B-C0030193
and O O
tenderness O O
in O O
left O O
lower O O
quadrant O O
( O O
LLQ O O
) O O
. O O

the O O
laboratory O O
data O O
showed O O
elevated O O
leukocyte O O
count O O
. O O

urgent O O
CT O O
scan O O
revealed O O
a O O
mass O O
in O O
LLQ O O
with O O
vesical O O
and O O
sigmoid O O
colon O O
wall O O
thickening O O
suggesting O O
a O O
bowel O O
perforation O O
by O O
a O O
strange O O
body O O
. O O

the O O
patient O O
underwent O O
a O O
laparotomy O O
, O O
an O O
inflammatory O O
sigmoid O O
mass O O
extending O O
to O O
the O O
bladder O O
and O O
abdominal O O
wall O O
was O O
found O O
and O O
a O O
sigmoid O O
and O O
partial O O
vesical O O
resection O O
was O O
performed O O
. O O

final O O
pathology O O
report O O
was O O
consistent O O
with O O
actinomycosis O B-C0001261
and O O
the O O
patient O O
started O O
a O O
12 O O
- O O
month O O
course O O
of O O
penicillin O O
. O O

at O O
1 O O
- O O
year O O
follow-up O O
he O O
was O O
free O O
from O O
disease O O
and O O
asymptomatic O O
. O O

A O O
49 O O
years O O
old O O
man O O
, O O
came O O
as O O
outpatient O O
to O O
the O O
clinic O O
with O O
complain O O
of O O
frequency O O
since O O
5 O O
months O O
ago O O
. O O

he O O
also O O
mentioned O O
dysuria O B-C0013428
, O O
mild O O
obstructive O O
urinary O O
symptoms O O
and O O
constipation O B-C0009806
, O O
with O O
gradual O O
onset O O
, O O
initiating O O
since O O
6 O O
months O O
ago O O
. O O

he O O
didn't O O
have O O
other O O
urinary O O
symptoms O O
, O O
hematuria O B-C0018965
, O O
flank O B-C0016199
pain O I-C0016199
or O O
weight O B-C1262477
loss O I-C1262477
. O O

past O O
medical O O
and O O
surgical O O
history O O
was O O
negative O O
. O O

on O O
physical O O
examination O O
, O O
all O O
organ O O
systems O O
were O O
normal O O
except O O
for O O
huge O O
prostate O O
, O O
palpable O O
at O O
digital O O
rectal O O
exam O O
which O O
was O O
rubbery O O
and O O
symmetric O O
. O O

we O O
had O O
started O O
our O O
work O O
up O O
by O O
checking O O
renal O O
function O O
test O O
, O O
PSA O B-C4086720
level O I-C4086720
and O O
sonography O O
of O O
kidneys O O
and O O
prostate O O
. O O

all O O
laboratory O O
data O O
came O O
back O O
within O O
normal O O
ranges O O
except O O
for O O
PSA O O
which O O
was O O
11.2 O O
. O O

sonography O O
reported O O
enlarged O O
prostate O O
with O O
volume O O
of O O
560ml O O
with O O
multiple O O
cystic O O
area O O
inside O O
it O O
. O O

post O O
void O O
residue O O
was O O
zero O O
. O O

CT O O
scan O O
and O O
abdomen O O
and O O
pelvic O O
MRI O O
with O O
and O O
without O O
gadolinium O O
also O O
performed O O
and O O
huge O O
( O O
120 O O
* O O
100 O O
* O O
100mm O O
) O O
heterogeneous O O
mass O O
in O O
anatomic O O
site O O
of O O
prostate O O
reported O O
. O O

the O O
mass O O
seen O O
with O O
solid O O
and O O
cystic O O
component O O
, O O
well O O
circumscribed O O
and O O
contained O O
partially O O
thick O O
peripheral O O
capsular O O
. O O

there O O
was O O
no O O
adjacent O O
structure O O
involvement O O
. O O

patient O O
underwent O O
pelvic O B-C0347944
mass O I-C0347944
resection O O
by O O
retro O O
vesical O O
abdominal O O
approach O O
. O O

the O O
mass O O
which O O
has O O
elongation O O
beside O O
prostatic O O
urethra O O
revealed O O
. O O

by O O
help O O
of O O
frozen O O
section O O
we O O
got O O
ensured O O
that O O
it O O
has O O
benign O O
nature O O
, O O
70% O O
of O O
mass O O
freed O O
from O O
adjacent O O
structures O O
. O O

due O O
to O O
its O O
extension O O
near O O
prostatic O O
urethra O O
and O O
risk O O
of O O
external O O
sphincter O O
injury O B-C3263723
or O O
neurovascular O O
bundle O O
injury O B-C3263723
, O O
we O O
spared O O
part O O
of O O
its O O
capsule O O
( O O
which O O
was O O
elongated O O
near O O
prostatic O O
urethra O O
) O O
but O O
enucleated O O
inside O O
it O O
. O O

after O O
recovery O O
from O O
surgery O O
patient O O
was O O
symptom O O
free O O
and O O
totally O O
continent O O
with O O
preserved O O
erectile O O
function O O
. O O

final O O
pathology O O
report O O
is O O
consistent O O
with O O
cystadenoma O B-C0010633
/ O O
epithelial O O
stromal O O
tumor O B-C0027651
of O O
the O O
seminal O O
vesicle O O
with O O
no O O
suggestion O O
for O O
malignancy O B-C0006826
. O O

case O O
1 O O
: O O
mrs O O
. O O

A O O
was O O
a O O
27 O O
year O O
old O O
patient O O
in O O
her O O
first O O
pregnancy O O
who O O
was O O
referred O O
at O O
15 O O
weeks O O
gestation O O
from O O
a O O
physician O O
with O O
a O O
diagnosis O O
of O O
RHD O O
. O O

she O O
had O O
just O O
been O O
diagnosed O O
with O O
severe O O
MS O O
3 O O
weeks O O
prior O O
to O O
presentation O O
although O O
she O O
had O O
been O O
symptomatic O O
since O O
childhood O O
. O O

an O O
echocardiogram O O
showed O O
mitral O O
valve O O
area O O
( O O
MVA O O
) O O
of O O
1cm O O
2 O O
, O O
ejection O O
fraction O O
( O O
EF O O
) O O
of O O
59.3% O O
and O O
a O O
moderately O O
dilated O B-C0344720
left O I-C0344720
atrium O I-C0344720
of O O
55 O O
- O O
60mm O O
diameter O O
with O O
no O O
pulmonary O B-C0020542
hypertension O I-C0020542
. O O

A O O
multidisciplinary O O
team O O
( O O
MDT O O
) O O
was O O
set O O
up O O
comprising O O
a O O
physician O O
, O O
cardiothoracic O O
surgeon O O
, O O
obstetricians O O
and O O
an O O
anaesthetist O O
. O O

the O O
cardiothoracic O O
surgeon O O
offered O O
open O O
commissurotomy O O
as O O
percutaneous O O
balloon O O
valvuloplasty O O
( O O
PBV O O
) O O
was O O
not O O
available O O
. O O

she O O
declined O O
the O O
in O O
view O O
of O O
the O O
procedure O O
related O O
risks O O
. O O

at O O
20 O O
weeks O O
gestation O O
she O O
was O O
commenced O O
on O O
propranolol O O
to O O
treat O O
a O O
persistent O O
tachycardia O O
and O O
prophylactic O O
warfarin O O
. O O

she O O
was O O
switched O O
from O O
warfarin O O
to O O
low O O
molecular O O
weight O O
heparin O O
( O O
LMWH O O
) O O
at O O
36 O O
weeks O O
gestation O O
. O O

at O O
38 O O
weeks O O
, O O
an O O
echocardiogram O O
showed O O
an O O
MVA O O
of O O
0.9cm O O
2 O O
and O O
EF O O
of O O
58% O O
. O O

her O O
functional O B-C0598463
status O I-C0598463
was O O
new O O
york O O
heart O O
association O O
( O O
NYHA O O
) O O
class O O
II O O
. O O

the O O
estimated O O
foetal O O
weight O O
( O O
EFW O O
) O O
was O O
1950g O O
, O O
with O O
normal O O
middle O O
cerebral O O
artery O O
( O O
MCA O O
) O O
and O O
umbilical O O
artery O O
( O O
UA O O
) O O
flow O O
. O O

in O O
order O O
to O O
time O O
the O O
required O O
lapse O O
period O O
between O O
last O O
dose O O
of O O
LMWH O O
and O O
the O O
epidural O O
procedure O O
, O O
she O O
had O O
elective O O
induction O O
of O O
labour O O
. O O

she O O
developed O O
foetal O O
bradycardia O B-C0428977
6 O O
hours O O
after O O
initiating O O
induction O O
. O O

an O O
emergency O O
caesarean O O
section O O
was O O
done O O
under O O
general O O
anaesthesia O B-C0278134
as O O
the O O
epidural O O
catheter O O
which O O
had O O
been O O
timed O O
for O O
established O O
labour O O
had O O
not O O
yet O O
been O O
inserted O O
. O O

she O O
was O O
given O O
frusemide O O
and O O
antibiotics O O
peri-partum O O
. O O

A O O
2020g O O
live O O
baby O O
was O O
delivered O O
. O O

she O O
was O O
discharged O O
from O O
hospital O O
on O O
day O O
7 O O
on O O
warfarin O O
and O O
was O O
stable O O
when O O
reviewed O O
by O O
both O O
physician O O
and O O
obstetrician O O
14 O O
days O O
postpartum O O
. O O

she O O
was O O
admitted O O
to O O
the O O
coronary O O
care O O
unit O O
4 O O
weeks O O
postpartum O O
with O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
, O O
severe O O
supraventricular O B-C0039240
tachycardia O I-C0039240
and O O
hypotension O B-C0020649
and O O
died O B-C1546956
3 O O
days O O
later O O
. O O

case O O
2 O O
: O O
mrs O O
. O O

B O O
is O O
a O O
28 O O
years O O
old O O
who O O
presented O O
at O O
10 O O
weeks O O
gestation O O
. O O

she O O
was O O
known O O
to O O
have O O
RHD O O
and O O
was O O
on O O
warfarin O O
for O O
a O O
mechanical O O
mitral O O
valve O O
. O O

the O O
pregnancy O O
had O O
been O O
planned O O
against O O
advice O B-C0740209
from O O
her O O
gynaecologist O O
and O O
cardiologist O O
. O O

she O O
was O O
asymptomatic O O
( O O
NYHA O O
class O O
I O O
) O O
. O O

she O O
was O O
started O O
on O O
folic O O
acid O O
5mg O O
daily O O
. O O

her O O
INR O O
was O O
within O O
therapeutic O O
range O O
. O O

at O O
20 O O
weeks O O
, O O
a O O
foetal O O
anomaly O O
scan O O
showed O O
severely O O
dilated O B-C3278923
cerebral O I-C3278923
ventricles O I-C3278923
dangling O O
choroid O O
plexus O O
, O O
lemon O O
shaped O O
head O O
. O O

the O O
inter-hemispheric O O
fissure O O
was O O
present O O
and O O
there O O
was O O
no O O
identifiable O O
cortical O O
brain O O
tissue O O
. O O

the O O
facial O O
anatomy O O
was O O
normal O O
. O O

there O O
was O O
a O O
discordant O O
growth O O
pattern O O
with O O
the O O
bi-parietal O O
diameter O O
corresponding O O
to O O
24 O O
weeks O O
, O O
head O O
circumference O O
to O O
23 O O
weeks O O
but O O
abdominal O O
circumference O O
and O O
femur O O
length O O
both O O
to O O
19 O O
weeks O O
. O O

A O O
repeat O O
scan O O
by O O
a O O
radiologist O O
showed O O
" O O
evidence O O
of O O
a O O
well O O
formed O O
cranium O O
but O O
with O O
severe O O
hydraencephaly O O
with O O
replacement O O
of O O
supratentorial O O
brain O O
parenchyma O O
by O O
cerebro-spinal O O
fluid O O
. O O

there O O
was O O
mild O O
preservation O O
of O O
posterior O O
fossa O O
structures O O
with O O
ventricles O O
not O O
easily O O
describable O O
. O O
" O O

in O O
the O O
opinion O O
of O O
both O O
the O O
sonographer O O
and O O
the O O
radiologist O O
the O O
findings O O
were O O
not O O
compatible O O
with O O
extra-uterine O O
life O O
. O O

the O O
couple O O
was O O
informed O O
and O O
termination O O
of O O
the O O
pregnancy O O
( O O
TOP O O
) O O
was O O
done O O
. O O

her O O
INR O O
was O O
2.3 O O
. O O

she O O
expelled O O
the O O
conceptus O O
complete O O
within O O
24hrs O O
of O O
induction O O
. O O

there O O
was O O
no O O
excessive O O
bleeding O B-C0019080
and O O
she O O
was O O
discharged O O
in O O
a O O
stable O O
condition O O
. O O

copper O O
T O O
intrauterine O O
contraceptive O B-C0344225
device O O
( O O
cu-iucd O O
) O O
was O O
offered O O
. O O

A O O
54 O O
- O O
years-old O O
woman O O
presented O O
with O O
a O O
history O O
of O O
right O O
mastectomy O O
for O O
a O O
breast O B-C0006142
cancer O I-C0006142
14 O O
years O O
previously O O
, O O
and O O
radio-chemotherapy O O
for O O
squamous O O
cells O O
carcinoma O B-C0302592
of O I-C0302592
the O I-C0302592
cervix O I-C0302592
12 O O
years O O
ago O O
, O O
and O O
a O O
cholecystectomy O O
5 O O
years O O
ago O O
. O O

she O O
consulted O O
for O O
a O O
winged O O
right O O
scapula O O
since O O
1 O O
year O O
. O O

in O O
recent O O
months O O
the O O
lesion O B-C0221198
had O O
increased O O
in O O
size O O
and O O
caused O O
discomfort O B-C2364135
and O O
even O O
pain O B-C0030193
in O O
response O O
to O O
exercise O O
. O O

physical O O
examination O O
revealed O O
bilateral O O
masses O O
that O O
became O O
manifest O O
on O O
abducting O O
and O O
flexing O O
arms O O
. O O

both O O
lesions O B-C0221198
were O O
grossly O O
rounded O O
, O O
of O O
rubber-like O O
consistency O O
, O O
not O O
adhering O O
to O O
the O O
skin O O
but O O
adhesive O O
to O O
deep O O
structures O O
, O O
measuring O O
about O O
9 O O
cm O O
in O O
diameter O O
, O O
and O O
slightly O O
painful O O
( O O
the O O
pain O B-C0030193
was O O
reported O O
mainly O O
in O O
the O O
right O O
side O O
) O O
. O O

ultrasound O O
showed O O
a O O
homogeneous O O
well O O
limited O O
echogenic O O
avascular O O
structure O O
measuring O O
67 O O
x O O
30 O O
mm O O
. O O

magnetic O O
resonance O O
imaging O O
set O O
the O O
diagnosis O O
by O O
revealing O O
bilateral O O
soft O B-C0037579
tissue O I-C0037579
tumors O I-C0037579
regarding O O
the O O
tip O O
of O O
the O O
scapula O O
, O O
roughly O O
symmetrical O O
and O O
poorly O O
circumscribed O O
with O O
dimensions O O
77 O O
x O O
21 O O
mm O O
in O O
the O O
right O O
side O O
and O O
83 O O
x O O
21 O O
mm O O
in O O
the O O
left O O
one O O
. O O

the O O
masses O O
consisted O O
of O O
elements O O
with O O
linear O O
fibrillary O O
signaling O O
which O O
intensity O O
was O O
equal O O
to O O
muscles O O
in O O
T1 O O
and O O
T2 O O
. O O

hypersignaling O O
bands O O
in O O
T1 O O
and O O
T2 O O
were O O
also O O
dispersed O O
among O O
them O O
with O O
intensity O O
equal O O
to O O
fat O O
. O O

no O O
signs O O
of O O
malignancy O B-C0006826
were O O
observed O O
, O O
particularly O O
absence O O
of O O
bone O O
invasion O O
. O O

the O O
MRI O O
data O O
were O O
compatible O O
with O O
elastofibroma O O
dorsi O O
. O O

surgical O O
excision O O
was O O
performed O O
under O O
general O O
anesthesia O B-C0278134
on O O
prone O O
position O O
and O O
with O O
abducted O O
arms O O
. O O

an O O
incision O O
was O O
made O O
over O O
the O O
palpable O O
masses O O
and O O
the O O
ill-defined O O
tumors O O
were O O
removed O O
. O O

macroscopically O O
, O O
the O O
lesions O B-C0221198
were O O
non O O
encapsulated O O
, O O
with O O
whitish O O
fibrous O O
tracts O O
alternating O O
with O O
yellowish O O
tissue O O
of O O
fatty O O
consistency O O
. O O

the O O
histological O O
study O O
revealed O O
a O O
benign O O
proliferation O O
composed O O
of O O
collagen O O
and O O
elastic O O
fibers O O
, O O
associated O O
with O O
some O O
fibroblasts O O
and O O
fat O O
cells O O
. O O

the O O
elastic O O
fibers O O
were O O
fragmented O O
into O O
globules O O
or O O
had O O
a O O
linear O O
arrangement O O
. O O

the O O
surgical O O
excision O O
was O O
complete O O
. O O

the O O
post O O
operative O O
course O O
was O O
without O O
complications O O
, O O
and O O
the O O
patient O O
was O O
discharged O O
3 O O
days O O
after O O
surgery O O
. O O

A O O
35 O O
year O O
old O O
female O O
, O O
presented O O
with O O
right O O
sided O O
chest O B-C0008031
pain O I-C0008031
, O O
associated O O
mild O O
abdominal O B-C0000737
pain O I-C0000737
, O O
and O O
partial O O
obstructive O O
symptoms O O
for O O
several O O
years O O
. O O

there O O
was O O
no O O
significant O O
past O O
personal O O
or O O
family O B-C0241889
history O I-C0241889
) O O
. O O

there O O
was O O
no O O
history O O
of O O
trauma O O
. O O

clinical O O
examination O O
revealed O O
that O O
she O O
was O O
mildly O O
dehydrated O B-C0011175
, O O
tachycardic O B-C0039231
( O O
heart O O
rate O O
110 O O
beats O O
per O O
minute O O
) O O
, O O
afebrile O O
, O O
normotensive O B-C2712122
, O O
and O O
had O O
mild O O
abdominal O O
tenderness O O
. O O

investigation O O
revealed O O
a O O
raised O O
white O O
cell O O
count O O
of O O
12.35x O O
10gl O O
( O O
reference O O
range O O
4 O O
- O O
10xgl O O
) O O
. O O

A O O
chest O O
radiograph O O
revealed O O
radio-opacity O O
of O O
right O O
basal O O
area O O
an O O
abdominal O O
erect O O
radiograph O O
was O O
unremarkable O O
. O O

the O O
patient O O
was O O
admitted O O
with O O
a O O
presumed O O
diagnosis O O
of O O
intra-abdominal O O
tuberculosis O B-C0041296
, O O
the O O
medical O O
officer O O
was O O
asked O O
to O O
do O O
right O O
thoracocentesis O O
, O O
which O O
yielded O O
a O O
small O O
amount O O
of O O
blood O O
. O O

while O O
the O O
patient O O
was O O
awaiting O O
a O O
chest O O
and O O
abdominal O O
computed O O
tomography O O
( O O
CT O O
) O O
, O O
she O O
developed O O
a O O
mechanical O O
intestinal O B-C0021843
obstruction O I-C0021843
. O O

an O O
emergency O O
exploratory O O
laparotomy O O
was O O
performed O O
through O O
a O O
midline O O
incision O O
. O O

we O O
found O O
a O O
right O O
sided O O
bochdalek's O O
hernia O B-C0019270
containing O O
transvers O O
colon O O
, O O
right O O
colon O O
, O O
along O O
with O O
the O O
appendix O O
and O O
terminal O O
ilium O O
. O O

the O O
worrisome O O
finding O B-C0037088
was O O
that O O
of O O
a O O
closed-loop O O
intestinal O B-C0021843
obstruction O I-C0021843
. O O

incidentally O O
, O O
there O O
were O O
three O O
accessory O B-C2939133
liver O I-C2939133
lobes O O
, O O
likely O O
constituting O O
the O O
right O O
lobe O O
of O O
the O O
liver O O
. O O

the O O
diaphragm O O
had O O
to O O
be O O
divided O O
slightly O O
to O O
enable O O
reduction O O
of O O
the O O
incarcerated O O
contents O O
. O O

these O O
contents O O
appeared O O
compromised O O
, O O
but O O
viable O O
. O O

of O O
particular O O
interest O O
, O O
there O O
was O O
no O O
hernia O B-C0019270
sac O O
. O O

the O O
right O O
lower O O
lobe O O
of O O
the O O
lung O O
appeared O O
hypoplastic O O
. O O

after O O
reduction O O
of O O
the O O
hernia O B-C0019270
contents O O
, O O
the O O
diaphragmatic O B-C1848873
defect O I-C1848873
was O O
repaired O O
in O O
a O O
tension-free O O
fashion O O
. O O

A O O
limited O O
resection O O
and O O
primary O O
repair O O
of O O
the O O
compromised O O
redundant O O
transvers O O
colon O O
was O O
carried O O
out O O
. O O

after O O
careful O O
consideration O O
, O O
we O O
decided O O
to O O
carry O O
out O O
an O O
incidental O O
appendectomy O O
. O O

A O O
right-sided O O
chest O O
tube O O
was O O
placed O O
under O O
direct O O
vision O O
, O O
before O O
closure O O
of O O
the O O
diaphragmatic O B-C1848873
defect O I-C1848873
. O O

the O O
patient O O
was O O
transferred O O
in O O
to O O
intensive O O
care O O
unit O O
( O O
ICU O O
) O O
. O O

she O O
made O O
an O O
uneventful O O
recovery O O
and O O
was O O
discharged O O
home O O
. O O

she O O
was O O
discharged O O
home O O
in O O
excellent O O
condition O O
, O O
and O O
remains O O
well O O
at O O
nine O O
month O O
follow-up O O
. O O

we O O
present O O
a O O
rare O O
case O O
of O O
a O O
middle O O
aged O O
female O O
with O O
a O O
history O O
of O O
rheumatoid O B-C0003873
arthritis O I-C0003873
under O O
non-steroidal O O
anti-inflammatory O O
drugs O O
which O O
is O O
currently O O
in O O
remission O O
. O O

since O O
2 O O
months O O
, O O
she O O
describes O O
inflammatory O O
lower O B-C0024031
back O I-C0024031
pain O I-C0024031
without O O
a O O
preceding O O
trauma O O
. O O

she O O
denied O O
nausea O B-C0027497
, O O
vomiting O B-C0042963
, O O
hematochezia O B-C0018932
, O O
melena O B-C0025222
or O O
weight O B-C1262477
loss O I-C1262477
. O O

his O O
family O B-C0241889
history O I-C0241889
was O O
negative O O
for O O
any O O
malignancies O B-C0006826
. O O

on O O
examination O O
the O O
patient O O
had O O
fever O B-C0015967
39 O O
° O O
C O O
, O O
pain O B-C0030193
in O O
the O O
pressure O O
of O O
the O O
thorny O O
of O O
dorsal O O
and O O
lumbar O O
vertebrae O O
. O O

she O O
had O O
normal O O
strength O O
and O O
sensation O O
in O O
the O O
lower O O
extremities O O
and O O
denied O O
any O O
fecal O O
or O O
urinary O B-C0042024
incontinence O I-C0042024
. O O

however O O
, O O
reflexes O O
were O O
increased O O
with O O
positive O O
babinski O B-C0034935
at O O
the O O
left O O
side O O
. O O

investigations O O
showed O O
hb O O
of O O
7 O O
, O O
2 O O
g O O
/ O O
dl O O
, O O
WBC O O
count O O
8600 O O
/ O O
mm O O
3 O O
, O O
hyper O O
eosinophilia O B-C0014457
of O O
1100 O O
/ O O
mm O O
3 O O
, O O
platelets O O
80,000 O O
/ O O
mm O O
3 O O
, O O
sedimentation O O
rate O O
135 O O
/ O O
mm O O
3 O O
, O O
c-reactive O O
protein O O
81 O O
mg O O
/ O O
l O O
, O O
alkaline O O
phosphatase O O
( O O
ALP O O
) O O
466 O O
U O O
/ O O
l O O
( O O
reference O O
range O O
35 O O
- O O
140 O O
IU O O
/ O O
L O O
) O O
, O O
calcium O O
and O O
prothrombin O O
time O O
80% O O
of O O
normal O O
. O O

renal O O
function O O
was O O
normal O O
. O O

we O O
noted O O
a O O
cholestasis O B-C0008370
( O O
2 O O
x O O
ULN O O
) O O
with O O
a O O
normal O O
rate O O
of O O
bilirubine O O
. O O

X O O
ray O O
of O O
the O O
spine O O
revealed O O
several O O
lytic O B-C0221204
lesions O I-C0221204
throughout O O
most O O
of O O
his O O
spine O O
which O O
initially O O
raised O O
suspicion O O
of O O
metastasis O B-C0027627
. O O

magnetic O O
resonance O O
imaging O O
showed O O
secondary O O
lesions O B-C0221198
in O O
the O O
spine O O
and O O
pelvis O O
. O O

bone O O
scintigraphy O O
revealed O O
abnormal O O
uptake O O
in O O
the O O
spine O O
( O O
T5 O O
, O O
T9 O O
and O O
T11 O O
) O O
, O O
ribs O O
and O O
in O O
sacro O O
iliac O O
joint O O
. O O

the O O
patient O O
was O O
then O O
investigated O O
to O O
look O O
for O O
the O O
primary O O
. O O

echo O O
mammography O O
was O O
normal O O
. O O

CT O O
scan O O
of O O
abdomen O O
and O O
pelvis O O
showed O O
multiples O O
hepatic O O
metastasis O B-C0027627
. O O

uppergasrointestinal O O
endoscopy O O
was O O
done O O
and O O
revealed O O
a O O
small O O
2 O O
cm O O
ulcerated O O
mass O O
at O O
the O O
antrum O O
which O O
was O O
not O O
visualized O O
on O O
the O O
CT O O
scan O O
. O O

A O O
biopsy O O
indicated O O
an O O
adenocarcinoma O B-C0001418
moderately O O
differentiated O O
and O O
infiltrating O O
of O O
the O O
stomach O O
. O O

the O O
patient O O
underwent O O
chemotherapy O O
with O O
oxaliplatin O O
and O O
5 O O
- O O
fluorouracil O O
along O O
with O O
radiation O O
figure O O
1 O O
. O O

67 O O
- O O
year-old O O
woman O O
with O O
one O O
year O O
history O O
of O O
intermittant O O
headache O B-C0018681
, O O
which O O
was O O
prominent O O
in O O
the O O
left O O
periorbital O O
region O O
, O O
was O O
first O O
evaluated O O
in O O
another O O
hospital O O
and O O
found O O
to O O
have O O
normal O B-C4315655
brain O I-C4315655
CT O I-C4315655
and O O
MRI O O
scan O O
. O O

she O O
was O O
recommended O O
analgesic O O
and O O
antidepressant O O
treatment O O
. O O
2 O O
months O O
before O O
admission O O
to O O
our O O
clinic O O
, O O
the O O
headache O B-C0018681
worsened O O
, O O
became O O
continuous O O
and O O
finally O O
medial O O
deviation O O
of O O
the O O
left O O
eye O O
appeared O O
. O O

this O O
time O O
she O O
was O O
suffering O O
from O O
diplopia O B-C0012569
. O O

neurological O O
examination O O
was O O
normal O O
except O O
left O O
abducens O B-C0271355
palsy O I-C0271355
. O O

the O O
medical O O
and O O
family O B-C0241889
history O I-C0241889
was O O
unremarkable O O
. O O

A O O
comprehensive O O
blood O O
survey O O
( O O
including O O
ESR O O
, O O
CRP O O
, O O
hemogram O O
, O O
serum O O
biochemistry O O
, O O
TFT O O
, O O
vitamin O O
B12 O O
, O O
folate O O
and O O
ASO O O
levels O O
) O O
was O O
normal O O
; O O
vasculitic O O
and O O
tumour O B-C0027651
markers O O
were O O
negative O O
. O O

transthoracic O O
echocardiogram O O
was O O
normal O O
. O O

an O O
orbita O O
MRI O O
and O O
MR O O
venogram O O
were O O
performed O O
for O O
exclusion O O
of O O
tolosa O B-C0040381
hunt O I-C0040381
syndrome O I-C0040381
; O O
brain O O
MRI O O
was O O
repeated O O
. O O

orbita O O
MRI O O
and O O
MR O O
venogram O O
were O O
normal O O
. O O

asymmetric O O
enlargement O O
of O O
the O O
left O O
cavernous O O
sinus O O
and O O
contiguous O O
tubular O O
signal-void O O
regions O O
were O O
detected O O
on O O
the O O
brain O O
MRI O O
. O O

there O O
was O O
asymmetric O O
dural O O
enhancement O O
on O O
the O O
anterior O O
part O O
of O O
the O O
temporal O O
pole O O
, O O
on O O
the O O
middle O O
cranial O O
fossa O O
. O O

cranial O O
arterial O O
MR O O
angiography O O
( O O
TOF O O
) O O
showed O O
enlargement O O
of O O
cavernous O O
sinuses O B-C0016169
, O O
more O O
prominent O O
on O O
the O O
left O O
side O O
and O O
homogenous O O
enhancement O O
after O O
contrast O O
administration O O
. O O

the O O
left O O
ophtalmic O O
artery O O
and O O
left O O
superior O O
ophtalmic O O
vein O O
were O O
increased O O
in O O
caliber O O
when O O
compared O O
to O O
the O O
right O O
side O O
. O O

since O O
the O O
findings O O
were O O
not O O
enough O O
to O O
make O O
definite O O
diagnosis O O
, O O
DSA O O
was O O
performed O O
, O O
which O O
revealed O O
the O O
presence O O
of O O
early O O
venous O O
drainage O O
to O O
the O O
cavernous O O
sinuses O B-C0016169
both O O
from O O
external O O
carotid O O
arteries O O
and O O
cavernous O O
segments O O
of O O
the O O
internal O O
carotid O O
arteries O O
. O O

the O O
venous O O
drainage O O
was O O
predominantly O O
supplied O O
by O O
superior O O
ophthalmic O O
and O O
angular O O
veins O O
. O O

the O O
lesion O B-C0221198
was O O
angiographically O O
classified O O
as O O
bilateral O O
type O O
D O O
dural O B-C0752156
arteriovenous O I-C0752156
fistula O I-C0752156
of O O
cavernous O O
sinuses O B-C0016169
. O O

neurosurgery O O
, O O
interventional O O
radiology O B-C1405978
and O O
neurology O O
departments O O
agreed O O
on O O
endovascular O O
embolization O O
therapy O O
. O O

the O O
patient O O
was O O
informed O O
about O O
the O O
management O O
but O O
she O O
disapproved O O
the O O
treatment O O
and O O
was O O
discharged O O
. O O

A O O
43 O O
- O O
year-old O O
women O O
visited O O
our O O
institution O O
at O O
36th O O
weeks O O
of O O
gestation O O
with O O
2 O O
- O O
months O O
history O O
of O O
headache O B-C0018681
and O O
left O O
ptosis O B-C0033377
. O O

after O O
a O O
review O O
by O O
the O O
obstetrician O O
, O O
she O O
was O O
admitted O O
to O O
our O O
departement O O
. O O

we O O
consulted O O
neurosurgeon O O
and O O
ophthalmologist O O
for O O
a O O
review O O
. O O

she O O
had O O
regular O O
menstruation O O
cycle O O
before O O
pregnancy O O
and O O
it O O
is O O
a O O
spontaneous O O
pregnancy O O
. O O

therefore O O
, O O
she O O
had O O
not O O
been O O
examined O O
any O O
evaluations O O
for O O
pituitary O O
gland O O
or O O
pituitary O O
hormones O O
before O O
pregnancy O O
. O O

there O O
were O O
no O O
specific O O
past O O
medical O O
or O O
operative O O
histories O O
. O O

ophtalmologic O O
examination O O
revealed O O
a O O
moderate O O
left O O
ptosis O B-C0033377
and O O
the O O
visual O O
field O O
was O O
normal O O
. O O

magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
demonstrated O O
a O O
macroadenoma O O
with O O
the O O
size O O
of O O
1.35 O O
× O O
2.9 O O
× O O
1.2cm O O
, O O
without O O
a O O
suprasellar O O
extension O O
or O O
a O O
compression O O
of O O
the O O
optic O O
chiasma O O
. O O

it O O
encased O O
the O O
left O O
cavernous O O
sinus O O
and O O
internal O O
carotid O O
artery O O
. O O

endocrine O O
tests O O
indicated O O
that O O
prolactin O O
level O O
was O O
6882 O O
mui O O
/ O O
l O O
( O O
but O O
our O O
patient O O
is O O
pregnant O O
) O O
. O O

we O O
practiced O O
a O O
1 O O
ug O O
synacthene O O
test O O
and O O
the O O
cortisol O O
levels O O
were O O
normal O O
( O O
T0 O O
= O O
1100.92 O O
nmol O O
/ O O
l O O
, O O
T1 O O
= O O
1256.39 O O
nmol O O
/ O O
l O O
) O O
excluding O O
a O O
cortitcotrope O O
insufficiency O O
. O O

the O O
patient O O
had O O
a O O
thyreotrope O O
insufficiency O O
: O O
FT4 O O
= O O
3.35 O O
pmol O O
/ O O
l O O
( O O
7.8 O O
- O O
14.4 O O
) O O
, O O
TSH O O
= O O
1.56 O O
mui O O
/ O O
ml O O
( O O
0.34 O O
- O O
5.6 O O
) O O
. O O

we O O
didn't O O
explore O O
the O O
somatotropic O O
axis O O
. O O

obstetric O O
ultrasound O O
was O O
normal O O
and O O
a O O
cesarean O O
was O O
planned O O
at O O
38 O O
th O O
weeks O O
of O O
gestation O O
. O O

we O O
initiated O O
dopamine O O
agonist O O
therapy O O
with O O
1.25 O O
mg O O
of O O
bromocriptine O O
once O O
for O O
2 O O
days O O
, O O
titrated O O
to O O
1.25 O O
mg O O
twice O O
daily O O
. O O
48 O O
hours O O
after O O
the O O
prescription O O
of O O
the O O
bromocriptine O O
, O O
we O O
had O O
a O O
spectacular O O
evolution O O
with O O
disappearance O O
of O O
the O O
headache O B-C0018681
and O O
a O O
total O O
regression O B-C1836830
of O O
the O O
ptosis O B-C0033377
. O O

the O O
patient O O
gave O O
birth O O
to O O
a O O
healthy O O
boy O O
. O O

they O O
are O O
both O O
doing O O
well O O
. O O

she O O
is O O
still O O
on O O
bromocriptine O O
1.25 O O
mg O O
twice O O
daily O O
and O O
we O O
didn't O O
allow O O
the O O
breastfeeding O O
. O O

the O O
prolactin O O
and O O
the O O
MRI O O
were O O
planned O O
at O O
the O O
first O O
and O O
the O O
third O O
month O O
of O O
the O O
post O O
partum O O
. O O

M.F O O
. O O
1 O O
year O O
, O O
and O O
M.B O O
. O O
2 O O
years O O
and O O
half O O
, O O
with O O
no O O
particular O O
antecedents O O
are O O
received O O
in O O
pediatric O O
emergencies O B-C2745965
for O O
post-circumcision O O
bleeding O B-C0019080
. O O

no O O
hemostasis O O
assessment O O
being O O
carried O O
out O O
before O O
the O O
act O O
. O O

on O O
admission O O
, O O
the O O
brothers O O
were O O
conscious O O
and O O
had O O
a O O
good O O
condition O O
. O O

there O O
were O O
no O O
familial O O
antecedents O O
. O O

after O O
stopping O O
bleeding O B-C0019080
, O O
blood O O
test O O
was O O
requested O O
for O O
both O O
brothers O O
. O O

for O O
M.F O O
: O O
as O O
result O O
of O O
hemostatic O O
balance O O
sheet O O
, O O
we O O
found O O
: O O
PT O O
= O O
95% O O
, O O
APTT O O
= O O
80 O O
sec O O
, O O
F O O
VIII O O
< O O
1% O O
, O O
F O O
IX O O
= O O
54% O O
. O O

haemogram O O
is O O
as O O
follow O O
: O O
HGB O O
= O O
8.7 O O
g O O
/ O O
dl O O
, O O
MCV O O
= O O
51 O O
fl O O
, O O
MCH O O
= O O
16 O O
pg O O
, O O
WBC O O
= O O
7760 O O
/ O O
mm O O
3 O O
and O O
platelets O O
= O O
391.000 O O
/ O O
mm O O
3 O O
. O O

because O O
of O O
the O O
microcytosis O B-C0221265
, O O
ferritin O O
blood O O
test O O
was O O
made O O
which O O
was O O
normal O O
, O O
about O O
30 O O
ng O O
/ O O
ml O O
. O O

electrophoresis O O
of O O
hemoglobin O O
was O O
realized O O
to O O
explore O O
the O O
microcytosis O B-C0221265
, O O
the O O
result O O
was O O
: O O
hb O O
A1 O O
= O O
60,9 O O
% O O
, O O
hb O O
S O O
= O O
35,9% O O
, O O
hb O O
A2 O O
= O O
3.2% O O
. O O

for O O
M.B O O
, O O
the O O
hemostatic O O
balance O O
sheet O O
is O O
as O O
follows O O
: O O
PT O O
= O O
110 O O
% O O
, O O
APTT O O
= O O
72 O O
sec O O
, O O
F O O
VIII O O
< O O
1% O O
, O O
F O O
IX O O
= O O
60 O O
% O O
. O O

haemogram O O
: O O
HGB O O
= O O
10.7 O O
g O O
/ O O
dl O O
, O O
MCV O O
= O O
66 O O
fl O O
, O O
MCH O O
= O O
22 O O
pg O O
, O O
WBC O O
= O O
6870 O O
/ O O
mm O O
3 O O
, O O
platelets O O
= O O
193.000 O O
/ O O
mm O O
3 O O
. O O

ferritin O O
was O O
32 O O
ng O O
/ O O
ml O O
. O O

electrophoresis O O
of O O
hemoglobin O O
was O O
as O O
follow O O
: O O
hb O O
A1 O O
= O O
57 O O
% O O
, O O
hb O O
S O O
= O O
38.5 O O
% O O
, O O
hb O O
A2 O O
= O O
4.5 O O
% O O
. O O

none O O
of O O
the O O
children O O
has O O
received O O
a O O
blood O O
transfusion O O
. O O

we O O
conclude O O
that O O
it O O
is O O
about O O
a O O
post-circumcision O O
bleeding O B-C0019080
due O O
to O O
major O O
hemophilia O B-C0019069
A O I-C0019069
associated O O
to O O
sickle O O
cell O O
AS O O
, O O
this O O
association O O
was O O
a O O
systematic O O
discovery O O
. O O

there O O
was O O
no O O
family O B-C0241889
history O I-C0241889
of O O
sickle O B-C0002895
cell O I-C0002895
anemia O I-C0002895
, O O
but O O
electrophoresis O O
of O O
hemoglobin O O
was O O
realized O O
for O O
the O O
mother O O
, O O
result O O
was O O
as O O
follow O O
: O O
hb O O
A1 O O
= O O
62 O O
% O O
, O O
hb O O
S O O
= O O
35,5 O O
% O O
, O O
hb O O
A2 O O
= O O
2,2 O O
% O O
. O O

A O O
30 O O
year O O
old O O
female O O
was O O
referred O O
to O O
the O O
university O O
teaching O O
hospital O O
from O O
a O O
primary O O
health O O
centre O O
for O O
persistent O O
itchy O O
generalised O O
body O O
rash O B-C0015230
of O O
2 O O
months O O
. O O

on O O
admission O O
, O O
a O O
diagnosis O O
of O O
acute O B-C0149518
gastritis O I-C0149518
with O O
persistent O O
skin O B-C0037278
infection O I-C0037278
was O O
made O O
. O O

on O O
subsequent O O
review O O
, O O
the O O
patient O O
gave O O
a O O
history O O
of O O
the O O
rash O B-C0015230
having O O
started O O
from O O
upper O O
limbs O O
and O O
then O O
spread O O
to O O
the O O
trunk O O
and O O
lower O O
limbs O O
. O O

the O O
rash O B-C0015230
begun O O
as O O
erythematous O O
grouped O O
vesicles O O
preceded O O
by O O
an O O
intense O O
pruritus O B-C0033774
. O O

the O O
patient O O
was O O
also O O
experiencing O O
abdominal O B-C0000737
pains O I-C0000737
of O O
two O O
weeks O O
' O O
duration O O
which O O
were O O
more O O
severe O O
during O O
and O O
after O O
meals O O
with O O
associated O O
nausea O B-C0027498
and O I-C0027498
vomiting O I-C0027498
. O O

she O O
denied O O
taking O O
any O O
medications O O
prior O O
to O O
development O O
of O O
the O O
rash O B-C0015230
and O O
had O O
no O O
previous O O
history O O
of O O
any O O
allergies O B-C0020517
. O O

the O O
review O O
of O O
other O O
systems O O
was O O
unremarkable O O
. O O

she O O
received O O
intravenous O O
and O O
topical O O
hydrocortisone O O
at O O
the O O
referring O O
clinic O O
with O O
no O O
improvement O O
noted O O
. O O

on O O
examination O O
, O O
she O O
was O O
stable O O
, O O
not O O
febrile O B-C0015967
and O O
had O O
no O O
lesions O B-C0221198
in O O
the O O
oral O O
cavity O O
. O O

the O O
systemic O O
examination O O
was O O
unremarkable O O
. O O

on O O
local O O
examination O O
, O O
she O O
had O O
generalised O O
, O O
symmetrical O O
skin O B-C0037284
lesions O I-C0037284
in O O
different O O
stages O O
of O O
development O O
( O O
vesicles O O
, O O
erosions O B-C1959609
, O O
crusts O O
and O O
post O O
inflammatory O O
hypo-and O O
hyper-pigmented O O
macules O O
) O O
. O O

the O O
lesions O B-C0221198
were O O
mostly O O
affecting O O
the O O
trunk O O
, O O
buttocks O O
, O O
extensor O O
surface O O
of O O
lower O O
limbs O O
and O O
upper O O
limbs O O
, O O
sparing O O
the O O
head O O
, O O
neck O O
and O O
palms O O
. O O

vesicular O O
lesions O B-C0221198
were O O
grouped O O
on O O
an O O
erythematous O O
base O O
. O O

A O O
diagnosis O O
of O O
dermatitis O B-C0011608
herpetiformis O I-C0011608
with O O
suspected O O
celiac O B-C0007570
disease O I-C0007570
was O O
made O O
. O O

endoscopy O O
was O O
done O O
and O O
a O O
skin O O
punch O O
biopsy O O
of O O
a O O
vesicle O O
was O O
taken O O
and O O
sent O O
for O O
histopathology O O
which O O
was O O
suggestive O O
of O O
DH O O
or O O
bullous O B-C0030805
pemphigoid O I-C0030805
. O O

the O O
patient O O
was O O
started O O
on O O
dapsone O O
and O O
a O O
gluten-free O O
diet O O
. O O

she O O
improved O O
markedly O O
and O O
was O O
discharged O O
with O O
a O O
planned O O
follow O O
up O O
. O O

the O O
results O O
of O O
the O O
investigations O O
ordered O O
are O O
displayed O O
in O O
the O O
table O O
below O O
( O O
table O O
1 O O
) O O
. O O

A O O
45 O O
- O O
year-old O O
patient O O
with O O
congenital O O
left O O
solitary O B-C0266294
kidney O I-C0266294
presented O O
to O O
the O O
emergency O O
department O O
due O O
to O O
poor O O
general O O
condition O O
. O O

his O O
urine O O
output O O
had O O
decreased O O
gradually O O
over O O
the O O
previous O O
5 O O
days O O
. O O

no O O
gross O O
hematuria O B-C0018965
or O O
any O O
urological O O
symptoms O O
( O O
pollakiuria O B-C0042023
, O O
dysuria O B-C0013428
, O O
urgency O O
etc O O
. O O
) O O
were O O
present O O
. O O

his O O
serum O O
blood O O
urea O O
nitrogen O O
level O O
was O O
128 O O
mg O O
/ O O
dl O O
, O O
creatinine O O
11.8 O O
mg O O
/ O O
dl O O
, O O
and O O
potassium O O
6.8 O O
mg O O
/ O O
dl O O
. O O

non-contrast O O
computerized O O
tomography O O
( O O
CT O O
) O O
and O O
ultrasonography O O
were O O
performed O O
under O O
emergency O O
conditions O O
due O O
to O O
acute O B-C0022660
renal O I-C0022660
failure O I-C0022660
. O O

mild O O
dilatation O O
was O O
observed O O
in O O
the O O
left O O
kidney O O
and O O
an O O
approximately O O
four O O
cm O O
mass O O
in O O
the O O
left O O
lateral O O
wall O O
of O O
the O O
bladder O O
were O O
observed O O
at O O
CT O O
. O O

the O O
patient O O
was O O
taken O O
for O O
emergency O O
hemodialysis O O
. O O

cystoscopy O O
was O O
performed O O
when O O
his O O
general O O
condition O B-C3242272
improved O I-C3242272
. O O

cystoscopy O O
revealed O O
a O O
necrotic O O
solid O O
mass O O
, O O
approximately O O
4 O O
cm O O
in O O
diameter O O
, O O
in O O
the O O
left O O
lateral O O
bladder O O
wall O O
. O O

the O O
mass O O
was O O
approximately O O
2 O O
cm O O
distant O O
from O O
the O O
left O O
orifice O O
, O O
which O O
was O O
normal O O
. O O

the O O
lesion O B-C0221198
in O O
the O O
bladder O O
was O O
transurethrally O O
resected O O
, O O
and O O
a O O
JJ O O
stent O O
was O O
inserted O O
in O O
the O O
left O O
kidney O O
. O O

following O O
JJ O O
stent O O
insertion O O
, O O
serum O O
biochemical O O
values O O
returned O O
to O O
normal O O
limits O O
, O O
and O O
no O O
further O O
hemodialysis O O
was O O
required O O
. O O

the O O
tumor O B-C0027651
pathology O O
was O O
reported O O
as O O
pure O O
type O O
LCNC O O
. O O

histological O O
examination O O
revealed O O
large O O
tumor O B-C0027651
cells O O
with O O
polymorphic O O
nuclei O O
and O O
organoid O O
, O O
trabecular O O
growth O O
, O O
and O O
a O O
low O O
nucleus O O
/ O O
cytoplasm O O
ratio O O
, O O
a O O
coarse O O
chromatin O O
pattern O O
, O O
prominent O B-C3280497
nucleoli O I-C3280497
, O O
a O O
high O O
mitotic O O
rate O O
and O O
necrosis O O
in O O
the O O
cells O O
. O O

immunohistochemically O O
, O O
the O O
tumor O B-C0027651
neuroendocrine O B-C0206754
tumor O I-C0206754
differentiation O O
markers O O
CD56 O O
, O O
chromogranin O O
A O O
and O O
synaptophysin O O
were O O
positive O O
while O O
CD44 O O
was O O
negative O O
, O O
exhibiting O O
neuroendocrine O O
differentiation O O
. O O

no O O
evidence O O
of O O
tumor O B-C0027651
was O O
observed O O
at O O
CT O O
of O O
the O O
chest O O
, O O
abdomen O O
and O O
pelvis O O
. O O

treatment O O
plans O O
and O O
alternatives O O
were O O
discussed O O
with O O
the O O
patient O O
. O O

A O O
combination O O
of O O
four O O
courses O O
of O O
carboplatin O O
/ O O
etoposide O O
chemotherapy O O
and O O
radiotherapy O O
to O O
the O O
pelvis O O
and O O
bladder O O
region O O
was O O
scheduled O O
. O O

the O O
patient O O
was O O
monitored O O
with O O
cyctoscopic O O
controls O O
. O O

an O O
advanced O O
surgical O O
approach O O
such O O
as O O
cystectomy O O
was O O
not O O
considered O O
. O O

A O O
38 O O
- O O
year-old O O
man O O
with O O
longilinear O O
shape O O
, O O
smoker O B-C0337664
( O O
38 O O
packs O O
/ O O
year O O
) O O
with O O
no O O
other O O
relevant O O
medical O O
history O O
was O O
referred O O
to O O
our O O
department O O
due O O
to O O
the O O
finding O B-C0037088
of O O
left O O
pulmonary O O
hyperlucency O O
on O O
a O O
chest O O
x-ray O O
done O O
because O O
an O O
upper O O
airway O O
disease O O
. O O

A O O
computed O O
tomography O O
( O O
CT O O
) O O
was O O
performed O O
and O O
a O O
giant O O
emphysematous O O
bulla O B-C0005758
with O O
thin-walled O O
partitions O O
inside O O
, O O
that O O
replaced O O
almost O O
the O O
entire O O
left O O
upper O O
lobe O O
, O O
was O O
shown O O
. O O

preoperative O O
spirometry O O
revealed O O
a O O
forced O O
vital O O
capacity O O
( O O
FVC O O
) O O
of O O
5.5lts O O
( O O
99% O O
) O O
and O O
forced O O
expiratory O O
volume O O
on O O
the O O
1st O O
second O O
( O O
FEV1 O O
) O O
of O O
3.27lts O O
( O O
71% O O
) O O
. O O

carbon O O
monoxide O O
diffusion O O
was O O
6.84 O O
( O O
58% O O
) O O
. O O

the O O
dosage O O
of O O
alpha O O
- O O
1 O O
antitrypsin O O
was O O
within O O
the O O
reference O O
values O O
. O O

the O O
patient O O
underwent O O
an O O
exploratory O O
thoracoscopy O O
to O O
evaluate O O
the O O
extension O O
of O O
the O O
bulla O B-C0005758
. O O

intraoperatively O O
we O O
saw O O
a O O
giant O O
bulla O B-C0005758
that O O
initially O O
impressed O O
to O O
replace O O
the O O
entire O O
upper O O
lobe O O
. O O

once O O
all O O
firm O O
adhesions O O
to O O
parietal O O
pleura O O
were O O
released O O
and O O
the O O
bulla O B-C0005758
was O O
opened O O
for O O
a O O
better O O
dissection O O
because O O
of O O
its O O
large O O
size O O
we O O
saw O O
that O O
the O O
upper O O
lobe O O
was O O
partially O O
affected O O
persisting O O
a O O
healthy O O
parenchyma O O
area O O
. O O

despite O O
the O O
large O O
size O O
we O O
decided O O
to O O
attempt O O
thoracoscopic O O
resection O O
trying O O
to O O
preserve O O
the O O
remaining O O
healthy O O
parenchyma O O
. O O

bullectomy O O
was O O
done O O
using O O
six O O
linear O O
endoscopic O O
stapling O O
devices O O
of O O
60mm O O
. O O

pulmonary O O
insufflation O O
after O O
resection O O
showed O O
a O O
good O O
lung O O
expansion O O
of O O
the O O
remnant O O
. O O

finally O O
mechanical O O
pleural O O
abrasion O B-C1302752
was O O
done O O
. O O

pleural O O
cavity O O
was O O
drained O O
with O O
two O O
chest O O
tubes O O
connected O O
to O O
a O O
water O O
seal O O
. O O

histopathology O O
examination O O
revealed O O
a O O
giant O O
cavitated O O
emphysematous O O
bulla O B-C0005758
with O O
walls O O
0.1cm O O
thick O O
. O O

patient O O
presented O O
lack O O
of O O
lung O O
expansion O O
on O O
chest O O
x-ray O O
with O O
persistent O O
air O O
loss O O
trough O O
both O O
drains O O
. O O

continuous O O
aspiration O O
was O O
placed O O
. O O

he O O
remained O O
with O O
pleural O O
drainage O O
for O O
13 O O
days O O
. O O

A O O
postoperative O O
spirometry O O
and O O
CT O O
showed O O
an O O
improvement O O
of O O
all O O
the O O
volumes O O
and O O
carbon O O
monoxide O O
diffusion O O
( O O
FVC O O
6.07lts O O
- O O
108% O O
, O O
FEV1 O O
5.31lts O O
- O O
116% O O
, O O
DLCO O O
9.42 O O
- O O
80% O O
) O O
and O O
complete O O
pulmonary O O
expansion O O
. O O

we O O
are O O
presenting O O
a O O
24 O O
- O O
year-old O O
african O O
premegravida O O
who O O
was O O
diagnosed O O
with O O
takayasu's O B-C0039263
arteritis O I-C0039263
and O O
underwent O O
caesarean O O
section O O
under O O
spinal O O
anesthesia O B-C0278134
at O O
princess O O
marina O O
hospital O O
, O O
the O O
largest O O
tertiary O O
teaching O O
hospital O O
in O O
gaborone O O
, O O
botswana O O
. O O

she O O
is O O
37 O O
weeks O O
pregnant O O
weighing O O
65kg O O
and O O
160cm O O
of O O
height O O
. O O

she O O
was O O
diagnosed O O
with O O
TA O O
5 O O
years O O
ago O O
fulfilling O O
four O O
of O O
the O O
american O O
college O O
of O O
rheumatology O O
diagnostic O O
criteria O O
: O O
age O O
< O O
40 O O
years O O
, O O
blood O O
pressure O O
difference O O
of O O
more O O
than O O
10mmhg O O
in O O
right O O
and O O
left O O
arm O O
, O O
claudication O O
and O O
bruit O O
in O O
the O O
abdominal O O
aorta O O
. O O

she O O
was O O
scheduled O O
for O O
elective O O
caesarean O O
section O O
for O O
severe O O
oligohydramnios O B-C0079924
with O O
intrauterine O B-C0015934
growth O I-C0015934
restriction O I-C0015934
( O O
IUGR O O
) O O
. O O

she O O
was O O
under O O
treatment O O
for O O
her O O
TA O O
and O O
hypertension O B-C0020538
taking O O
amlodipine O O
10mg O O
peros O O
per O O
day O O
, O O
methyldopa O O
500mg O O
twice O O
peros O O
per O O
day O O
and O O
prednisolone O O
5mg O O
peros O O
per O O
day O O
. O O

except O O
for O O
occasional O O
headache O B-C0018681
the O O
hypertension O B-C0020538
and O O
TA O O
were O O
well O O
controlled O O
. O O

on O O
examination O O
she O O
looks O O
healthy O O
, O O
with O O
BP O O
140 O O
/ O O
80mmhg O O
on O O
her O O
right O O
arm O O
and O O
190 O O
/ O O
101mmhg O O
on O O
her O O
left O O
arm O O
with O O
pulse O O
rate O O
of O O
96 O O
per O O
minute O O
. O O

all O O
pulses O O
in O O
both O O
lower O O
limb O O
are O O
present O O
. O O

she O O
has O O
no O O
features O O
of O O
cardiac O B-C0018801
failure O I-C0018801
. O O

laboratory O O
tests O O
such O O
as O O
: O O
full O O
blood O O
count O O
, O O
serum O O
electrolyte O O
, O O
and O O
renal O O
function O O
tests O O
were O O
normal O O
. O O

echocardiogram O O
showed O O
60% O O
left O O
ventricular O O
ejection O O
fraction O O
and O O
mild O O
left O B-C0149721
ventricular O I-C0149721
hypertrophy O I-C0149721
and O O
normal O O
right O O
ventricle O O
. O O

preoperative O O
anaesthetic O O
evaluation O O
showed O O
oxygen O O
saturation O O
of O O
98% O O
on O O
room O O
air O O
, O O
mallampatti O O
airway O O
and O O
ASA O O
each O O
class O O
2 O O
. O O

peripheral O O
venous O O
access O O
is O O
secured O O
on O O
the O O
left O O
forearm O O
and O O
500ml O O
of O O
lactated O O
ringer O O
was O O
infused O O
to O O
overcome O O
acute O O
reduction O O
of O O
blood O O
pressure O O
following O O
spinal O O
anaesthesia O B-C0278134
. O O

she O O
was O O
given O O
amoxicillin O O
2gm O O
peros O O
, O O
ranitidine O O
50mg O O
intravenous O O
, O O
metoclopramide O O
injection O O
10mg O O
intravenous O O
, O O
and O O
hydrocortisone O O
100mg O O
intravenous O O
to O O
prevent O O
addison's O O
crisis O O
. O O

she O O
was O O
positioned O O
in O O
sitting O B-C0277814
position O I-C0277814
and O O
a O O
25G O O
quinicke's O O
spinal O O
needle O O
is O O
used O O
to O O
administer O O
1.5ml O O
of O O
0.5% O O
hyperbaric O O
bupivacaine O O
combined O O
with O O
20µg O O
fentanyl O O
at O O
L3 O O
- O O
L4 O O
space O O
under O O
aseptic O O
condition O O
. O O

sensory O O
block O O
was O O
achieved O O
at O O
T4 O O
level O O
. O O

A O O
pillow O O
was O O
placed O O
under O O
her O O
neck O O
to O O
prevent O O
stretching O O
of O O
the O O
carotid O O
arteries O O
with O O
further O O
compromise O O
in O O
blood O O
flow O O
, O O
tilted O O
to O O
the O O
left O O
lateral O O
to O O
prevent O O
aorto-caval O O
compression O O
. O O

she O O
was O O
monitored O O
by O O
three O O
leads O O
electrocardiogram O O
, O O
pulse O O
oximeter O O
on O O
her O O
left O O
index O O
finger O O
, O O
and O O
non-invasive O O
blood O O
pressure O O
. O O

following O O
administration O O
of O O
the O O
spinal O O
anaesthesia O B-C0278134
there O O
was O O
a O O
drop O O
of O O
BP O O
in O O
the O O
right O O
arm O O
from O O
140 O O
/ O O
80mmhg O O
to O O
120 O O
/ O O
60mmhg O O
which O O
was O O
corrected O O
back O O
to O O
base O O
line O O
by O O
1l O O
of O O
lactated O O
ringer O O
. O O

no O O
vasopressor O O
was O O
used O O
as O O
the O O
blood O O
pressure O O
remained O O
in O O
the O O
range O O
of O O
140 O O
/ O O
80mmhg O O
to O O
135 O O
/ O O
78mmhg O O
. O O

lower O O
segment O O
caesarean O O
section O O
was O O
performed O O
and O O
a O O
baby O O
boy O O
with O O
APGAR O O
score O O
of O O
9 O O
and O O
10 O O
at O O
5 O O
th O O
and O O
10 O O
th O O
minute O O
weighing O O
2.2kg O O
was O O
delivered O O
. O O

then O O
10 O O
IU O O
of O O
oxytocin O O
in O O
500ml O O
of O O
lactated O O
ringer O O
was O O
infused O O
post-delivery O O
. O O

the O O
operation O O
took O O
25 O O
minutes O O
and O O
the O O
estimated O O
blood O O
loss O O
was O O
500ml O O
. O O

patient O O
was O O
admitted O O
to O O
post-natal O O
high O O
dependency O O
ward O O
. O O

postoperatively O O
her O O
blood O O
pressure O O
remained O O
around O O
preoperative O O
levels O O
. O O

she O O
was O O
discharged O O
home O O
on O O
fifth O O
postoperative O O
day O O
on O O
her O O
regular O O
PO O O
medications O O
and O O
advised O O
to O O
follow O O
at O O
postnatal O O
and O O
cardiology O O
clinic O O
. O O

A O O
49 O O
- O O
year-old O O
woman O O
with O O
no O O
past O O
medical O O
history O O
or O O
cardiovascular O B-C0850624
risk O I-C0850624
factors O I-C0850624
presents O O
to O O
the O O
emergency O O
department O O
with O O
severe O O
chest O B-C0008031
pain O I-C0008031
and O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
. O O

review O O
of O O
system O O
revealed O O
left O O
hip O B-C4551516
pain O I-C4551516
for O O
which O O
patient O O
took O O
aspirin O O
1 O O
g O O
couple O O
of O O
hours O O
prior O O
to O O
her O O
current O O
presentation O O
. O O

further O O
history O O
reveals O O
that O O
she O O
experiences O O
similar O O
symptoms O O
of O O
chest O B-C0008031
pain O I-C0008031
and O O
shorness O O
of O O
breath O O
after O O
taking O O
aspirin O O
or O O
nonsteroidal O O
anti-inflammatory O O
drugs O O
( O O
nsaids O O
) O O
. O O

on O O
arrival O O
, O O
the O O
heart O O
rate O O
was O O
100 O O
bpm O O
, O O
blood O O
pressure O O
: O O
120 O O
/ O O
70 O O
mmhg O O
. O O

physical O O
exam O O
reveals O O
bilateral O O
expiratory O O
lung O O
wheezing O B-C0043144
. O O

chest O O
X O O
ray O O
was O O
unremarkable O O
, O O
ECG O O
showed O O
ST O O
segment O O
elevation O O
in O O
the O O
inferior O O
leads O O
. O O

transthoracic O O
echocardiography O O
showed O O
a O O
kinetic O O
abnormalities O O
of O O
anterolateral O O
and O O
inferior O O
walls O O
with O O
a O O
left O O
ventricule O O
ejection O O
fraction O O
of O O
35% O O
. O O

the O O
initial O O
troponin O O
I O O
us O O
was O O
makeredly O O
increased O O
with O O
concentration O O
of O O
50 O O
ng O O
/ O O
ml O O
( O O
147 O O
times O O
the O O
normal O O
laboratory O O
value O O
) O O
. O O

coronary O O
angiogram O O
revealed O O
a O O
severe O O
stenosis O O
in O O
the O O
ostium O O
of O O
right O O
coronary O O
artery O O
( O O
RCA O O
) O O
and O O
a O O
discrete O O
stenosis O O
in O O
the O O
distal O O
left O O
anterior O O
descending O O
artery O O
( O O
LAD O O
) O O
. O O

A O O
percutaneous O O
angioplasty O O
was O O
performed O O
on O O
RCA O O
lesion O B-C0221198
. O O

repeated O O
echocardiogram O O
showed O O
an O O
improvement O O
of O O
the O O
left O O
ventricule O O
ejection O O
fraction O O
to O O
50% O O
. O O

patient O O
was O O
discharged O O
on O O
standard O O
medical O O
therapy O O
including O O
aspirin O O
and O O
clopidogrel O O
. O O

in O O
the O O
subsequent O O
month O O
, O O
patient O O
had O O
multiple O O
recurrences O B-C2825055
of O O
chest O B-C0008031
pain O I-C0008031
asthma O O
attacks O O
and O O
was O O
admitted O O
with O O
a O O
NSTEMI O O
a O O
month O O
later O O
. O O

repeat O O
coronary O O
angiography O O
showed O O
a O O
patent O O
LAD O O
stent O O
and O O
severe O O
diffuse O O
stenosis O O
affecting O O
all O O
coronary O O
arteries O O
. O O

this O O
time O O
patient O O
was O O
treated O O
with O O
intracoronary O O
nitroglycerin O O
with O O
relieve O O
of O O
symptoms O O
. O O

the O O
new O O
occurrence O O
of O O
asthma O O
attacks O O
associated O O
with O O
asprin O O
consumption O O
was O O
finalty O O
related O O
to O O
samter's O O
syndrome O O
. O O

sinus O O
tomography O O
and O O
a O O
nasal O O
endoscopy O O
revealed O O
the O O
presence O O
of O O
bilateral O O
nasal O B-C0027430
polyposis O I-C0027430
confirming O O
the O O
diagnosis O O
of O O
the O O
aspirin-exacerbated O O
respiratory O B-C0035204
disease O I-C0035204
( O O
AERD O O
) O O
diagnosed O O
as O O
the O O
coexistence O O
of O O
asthma O O
, O O
nasal O B-C0027430
polyps O I-C0027430
and O O
aspirin O O
allergy O O
. O O

aspirin O O
was O O
discontinued O O
and O O
patient O O
discharged O O
on O O
clopidogrel O O
. O O

patient O O
remained O O
free O O
of O O
asthma O O
attack O O
and O O
chest O B-C0008031
pain O I-C0008031
during O O
two O O
year O O
follow-up O O
. O O

on O O
27 O O
th O O
of O O
august O O
, O O
2015 O O
, O O
a O O
37 O O
year O O
old O O
male O O
patient O O
reported O O
to O O
the O O
department O O
of O O
prosthodontics O O
, O O
DY O O
patil O O
school O O
of O O
dentistry O O
, O O
navi-mumbai O O
. O O

his O O
chief O O
complaint O O
was O O
of O O
a O O
fractured O O
tooth O O
which O O
had O O
undergone O O
a O O
root O O
canal O O
treatment O O
a O O
month O O
back O O
. O O

the O O
tooth O O
was O O
evaluated O O
to O O
rule O O
out O O
vertical O O
fracture O O
using O O
trans-illumination O O
and O O
gentian O O
violet O O
dye O O
. O O

no O O
fractures O B-C0016658
were O O
detected O O
figure O O
1 O O
. O O

cast-post O O
procedure O O
: O O
the O O
lingual O O
aspect O O
of O O
the O O
tooth O O
was O O
a O O
millimeter O O
sub-gingival O O
. O O

so O O
a O O
crown O O
lengthening O O
procedure O O
was O O
carried O O
out O O
using O O
scalpel O O
. O O

there O O
was O O
adequate O O
keratinized O O
tissue O O
present O O
on O O
the O O
lingual O O
aspect O O
after O O
crown O O
lengthening O O
procedure O O
. O O

no O O
osseous O O
reduction O O
was O O
required O O
[ O O
2 O O
] O O
. O O

two O O
weeks O O
after O O
crown O O
lengthening O O
, O O
the O O
canals O O
were O O
prepared O O
using O O
no O O
. O O
2 O O
and O O
no O O
. O O
3 O O
peso-reamers O O
in O O
mesio-buccal O O
and O O
distal O O
canal O O
respectively O O
. O O

A O O
direct O O
pattern O O
was O O
made O O
using O O
GC O O
pattern O O
resin O O
and O O
a O O
prefabricated O O
no O O
. O O
2 O O
MANI O O
post O O
. O O

the O O
pattern O O
was O O
made O O
with O O
the O O
prefabricated O O
post O O
in O O
the O O
mesio-buccal O O
canal O O
. O O

after O O
the O O
resin O O
has O O
set O O
, O O
the O O
prefabricated O O
post O O
was O O
rotated O O
and O O
removed O O
from O O
the O O
resin O O
post O O
and O O
core O O
. O O

the O O
resin O O
pattern O O
was O O
carefully O O
removed O O
from O O
the O O
distal O O
canal O O
after O O
it O O
had O O
set O O
completely O O
. O O

the O O
pattern O O
was O O
casted O O
using O O
semi-precious O O
alloy O O
. O O

both O O
, O O
the O O
pre-fabricated O O
post O O
and O O
the O O
finished O O
cast O O
past O O
was O O
sand O O
blasted O O
using O O
50 O O
microns O O
aluminum O O
oxide O O
. O O

also O O
a O O
small O O
slot O O
was O O
prepared O O
on O O
the O O
prefabricated O O
post O O
at O O
the O O
occlusal O O
level O O
of O O
the O O
cast-core O O
. O O

this O O
was O O
done O O
to O O
felicitate O O
easy O O
removal O O
of O O
the O O
occlusal O O
excess O O
without O O
using O O
any O O
rotary O O
tools O O
, O O
as O O
the O O
vibrations O O
caused O O
by O O
the O O
rotary O O
instruments O O
to O O
cut O B-C0000925
off O O
the O O
excess O O
pre-fabricated O O
post O O
, O O
may O O
loosen O O
the O O
bond O O
of O O
the O O
unset O O
cement O O
figure O O
2 O O
, O O
figure O O
3 O O
. O O

the O O
tooth O O
was O O
isolated O O
using O O
a O O
rubber O O
dam O O
. O O

the O O
tooth O O
was O O
treated O O
using O O
37% O O
phosphoric O O
acid O O
. O O

the O O
canals O O
were O O
rinsed O O
and O O
dried O O
using O O
distilled O O
water O O
and O O
paper O O
points O O
. O O

the O O
cement O O
used O O
was O O
resin O O
modified O O
GIC O O
[ O O
3 O O
] O O
. O O

the O O
cement O O
was O O
dispensed O O
using O O
dispensing O O
tips O O
into O O
both O O
the O O
prepared O O
canals O O
. O O

the O O
cast O O
post O O
was O O
coated O O
with O O
some O O
more O O
cement O O
and O O
seated O O
into O O
the O O
tooth O O
. O O

the O O
pre-fabricated O O
post O O
was O O
also O O
immediately O O
pushed O O
into O O
the O O
mesio-buccal O O
canal O O
before O O
the O O
cement O O
had O O
passed O O
its O O
working O O
time O O
. O O

the O O
cement O O
was O O
allowed O O
to O O
set O O
for O O
5 O O
minutes O O
. O O

after O O
the O O
initial O O
set O O
had O O
occurred O O
, O O
the O O
excess O O
part O O
of O O
the O O
prefabricated O O
post O O
was O O
tilted O O
and O O
broken O O
off O O
from O O
the O O
assembly O O
. O O

the O O
slot O O
made O O
at O O
the O O
occlusal O O
level O O
provided O O
an O O
easy O O
means O O
to O O
cut O B-C0000925
the O O
excess O O
off O O
and O O
allowed O O
the O O
patient O O
to O O
occlude O O
. O O

tooth O O
preparation O O
procedure O O
: O O
post O O
cementation O O
, O O
after O O
48 O O
hours O O
, O O
the O O
patient O O
was O O
recalled O O
. O O

tooth O O
preparation O O
was O O
done O O
during O O
this O O
appointment O O
. O O

the O O
margins O O
chosen O O
were O O
chamfer O O
on O O
distal O O
, O O
lingual O O
and O O
buccal O O
aspect O O
figure O O
4 O O
, O O
figure O O
5 O O
. O O

A O O
knife O O
edge O O
margin O O
was O O
chosen O O
on O O
the O O
mesial O O
aspect O O
. O O

studies O O
claim O O
that O O
the O O
zirconia O O
preparation O O
with O O
no O O
margin O O
and O O
a O O
sub-gingival O O
margin O O
has O O
a O O
very O O
good O O
longitivity O O
[ O O
4 O O
] O O
. O O

modern O O
day O O
zirconia O O
allows O O
the O O
clinician O O
to O O
have O O
margins O O
as O O
thin O O
as O O
0.2 O O
mm O O
. O O

also O O
the O O
highly O O
polished O O
zirconia O O
facilitates O O
hemi-desmosomal O O
attachment O O
with O O
the O O
gingiva O O
. O O

this O O
also O O
prevents O O
marginal O O
leakage O O
figure O O
6 O O
. O O

female O O
patient O O
, O O
45 O O
years O O
old O O
, O O
referred O O
for O O
left O O
mastectomy O O
with O O
sentinel O O
lymph O O
node O O
resection O O
. O O

there O O
was O O
no O O
other O O
comorbidities O O
; O O
she O O
denied O O
smoking O O
and O O
allergies O B-C0020517
to O O
medicines O O
, O O
foods O O
and O O
latex O O
. O O

preoperative O O
tests O O
, O O
such O O
as O O
cardiac O O
examination O O
, O O
blood O O
count O O
, O O
coagulation O O
, O O
biochemistry O O
( O O
urea O O
, O O
glucose O O
, O O
creatinine O O
, O O
AST O O
, O O
ALT O O
) O O
and O O
urinalysis O O
were O O
normal O O
. O O

the O O
patient O O
was O O
not O O
premedicated O O
. O O

at O O
the O O
operating O O
room O O
, O O
intra O O
venous O O
infusion O O
was O O
performed O O
at O O
the O O
right O O
upper O O
limb O O
with O O
20G O O
teflon O O
catheter O O
. O O

basic O O
monitoring O O
with O O
cardioscope O O
, O O
pulse O O
oximeter O O
, O O
and O O
non O O
invasive O O
blood O O
pressure O O
showed O O
normal O O
sinus O O
rhythm O O
, O O
heart O O
rate O O
( O O
HR O O
) O O
of O O
78 O O
bpm O O
, O O
oxygen O O
saturation O O
( O O
spo2 O O
) O O
of O O
98% O O
and O O
blood O O
pressure O O
of O O
120 O O
× O O
70 O O
mmhg O O
. O O

after O O
preoxygenation O O
with O O
100% O O
O2 O O
via O O
face O O
mask O O
and O O
administration O O
of O O
cefazolin O O
\ O O
( O O
2 O O
g O O
) O O
, O O
induction O O
of O O
anesthesia O B-C0278134
was O O
achieved O O
with O O
fentanyl O O
( O O
250 O O
g O O
) O O
, O O
propofol O O
( O O
150 O O
mg O O
) O O
and O O
rocuronium O O
( O O
50 O O
mg O O
) O O
. O O

tracheal O O
intubation O O
was O O
performed O O
with O O
a O O
7.5 O O
mm O O
cuffed O O
tube O O
and O O
basic O O
monitoring O O
complemented O O
with O O
capnography O O
; O O
controlled O O
mechanical O B-C4760388
ventilation O I-C4760388
with O O
570 O O
ml O O
tidal O O
volume O O
and O O
12 O O
ipm O O
respiratory O O
rate O O
. O O

at O O
that O O
point O O
, O O
cardiorespiratory O O
parameters O O
evidenced O O
normal O O
sinus O O
rhythm O O
, O O
HR O O
84 O O
bpm O O
, O O
spo2 O O
100% O O
, O O
ETCO2 O O
30 O O
, O O
and O O
PA O O
110 O O
× O O
75 O O
mmhg O O
. O O

maintenance O O
of O O
anesthesia O B-C0278134
was O O
achieved O O
with O O
sevoflurane O O
( O O
2 O O
- O O
- O O
- O O
2.5% O O
) O O
and O O
O2 O O
/ O O
N2O O O
( O O
50 O O
/ O O
50% O O
) O O
. O O

immediately O O
before O O
the O O
incision O O
, O O
a O O
subdermal O O
per O O
areolarinjection O O
of O O
2.5% O O
patent O O
blue O O
( O O
2 O O
ml O O
) O O
was O O
performed O O
. O O

about O O
25 O O
min O O
after O O
the O O
blue O O
dye O O
injection O O
, O O
increased O O
HR O O
( O O
110 O O
bpm O O
) O O
and O O
allergic O O
skin O O
reaction O O
occurred O O
without O O
changes O O
in O O
blood O O
pressure O O
, O O
spo2 O O
, O O
and O O
capnography O O
. O O

ringer's O O
lactate O O
( O O
400 O O
ml O O
) O O
was O O
administered O O
and O O
end-tidal O O
sevoflurane O O
concentration O O
decreased O O
to O O
1.5% O O
. O O

about O O
10 O O
min O O
after O O
volume O O
replacement O O
and O O
a O O
decrease O O
in O O
the O O
fraction O O
of O O
inspired O O
halogenated O O
, O O
blood O O
pressure O O
was O O
100 O O
× O O
60 O O
mmhg O O
and O O
HR O O
85 O O
bpm O O
, O O
without O O
changes O O
in O O
the O O
remaining O O
parameters O O
. O O

the O O
anesthetic-surgical O O
procedure O O
went O O
through O O
without O O
complications O O
. O O

dipyrone O O
( O O
2 O O
g O O
) O O
was O O
used O O
for O O
postoperative O O
analgesia O O
. O O

the O O
duration O O
of O O
surgery O O
was O O
50 O O
min O O
. O O

at O O
the O O
end O O
of O O
the O O
procedure O O
, O O
atropine O O
( O O
1 O O
mg O O
) O O
and O O
neostigmine O O
( O O
2 O O
mg O O
) O O
were O O
used O O
for O O
neuromuscular O O
blockade O O
reversal O O
. O O

after O O
surgical O O
field O O
removal O O
, O O
the O O
presence O O
of O O
numerous O O
urticaria-like O O
plates O O
( O O
bluish O O
) O O
was O O
observed O O
mainly O O
in O O
the O O
face O O
, O O
neck O O
, O O
upper O O
limbs O O
, O O
and O O
thorax O O
. O O

hydrocortisone O O
( O O
500 O O
mg O O
) O O
was O O
administered O O
. O O

the O O
patient O O
quickly O O
awakened O O
from O O
anesthesia O B-C0278134
and O O
was O O
extubated O O
in O O
the O O
operating O O
room O O
. O O

she O O
was O O
conscious O O
, O O
free O O
of O O
pain O B-C0030193
and O O
with O O
cardiovascular O O
and O O
respiratory O O
stability O O
( O O
blood O O
pressure O O
: O O
120 O O
× O O
80 O O
mmhg O O
, O O
HR O O
: O O
78 O O
bpm O O
, O O
and O O
spo2 O O
: O O
98% O O
) O O
. O O

the O O
patient O O
was O O
taken O O
to O O
the O O
post-anesthesia O O
care O O
unit O O
( O O
PACU O O
) O O
. O O

after O O
60 O O
min O O
, O O
the O O
patient O O
had O O
no O O
skin O O
changes O O
and O O
was O O
discharged O O
from O O
PACU O O
180 O O
min O O
after O O
surgery O O
. O O

the O O
patient O O
was O O
discharged O O
from O O
hospital O O
the O O
morning O O
after O O
surgery O O
without O O
complications O O
. O O

patient O O
gave O O
her O O
informed O O
written O O
consent O O
for O O
publication O O
. O O

A O O
40 O O
- O O
year-old O O
male O O
, O O
presented O O
to O O
the O O
emergency O O
department O O
with O O
sudden O O
onset O O
of O O
right O O
upper O O
quadrant O O
. O O

the O O
pain O B-C0030193
was O O
severe O O
, O O
constant O O
in O O
nature O O
, O O
radiating O O
to O O
the O O
right O O
shoulder O O
and O O
aggravated O O
by O O
movement O O
. O O

associated O O
symptoms O O
included O O
nausea O B-C0027497
and O O
one O O
episode O O
of O O
vomiting O B-C0042963
. O O

his O O
medical O O
history O O
is O O
unremarkable O O
. O O

the O O
patient O O
was O O
an O O
ex-smoker O O
( O O
stopped O O
at O O
the O O
age O O
of O O
30 O O
) O O
and O O
denied O O
drinking O O
alcohol O O
. O O

on O O
physical O O
examination O O
, O O
the O O
patient O O
looked O O
ill O O
and O O
was O O
not O O
pale O O
or O O
jaundiced O O
. O O

he O O
was O O
hemodynamically O O
stable O O
with O O
a O O
heart O O
rate O O
of O O
104 O O
and O O
a O O
blood O O
pressure O O
of O O
136 O O
/ O O
84 O O
mm O O
hg O O
. O O

oxygen O O
saturations O O
were O O
97% O O
on O O
room O O
air O O
and O O
he O O
was O O
afebrile O O
. O O

there O O
was O O
no O O
evidence O O
of O O
jaundice O O
or O O
lymphadenopathy O B-C0497156
. O O

his O O
abdomen O O
was O O
not O O
distended O O
, O O
and O O
no O O
signs O O
were O O
elicited O O
on O O
palpation O O
, O O
suggestive O O
of O O
peritonitis O B-C0031154
. O O

bowel O O
sounds O O
were O O
audible O O
. O O

neurological O O
, O O
respiratory O O
and O O
cardiovascular O O
examinations O O
were O O
normal O O
. O O

laboratory O O
results O O
demonstrated O O
hemoglobin O O
133 O O
g O O
/ O O
L O O
, O O
white O O
cell O O
count O O
8.5 O O
× O O
109 O O
/ O O
L O O
, O O
platelets O O
188 O O
× O O
109 O O
/ O O
L O O
. O O

the O O
patient O O
had O O
a O O
normal O O
renal O O
, O O
liver O O
and O O
coagulation O O
screen O O
. O O

an O O
abdominal O O
ultrasound O O
revealed O O
fluid O O
collection O O
around O O
the O O
right O O
and O O
left O O
liver O O
lobes O O
suggestive O O
of O O
a O O
hematoma O B-C0018944
. O O

the O O
CT O O
scan O O
of O O
the O O
abdomen O O
showed O O
16 O O
x O O
10 O O
x O O
3 O O
cm O O
large O O
hepatic O O
subcapsular O O
hematoma O B-C0018944
and O O
no O O
focal O O
lesion O B-C0221198
. O O

A O O
diagnosis O O
of O O
hepatic O O
subcapsular O O
hematoma O B-C0018944
was O O
made O O
. O O

he O O
was O O
managed O O
conservatively O O
, O O
as O O
he O O
was O O
stable O O
, O O
with O O
complete O O
bed O O
rest O O
, O O
prophylactic O O
antibiotics O O
and O O
analgesics O O
. O O

he O O
didn't O O
require O O
any O O
blood O O
transfusion O O
. O O

the O O
patient's O O
symptoms O O
resolved O O
with O O
conservative O O
management O O
and O O
remained O O
hemodynamically O O
stable O O
during O O
admission O O
. O O

he O O
was O O
discharged O O
home O O
one O O
week O O
later O O
, O O
clinically O O
back O O
to O O
his O O
baseline O O
and O O
pain O B-C0030193
free O O
. O O

he O O
is O O
asymptomatic O O
during O O
follow-up O O
visits O O
till O O
a O O
period O O
of O O
6 O O
months O O
, O O
his O O
serial O O
sonographic O O
scans O O
show O O
gradual O O
decrease O O
in O O
the O O
size O O
of O O
the O O
hematoma O B-C0018944
. O O

A O O
follow O O
up O O
ultrasonography O O
was O O
done O O
after O O
6 O O
months O O
and O O
showed O O
near O O
complete O O
resolution O O
of O O
the O O
hematoma O B-C0018944
. O O

mrs O O
. O O

CD O O
, O O
a O O
27 O O
year O O
old O O
para O O
2 O O
gravida O O
3 O O
patient O O
was O O
referred O O
from O O
a O O
district O O
hospital O O
with O O
a O O
diagnosis O O
of O O
multiple O B-C0032989
pregnancy O I-C0032989
with O O
intrauterine O O
demise O O
of O O
a O O
co-twin O O
at O O
26 O O
weeks O O
gestation O O
. O O

she O O
had O O
no O O
complaints O O
at O O
presentation O O
and O O
had O O
not O O
experienced O O
excessive O O
symptoms O O
of O O
pregnancy O O
earlier O O
on O O
in O O
the O O
pregnancy O O
. O O

she O O
believed O O
her O O
abdomen O O
was O O
growing O O
at O O
a O O
normal O O
rate O O
and O O
she O O
had O O
felt O O
quickening O O
a O O
few O O
weeks O O
before O O
. O O

the O O
pregnancy O O
was O O
planned O O
and O O
she O O
booked O O
the O O
pregnancy O O
at O O
the O O
district O O
hospital O O
a O O
week O O
prior O O
to O O
presentation O O
. O O

she O O
had O O
normal O O
vaginal O O
deliveries O O
of O O
her O O
first O O
2 O O
children O O
with O O
no O O
antepartum O O
or O O
intrapartum O O
complications O O
but O O
was O O
diagnosed O O
with O O
chronic O O
hypertension O B-C0020538
during O O
her O O
6 O O
week O O
post-natal O O
visit O O
after O O
delivery O O
of O O
her O O
second O O
child O O
. O O

she O O
was O O
started O O
on O O
enalapril O O
and O O
nifedipine O O
but O O
she O O
defaulted O O
treatment O O
2 O O
months O O
before O O
falling O B-C0000921
pregnant O O
. O O

her O O
method O O
of O O
contraception O O
was O O
a O O
combined O O
oral O O
contraceptive O B-C0344225
( O O
lofeminal O O
) O O
which O O
she O O
stopped O O
taking O O
one O O
month O O
before O O
she O O
fell O O
pregnant O O
. O O

nifedipine O O
and O O
methyldopa O O
were O O
commenced O O
at O O
26 O O
weeks O O
gestation O O
when O O
the O O
blood O O
pressure O O
was O O
noted O O
to O O
be O O
elevated O O
and O O
the O O
blood O O
pressure O O
was O O
well O O
controlled O O
thereafter O O
. O O

clinical O O
examination O O
was O O
unremarkable O O
. O O

an O O
ultrasound O O
scan O O
showed O O
monochorioinic O O
diamniotic O O
twins O O
with O O
normal O O
liquor O O
volume O O
in O O
the O O
viable O O
twin O O
but O O
there O O
was O O
gross O O
oedema O B-C0013604
of O O
the O O
foetal O O
skin O O
and O O
no O O
skull O O
bones O O
in O O
the O O
non-viable O O
twin O O
. O O

later O O
scans O O
suggested O O
that O O
the O O
foetal O O
parts O O
were O O
encapsulated O O
in O O
a O O
cystic O O
mass O O
suggestive O O
of O O
a O O
partial O O
mole O B-C0027960
. O O

umbilical O O
artery O O
doppler O O
studies O O
showed O O
similar O O
indices O O
for O O
both O O
foetuses O O
and O O
there O O
was O O
no O O
mention O O
of O O
reversed O O
flow O O
in O O
the O O
scans O O
at O O
26 O O
weeks O O
. O O

A O O
plan O O
to O O
manage O O
her O O
expectantly O O
was O O
made O O
and O O
she O O
was O O
followed O O
up O O
by O O
two O O
weekly O O
ultrasound O O
scan O O
and O O
doppler O O
velocimetry O O
. O O

the O O
patient O O
was O O
counselled O O
on O O
the O O
risks O O
for O O
preterm O B-C0151526
birth O I-C0151526
, O O
cardiac O B-C0018801
failure O I-C0018801
and O O
higher O O
perinatal O B-C0701826
mortality O I-C0701826
associated O O
with O O
the O O
condition O O
. O O

she O O
was O O
counselled O O
for O O
an O O
elective O O
caesarean O O
section O O
( O O
CS O O
) O O
once O O
the O O
foetus O O
reached O O
viability O O
. O O

follow O O
up O O
scans O O
and O O
doppler O O
velocimetry O O
showed O O
that O O
growth O O
of O O
the O O
pump O O
twin O O
was O O
below O O
the O O
5 O O
th O O
percentile O O
but O O
the O O
weight O O
of O O
the O O
acardiac O O
twin O O
was O O
difficult O O
to O O
estimate O O
and O O
not O O
recorded O O
. O O

the O O
amniotic O O
fluid O O
volume O O
remained O O
normal O O
in O O
serial O O
scans O O
. O O

at O O
34 O O
weeks O O
there O O
was O O
absent O O
diastolic O O
flow O O
in O O
the O O
umbilical O O
artery O O
. O O

the O O
patient O O
received O O
corticosteroids O O
and O O
had O O
a O O
lower O O
segment O O
CS O O
. O O

A O O
live O O
baby O O
girl O O
with O O
a O O
birth O O
weight O O
of O O
1370g O O
and O O
apgar O O
score O O
of O O
7 O O
/ O O
10 O O
at O O
1 O O
minute O O
and O O
8 O O
/ O O
10 O O
at O O
5 O O
minutes O O
was O O
delivered O O
. O O

the O O
acardiac O O
twin O O
weighed O O
3000g O O
. O O

the O O
pump O O
twin O O
had O O
respiratory O B-C0852283
distress O I-C0852283
syndrome O I-C0852283
for O O
3 O O
days O O
after O O
delivery O O
and O O
was O O
weaned O O
off O O
oxygen O O
by O O
day O O
4 O O
. O O

she O O
had O O
no O O
obvious O O
congenital O B-C0000768
anomalies O I-C0000768
. O O

A O O
22 O O
- O O
year O O
old O O
lady O O
from O O
the O O
rural O O
eastern O O
cape O O
province O O
of O O
south O O
africa O O
, O O
23 O O
weeks O O
pregnant O O
was O O
referred O O
to O O
the O O
nelson O B-C0027577
mandela O O
academic O O
hospital O O
( O O
NMAH O O
) O O
from O O
a O O
base O O
hospital O O
with O O
history O O
of O O
severe O O
symptomatic O O
anaemia O B-C0002871
( O O
hb O O
5.6g O O
/ O O
L O O
) O O
and O O
massive O O
splenomegaly O B-C0038002
. O O

on O O
further O O
enquiry O O
she O O
reported O O
intermittent O O
yellowish O B-C3805689
discoloration O I-C3805689
of O O
her O O
eyes O O
for O O
the O O
past O O
4 O O
years O O
. O O

she O O
also O O
gave O O
a O O
history O O
of O O
previous O O
blood O O
transfusions O O
on O O
multiple O O
occasions O O
over O O
the O O
past O O
4 O O
years O O
. O O

she O O
had O O
not O O
been O O
investigated O O
for O O
the O O
recurring O O
episodes O O
of O O
anaemia O B-C0002871
and O O
jaundice O O
. O O

family O B-C0241889
history O I-C0241889
revealed O O
that O O
her O O
late O O
father O O
had O O
similar O O
episodes O O
of O O
recurring O O
anaemia O B-C0002871
and O O
jaundice O O
but O O
with O O
no O O
established O O
diagnosis O O
. O O

she O O
had O O
never O O
travelled O O
to O O
any O O
malaria O O
zones O O
. O O

examination O O
revealed O O
a O O
young O O
lady O O
, O O
who O O
was O O
pale O O
, O O
jaundiced O O
, O O
but O O
with O O
no O O
lymphadenopathy O B-C0497156
and O O
she O O
had O O
a O O
massive O O
splenomegaly O B-C0038002
with O O
no O B-C1856554
hepatomegaly O I-C1856554
or O O
ascites O B-C0003962
. O O

the O O
rest O O
of O O
the O O
examination O O
was O O
unremarkable O O
. O O

laboratory O O
results O O
showed O O
severe O O
normocytic O O
, O O
normochromic O O
anaemia O B-C0002871
, O O
with O O
marked O O
reticulocytosis O B-C0206160
( O O
reticulocyte O O
count O O
of O O
10.97% O O
, O O
reticulocyte O O
production O O
index O O
( O O
RPI O O
) O O
of O O
2.6 O O
) O O
, O O
low O O
haptoglobin O O
level O O
, O O
unconjugated O B-C0268306
hyperbilirubinemia O I-C0268306
with O O
positive O O
urobilinogen O O
on O O
urine O O
dipsticks O O
. O O

her O O
blood O O
smears O O
confirmed O O
the O O
presence O O
of O O
spherocytes O O
. O O

coombs O O
test O O
was O O
negative O O
. O O

serum O O
compliments O O
C3 O O
and O O
C4 O O
level O O
were O O
normal O O
. O O

serum O O
anti-nuclear O O
antibody O O
was O O
negative O O
. O O

glucose O O
- O O
6 O O
- O O
phosphate O O
dehydrogenase O O
( O O
G6PD O O
) O O
assay O O
was O O
normal O O
. O O

serum O O
iron O O
studies O O
and O O
haemoglobin O O
electrophoresis O O
were O O
normal O O
. O O

the O O
rest O O
of O O
the O O
laboratory O O
tests O O
at O O
presentation O O
are O O
shown O O
on O O
table O O
1 O O
. O O

osmotic O O
fragility O O
test O O
( O O
OFT O O
) O O
was O O
not O O
done O O
. O O

based O O
on O O
the O O
clinical O O
and O O
laboratory O O
investigations O O
which O O
are O O
in O O
keeping O O
with O O
chronic O O
haemolysis O B-C0019054
( O O
recurring O O
anaemia O B-C0002871
and O O
jaundice O O
) O O
, O O
spherocytosis O B-C0553720
with O O
negative O O
coombs O O
test O O
, O O
our O O
patient O O
was O O
diagnosed O O
as O O
having O O
severe O O
haemolytic O B-C0002878
anaemia O I-C0002878
due O O
to O O
hereditary O B-C0037889
spherocytosis O I-C0037889
in O O
pregnancy O O
. O O

she O O
was O O
continued O O
on O O
folic O O
acid O O
5mg O O
daily O O
. O O

A O O
decision O O
on O O
splenectomy O O
was O O
taken O O
after O O
consultation O O
with O O
the O O
obstetrics O O
team O O
as O O
she O O
was O O
likely O O
to O O
require O O
further O O
red O O
cell O O
transfusions O O
in O O
the O O
course O O
of O O
pregnancy O O
. O O

she O O
was O O
transfused O O
with O O
five O O
units O O
of O O
red O O
cells O O
on O O
2 O O
separate O O
occasions O O
and O O
vaccinated O O
against O O
pneumococcus O O
, O O
meningococcus O O
and O O
H O O
influenza O B-C0021400
. O O

the O O
immediate O O
postoperative O O
period O O
was O O
uneventful O O
. O O

the O O
histopathology O O
report O O
confirmed O O
a O O
spleen O O
size O O
of O O
1028g O O
, O O
measuring O O
20x15x5.5cm O O
( O O
splenic O O
tissue O O
with O O
congested O O
red O O
pulp O O
noted O O
and O O
no O O
granulomas O B-C0018188
, O O
pathogens O O
or O O
evidence O O
of O O
malignancy O B-C0006826
) O O
. O O

she O O
was O O
counselled O O
on O O
the O O
importance O O
of O O
regular O O
follow-up O O
and O O
advised O O
to O O
inform O O
her O O
family O O
members O O
on O O
screening O O
for O O
hereditary O B-C0037889
spherocytosis O I-C0037889
. O O

she O O
was O O
reviewed O O
6 O O
weeks O O
splenectomy O O
at O O
our O O
outpatient O O
clinic O O
and O O
was O O
found O O
to O O
be O O
in O O
a O O
good O O
general O O
condition O O
without O O
anaemia O B-C0002871
and O O
with O O
significant O O
regression O B-C1836830
of O O
jaundice O O
. O O

the O O
results O O
of O O
laboratory O O
tests O O
repeated O O
8 O O
weeks O O
after O O
splenectomy O O
are O O
shown O O
in O O
table O O
1 O O
. O O

she O O
is O O
currently O O
being O O
followed O O
up O O
by O O
the O O
obstetrics O O
unit O O
and O O
is O O
expectant O O
of O O
her O O
first O O
baby O O
. O O

it O O
consists O O
in O O
a O O
64 O O
- O O
year-old O O
female O O
patient O O
presented O O
with O O
persistent O O
polyuria O B-C0032617
and O O
polydipsia O B-C0085602
during O O
the O O
last O O
4 O O
years O O
with O O
difficulties O O
to O O
walk O O
. O O

she O O
had O O
no O O
history O O
of O O
diabetes O B-C0011849
mellitus O I-C0011849
, O O
cranial O O
trauma O O
or O O
surgery O O
. O O

the O O
patient O O
had O O
consulted O O
several O O
times O O
before O O
referring O O
her O O
to O O
the O O
internal O O
medicine O O
and O O
endocrinology O O
department O O
for O O
polyuria-polydipsia O O
syndrome O O
investigation O O
. O O

physical O O
examination O O
showed O O
eyelid O O
xanthelasmas O B-C0302314
and O O
cerebellar O B-C0007758
ataxia O I-C0007758
. O O

diabetes O B-C0011849
mellitus O I-C0011849
was O O
ruled O O
out O O
on O O
routine O O
workup O O
and O O
assessment O O
of O O
anterior O O
pituitary O O
functions O O
was O O
normal O O
. O O

after O O
a O O
water O O
deprivation O O
test O O
combined O O
with O O
desmopressin O O
administration O O
, O O
central O B-C0687720
diabetes O I-C0687720
insipidus O I-C0687720
was O O
confirmed O O
. O O

hypothalamo-pituitary O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
showed O O
no O O
pituitary O O
stalk O O
abnormalities O O
but O O
the O O
loss O O
of O O
hyperintense O O
signal O O
on O O
sagittal O O
T1 O O
weighted O O
imaging O O
. O O

it O O
also O O
showed O O
white O O
matter O O
nodular O O
hyper O O
intensities O O
on O O
fluid O O
attenuated O O
inversion O O
recovery O O
( O O
FLAIR O O
) O O
brain O O
MRI O O
. O O

because O O
of O O
this O O
association O O
( O O
diabetes O B-C0011848
insipidus O I-C0011848
, O O
cerebellar O B-C0007758
ataxia O I-C0007758
, O O
and O O
xanthelasmas O B-C0302314
) O O
, O O
diagnosis O O
of O O
ECD O O
was O O
suspected O O
. O O

bone O O
involvement O O
was O O
investigated O O
by O O
tc O O
99m O O
methyl-diphosphonate O O
( O O
MDP O O
) O O
scintigraphy O O
that O O
showed O O
symmetric O O
uptake O O
in O O
both O O
tibias O O
, O O
on O O
the O O
left O O
radius O O
and O O
on O O
the O O
left O O
femur O O
. O O

proximal O O
tibia O O
bone O O
biopsy O O
was O O
then O O
performed O O
. O O

histopathological O O
findings O O
showed O O
bone O O
infiltration O O
by O O
foamy O O
histiocytes O O
with O O
fibrosis O B-C0016059
. O O

immuno-histochemical O O
staining O O
was O O
positive O O
for O O
CD68 O O
and O O
negative O O
for O O
cd1a O O
. O O

once O O
the O O
diagnosis O O
was O O
confirmed O O
, O O
the O O
involvement O O
of O O
other O O
organs O O
was O O
assessed O O
by O O
transesophageal O O
echocardiography O O
that O O
showed O O
a O O
left O B-C0149721
ventricular O I-C0149721
hypertrophy O I-C0149721
and O O
pericardial O B-C0031039
effusion O I-C0031039
, O O
while O O
thoracoabdominal O O
tomodensitometry O O
showed O O
pericardial O O
thickening O O
with O O
minimal O O
pericardial O B-C0031039
effusion O I-C0031039
. O O

the O O
aorta O O
, O O
adrenal O O
glands O O
and O O
kidneys O O
were O O
normal O O
. O O

there O O
were O O
no O O
pulmonary O O
abnormalities O O
or O O
retroperitoneal O O
infiltration O O
. O O

the O O
patient O O
was O O
initially O O
treated O O
with O O
prednisone O O
( O O
1mg O O
/ O O
kg O O
/ O O
day O O
) O O
. O O

three O O
months O O
later O O
, O O
she O O
developed O O
corticosteroids-induced O O
diabetes O O
that O O
responded O O
well O O
to O O
treatment O O
with O O
metformin O O
and O O
insulin O O
NPH O O
. O O

corticosteroids O O
was O O
gradually O O
stopped O O
and O O
pegylated O O
ifn-α O O
was O O
initiated O O
at O O
the O O
dose O O
of O O
180 O O
µg O O
/ O O
week O O
. O O

after O O
9 O O
months O O
of O O
treatment O O
, O O
patient O O
was O O
clinically O O
stable O O
and O O
there O O
is O O
no O B-C0497153
disease O I-C0497153
progression O O
. O O

this O O
was O O
a O O
13 O O
- O O
year-old O O
boy O O
monitored O O
in O O
the O O
unit O O
since O O
2017 O O
- O O
10 O O
- O O
04 O O
for O O
stage O O
V O O
chronic O B-C1561643
kidney O I-C1561643
disease O I-C1561643
( O O
CKD O O
) O O
following O O
a O O
primary O O
nephrotic O B-C0027726
syndrome O I-C0027726
by O O
segmental O O
and O O
focal O B-C0017668
glomerulosclerosis O I-C0017668
( O O
FSGS O O
) O O
cortico-resistant O O
and O O
cyclo-resistant O O
since O O
he O O
was O O
11 O O
years O O
old O O
. O O

the O O
patient O O
was O O
anuric O O
with O O
diuresis O O
at O O
0.19ml O O
/ O O
kg O O
/ O O
h O O
. O O

he O O
weighed O O
32kg O O
and O O
measured O O
131cm O O
with O O
a O O
normal O B-C4229017
BMI O I-C4229017
for O O
his O O
age O O
. O O

he O O
had O O
delayed O B-C0034012
pubertal O I-C0034012
development O I-C0034012
( O O
P1G3 O O
) O O
. O O

faced O O
with O O
signs O O
of O O
intolerance O O
in O O
uremia O B-C0041948
, O O
he O O
first O O
received O O
two O O
successive O O
sessions O O
of O O
haemodialysis O O
then O O
three O O
sessions O O
per O O
week O O
for O O
over O O
3 O O
months O O
in O O
an O O
adult O O
center O O
. O O

he O O
was O O
switched O O
to O O
CAPD O O
following O O
his O O
parents O O
' O O
choice O O
motivated O O
by O O
a O O
desire O O
to O O
return O O
home O O
situated O O
121km O O
from O O
dakar O O
. O O

the O O
TENCKOFF O O
catheter O O
was O O
inserted O O
on O O
2018 O O
- O O
03 O O
- O O
05 O O
in O O
urology O O
in O O
collaboration O O
with O O
the O O
pediatrics O O
and O O
adult O O
nephrology O O
team O O
. O O

on O O
day O O
1 O O
after O O
catheter O O
insertion O O
, O O
the O O
peritoneal O O
cavity O O
was O O
rinsed O O
. O O

on O O
day O O
2 O O
after O O
insertion O O
, O O
the O O
patient O O
had O O
a O O
fever O B-C0015967
at O O
39oc O O
, O O
abdominal O B-C0000737
pain O I-C0000737
and O O
greenish O O
vomiting O B-C0042963
. O O

upon O O
examination O O
, O O
he O O
would O O
scream O O
when O O
his O O
navel O O
is O O
touched O O
. O O

analysis O O
of O O
the O O
drainage O O
liquid O O
had O O
revealed O O
650 O O
leucocytes O O
/ O O
mm O O
3 O O
with O O
62% O O
of O O
neutrophils O O
. O O

the O O
dialysate O O
culture O O
was O O
sterile O O
. O O

the O O
hemoculture O O
came O O
back O O
negative O O
. O O

the O O
nasal O O
swab O O
isolated O O
staphylococcus O B-C1318973
aureus O I-C1318973
. O O

the O O
patient O O
received O O
1g O O
of O O
C3G O O
in O O
each O O
bag O O
of O O
2L O O
of O O
dialysate O O
associated O O
with O O
a O O
bacitracin O O
+ O O
neomycine O O
nasal O O
rub O O
as O O
from O O
day O O
2 O O
after O O
catheter O O
insertion O O
. O O

the O O
plan O O
proposed O O
to O O
the O O
patient O O
was O O
4 O O
swabs O O
a O O
day O O
( O O
8am O O
- O O
12noon O O
- O O
4pm O O
- O O
8pm O O
- O O
8am O O
) O O
with O O
a O O
stasis O O
of O O
isotonic O O
dialysate O O
of O O
4 O O
hours O O
per O O
session O O
during O O
the O O
day O O
and O O
a O O
stasis O O
of O O
icodextrin O O
for O O
8 O O
hours O O
at O O
night O O
. O O

the O O
total O O
time O O
for O O
dialysis O O
was O O
24 O O
h O O
/ O O
day O O
and O O
the O O
volume O O
of O O
injection O O
per O O
cycle O O
was O O
1L O O
of O O
dialysate O O
. O O

the O O
peritoneal O O
control O O
fluid O O
at O O
day O O
7 O O
was O O
sterile O O
( O O
leucocytes O O
21 O O
elements O O
/ O O
mm O O
3 O O
with O O
95% O O
lymphocytes O O
) O O
. O O

the O O
antibiotic O O
treatment O O
was O O
done O O
by O O
oral O O
route O O
for O O
14 O O
days O O
. O O

besides O O
the O O
PD O O
, O O
the O O
patient O O
was O O
receiving O O
anti-hypertensive O O
treatment O O
, O O
water O O
restriction O O
, O O
active O O
calcium O O
and O O
vitamin O O
D O O
supplementation O O
, O O
erythropoietin O O
and O O
a O O
CKD O O
diet O O
. O O

after O O
the O O
infection O B-C3714514
period O O
, O O
an O O
equilibration O O
test O O
( O O
PET O O
test O O
) O O
revealed O O
a O O
hyper-permeable O O
peritoneal O O
membrane O O
with O O
D O O
/ O O
P O O
creatinine O O
at O O
0.91 O O
. O O

the O O
patient O O
and O O
his O O
mother O O
were O O
trained O O
and O O
assessed O O
on O O
the O O
PD O O
technique O O
. O O

by O O
the O O
end O O
of O O
a O O
month O O
, O O
they O O
had O O
become O O
independent O O
and O O
could O O
recognize O O
the O O
signs O O
or O O
dysfunction O O
of O O
the O O
catheter O O
. O O

patient O O
assessment O O
during O O
this O O
first O O
month O O
of O O
dialysis O O
revealed O O
an O O
adequate O O
clinical O O
and O O
biological O O
condition O O
( O O
table O O
1 O O
) O O
. O O

the O O
patient O O
and O O
his O O
mother O O
returned O O
home O O
at O O
bambey O O
, O O
a O O
town O O
situated O O
121km O O
from O O
dakar O O
with O O
a O O
tracking O O
sheet O O
in O O
which O O
the O O
weight O O
, O O
blood O O
pressure O O
, O O
temperature O O
and O O
ultra O O
filtrate O O
are O O
noted O O
. O O

after O O
a O O
second O O
month O O
of O O
observation O O
, O O
the O O
patient O O
complained O O
of O O
abdominal O B-C0000737
pain O I-C0000737
at O O
the O O
day O O
hospital O O
. O O

the O O
plain O O
abdominal O O
x-ray O O
revealed O O
a O O
catheter O O
migration O O
to O O
the O O
right O O
. O O

the O O
catheter O O
was O O
repositioned O O
in O O
the O O
patient O O
through O O
the O O
use O O
of O O
laxatives O O
. O O

after O O
4 O O
months O O
of O O
observation O O
, O O
the O O
dialysis O O
was O O
considered O O
adequate O O
on O O
a O O
clinical O O
and O O
biological O O
basis O O
( O O
table O O
1 O O
) O O
. O O

A O O
54 O O
years O O
old O O
moroccan O O
man O O
presented O O
to O O
our O O
otolaryngology O O
( O O
ENT O O
) O O
department O O
with O O
a O O
5 O O
months O O
history O O
of O O
worsening O O
bilateral O B-C2350171
nasal O I-C2350171
obstruction O I-C2350171
, O O
anosmia O B-C0003126
and O O
rhinorrhea O B-C1260880
from O O
both O O
nostrils O O
without O O
epistaxis O B-C0014591
, O O
associated O O
with O O
progressive O O
bilateral O B-C0018775
hearing O I-C0018775
loss O I-C0018775
. O O

his O O
past O O
medical O O
history O O
included O O
undifferentiated O B-C0279748
carcinoma O I-C0279748
of O I-C0279748
the O I-C0279748
nasopharynx O I-C0279748
( O O
UNCT O O
) O O
diagnosed O O
on O O
2001 O O
, O O
american O O
joint O O
committee O O
for O O
cancer O B-C0006826
TNM O O
staging O O
of O O
T1N0M0 O O
. O O

he O O
received O O
a O O
course O O
of O O
radiotherapy O O
( O O
65 O O
grays O O
) O O
. O O

the O O
patient O O
had O O
no O O
other O O
significant O O
past O O
medical O O
history O O
. O O

on O O
examination O O
, O O
patient O O
was O O
breathing O O
with O O
mouth O O
open O O
. O O

A O O
cold O B-C0009443
spatula O O
test O O
showed O O
absence O O
of O O
air O O
flow O O
on O O
left O O
nostril O O
and O O
minimal O O
air O O
flow O O
on O O
the O O
right O O
side O O
. O O

rigid O O
endoscopic O O
nasal O O
examination O O
revealed O O
a O O
complete O O
choanal O B-C0584837
stenosis O I-C0584837
in O O
the O O
left O O
side O O
and O O
incomplete O O
in O O
the O O
right O O
side O O
. O O

there O O
were O O
no O O
signs O O
of O O
tumor O B-C0027651
recurrence O O
. O O

otoscopic O O
examination O O
showed O O
signs O O
of O O
fibro-adhesive O O
otitis O B-C0029877
and O O
tonal O O
audiometry O O
showed O O
mixed O B-C0155552
deafness O I-C0155552
. O O

the O O
computed O O
tomography O O
( O O
CT O O
) O O
scan O O
of O O
the O O
nose O O
and O O
paranasal O O
sinuses O B-C0016169
was O O
done O O
, O O
and O O
showed O O
a O O
stenosis O O
of O O
the O O
light O O
of O O
the O O
two O O
choanae O O
by O O
tissue O O
density O O
lesion O B-C0221198
in O O
both O O
choanae O O
of O O
7.30mm O O
. O O

the O O
patient O O
underwent O O
endoscopic O O
surgery O O
under O O
general O O
anesthesia O B-C0278134
, O O
where O O
the O O
fibrous O O
obstacle O O
was O O
resected O O
and O O
widening O O
of O O
the O O
posterior O O
choanal O B-C0584837
stenosis O I-C0584837
. O O

A O O
5mm O O
diameter O O
tube O O
was O O
placed O O
in O O
both O O
nasal O O
cavities O O
and O O
kept O O
for O O
3 O O
weeks O O
to O O
ensure O O
a O O
good O O
calibration O O
and O O
prevent O O
the O O
recurrence O O
of O O
the O O
stenosis O O
. O O

the O O
anatomopathological O O
study O O
did O O
not O O
show O O
signs O O
of O O
tumor O B-C0027651
recurrence O O
or O O
specific O O
inflammation O O
. O O

deafness O B-C0011053
has O O
been O O
treated O O
by O O
bilateral O O
hearing O O
aids O O
. O O

the O O
evolution O O
was O O
marked O O
by O O
the O O
improvement O O
of O O
the O O
clinical O O
symptomatology O O
with O O
restitution O O
of O O
the O O
nasal O O
ventilation O O
and O O
the O O
smell O O
. O O

an O O
endoscopic O O
control O O
after O O
6 O O
months O O
of O O
the O O
surgical O O
procedure O O
did O O
not O O
find O O
any O O
sign O O
of O O
restenosis O O
with O O
a O O
rather O O
satisfactory O O
choanal O O
light O O
. O O

A O O
69 O O
- O O
year-old O O
tunisian O O
female O O
was O O
admitted O O
in O O
2005 O O
for O O
arthritis O O
and O O
fever O B-C0015967
. O O

the O O
examination O O
revealed O O
a O O
temperature O O
of O O
39.7 O O
° O O
C O O
, O O
an O O
evanescent O O
diffuse O O
maculopapular O O
rash O B-C0015230
and O O
symmetrical O O
polyarthritis O B-C0162323
involving O O
knees O O
, O O
wrists O O
and O O
metacarpophalangeal O O
joints O O
. O O

there O O
was O O
neither O O
lymphadenopathy O B-C0497156
nor O O
hepatosplenomegaly O B-C0019214
. O O

laboratory O O
evaluation O O
revealed O O
: O O
hb O O
: O O
74g O O
/ O O
l O O
, O O
a O O
white O O
blood O O
cell O O
count O O
of O O
17.6 O O
× O O
10 O O
9 O O
/ O O
l O O
( O O
neutrophils O O
: O O
89% O O
) O O
platelets O O
: O O
471 O O
× O O
10 O O
9 O O
/ O O
l O O
, O O
erythrocyte O O
sedimentation O O
rate O O
of O O
145mm O O
/ O O
h O O
and O O
c-reactive O O
protein O O
: O O
440mg O O
/ O O
l O O
. O O

the O O
liver O O
function O O
test O O
scores O O
were O O
elevated O O
: O O
AST O O
: O O
56 O O
IU O O
/ O O
l O O
, O O
ALT O O
: O O
53IU O O
/ O O
l O O
( O O
normal O O
value O O
: O O
10 O O
to O O
40IU O O
/ O O
l O O
) O O
, O O
GGT O O
: O O
124IU O O
/ O O
l O O
( O O
normal O O
value O O
: O O
10 O O
- O O
35IU O O
/ O O
l O O
) O O
. O O

the O O
serum O O
ferritin O O
was O O
elevated O O
: O O
3000ng O O
/ O O
ml O O
( O O
normal O O
value O O
: O O
11 O O
to O O
250ng O O
/ O O
ml O O
) O O
. O O

urinalysis O O
was O O
normal O O
and O O
proteinuria O B-C0033687
was O O
absent O O
. O O

serological O O
evaluation O O
for O O
hepatitis O B-C0019163
B O I-C0019163
and O O
C O O
, O O
epstein-barr O O
virus O O
( O O
EBV O O
) O O
, O O
cytomegalovirus O O
, O O
herpes O B-C0019348
simplex O I-C0019348
, O O
chlamydia O B-C0008149
, O O
mycoplasma O B-C0026936
, O O
rickettsia O O
conorii O O
, O O
coxiella O O
burnetti O O
, O O
toxoplasma O O
, O O
borrelia O O
, O O
aspergillus O O
, O O
candida O O
, O O
agglutination O O
test O O
for O O
brucella O O
were O O
negative O O
. O O

blood O O
, O O
urine O O
and O O
stool O O
cultures O O
were O O
also O O
negative O O
. O O

tuberculosis O B-C0041296
was O O
discarded O O
by O O
acid-fast O O
stained O O
smears O O
and O O
culture O O
. O O

laboratory O O
evaluation O O
for O O
systemic O O
or O O
malignant O O
diseases O O
were O O
negative O O
( O O
antinuclear O O
antibodies O O
, O O
anti-dna O O
antibodies O O
, O O
antiphospholipid O O
antibodies O O
, O O
anti O O
mitochondrial O O
antibodies O O
, O O
anti O O
smooth-muscle O O
antibodies O O
, O O
rheumatoid O O
factor O O
, O O
antineutrophil O O
cytoplasmic O O
antibodies O O
( O O
ANCA O O
) O O
, O O
cryoglobulins O O
, O O
tumor O B-C0027651
markers O O
) O O
. O O

chest O O
x-rays O O
, O O
ultrasound O O
examination O O
, O O
and O O
echocardiography O O
were O O
normal O O
as O O
well O O
. O O

the O O
temporal O O
artery O O
biopsy O O
and O O
the O O
bone O O
marrow O O
examination O O
were O O
normal O O
. O O

we O O
diagnosed O O
AOSD O O
according O O
to O O
the O O
yamaguchi O O
criteria O O
[ O O
1 O O
] O O
and O O
we O O
started O O
a O O
steroid O O
therapy O O
( O O
prednisone O O
: O O
1mg O O
/ O O
kg O O
/ O O
day O O
) O O
. O O

the O O
symptoms O O
began O O
to O O
improve O O
. O O

ten O O
months O O
later O O
, O O
she O O
presented O O
the O O
same O O
clinical O O
picture O O
. O O

x-rays O O
of O O
both O O
hands O O
showed O O
bone O O
erosions O B-C1959609
at O O
the O O
carps O O
. O O

we O O
used O O
oral O O
methotrexate O O
in O O
weekly O O
dose O O
of O O
10mg O O
. O O
8 O O
months O O
later O O
, O O
the O O
patient O O
developed O O
an O O
ulcerated O O
tumor O B-C0027651
at O O
the O O
scalp O O
with O O
cervical O O
lymph O O
nodes O O
whose O O
biopsy O O
revealed O O
a O O
squamous O B-C0007137
cell O I-C0007137
carcinoma O I-C0007137
. O O

methotrexate O O
was O O
stopped O O
and O O
she O O
was O O
treated O O
with O O
chemotherapy O O
and O O
radiotherapy O O
. O O

she O O
did O O
not O O
present O O
a O O
recurrence O O
during O O
a O O
12 O O
months O O
follow O O
up O O
period O O
. O O

A O O
59 O O
year O O
old O O
male O O
was O O
admitted O O
to O O
the O O
orthopaedic O O
ward O O
with O O
complaints O O
of O O
multiple O O
draining O O
sinuses O B-C0016169
in O O
the O O
right O O
calf O O
since O O
3 O O
weeks O O
. O O

he O O
gave O O
history O O
of O O
2 O O
episodes O O
of O O
similar O O
draining O O
sinuses O B-C0016169
at O O
a O O
site O O
above O O
the O O
current O O
sinus O O
which O O
occurred O O
15 O O
years O O
back O O
. O O

at O O
that O O
time O O
he O O
had O O
not O O
sought O O
any O O
treatment O O
and O O
the O O
sinus O O
had O O
healed O O
by O O
itself O O
. O O

currently O O
, O O
the O O
patient O O
complained O O
of O O
severe O O
pain O B-C0030193
and O O
bloody O O
discharge O O
from O O
the O O
sinuses O B-C0016169
. O O

he O O
gave O O
history O O
of O O
taking O O
antibiotics O O
prescribed O O
by O O
local O O
physicians O O
. O O

there O O
was O O
no O O
history O O
of O O
trauma O O
, O O
fever O B-C0015967
, O O
chronic O B-C0010201
cough O I-C0010201
or O O
loss O B-C1262477
of O I-C1262477
weight O I-C1262477
and O O
appetite O O
. O O

the O O
patient O O
was O O
a O O
diabetic O B-C0011847
since O O
the O O
past O O
ten O O
years O O
and O O
was O O
on O O
oral O O
hypoglycaemic O O
agents O O
. O O

on O O
examination O O
of O O
the O O
right O O
leg O O
, O O
two O O
sinuses O B-C0016169
were O O
present O O
on O O
the O O
anterior O O
aspect O O
of O O
the O O
tibia O O
in O O
the O O
proximal O O
1 O O
/ O O
3 O O
rd O O
portion O O
. O O

blood O O
stained O O
purulent O O
discharge O O
was O O
observed O O
in O O
both O O
these O O
sinuses O B-C0016169
. O O

another O O
sinus O O
was O O
observed O O
in O O
the O O
posterior O O
calf O O
region O O
, O O
without O O
any O O
discharge O O
. O O

tenderness O O
was O O
elicited O O
around O O
the O O
sinuses O B-C0016169
. O O

no O O
neurovascular O O
deficits O O
were O O
observed O O
and O O
distal O O
pulse O O
and O O
movements O O
were O O
preserved O O
. O O

x-ray O O
of O O
the O O
right O O
lower O O
limb O O
showed O O
cortical O B-C2677810
thickening O I-C2677810
of O O
the O O
right O O
tibia O O
in O O
the O O
proximal O O
aspect O O
. O O

magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
with O O
contrast O O
showed O O
enhancing O O
soft O O
tissue O O
mass O O
in O O
medial O O
aspect O O
of O O
tibia O O
in O O
right O O
upper O O
leg O O
in O O
subcutaneous O O
plane O O
which O O
was O O
suggestive O O
of O O
soft O B-C0149778
tissue O I-C0149778
infection O I-C0149778
. O O

in O O
view O O
of O O
the O O
chronic O O
draining O O
sinus O O
, O O
a O O
wound O O
debridement O O
and O O
curettage O O
was O O
done O O
. O O

the O O
intra-operative O O
tissue O O
was O O
sent O O
for O O
histopathology O O
and O O
culture O O
. O O

the O O
patient O O
was O O
discharged O O
on O O
tablet O O
cefuroxime O O
500mg O O
, O O
with O O
advice O B-C0740209
to O O
avoid O O
weight O O
bearing O O
on O O
the O O
affected O O
limb O O
. O O

histopathology O O
of O O
the O O
tissue O O
showed O O
hyalinised O O
fibro-collagenous O O
tissue O O
with O O
multiple O O
granuloma O B-C0018188
formation O O
and O O
necrosis O O
. O O

sheets O O
of O O
macrophage O O
collection O O
and O O
lympho-plasmacytic O O
infiltration O O
were O O
also O O
seen O O
. O O

many O O
areas O O
showed O O
collections O O
of O O
neutrophils O O
around O O
circumscribed O O
pink O O
eosinophilic O O
material O O
with O O
few O O
filamentous O O
structures O O
suggestive O O
of O O
fungal O O
organism O O
which O O
were O O
PAS O O
& O O
GMS O O
positive O O
. O O

the O O
histopathological O O
picture O O
was O O
suggestive O O
of O O
fungal O O
osteomyelitis O B-C0029443
with O O
granulomatous O O
reaction O O
. O O

fungal O O
culture O O
on O O
sabouraud O O
’ O O
s O O
dextrose O O
agar O O
grew O O
slow O O
growing O O
colonies O O
of O O
a O O
filamentous O O
fungi O O
which O O
were O O
moist O O
at O O
first O O
then O O
became O O
powdery O O
grey O O
in O O
colour O O
. O O

hyphae O O
were O O
hyaline O O
with O O
erect O O
phialides O O
and O O
conidia O O
were O O
aggregated O O
at O O
the O O
slimy O O
head O O
of O O
these O O
phialides O O
. O O

the O O
organism O O
was O O
identified O O
as O O
acremonium O O
spp O O
and O O
sent O O
for O O
further O O
identification O O
to O O
a O O
reference O O
centre O O
( O O
VP O O
chest O O
institute O O
, O O
new O O
delhi O B-C0086541
) O O
. O O

the O O
organism O O
was O O
identified O O
as O O
acremonium O O
curvulum O O
by O O
the O O
reference O O
laboratory O O
. O O

the O O
patient O O
was O O
started O O
on O O
oral O O
voriconazole O O
200mg O O
bd O O
before O O
the O O
fungal O O
identification O O
reports O O
were O O
available O O
. O O

as O O
there O O
was O O
good O O
response O O
to O O
voriconazole O O
initially O O
and O O
the O O
patient O O
was O O
not O O
willing O O
for O O
intravenous O O
therapy O O
; O O
it O O
was O O
continued O O
for O O
6 O O
weeks O O
initially O O
and O O
prolonged O O
to O O
6 O O
months O O
. O O

the O O
patient O O
recovered O O
completely O O
and O O
no O O
new O O
sinuses O B-C0016169
were O O
observed O O
till O O
his O O
last O O
visit O O
which O O
was O O
24 O O
months O O
after O O
treatment O O
was O O
initiated O O
. O O

A O O
41 O O
years O O
old O O
patient O O
, O O
presented O O
with O O
epigastric O B-C0232493
pain O I-C0232493
and O O
indigestion O B-C0013395
since O O
1 O O
year O O
. O O

physical O O
examination O O
and O O
ultrasound O O
abdomen O O
were O O
normal O O
. O O

A O O
symptomatic O O
treatment O O
was O O
prescribed O O
without O O
improvement O O
. O O

on O O
physical O O
examination O O
the O O
abdomen O O
was O O
soft O O
, O O
blood O O
pressure O O
was O O
130 O O
/ O O
85 O O
mm O O
hg O O
and O O
pulse O O
rate O O
was O O
72 O O
beats O O
/ O O
min O O
; O O
sinus O O
rhythm O O
was O O
normal O O
. O O

blood O O
count O O
and O O
biochemistry O O
analysis O O
were O O
within O O
normal O O
limits O O
. O O

computed O O
tomography O O
of O O
the O O
abdomen O O
showed O O
a O O
left O O
adrenal O B-C0342500
mass O I-C0342500
( O O
2.5 O O
X O O
3.4 O O
cm O O
) O O
; O O
with O O
a O O
spontaneous O O
density O O
of O O
20 O O
hounsfield O O
units O O
( O O
UH O O
) O O
. O O

the O O
relative O O
and O O
absolute O O
washouts O O
were O O
10 O O
% O O
and O O
16 O O
% O O
respectively O O
. O O

based O O
on O O
a O O
density O O
of O O
20 O O
UH O O
, O O
the O O
mass O O
did O O
not O O
meet O O
strict O O
CT O O
criteria O O
for O O
diagnosis O O
of O O
adenoma O B-C0001430
. O O

therefore O O
, O O
MRI O O
was O O
indicated O O
for O O
additional O O
tumor O B-C0027651
characterization O O
. O O

it O O
showed O O
a O O
left O O
adrenal O O
, O O
well O O
limited O O
; O O
with O O
low-signal O O
intensity O O
on O O
the O O
T1 O O
- O O
weighted O O
image O O
, O O
and O O
slightly O O
high-signal O O
intensity O O
on O O
the O O
T2 O O
- O O
weighted O O
image O O
; O O
moderately O O
enhanced O O
after O O
contrast O O
. O O

the O O
calculation O O
of O O
the O O
signal O O
drop O O
on O O
the O O
in-phase O O
and O O
out-phase O O
sequences O O
shows O O
a O O
value O O
of O O
less O O
than O O
10% O O
. O O

the O O
metabolic O O
workup O O
, O O
including O O
serum O O
electrolytes O O
, O O
urinary O O
metanephrine O O
, O O
was O O
within O O
the O O
normal O O
range O O
. O O

also O O
, O O
a O O
dexamethasone O O
suppression O O
test O O
showed O O
values O O
within O O
the O O
normal O O
range O O
. O O

due O O
to O O
the O O
suspect O O
nature O O
of O O
the O O
masse O O
; O O
a O O
left O O
adrenalectomy O O
was O O
indicated O O
, O O
which O O
was O O
performed O O
via O O
a O O
transperitoneal O O
laparoscopic O O
approach O O
. O O

the O O
histopathological O O
and O O
immunohistochemical O O
study O O
revealed O O
the O O
presence O O
of O O
a O O
well-limited O O
tumor O B-C0027651
of O O
3.3 O O
X O O
2.9 O O
cm O O
. O O

the O O
tumor O B-C0027651
cells O O
expressed O O
PS O O
100 O O
. O O

they O O
did O O
not O O
express O O
AML O O
; O O
the O O
desmin O O
; O O
synaptophysin O O
; O O
chromogranin O O
A O O
or O O
CD O O
117 O O
. O O

this O O
aspect O O
is O O
in O O
favor O O
of O O
a O O
benign O O
tumor O B-C0027651
schwannoma O B-C0027809
type O O
. O O

the O O
postoperative O O
recovery O O
was O O
uneventful O O
. O O

A O O
long O O
term O O
CT O O
scanner O O
follow-up O O
at O O
6 O O
, O O
12 O O
, O O
and O O
18 O O
months O O
will O O
be O O
necessary O O
to O O
get O O
a O O
recurrence O O
. O O

A O O
male O O
child O O
aged O O
three O O
years O O
was O O
referred O O
to O O
our O O
hospital O O
from O O
a O O
rural O O
health O O
facility O O
. O O

he O O
had O O
been O O
initiated O O
on O O
empiric O O
anti-tuberculous O O
therapy O O
with O O
no O O
clinical O O
improvement O O
after O O
three O O
months O O
of O O
treatment O O
. O O

the O O
patient O O
had O O
been O O
in O O
good O O
health O O
until O O
six O O
months O O
prior O O
when O O
he O O
developed O O
cough O B-C0010200
and O O
intermittent O B-C0277799
fever O I-C0277799
. O O

he O O
was O O
admitted O O
with O O
a O O
clinical O O
diagnosis O O
of O O
pneumonia O B-C0032285
for O O
which O O
unspecified O B-C4048188
antibiotic O O
therapy O O
was O O
given O O
with O O
transient O B-C0687129
improvement O O
. O O

similar O O
symptoms O O
recurred O O
two O O
months O O
later O O
and O O
he O O
was O O
readmitted O O
. O O

A O O
chest O O
radiograph O O
showed O O
right O O
upper O O
lobe O O
consolidation O O
with O O
volume O O
loss O O
, O O
right O O
para-tracheal O O
and O O
left O O
hilar O O
adenopathy O B-C0497156
and O O
bilateral O O
fine O O
reticulonodular O O
opacification O O
. O O

A O O
gene O O
® O O
xpert O O
™ O O
( O O
MTB O O
/ O O
RIF O O
) O O
performed O O
on O O
fasting O B-C0015663
gastric O O
aspirates O O
was O O
negative O O
. O O

A O O
clinical O O
diagnosis O O
of O O
pulmonary O B-C0041327
tuberculosis O I-C0041327
was O O
made O O
based O O
on O O
the O O
algorithm O O
for O O
diagnosis O O
of O O
paediatric O O
tuberculosis O B-C0041296
[ O O
1 O O
] O O
and O O
standard O O
anti-tuberculous O O
therapy O O
( O O
2HRZE O O
/ O O
4HR O O
) O O
was O O
initiated O O
. O O

his O O
condition O O
continued O O
to O O
deteriorate O O
; O O
he O O
developed O O
a O O
mass O O
on O O
the O O
right O O
upper O O
chest O O
wall O O
and O O
was O O
referred O O
to O O
our O O
facility O O
three O O
months O O
into O O
tuberculosis O B-C0041296
( O O
TB O O
) O O
treatment O O
, O O
for O O
evaluation O O
of O O
suspected O O
malignancy O B-C0006826
. O O

at O O
presentation O O
, O O
he O O
had O O
persistent O O
fever O B-C0015967
and O O
cough O B-C0010200
with O O
dyspnea O B-C0013404
that O O
disrupted O O
feeding O O
. O O

the O O
cough O B-C0010200
was O O
scantily O O
productive O O
of O O
white O O
sputum O O
. O O

progressive O O
swelling O B-C0038999
had O O
been O O
noted O O
on O O
the O O
right O O
chest O O
wall O O
and O O
there O O
was O O
marked O O
weight O B-C1262477
loss O I-C1262477
. O O

there O O
was O O
no O O
recent O O
travel O O
history O O
. O O

there O O
had O O
been O O
no O O
contact O O
with O O
domestic O O
livestock O O
or O O
birds O O
nor O O
with O O
any O O
person O O
with O O
tuberculosis O B-C0041296
. O O

he O O
was O O
HIV O B-C0481430
negative O I-C0481430
. O O

at O O
presentation O O
, O O
temperature O O
was O O
39.4 O O
° O O
C O O
, O O
respiratory O O
rate O O
40 O O
/ O O
min O O
, O O
pulse O O
rate O O
125 O O
/ O O
min O O
, O O
blood O O
pressure O O
100 O O
/ O O
70 O O
mmhg O O
, O O
spo2 O O
88% O O
. O O

he O O
had O O
no O O
conjunctival O O
pallor O B-C0030232
or O O
jaundice O O
. O O

he O O
had O O
multiple O O
enlarged O O
discrete O O
right O O
axillary O O
lymph O O
nodes O O
, O O
largest O O
2cm O O
in O O
diameter O O
; O O
firm O O
, O O
non-tender O O
and O O
mobile O O
. O O

he O O
had O O
a O O
firm O O
, O O
tender O O
, O O
diffuse O O
swelling O B-C0038999
on O O
the O O
right O O
upper O O
chest O O
wall O O
with O O
fluctuant O O
areas O O
, O O
that O O
over O O
subsequent O O
days O O
developed O O
draining O O
sinuses O B-C0016169
with O O
no O O
discharging O O
granules O O
. O O

he O O
was O O
tachypnoeic O O
with O O
dullness O O
to O O
percussion O O
and O O
bronchial O O
breathing O O
in O O
the O O
right O O
upper O O
zones O O
posteriorly O O
. O O

the O O
rest O O
of O O
the O O
systemic O O
examination O O
was O O
normal O O
. O O

serial O O
results O O
of O O
laboratory O O
test O O
results O O
are O O
shown O O
in O O
table O O
1 O O
. O O

blood O O
cultures O O
and O O
pus O O
swab O O
cultures O O
of O O
the O O
draining O O
sinuses O B-C0016169
showed O O
no O O
growth O O
. O O
β O O
D O O
glucan O O
and O O
galactomannan O O
assays O O
were O O
not O O
available O O
. O O

chest O O
radiographs O O
taken O O
on O O
admission O O
showed O O
no O O
improvement O O
when O O
compared O O
to O O
previous O O
films O O
. O O

contrast O O
enhanced O O
CT O O
scan O O
of O O
the O O
chest O O
was O O
done O O
with O O
images O O
as O O
shown O O
. O O

an O O
ultrasound O O
guided O O
fine O O
needle O O
core O O
biopsy O O
of O O
the O O
chest O O
wall O O
mass O O
was O O
carried O O
out O O
. O O

histology O O
revealed O O
necrotizing O O
granulomatous O O
inflammation O O
with O O
pieces O O
of O O
acutely O O
branching O O
hyphae O O
morphologically O O
consistent O O
with O O
aspergillus O O
sp O O
. O O

these O O
were O O
also O O
demonstrated O O
on O O
periodic O O
acid O O
schiff O O
stained O O
sections O O
. O O

genomic O O
testing O O
and O O
fungal O O
culture O O
were O O
not O O
performed O O
. O O

on O O
admission O O
the O O
patient O O
had O O
been O O
empirically O O
started O O
on O O
ceftriaxone O O
and O O
vancomycin O O
therapy O O
; O O
when O O
the O O
histology O O
was O O
received O O
, O O
treatment O O
with O O
amphotericin O O
B O O
was O O
initiated O O
and O O
the O O
patient O O
was O O
scheduled O O
for O O
surgical O O
debridement O O
and O O
lobectomy O O
. O O

he O O
developed O O
respiratory O B-C1145670
failure O I-C1145670
and O O
succumbed O O
on O O
the O O
second O O
day O O
of O O
treatment O O
. O O

the O O
next O O
of O O
kin O O
did O O
not O O
consent O O
for O O
an O O
autopsy O O
. O O

we O O
present O O
our O O
experience O O
in O O
the O O
management O O
of O O
SPT O O
in O O
a O O
12 O O
years O O
old O O
girl O O
with O O
no O O
past O O
medical O O
history O O
. O O

the O O
story O O
of O O
her O O
illness O O
began O O
2 O O
months O O
previously O O
with O O
abdominal O B-C0000737
pain O I-C0000737
without O O
other O O
associated O O
signs O O
. O O

abdominal O O
examination O O
revealed O O
a O O
palpable O O
mass O O
in O O
the O O
left O O
hypochondrium O O
. O O

ultrasound O O
demonstrated O O
a O O
heterogeneous O O
mass O O
, O O
having O O
a O O
contact O O
with O O
the O O
tail O O
of O O
the O O
pancreas O O
and O O
the O O
spleen O O
. O O

on O O
computed O O
tomography O O
( O O
CT O O
) O O
, O O
this O O
mass O O
was O O
located O O
in O O
the O O
body O O
and O O
the O O
tail O O
of O O
the O O
pancreas O O
. O O

it O O
was O O
heterogeneous O O
, O O
solido-cystic O O
, O O
with O O
peripheral O O
calcifications O B-C0006663
, O O
measuring O O
approximatively O O
7 O O
x O O
8 O O
x O O
10.5 O O
cm O O
in O O
maximum O O
transverse O O
, O O
anterior-posterior O O
and O O
craniocaudal O O
dimensions O O
, O O
respectively O O
. O O

several O O
lung O O
nodules O O
were O O
present O O
, O O
considered O O
as O O
metastatic O O
lesions O B-C0221198
. O O

no O O
other O O
metastatic O O
lesions O B-C0221198
were O O
observed O O
. O O

as O O
for O O
serum O O
tumor O B-C0027651
markers O O
, O O
all O O
were O O
negative O O
: O O
lactate O O
deshydrogenase O O
, O O
α-fetoprotein O O
, O O
carbohydrate O O
antigen O O
19 O O
- O O
9 O O
and O O
uric O O
acid O O
. O O

to O O
determine O O
the O O
histological O O
type O O
of O O
this O O
tumor O B-C0027651
, O O
we O O
performed O O
a O O
percutaneous O O
biopsy O O
with O O
ultrasound O O
guidance O O
. O O

pathologic O O
results O O
, O O
combined O O
with O O
immunohistochemical O O
study O O
were O O
consistent O O
with O O
the O O
diagnosis O O
of O O
SPT O O
. O O

CD O O
99 O O
which O O
is O O
a O O
particular O O
dot-like O O
intracytoplasmatic O O
marker O O
, O O
was O O
highly O O
expressed O O
. O O

this O O
last O O
appears O O
to O O
be O O
highly O O
unique O O
for O O
spts O O
. O O

chromogranin O O
and O O
desmine O O
markers O O
were O O
negative O O
, O O
thereby O O
eliminating O O
an O O
endocrine O O
tumor O B-C0027651
. O O

the O O
decision O O
of O O
the O O
multi-disciplinary O O
meeting O O
was O O
surgery O O
without O O
preoperative O O
chemotherapy O O
or O O
radiotherapy O O
. O O

the O O
tumor O B-C0027651
was O O
resected O O
en O O
bloc O O
with O O
a O O
corporo-caudal O O
pancreatectomy O O
without O O
splenectomy O O
. O O

macroscopically O O
, O O
it O O
demonstrated O O
characteristic O O
areas O O
of O O
hemorrhage O B-C0019080
and O O
necrosis O O
, O O
that O O
were O O
friable O O
, O O
with O O
tissular O O
portions O O
having O O
a O O
brownish O O
color O O
. O O

histological O O
examination O O
showed O O
a O O
proliferation O O
of O O
tumors O O
arranged O O
in O O
islets O O
, O O
layers O O
, O O
papillae O O
, O O
cords O O
and O O
tubes O O
. O O

mitotic O O
activity O O
( O O
ki O O
- O O
67 O O
) O O
was O O
very O O
low O O
( O O
5% O O
) O O
. O O

no O O
perineural O O
or O O
vascular O O
invasion O O
was O O
found O O
. O O

surgical O O
margins O O
were O O
negative O O
. O O

no O O
postoperative O O
diabetes O O
was O O
developed O O
. O O

follow-up O O
imaging O O
will O O
include O O
CT O O
at O O
3 O O
to O O
6 O O
month O O
intervals O O
and O O
later O O
annually O O
. O O

A O O
9 O O
year O O
old O O
male O O
patient O O
who O O
was O O
apparently O O
well O O
until O O
about O O
10 O O
months O O
prior O O
to O O
presentation O O
when O O
he O O
was O O
observed O O
to O O
have O O
developed O O
a O O
painless O O
right O O
scrotal O O
swelling O B-C0038999
. O O

the O O
swelling O B-C0038999
steadily O O
increased O O
in O O
size O O
and O O
never O O
reduced O O
. O O

he O O
was O O
taken O O
to O O
a O O
peripheral O O
hospital O O
where O O
he O O
was O O
referred O O
to O O
the O O
paediatric O O
surgical O O
unit O O
of O O
a O O
secondary O O
health O O
care O O
facility O O
. O O

he O O
was O O
born O O
in O O
saki O O
, O O
a O O
community O O
in O O
the O O
south-western O O
region O O
of O O
nigeria O O
where O O
he O O
grew O O
up O O
till O O
about O O
3 O O
years O O
ago O O
when O O
he O O
relocated O O
with O O
his O O
family O O
to O O
lagos O O
metropolis O O
. O O

while O O
in O O
saki O O
, O O
he O O
often O O
swam O O
in O O
the O O
local O O
river O O
. O O

there O O
was O O
neither O O
history O O
of O O
haematuria O B-C0018965
in O O
the O O
past O O
nor O O
during O O
the O O
course O O
of O O
the O O
illness O O
. O O

examination O O
revealed O O
a O O
small O B-C1846336
for O I-C1846336
age O I-C1846336
boy O O
with O O
an O O
encysted O O
, O O
irreducible O O
right O O
hemiscrotal O O
mass O O
( O O
10x4.5cm O O
) O O
which O O
was O O
neither O O
tender O O
nor O O
warmer O O
than O O
the O O
surrounding O O
skin O O
and O O
trans-illuminated O O
brilliantly O O
to O O
light O O
. O O

the O O
left O O
testis O O
was O O
unremarkable O O
. O O

A O O
diagnosis O O
of O O
a O O
right O O
vaginal O O
hydrocoele O B-C1720771
was O O
made O O
and O O
the O O
parent O O
was O O
counseled O O
for O O
surgery O O
. O O

pre-operative O O
laboratory O O
investigations O O
revealed O O
a O O
haematocrit O O
level O O
of O O
35% O O
, O O
HIV O O
status O O
( O O
after O O
obtaining O O
consent O O
from O O
parents O O
) O O
was O O
negative O O
, O O
hbsag O O
was O O
positive O O
, O O
blood O O
genotype O O
AA O O
, O O
electrolyte O O
, O O
urea O O
and O O
creatinine O O
values O O
were O O
essentially O O
normal O O
. O O

he O O
was O O
subsequently O O
scheduled O O
for O O
a O O
day O O
case O O
routine O O
herniotomy O O
. O O

intraoperative O O
findings O O
include O O
hydrocoele O B-C1720771
with O O
multiple O O
cysts O B-C0010709
, O O
flat O O
testis O O
and O O
thickened O O
spermatic O O
cord O O
. O O

biopsy O O
was O O
taken O O
from O O
the O O
testis O O
and O O
spermatic O O
cord O O
. O O

he O O
was O O
discharged O O
home O O
on O O
same O O
day O O
. O O

histology O O
revealed O O
fibrocollagenous O O
tissue O O
containing O O
numerous O O
granulomata O B-C0018188
in O O
a O O
background O O
of O O
dense O O
admixed O O
eosinophilic O O
rich O O
inflammatory O O
infiltrates O O
. O O

also O O
identified O O
were O O
numerous O O
multinucleated O O
giant O O
cells O O
and O O
schistosoma O O
ova O O
, O O
some O O
of O O
which O O
were O O
calcified O O
with O O
terminal O O
spine O O
. O O

the O O
presence O O
of O O
terminal O O
spine O O
confirmed O O
schistosoma O O
haematobium O O
and O O
a O O
diagnosis O O
of O O
schistosomiasis O B-C0036323
was O O
made O O
. O O

he O O
was O O
commenced O O
on O O
praziquantel O O
400mg O O
stat O O
following O O
the O O
histology O O
report O O
and O O
he O O
is O O
being O O
followed O O
up O O
in O O
the O O
outpatient O O
clinic O O
. O O

in O O
this O O
report O O
we O O
describe O O
a O O
case O O
of O O
onychomycosis O B-C0040261
in O O
a O O
55 O O
- O O
year-old O O
female O O
with O O
no O O
underlying O O
clinical O O
illness O O
. O O

she O O
was O O
presented O O
with O O
a O O
lesion O B-C0221198
on O O
digital O O
minimus O O
nail O O
of O O
her O O
left O O
hand O O
suggestive O O
of O O
proximal O O
subungual O O
onychomycosis O B-C0040261
. O O

it O O
was O O
also O O
accompanied O O
by O O
paronychia O B-C0030578
and O O
hyperkeratosis O B-C0870082
. O O

the O O
nail O O
also O O
showed O O
discoloration O O
which O O
covered O O
the O O
entire O O
nail O O
plate O O
. O O

nail O O
margins O O
were O O
fragile O O
and O O
broken O O
but O O
the O O
nail O O
plate O O
remained O O
intact O O
. O O

although O O
the O O
patient O O
had O O
this O O
lesion O B-C0221198
for O O
months O O
, O O
she O O
reported O O
until O O
it O O
was O O
painful O O
. O O

it O O
was O O
tender O O
too O O
. O O

patient O O
history O O
revealed O O
that O O
she O O
suffered O O
nail O O
trauma O O
twenty O O
years O O
ago O O
. O O

the O O
patient O O
was O O
non-diabetic O O
and O O
long-term O O
steroid O O
use O O
was O O
also O O
ruled O O
out O O
. O O

routine O O
blood O O
examination O O
done O O
for O O
blood O O
cell O O
abnormalities O O
, O O
liver O O
function O O
and O O
kidney O O
function O O
test O O
showed O O
normal O O
values O O
. O O

direct O O
microscopy O O
of O O
the O O
nail O O
specimen O O
was O O
done O O
by O O
using O O
40% O O
potassium O O
hydroxide O O
( O O
KOH O O
) O O
which O O
revealed O O
the O O
presence O O
of O O
septate O O
hyphae O O
with O O
dichotomous O O
branching O O
. O O

the O O
sample O O
was O O
grown O O
on O O
sabouraud O O
dextrose O O
agar O O
( O O
SDA O O
) O O
with O O
and O O
without O O
cycloheximide O O
and O O
chloramphenicol O O
. O O

tubes O O
were O O
then O O
incubated O O
at O O
25 O O
° O O
C O O
and O O
37 O O
° O O
C O O
for O O
four O O
weeks O O
. O O

the O O
fungal O O
growth O O
was O O
seen O O
in O O
SDA O O
tube O O
without O O
cycloheximide O O
and O O
chloramphenicol O O
. O O

initially O O
the O O
growth O O
was O O
whitish O O
which O O
turned O O
black O O
later O O
on O O
. O O

the O O
reverse O O
of O O
the O O
slant O O
was O O
yellowish O O
. O O

lactophenol O O
cotton O O
blue O O
mount O O
of O O
the O O
growth O O
showed O O
septate O O
hyphae O O
and O O
biseriate O O
phialides O O
which O O
covered O O
the O O
entire O O
vesicle O O
with O O
radiating O O
conidial O O
heads O O
. O O

the O O
culture O O
was O O
repeated O O
thrice O O
at O O
an O O
interval O O
of O O
fourteen O O
days O O
to O O
confirm O O
the O O
findings O O
. O O

all O O
the O O
three O O
cultures O O
showed O O
similar O O
findings O O
. O O

the O O
patient O O
was O O
treated O O
orally O O
with O O
250mg O O
terbinafine O O
daily O O
and O O
topical O O
amorolfine O O
( O O
5% O O
) O O
nail O O
lacquer O O
twice O O
a O O
week O O
for O O
three O O
months O O
. O O

the O O
patient O O
responded O O
well O O
to O O
the O O
treatment O O
. O O

mycological O O
culture O O
post O O
treatment O O
did O O
not O O
reveal O O
any O O
fungal O O
elements O O
. O O

we O O
present O O
here O O
a O O
case O O
of O O
nijmegen O B-C0398791
breakage O I-C0398791
syndrome O I-C0398791
in O O
an O O
8 O O
- O O
year-old O O
girl O O
born O O
of O O
consanguineous O O
parentage O O
. O O

her O O
birth O B-C0005603
histories O I-C0005603
, O O
her O O
family O O
social O O
history O O
, O O
and O O
developmental O O
milestones O O
were O O
unremarkable O O
. O O

she O O
was O O
born O O
at O O
a O O
local O O
birthing O O
centre O O
, O O
at O O
full O O
term O O
with O O
no O O
antenatal O O
or O O
perinatal O O
complications O O
, O O
attended O O
solely O O
by O O
midwives O O
, O O
she O O
was O O
exclusively O O
breast-fed O O
, O O
food O O
diversification O O
was O O
started O O
at O O
6 O O
months O O
old O O
, O O
her O O
weight O O
, O O
length O O
and O O
psychomotor O O
development O O
were O O
within O O
the O O
normal O O
range O O
, O O
the O O
child O O
was O O
described O O
as O O
a O O
good O O
eater O O
on O O
a O O
normal O O
diet O O
, O O
and O O
was O O
thriving O O
appropriately O O
. O O

furthermore O O
, O O
the O O
girl O O
presented O O
recurrent O O
episodes O O
of O O
respiratory O B-C0035243
tract O I-C0035243
infections O I-C0035243
such O O
as O O
pneumonia O B-C0032285
and O O
sinusitis O B-C0037199
since O O
2 O O
years O O
of O O
age O O
, O O
indeed O O
there O O
was O O
history O O
of O O
5 O O
hospitalizations O O
at O O
a O O
health O O
centre O O
; O O
the O O
last O O
one O O
goes O O
back O O
to O O
the O O
age O O
of O O
6 O O
, O O
then O O
she O O
was O O
sent O O
back O O
to O O
our O O
department O O
for O O
a O O
complete O O
management O O
. O O

on O O
admission O O
, O O
our O O
patient O O
had O O
characteristic O O
facial O O
appearance O O
with O O
a O O
combination O O
of O O
receding O B-C1857679
forehead O I-C1857679
, O O
receding O O
mandible O O
and O O
prominent O B-C1858732
midface O I-C1858732
, O O
she O O
had O O
also O O
epicanthal O B-C0678230
folds O I-C0678230
, O O
large O B-C0554972
ears O I-C0554972
, O O
and O O
sparse O O
. O O

in O O
addition O O
, O O
profound O O
microcephaly O B-C0025958
was O O
noticed O O
( O O
- O O
3SD O O
) O O
that O O
contrasted O O
with O O
normal O O
developmental O O
milestones O O
and O O
good O O
comprehension O O
, O O
while O O
no O O
motor O O
problems O O
and O O
no O O
delayed O B-C0241210
speech O I-C0241210
were O O
observed O O
. O O

on O O
the O O
other O O
side O O
, O O
mild O O
growth O B-C0456070
delay O I-C0456070
was O O
observed O O
( O O
- O O
2SD O O
on O O
the O O
weight O O
and O O
length O O
) O O
with O O
periorbital O O
squamous O O
lesions O B-C0221198
. O O

on O O
the O O
basis O O
of O O
this O O
clinical O O
presentation O O
, O O
a O O
tentative O O
diagnosis O O
of O O
nijmegen O B-C0398791
breakage O I-C0398791
syndrome O I-C0398791
had O O
been O O
made O O
; O O
it O O
was O O
confirmed O O
later O O
by O O
genetic O O
analysis O O
. O O

because O O
of O O
recurrent O O
episodes O O
of O O
respiratory O B-C0035243
tract O I-C0035243
infections O I-C0035243
and O O
susceptibility O O
to O O
develop O O
an O O
immune O B-C0021051
deficiency O I-C0021051
further O O
laboratory O O
work-up O O
was O O
notable O O
for O O
increased O B-C0151632
erythrocyte O I-C0151632
sedimentation O I-C0151632
rate O I-C0151632
( O O
ESR O O
) O O
of O O
96 O O
mm O O
/ O O
h O O
, O O
and O O
combined O B-C4227541
variable O I-C4227541
immunodeficiency O I-C4227541
( O O
lymphocytopenia O B-C0024312
, O O
T O O
helper O O
cell O O
and O O
B O O
cell O O
count O O
significantly O O
decreased O O
, O O
IGA O O
and O O
igg4 O O
deficiency O O
) O O
. O O

in O O
accordance O O
to O O
this O O
diagnosis O O
and O O
the O O
fact O O
that O O
patients O O
with O O
NBS O O
have O O
a O O
high O O
risk O O
for O O
developing O O
malignancy O B-C0006826
, O O
predominantly O O
hodgkin O B-C0019829
lymphomas O B-C0024299
( O O
HL O O
) O O
and O O
non-hodgkin O O
lymphomas O B-C0024299
( O O
NHL O O
) O O
the O O
major O O
cause O B-C0007465
of O I-C0007465
death O I-C0007465
in O O
these O O
individuals O O
, O O
initial O O
radiological O O
exploration O O
showed O O
some O O
multiple O O
lymph O O
nodes O O
( O O
mediastinal O O
, O O
hilar O O
and O O
supraclavicular O O
) O O
. O O

moreover O O
, O O
there O O
was O O
a O O
small O O
mass O O
in O O
the O O
left O O
lung O O
with O O
the O O
splenic O O
nodule O B-C0028259
figure O O
2 O O
. O O

biopsy O O
of O O
lymph O O
nodes O O
, O O
pulmonary O O
and O O
splenic O O
nodules O O
had O O
established O O
the O O
diagnosis O O
of O O
nodular O O
sclerosing O O
classical O O
HL O O
while O O
histological O O
examination O O
of O O
the O O
bone O O
marrow O O
showed O O
no O O
infiltration O O
by O O
HL O O
. O O

these O O
findings O O
are O O
consistent O O
with O O
hodgkin O B-C0019829
lymphomas O B-C0024299
ann O O
arbor O O
stage O O
IVB O O
. O O

the O O
initial O O
step O O
of O O
management O O
was O O
based O O
on O O
systemic O O
chemotherapy O O
in O O
combination O O
with O O
gamma-globulin O O
replacement O O
therapy O O
every O O
week O O
. O O

overall O O
, O O
we O O
applied O O
eight O O
cycles O O
of O O
chemotherapy O O
, O O
two O O
of O O
them O O
COP O O
two O O
OEPA O O
, O O
and O O
we O O
were O O
able O O
to O O
escalate O O
full O O
doses O O
of O O
copdac O O
, O O
in O O
spite O O
of O O
decrease O O
of O O
white O O
blood O O
count O O
that O O
was O O
managed O O
by O O
using O O
granulocyte O O
stimulating O O
factor O O
( O O
G-CSF O O
) O O
. O O

follow-up O O
MRI O O
was O O
performed O O
at O O
3 O O
, O O
6 O O
, O O
12 O O
and O O
18 O O
- O O
months O O
after O O
initial O O
diagnosis O O
and O O
continued O O
to O O
show O O
complete O O
remission O O
. O O

at O O
20 O O
- O O
months O O
after O O
the O O
initial O O
diagnosis O O
, O O
the O O
patient O O
does O O
not O O
exhibit O O
any O O
clinical O O
sequelae O B-C0243088
of O O
the O O
disease O O
. O O

A O O
37 O O
- O O
year-old O O
woman O O
, O O
gravida O O
5 O O
para O O
2 O O
, O O
at O O
38 O O
weeks O O
' O O
gestation O O
was O O
referred O O
to O O
lagos O O
university O O
teaching O O
hospital O O
( O O
LUTH O O
) O O
for O O
caesarean O O
delivery O O
. O O

prior O O
to O O
her O O
referral O O
, O O
she O O
had O O
been O O
scheduled O O
for O O
an O O
elective O O
caesarean O O
section O O
at O O
38 O O
weeks O O
' O O
gestation O O
due O O
to O O
two O O
previous O O
caesarean O O
sections O O
and O O
a O O
previous O O
abdominal O O
myomectomy O O
. O O

her O O
antenatal O O
care O O
was O O
essentially O O
uneventful O O
and O O
ultrasonography O O
confirmed O O
a O O
singleton O O
pregnancy O O
. O O

she O O
had O O
nasopharyngeal O O
and O O
oropharyngeal O O
swabs O O
collected O O
for O O
RT-PCR O O
test O O
, O O
after O O
close O O
contact O O
with O O
a O O
confirmed O O
case O O
of O O
COVID O O
- O O
19 O O
. O O

she O O
had O O
no O O
symptoms O O
associated O O
with O O
COVID O O
- O O
19 O O
infection O B-C3714514
and O O
no O O
history O O
of O O
recent O O
travel O O
. O O

however O O
, O O
she O O
complained O O
of O O
abdominal O B-C0000737
pain O I-C0000737
and O O
intermittent O O
uterine O O
contractions O O
. O O

she O O
was O O
commenced O O
on O O
oral O O
nifedipine O O
for O O
tocolysis O O
. O O

her O O
laboratory O O
test O O
confirmed O O
COVID O O
- O O
19 O O
infection O B-C3714514
after O O
48 O O
hours O O
and O O
she O O
was O O
referred O O
to O O
LUTH O O
immediately O O
. O O

although O O
LUTH O O
has O O
assigned O O
wards O O
for O O
the O O
management O O
of O O
patients O O
with O O
COVID O O
- O O
19 O O
, O O
there O O
were O O
no O O
dedicated O O
spaces O O
for O O
infected O O
pregnant O O
women O O
and O O
their O O
neonates O O
. O O

however O O
, O O
there O O
was O O
a O O
dedicated O O
operating O O
theatre O O
with O O
a O O
safe O O
corridor O O
to O O
one O O
of O O
the O O
COVID O O
- O O
19 O O
isolation O B-C0260397
wards O O
. O O

the O O
woman O O
was O O
admitted O O
in O O
a O O
private O O
room O O
at O O
the O O
isolation O B-C0260397
ward O O
prior O O
to O O
the O O
caesarean O O
section O O
. O O

A O O
multidisciplinary O O
team O O
of O O
obstetricians O O
, O O
anaesthetists O O
, O O
neonatologists O O
, O O
nurses O O
, O O
psychiatrists O O
and O O
infectious O B-C0009450
disease O I-C0009450
experts O O
were O O
assembled O O
and O O
simulation O O
sessions O O
were O O
undertaken O O
based O O
on O O
the O O
established O O
infection O B-C3714514
prevention O O
and O O
control O O
( O O
IPC O O
) O O
guidelines O O
. O O

all O O
staff O O
caring O O
for O O
the O O
woman O O
wore O O
appropriate O O
personal O O
protective O O
equipment O O
( O O
PPE O O
) O O
. O O

her O O
laboratory O O
results O O
were O O
unremarkable O O
except O O
for O O
lymphopenia O O
( O O
a O O
common O O
laboratory O O
finding O B-C0037088
in O O
patients O O
with O O
COVID O O
- O O
19 O O
) O O
[ O O
6 O O
, O O
9 O O
] O O
and O O
hypokalaemia O B-C0020621
. O O

the O O
correction O O
of O O
hypokalaemia O B-C0020621
was O O
commenced O O
with O O
parenteral O O
potassium O O
infusion O O
. O O

she O O
was O O
appropriately O O
counselled O O
and O O
reassured O O
to O O
calm O O
her O O
perioperative O O
anxiety O B-C0003467
. O O

A O O
remote O O
consent O O
was O O
taken O O
via O O
video O O
call O O
, O O
after O O
sharing O O
appropriate O O
information O O
material O O
via O O
whatsapp O O
messaging O O
. O O

on O O
admission O O
day O O
2 O O
, O O
she O O
was O O
transported O O
to O O
the O O
operating O O
theatre O O
while O O
observing O O
all O O
the O O
necessary O O
IPC O O
measures O O
. O O

after O O
signing O O
a O O
written O O
informed O O
consent O O
, O O
she O O
had O O
a O O
lower O O
segment O O
caesarean O O
section O O
and O O
bilateral O O
tubal O O
ligation O O
performed O O
under O O
spinal O O
anaesthesia O B-C0278134
. O O

she O O
was O O
delivered O O
of O O
a O O
full-term O O
male O O
baby O O
weighing O O
2600g O O
with O O
apgar O O
score O O
9 O O
and O O
10 O O
in O O
1 O O
and O O
5 O O
minutes O O
, O O
respectively O O
. O O

intraoperative O O
oxygen O O
saturation O O
was O O
maintained O O
at O O
a O O
minimum O O
of O O
98% O O
, O O
intraoperative O O
infusion O O
volume O O
was O O
1000ml O O
and O O
estimated O O
blood O O
loss O O
was O O
600ml O O
. O O

she O O
had O O
prophylactic O O
intravenous O O
tranexamic O O
acid O O
1g O O
and O O
carbetocin O O
100μg O O
. O O

the O O
mother O O
and O O
baby O O
were O O
nursed O O
in O O
the O O
recovery O O
room O O
of O O
the O O
operating O O
theatre O O
and O O
the O O
immediate O O
postnatal O O
period O O
was O O
uneventful O O
. O O

the O O
newborn O O
was O O
commenced O O
on O O
breast O O
milk O O
substitute O O
until O O
the O O
mother O O
was O O
able O O
to O O
breastfeed O O
the O O
baby O O
on O O
demand O O
. O O

on O O
day O O
3 O O
after O O
delivery O O
, O O
the O O
mother O O
and O O
her O O
newborn O O
were O O
transferred O O
back O O
to O O
the O O
isolation O B-C0260397
ward O O
. O O

the O O
nasopharyngeal O O
swabs O O
collected O O
from O O
the O O
neonate O O
( O O
at O O
birth O O
and O O
48 O O
hours O O
after O O
birth O O
) O O
were O O
all O O
negative O O
for O O
COVID O O
- O O
19 O O
infection O B-C3714514
. O O

both O O
mother O O
and O O
baby O O
remained O O
asymptomatic O O
during O O
the O O
postpartum O O
period O O
. O O

on O O
day O O
15 O O
after O O
delivery O O
, O O
the O O
mother O O
met O O
the O O
criteria O O
for O O
discharge O O
because O O
she O O
had O O
remained O O
asymptomatic O O
for O O
more O O
than O O
14 O O
days O O
after O O
her O O
initial O O
positive O O
result O O
[ O O
4 O O
] O O
. O O

after O O
appropriate O O
counselling O O
, O O
the O O
mother O O
and O O
her O O
baby O O
were O O
discharged O O
home O O
and O O
scheduled O O
for O O
a O O
follow-up O O
visit O O
in O O
2 O O
weeks O O
. O O

throughout O O
the O O
period O O
of O O
care O O
, O O
contact O O
between O O
staff O O
and O O
patient O O
was O O
minimised O O
and O O
she O O
wore O O
a O O
surgical O O
mask O O
all O O
the O O
time O O
. O O

telephone O O
conversations O O
were O O
frequently O O
used O O
for O O
communication O O
between O O
the O O
woman O O
and O O
the O O
multi-disciplinary O O
team O O
members O O
( O O
obstetrician O O
, O O
anaesthetist O O
, O O
neonatologist O O
and O O
psychiatrist O O
) O O
. O O

fourteen O O
days O O
after O O
the O O
delivery O O
, O O
all O O
her O O
caregivers O O
remained O O
well O O
. O O

this O O
is O O
the O O
case O O
of O O
an O O
8 O O
- O O
hours-old O O
male O O
neonate O O
infant O O
who O O
was O O
referred O O
from O O
a O O
3 O O
rd O O
category O O
hospital O O
in O O
yaounde O O
for O O
a O O
better O O
management O O
of O O
congenital O O
abdominal O O
wall O O
malformation O O
. O O

the O O
mother O O
of O O
the O O
baby O O
was O O
an O O
18 O O
- O O
years-old O O
primipara O O
of O O
chadian O O
nationality O O
, O O
without O O
a O O
history O O
of O O
chronic O O
pathology O O
, O O
nor O O
consanguinity O B-C0009789
or O O
inbreeding O O
. O O

the O O
pregnancy O O
was O O
poorly O O
followed-up O O
to O O
a O O
term O O
of O O
37 O O
weeks O O
of O O
gestation O O
( O O
GA O O
) O O
+ O O
5 O O
days O O
, O O
no O O
infectious O O
risk O B-C0035648
factor O I-C0035648
was O O
found O O
and O O
there O O
was O O
not O O
a O O
notion O O
of O O
oligoamnios O O
. O O

delivery O O
was O O
by O O
vaginal O O
route O O
with O O
cephalic O O
presentation O O
, O O
and O O
adaptation O O
to O O
extra-uterine O O
life O O
was O O
normal O O
with O O
apgar O O
scores O O
of O O
8 O O
, O O
10 O O
and O O
10 O O
respectively O O
at O O
the O O
1 O O
st O O
, O O
5 O O
th O O
, O O
and O O
10 O O
th O O
minutes O O
. O O

meconium O O
and O O
urine O O
were O O
not O O
emitted O O
immediately O O
after O O
birth O O
. O O

on O O
physical O O
exam O O
, O O
the O O
baby's O O
hue O O
was O O
normal O O
, O O
the O O
limbs O O
were O O
quadriflexed O O
and O O
reactive O O
. O O

the O O
vital O O
parameters O O
were O O
normal O O
as O O
follows O O
: O O
temperature O O
( O O
T O O
° O O
) O O
= O O
36.5 O O
° O O
C O O
; O O
breathing O O
rate O O
( O O
BR O O
) O O
= O O
58 O O
cycle O O
per O O
minutes O O
; O O
the O O
heart O O
rate O O
( O O
HR O O
) O O
= O O
148 O O
beats O O
per O O
minute O O
; O O
blood O O
oxygen O O
saturation O O
( O O
SPO2 O O
) O O
= O O
98% O O
. O O

anthropometric O O
parameters O O
were O O
height O O
= O O
47cm O O
; O O
head O O
circumference O O
= O O
35cm O O
; O O
the O O
weight O O
= O O
2965kg O O
. O O

the O O
conjunctivae O O
and O O
sclera O O
were O O
normal O O
, O O
no O O
facial O O
dysmorphy O O
was O O
noted O O
, O O
and O O
the O O
nasal O O
catheter O O
testing O O
for O O
choanal O B-C0008297
atresia O I-C0008297
was O O
negative O O
. O O

the O O
cardio-pulmonary O O
exam O O
was O O
normal O O
. O O

the O O
abdomen O O
was O O
slightly O O
distended O O
, O O
asymetric O O
, O O
with O O
a O O
batrachian-like O O
spread O O
out O O
. O O

the O O
abdominal O O
wall O O
seemed O O
crumpled O O
, O O
especially O O
on O O
the O O
left O O
flank O O
. O O

the O O
intestines O O
could O O
be O O
felt O O
beneath O O
the O O
abdominal O O
skin O O
. O O

the O O
umbilical O O
stump O O
was O O
fresh O O
and O O
normally O O
vascularized O O
. O O

the O O
osteo-articular O O
exam O O
was O O
without O O
peculiarities O O
, O O
with O O
an O O
upper O O
segment O O
height O O
= O O
26cm O O
, O O
while O O
that O O
of O O
the O O
lower O O
segment O O
was O O
= O O
21cm O O
. O O

the O O
external O O
genitalia O O
were O O
masculine O O
, O O
but O O
the O O
scrotum O O
was O O
empty O O
, O O
due O O
to O O
undescended O B-C0010417
testes O I-C0010417
. O O

there O O
was O O
no O O
sexual O O
differentiation O O
anomaly O O
; O O
the O O
anus O O
was O O
present O O
and O O
permeable O O
. O O

the O O
minimal O O
neurological O O
exam O O
was O O
normal O O
with O O
primitive O B-C0422895
reflexes O I-C0422895
, O O
axial O O
and O O
peripheral O O
tonus O O
that O O
were O O
normal O O
. O O

the O O
paraclinical O O
exams O O
done O O
comprised O O
an O O
abdominal O O
ultrasound O O
which O O
showed O O
features O O
in O O
favor O O
of O O
aplasia O O
of O O
the O O
left O O
antero-lateral O O
abdominal O O
muscles O O
, O O
the O O
kidneys O O
had O O
normal O O
topography O O
, O O
sizes O O
( O O
left O O
kidney O O
= O O
47mm O O
; O O
right O O
kidney O O
= O O
48mm O O
) O O
, O O
and O O
were O O
well-differentiated O O
. O O

there O O
was O O
however O O
, O O
dilatation O O
of O O
the O O
ureters O O
and O O
pyelocaliectasis O O
, O O
characterizing O O
hydro O O
ureteronephrosis O O
. O O

the O O
kidney O O
function O O
was O O
altered O O
with O O
blood O O
urea O O
= O O
2.19 O O
g O O
/ O O
l O O
, O O
creatinine O O
= O O
33.0mg O O
/ O O
l O O
and O O
a O O
creatinine O O
clearance O O
of O O
5.88ml O O
/ O O
min O O
. O O

the O O
first O O
micturition O O
occurred O O
50 O O
hours O O
after O O
birth O O
. O O

the O O
mother's O O
kidney O O
function O O
was O O
rather O O
normal O O
. O O

further O O
complementary O O
exams O O
such O O
as O O
cardiac O O
and O O
trans-fontanellar O O
doppler O O
ultrasounds O O
, O O
rachis O O
and O O
thoraco-abdominal O O
radiography O O
, O O
as O O
well O O
as O O
abdomino-pelvic O O
computed O O
tomography O O
( O O
CT O O
) O O
- O O
scan O O
in O O
search O O
of O O
other O O
malformations O O
could O O
not O O
be O O
done O O
because O O
of O O
financial O O
limitations O O
. O O

the O O
management O O
consisted O O
in O O
the O O
maintenance O O
of O O
a O O
balanced O O
hydroelectrolytic O O
state O O
, O O
adequate O O
postures O B-C1262869
, O O
enteral O O
feeding O O
through O O
a O O
nasogatric O O
tube O O
, O O
given O O
the O O
difficulty O O
to O O
put O O
the O O
baby O O
onto O O
the O O
breast O O
, O O
and O O
delayed O O
digestion O O
. O O

the O O
surgical O O
management O O
would O O
have O O
consisted O O
in O O
a O O
sequential O O
intervention O O
comprising O O
: O O
orchidopexy O O
, O O
urinary O O
tract O O
reconstruction O O
and O O
abdominoplasty O O
respectively O O
. O O

however O O
, O O
these O O
could O O
not O O
be O O
practiced O O
in O O
due O O
time O O
, O O
because O O
of O O
renal O B-C0035078
failure O I-C0035078
and O O
limited O O
financial O O
resources O O
. O O

the O O
neonate O O
died O B-C1546956
after O O
7 O O
days O O
of O O
life O O
. O O

A O O
21 O O
- O O
year-old O O
male O O
patient O O
with O O
a O O
long O O
history O O
of O O
recurrent O O
epistaxis O B-C0014591
, O O
with O O
onset O O
of O O
progressive O O
right O O
unilateral O B-C2350170
nasal O I-C2350170
obstruction O I-C2350170
, O O
motivated O O
him O O
to O O
consult O O
the O O
ear O O
, O O
nose O O
and O O
throat O O
department O O
, O O
where O O
he O O
initially O O
benefited O O
from O O
a O O
nasofibroscopy O O
that O O
showed O O
a O O
right O O
pterygo-maxillary O O
fossa O O
process O O
. O O

on O O
physical O O
examination O O
, O O
there O O
was O O
no O O
cervical O O
adenopathy O B-C0497156
palpable O O
. O O

A O O
cervico-facial O O
CT O O
scan O O
and O O
brain O O
level O O
was O O
performed O O
and O O
showed O O
a O O
hypervascular O O
tumor O B-C0027651
process O O
centered O O
on O O
the O O
right O O
pterygo-maxillary O O
fossa O O
. O O

the O O
diagnosis O O
of O O
an O O
angiofibroma O B-C0206731
was O O
confirmed O O
by O O
biopsy O O
with O O
anatomopathological O O
and O O
immunohistochemical O O
analysis O O
. O O

he O O
was O O
operated O O
on O O
with O O
total O O
removal O O
of O O
the O O
tumor O B-C0027651
. O O

the O O
clinical O O
course O O
was O O
marked O O
by O O
an O O
improvement O O
in O O
the O O
patient's O O
clinical O O
symptomatology O O
with O O
disappearance O O
of O O
epistaxis O B-C0014591
and O O
nasal O B-C0027429
obstruction O I-C0027429
. O O

CT O O
scan O O
of O O
the O O
control O O
facial O O
mass O O
after O O
surgery O O
showed O O
no O O
sign O O
of O O
tumour O B-C0027651
recurrence O O
. O O

after O O
a O O
free O O
interval O O
of O O
nine O O
months O O
after O O
surgery O O
, O O
the O O
patient O O
presented O O
a O O
reappearance O O
of O O
the O O
epistaxis O B-C0014591
and O O
obstruction O O
, O O
which O O
this O O
time O O
associated O O
with O O
a O O
notion O O
of O O
right O O
temporal O O
headaches O B-C0018681
. O O

in O O
addition O O
, O O
it O O
was O O
refractory O O
to O O
usual O O
analgesics O O
, O O
and O O
was O O
associated O O
with O O
decreased O B-C0234632
visual O I-C0234632
acuity O I-C0234632
in O O
the O O
right O O
eye O O
. O O

the O O
patient O O
consulted O O
again O O
in O O
the O O
ear O O
, O O
nose O O
and O O
throat O O
department O O
. O O

the O O
physical O O
examination O O
found O O
visual O O
acuity O O
at O O
6 O O
/ O O
10 O O
of O O
the O O
right O O
eye O O
and O O
10 O O
/ O O
10 O O
of O O
the O O
left O O
eye O O
. O O

the O O
fundus O O
of O O
both O O
eyes O O
was O O
normal O O
. O O

there O O
was O O
no O O
cervical O B-C0235592
lymphadenopathy O I-C0235592
. O O

A O O
nasofibroscopy O O
done O O
in O O
the O O
patient O O
who O O
showed O O
a O O
recurrence O O
of O O
his O O
tumor O B-C0027651
process O O
. O O

the O O
exploration O O
was O O
completed O O
by O O
MRI O O
of O O
the O O
facial O O
mass O O
which O O
revealed O O
the O O
presence O O
of O O
an O O
ethmoidonasal O O
tumour O B-C0027651
process O O
measuring O O
70x50x40 O O
mm O O
, O O
heterogeneous O O
with O O
a O O
double O O
cystic O O
and O O
fleshy O O
component O O
, O O
extending O O
into O O
the O O
right O O
maxillary O O
sinus O O
and O O
the O O
homolateral O O
para-pharyngeal O O
space O O
, O O
with O O
extra-axial O O
intracranial O B-C4727074
extension O I-C4727074
in O O
the O O
right O O
temporal O O
region O O
. O O

the O O
tumor O B-C0027651
has O O
been O O
classified O O
V O O
according O O
to O O
the O O
classification O O
of O O
snyderman O O
et O O
al O O
. O O

( O O
table O O
1 O O
) O O
. O O

the O O
patient's O O
file O O
was O O
discussed O O
in O O
a O O
multidisciplinary O O
consultation O O
meeting O O
and O O
the O O
tumor O B-C0027651
was O O
judged O O
by O O
the O O
surgeons O O
to O O
be O O
in O O
extirpated O O
. O O

external O O
radiotherapy O O
( O O
RT O O
) O O
was O O
then O O
decided O O
. O O

he O O
was O O
planned O O
for O O
a O O
total O O
dose O O
of O O
45 O O
gy O O
of O O
RT O O
in O O
25 O O
fractions O O
, O O
at O O
a O O
daily O O
dose O O
fraction O O
of O O
1,8 O O
gy O O
over O O
5 O O
weeks O O
using O O
the O O
intensity-modulated O O
radiotherapy O O
( O O
IMRT O O
) O O
technique O O
with O O
fields O O
prescribed O O
to O O
the O O
100% O O
isodose O O
line O O
, O O
using O O
6 O O
- O O
MV O O
photons O O
. O O

we O O
were O O
able O O
to O O
keep O O
the O O
tolerance O O
doses O O
of O O
organs O O
at O O
risk O O
such O O
as O O
the O O
optic O O
chiasma O O
, O O
optic O O
nerves O O
, O O
retina O O
, O O
pituitary O O
and O O
parotids O O
within O O
normal O O
limits O O
and O O
at O O
the O O
same O O
time O O
deliver O O
the O O
intended O O
dose O O
of O O
radiation O O
to O O
the O O
tumor O B-C0027651
site O O
. O O

the O O
ophthalmological O O
examination O O
performed O O
at O O
the O O
end O O
of O O
the O O
treatment O O
resulted O O
in O O
an O O
improvement O O
in O O
the O O
visual O O
acuity O O
of O O
the O O
right O O
side O O
measured O O
at O O
9 O O
/ O O
10 O O
. O O

the O O
patient O O
reported O O
an O O
improvement O O
in O O
clinical O O
symptomatology O O
, O O
with O O
disappearance O O
of O O
epistaxis O B-C0014591
, O O
nasal O B-C0027429
obstruction O I-C0027429
and O O
headache O B-C0018681
. O O

A O O
CT O O
scan O O
of O O
the O O
facial O O
mass O O
and O O
cerebral O O
area O O
performed O O
at O O
two O O
months O O
after O O
the O O
end O O
of O O
irradiation O O
which O O
showed O O
a O O
clear O O
reduction O O
in O O
tumor O B-C3273930
mass O I-C3273930
. O O

M.M O O
female O O
, O O
had O O
for O O
20 O O
years O O
a O O
mass O O
of O O
the O O
inner O O
side O O
of O O
the O O
right O O
thigh O O
painless O O
, O O
gradually O O
increasing O O
in O O
volume O O
, O O
and O O
evolving O O
in O O
a O O
context O O
of O O
apyrexia O O
and O O
conservation O O
of O O
the O O
general O O
state O O
. O O

the O O
clinical O O
examination O O
showed O O
a O O
mass O O
at O O
the O O
antero-internal O O
surface O O
of O O
the O O
right O O
thigh O O
of O O
18 O O
/ O O
12cm O O
, O O
well O O
limited O O
, O O
firm O O
consistency O O
, O O
non-flapping O O
, O O
painless O O
on O O
palpation O O
, O O
mobile O O
in O O
relation O O
to O O
the O O
superficial O O
plane O O
and O O
adherent O O
to O O
the O O
deep O O
one O O
, O O
with O O
no O O
inflammatory O O
signs O O
or O O
satellite O O
lymphadenopathies O B-C0497156
with O O
a O O
normal O O
neurovascular O O
examination O O
. O O

the O O
patient O O
underwent O O
standard O O
radiography O O
of O O
the O O
thigh O O
revealing O O
opacity O O
of O O
the O O
soft O O
tissues O O
, O O
and O O
MRI O O
which O O
showed O O
a O O
sub O O
fascial O O
mass O O
of O O
the O O
inner O O
side O O
of O O
the O O
right O O
thigh O O
, O O
well-defined O O
, O O
contours O O
irregular O O
in O O
places O O
, O O
in O O
heterogeneous O O
hypersignal O O
T2 O O
/ O O
isosignal O O
T1 O O
, O O
closing O O
areas O O
in O O
hyposignal O O
T1 O O
and O O
T2 O O
in O O
relation O O
to O O
calcifications O B-C0006663
, O O
and O O
raising O O
intensively O O
and O O
heterogeneously O O
after O O
injection O O
of O O
contrast O O
product O O
. O O

this O O
mass O O
drove O O
the O O
superficial O O
veins O O
and O O
respected O O
the O O
neighboring O O
muscular O O
structures O O
. O O

she O O
first O O
benefited O O
from O O
a O O
surgical O O
biopsy O O
with O O
regard O O
to O O
the O O
mass O O
whose O O
pathology O O
showed O O
epithelioid O O
cells O O
sometimes O O
fusiform O O
arranged O O
in O O
bundles O O
or O O
single O O
file O O
and O O
marked O O
by O O
fibrosis O B-C0016059
, O O
the O O
nuclei O O
were O O
chromatic O O
with O O
abundant O B-C3280496
cytoplasm O I-C3280496
, O O
the O O
figures O O
of O O
the O O
mitoses O O
were O O
few O O
. O O

immunohistochemically O O
, O O
cells O O
expressed O O
EMA O O
, O O
but O O
were O O
negative O O
for O O
AE1 O O
/ O O
AE3 O O
, O O
PS100 O O
, O O
desmin O O
, O O
AML O O
. O O

it O O
is O O
therefore O O
a O O
FLNCC O O
grade O O
II O O
of O O
sclerosing O O
epithelioid O O
fibrosarcoma O B-C0016057
. O O

the O O
extension O O
assessment O O
was O O
negative O O
( O O
thoraco-abdominopelvic O O
computed O O
tomography O O
( O O
CT O O
) O O
and O O
bone O O
scintigraphy O O
) O O
, O O
and O O
after O O
a O O
multidisciplinary O O
consultation O O
meeting O O
, O O
the O O
decision O O
was O O
a O O
first O O
surgery O O
. O O

A O O
large O O
excision O O
was O O
made O O
taking O O
the O O
path O O
of O O
the O O
biopsy O O
including O O
without O O
seeing O O
the O O
tumor O B-C0027651
with O O
a O O
margin O O
of O O
safety O O
of O O
4cm O O
reaching O O
the O O
superficial O O
plane O O
of O O
sartorius O O
. O O

the O O
anatomopathological O O
result O O
confirmed O O
the O O
same O O
diagnosis O O
with O O
resection O O
margins O O
at O O
R0 O O
. O O

the O O
patient O O
is O O
a O O
candidate O O
for O O
adjuvant O O
radiotherapy O O
. O O

A O O
53 O O
- O O
year-old O O
female O O
presented O O
to O O
the O O
emergency O O
department O O
with O O
a O O
1 O O
- O O
week O O
history O O
of O O
dull O O
progressive O O
lower O O
abdominal O B-C0000737
pain O I-C0000737
radiating O O
to O O
the O O
upper O O
abdomen O O
and O O
back O O
. O O

the O O
patient O O
reported O O
fevers O B-C0015967
and O O
shivering O B-C0036973
. O O

she O O
had O O
a O O
past O O
medical O O
history O O
of O O
irritable O B-C0022104
bowel O I-C0022104
syndrome O I-C0022104
, O O
depression O B-C0011570
and O O
had O O
an O O
open O O
appendicectomy O O
at O O
the O O
age O O
of O O
17 O O
. O O

on O O
examination O O
, O O
the O O
patient O O
had O O
a O O
fever O B-C0015967
at O O
38 O O
o O O
C O O
and O O
a O O
heart O O
rate O O
of O O
92 O O
/ O O
min O O
. O O

her O O
abdomen O O
was O O
tender O O
throughout O O
, O O
markedly O O
in O O
the O O
right O O
upper O O
quadrant O O
. O O

blood O O
tests O O
showed O O
leukocytosis O B-C0023518
at O O
14.8 O O
10 O O
9 O O
/ O O
L O O
( O O
normal O O
value O O
: O O
4 O O
- O O
11 O O
10 O O
9 O O
/ O O
L O O
) O O
, O O
high O O
c-reactive O O
protein O O
at O O
253mg O O
/ O O
L O O
( O O
normal O O
value O O
: O O
0 O O
- O O
5mg O O
/ O O
L O O
) O O
with O O
normal O O
amylase O O
level O O
at O O
18U O O
/ O O
L O O
( O O
normal O O
value O O
: O O
30 O O
- O O
118U O O
/ O O
L O O
) O O
. O O

A O O
computed O O
tomography O O
( O O
CT O O
) O O
scan O O
done O O
on O O
admission O O
, O O
showed O O
an O O
ingested O O
FB O O
perforating O O
through O O
the O O
pylorus O O
, O O
embedded O O
in O O
the O O
liver O O
with O O
adjacent O O
mesenteric O O
stranding O O
and O O
a O O
5.6cm O O
loculated O O
liver O B-C0023885
abscess O I-C0023885
transgressing O O
segments O O
III O O
/ O O
ivb O O
. O O

it O O
then O O
transpired O O
that O O
the O O
patient O O
had O O
inadvertently O O
swallowed O O
a O O
fishbone O O
approximately O O
one O O
week O O
prior O O
to O O
presentation O O
. O O

the O O
abscess O B-C0000833
was O O
not O O
amenable O O
to O O
drainage O O
owing O O
to O O
its O O
multilocularity O O
. O O

hence O O
, O O
she O O
was O O
managed O O
conservatively O O
as O O
an O O
inpatient O O
with O O
a O O
month's O O
therapy O O
of O O
intravenous O O
antibiotics O O
and O O
received O O
piperacillin O O
tazobactam O O
4.5grams O O
four O O
times O O
daily O O
and O O
metronidazole O O
500mgs O O
three O O
times O O
daily O O
. O O

in O O
addition O O
, O O
total O O
parenteral O O
nutrition O O
was O O
started O O
, O O
whilst O O
the O O
patient O O
was O O
nil O O
by O O
mouth O O
. O O

following O O
satisfactory O O
clinical O O
and O O
radiological O O
improvement O O
the O O
patient O O
was O O
discharged O O
home O O
with O O
outpatient O O
follow-up O O
. O O

six O O
weeks O O
follow O O
up O O
CT O O
scan O O
demonstrated O O
replacement O O
of O O
the O O
complex O O
liver O B-C0023885
abscess O I-C0023885
with O O
a O O
small O O
focus O O
of O O
low O O
attenuation O O
change O O
on O O
either O O
side O O
of O O
the O O
falciform O O
ligament O O
and O O
the O O
linear O O
foreign O B-C0016542
body O I-C0016542
extending O O
from O O
the O O
pyloric O O
wall O O
into O O
segment O O
four O O
of O O
the O O
liver O O
remained O O
unchanged O O
in O O
position O O
. O O

on O O
her O O
annual O O
follow O O
up O O
, O O
the O O
patient O O
reported O O
being O O
completely O O
asymptomatic O O
. O O

an O O
ultrasound O O
scan O O
( O O
US O O
) O O
confirmed O O
complete O O
resolution O O
of O O
the O O
abscess O B-C0000833
, O O
but O O
the O O
fishbone O O
was O O
still O O
visible O O
. O O

she O O
was O O
discharged O O
from O O
routine O O
follow-up O O
. O O

A O O
healthy O O
37 O O
- O O
year-old O O
man O O
presented O O
with O O
complaints O O
of O O
swelling O B-C0038999
and O O
pain O B-C0030193
involving O O
the O O
left O O
sternoclavicular O O
joint O O
region O O
of O O
three O O
weeks O O
' O O
duration O O
in O O
september O O
2017 O O
. O O

there O O
was O O
no O O
history O O
of O O
fever O B-C0015967
, O O
loss O B-C1971624
of O I-C1971624
appetite O I-C1971624
or O O
loss O B-C1262477
of O I-C1262477
weight O I-C1262477
. O O

he O O
was O O
treated O O
with O O
antibiotics O O
for O O
one O O
week O O
by O O
his O O
family O O
doctor O O
. O O

the O O
patient O O
had O O
no O O
history O O
of O O
drug O B-C0013146
abuse O I-C0013146
or O O
high-risk O O
behavior O O
. O O

he O O
has O O
primary O B-C0553573
infertility O I-C0553573
for O O
which O O
he O O
was O O
investigated O O
and O O
received O O
hormonal O O
therapy O O
. O O

there O O
was O O
no O O
family O B-C0241889
history O I-C0241889
of O O
tuberculosis O B-C0041296
. O O

on O O
general O O
physical O O
examination O O
, O O
his O O
vital O O
signs O O
were O O
normal O O
. O O

body O O
mass O O
index O O
was O O
34 O O
kg O O
/ O O
m O O
2 O O
. O O

no O O
cervical O O
or O O
axillary O O
lymphadenopathy O B-C0497156
. O O

there O O
was O O
a O O
swelling O B-C0038999
measuring O O
4x4 O O
cm O O
over O O
the O O
left O O
sternoclavicular O O
joint O O
region O O
. O O

the O O
skin O O
over O O
the O O
swelling O B-C0038999
was O O
stretched O O
and O O
erythematous O O
. O O

it O O
was O O
non-tender O O
and O O
soft O O
inconsistency O O
. O O

movements O O
of O O
the O O
left O O
shoulder O O
joint O O
were O O
normal O O
. O O

the O O
chest O O
was O O
clear O O
; O O
heart O O
sounds O O
were O O
normal O O
. O O

abdominal O O
examination O O
was O O
normal O O
. O O

full O O
blood O O
count O O
revealed O O
haemoglobin O O
of O O
11.8 O O
g O O
/ O O
dl O O
, O O
white O O
cell O O
count O O
of O O
6.8x10 O O
3 O O
μl O O
, O O
neutrophil O O
57.7% O O
, O O
lymphocytes O O
33.4% O O
, O O
eosinophil O O
2.6% O O
, O O
monocyte O O
5.7% O O
, O O
basophil O O
0.6% O O
. O O

the O O
erythrocyte O O
sedimentation O O
rate O O
( O O
ESR O O
) O O
was O O
elevated O O
to O O
70 O O
mm O O
/ O O
hour O O
, O O
and O O
the O O
test O O
for O O
c-reactive O O
protein O O
( O O
CRP O O
) O O
was O O
positive O O
( O O
thirty O O
milligrams O O
per O O
liter O O
) O O
. O O

A O O
serological O O
test O O
done O O
for O O
HIV O O
was O O
negative O O
. O O

A O O
tuberculin O O
skin O O
test O O
was O O
also O O
negative O O
. O O

ziehl O O
neelson O O
stain O O
was O O
negative O O
. O O

chest O O
radiograph O O
revealed O O
normal O O
lung O O
fields O O
with O O
suspicious O O
of O O
the O O
irregularity O O
of O O
right O O
sternoclavicular O O
joint O O
. O O

A O O
computerized O O
tomographic O O
scan O O
showed O O
extensive O O
destruction O O
involving O O
cortices O O
of O O
clavicular O O
as O O
well O O
as O O
the O O
sternal O O
end O O
of O O
the O O
joint O O
with O O
loculated O O
collection O O
in O O
the O O
subcutaneous O O
tissue O O
at O O
the O O
left O O
side O O
of O O
lower O O
neck O O
extending O O
into O O
the O O
left O O
sternoclavicular O O
and O O
first O O
sternochondral O O
joint O O
with O O
the O O
impression O O
of O O
septic O B-C0003869
arthritis O I-C0003869
in O O
these O O
two O O
joints O O
. O O

ceftriaxone O O
one O O
gram O O
intravenously O O
was O O
commenced O O
. O O

an O O
open O O
biopsy O O
was O O
performed O O
. O O

frank O B-C0398650
yellow O O
creamy O O
pus O O
found O O
in O O
the O O
subcutaneous O O
communicating O O
with O O
the O O
joint O O
. O O

culture O O
of O O
pus O O
identified O O
as O O
mycobacterium O B-C0026918
tuberculosis O B-C0041296
. O O

biopsy O O
of O O
the O O
abscess O B-C0000833
wall O O
showed O O
multiple O O
granulomatous O O
lesion O B-C0221198
with O O
large O O
caseous O O
necrosis O O
. O O

A O O
diagnosis O O
of O O
tuberculous O O
arthritis O O
was O O
made O O
, O O
based O O
on O O
the O O
presence O O
of O O
granulomatous O O
lesion O B-C0221198
and O O
mycobacteria O O
in O O
the O O
histological O O
material O O
. O O

A O O
hospital O O
stay O O
of O O
the O O
patient O O
was O O
10 O O
days O O
. O O
lsoniazid O O
( O O
300 O O
mg O O
per O O
day O O
) O O
, O O
rifampin O O
( O O
600 O O
mg O O
per O O
day O O
) O O
, O O
ethambutol O O
( O O
1600 O O
mg O O
per O O
day O O
) O O
, O O
pyrazinamide O O
( O O
2000 O O
mg O O
per O O
day O O
) O O
, O O
pyridoxine O O
( O O
20 O O
mg O O
per O O
day O O
) O O
were O O
administered O O
for O O
two O O
months O O
and O O
then O O
isoniazid O O
( O O
300 O O
mg O O
per O O
day O O
) O O
, O O
rifampin O O
( O O
600 O O
mg O O
per O O
day O O
) O O
and O O
pyridoxine O O
( O O
20 O O
mg O O
per O O
day O O
) O O
were O O
continued O O
for O O
seven O O
months O O
. O O

at O O
a O O
follow-up O O
examination O O
ten O O
months O O
after O O
treatment O O
, O O
the O O
patient O O
recovered O O
well O O
and O O
there O O
was O O
no O O
evidence O O
of O O
recurrence O O
of O O
the O O
infection O B-C3714514
clinically O O
and O O
by O O
laboratory O O
investigations O O
, O O
but O O
he O O
did O O
show O O
mild O O
pain O B-C0030193
due O O
to O O
osteoarthritis O B-C0029408
of O O
the O O
sternoclavicular O O
joint O O
. O O

in O O
april O O
2020 O O
, O O
a O O
37 O O
- O O
year-old O O
man O O
was O O
admitted O O
to O O
the O O
emergency O O
department O O
due O O
to O O
the O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
and O O
fever O B-C0015967
. O O

he O O
complained O O
of O O
severe O O
headaches O B-C0018681
, O O
myalgias O B-C0231528
and O O
chest O B-C0232292
tightness O I-C0232292
. O O

the O O
patient O O
had O O
fever O B-C0015967
( O O
39.5 O O
° O O
C O O
) O O
, O O
orthopnea O B-C0085619
with O O
arterial O O
oxygen O O
saturation O O
( O O
sao O O
2 O O
) O O
at O O
86% O O
and O O
tachycardia O O
with O O
a O O
heart O O
rate O O
of O O
125 O O
bpm O O
. O O

physical O O
examination O O
demonstrated O O
cardiac O O
gallop O B-C0232200
rhythm O I-C0232200
and O O
coarse O O
crackles O B-C0034642
up O O
to O O
the O O
middle O O
third O O
of O O
both O O
lungs O O
. O O

the O O
patient O O
was O O
a O O
non-smoker O O
. O O

he O O
denied O O
alcohol O O
consumption O O
, O O
drug O B-C0013146
abuse O I-C0013146
, O O
or O O
recent O O
contact O O
with O O
sick O O
people O O
. O O

the O O
differential O O
diagnosis O O
included O O
pneumonia O B-C0032285
, O O
heart O B-C0018801
failure O I-C0018801
and O O
COVID O O
- O O
19 O O
. O O

the O O
chest O O
radiograph O O
revealed O O
para-hilar O O
opacities O O
and O O
enlarged O O
cardiac O O
silhouette O O
. O O

chest O O
computed O O
tomography O O
showed O O
ground-glass O O
changes O O
indicative O O
of O O
viral O B-C0032310
pneumonia O I-C0032310
. O O

the O O
electrocardiogram O O
revealed O O
sinus O B-C0039239
tachycardia O I-C0039239
, O O
diffuse O O
and O O
nonspecific O O
disturbances O O
of O O
ventricular O O
repolarization O O
. O O

laboratory-based O O
tests O O
conducted O O
upon O O
admission O O
revealed O O
the O O
following O O
: O O
hemoglobin O O
level O O
was O O
normal O O
( O O
15.5 O O
g O O
/ O O
dl O O
) O O
, O O
as O O
well O O
as O O
platelets O O
( O O
296,000 O O
/ O O
mm O O
3 O O
) O O
, O O
unchanged O O
coagulation O O
; O O
inflammation O O
syndrome O O
was O O
evident O O
: O O
white O O
cell O O
count O O
was O O
21390 O O
/ O O
mm O O
3 O O
elevated O O
CRP O O
hs O O
( O O
341 O O
mg O O
/ O O
L O O
) O O
. O O

blood O O
and O O
urine O O
cultures O O
were O O
all O O
negative O O
. O O

there O O
were O O
increases O O
in O O
lactate O O
dehydrogenase O O
( O O
425 O O
UI O O
/ O O
l O O
) O O
, O O
ferritin O O
( O O
594 O O
ng O O
/ O O
ml O O
) O O
and O O
d-dimer O O
levels O O
( O O
1415 O O
ng O O
/ O O
ml O O
) O O
. O O

in O O
addition O O
, O O
the O O
patient O O
showed O O
deranged O O
liver O O
and O O
renal O O
function O O
. O O

markers O O
of O O
myocardial O O
injury O B-C3263723
included O O
elevated O O
troponin O O
I O O
( O O
trop O O
I O O
) O O
( O O
111 O O
ng O O
/ O O
ml O O
) O O
, O O
and O O
n-terminal O O
brain O O
natriuretic O O
peptide O O
( O O
NT-BNP O O
) O O
( O O
1400 O O
pg O O
/ O O
ml O O
) O O
. O O

laboratory O O
data O O
are O O
summarized O O
in O O
table O O
1 O O
. O O

two O O
nasopharyngeal O O
swab O O
were O O
taken O O
, O O
one O O
day O O
apart O O
and O O
were O O
negative O O
for O O
COVID O O
- O O
19 O O
. O O

we O O
still O O
suspected O O
the O O
COVID O O
- O O
19 O O
as O O
he O O
had O O
many O O
clinical O O
, O O
biological O O
and O O
radiological O O
arguments O O
. O O

bedside O O
transthoracic O O
echocardiography O O
revealed O O
an O O
enlarged O O
left O O
ventricle O O
( O O
61 O O
mm O O
) O O
, O O
segmental O O
myocardial O O
hypokinesis O B-C0086439
along O O
with O O
a O O
low O O
left O O
ventricular O O
ejection O O
fraction O O
( O O
LVEF O O
) O O
( O O
30% O O
) O O
and O O
elevated O O
left O O
ventricular O B-C0206177
pressures O I-C0206177
. O O

coronary O O
angiography O O
revealed O O
no O O
obstructive O O
atherosclerosis O B-C0004153
lesions O B-C0221198
in O O
the O O
coronary O O
artery O O
. O O

most O O
of O O
the O O
etiologic O O
analyses O O
for O O
this O O
dilated O B-C0007193
cardiomyopathy O I-C0007193
remained O O
negative O O
. O O

ELISA O O
tests O O
demonstrated O O
a O O
recent O O
CMV O B-C0010823
infection O I-C0010823
( O O
igg O O
negative O O
, O O
igm O O
positive O O
) O O
( O O
table O O
1 O O
) O O
. O O

an O O
extensive O O
biological O O
screening O O
was O O
performed O O
to O O
identify O O
another O O
potential O O
cause O O
of O O
acute O B-C0267797
hepatitis O I-C0267797
: O O
total O O
igg O O
was O O
negative O O
. O O

we O O
ruled O O
out O O
drug O O
induced O O
and O O
autoimmune O B-C0241910
hepatitis O I-C0241910
, O O
hereditary O O
hemochromatosis O B-C0018995
and O O
1 O O
- O O
antitrypsin O O
deficiency O O
. O O

abdominal O O
ultrasonography O O
showed O O
normal O B-C0577059
liver O I-C0577059
characteristics O O
with O O
no O O
biliary O O
tract O O
dilatation O O
. O O

cardiac O O
mr-scan O O
was O O
performed O O
day O O
6 O O
. O O

delayed O O
enhancement O O
sequences O O
demonstrated O O
subepicardial O O
enhancement O O
in O O
the O O
lateral O O
free-wall O O
of O O
the O O
left O O
ventricle O O
. O O

the O O
diagnosis O O
of O O
cmv-induced O O
fulminant O O
myocarditis O B-C0027059
was O O
made O O
on O O
the O O
basis O O
of O O
the O O
acute O O
clinical O O
presentation O O
and O O
serologic O O
evidence O O
of O O
infection O B-C3714514
. O O

his O O
hepatitis O O
and O O
pulmonary O O
lesions O B-C0221198
were O O
probably O O
due O O
to O O
this O O
primary O O
CMV O B-C0010823
infection O I-C0010823
. O O

the O O
cardiogenic O B-C0036980
shock O I-C0036980
and O O
the O O
congestive O B-C0018802
heart O I-C0018802
failure O I-C0018802
were O O
treated O O
with O O
intravenous O O
inotropic O O
agents O O
and O O
diuretic O O
; O O
without O O
the O O
need O O
of O O
an O O
anti-viral O O
medication O O
. O O

two O O
days O O
later O O
, O O
the O O
patient O O
showed O O
clinical O O
improvement O O
. O O

we O O
started O O
supportive O O
medication O O
that O O
included O O
oral O O
administration O O
of O O
5 O O
mg O O
of O O
ramipril O O
, O O
2.5 O O
mg O O
of O O
bisoprolol O O
, O O
40 O O
mg O O
of O O
furosemide O O
twice O O
a O O
day O O
, O O
and O O
25 O O
mg O O
of O O
spironolactone O O
once O O
a O O
day O O
. O O

during O O
the O O
next O O
week O O
, O O
the O O
patient O O
made O O
steady O O
progress O O
, O O
his O O
liver O O
enzyme O O
levels O O
and O O
infection-related O O
markers O O
decreased O O
( O O
table O O
1 O O
) O O
. O O

after O O
13 O O
days O O
of O O
hospitalization O O
, O O
the O O
electrocardiogram O O
, O O
chest O O
CT O O
and O O
echocardiography O O
had O O
become O O
normal O O
. O O

he O O
was O O
discharged O O
under O O
bisoprolol O O
2.5 O O
mg O O
and O O
ramipril O O
5 O O
mg O O
per O O
day O O
. O O

the O O
patient O O
remained O O
asymptomatic O O
with O O
no O O
further O O
episodes O O
of O O
breathlessness O B-C0013404
at O O
two-week O O
follow-up O O
. O O

new O O
born O O
at O O
25 O O
days O O
of O O
life O O
, O O
male O O
, O O
eutrophic O O
was O O
resulted O O
from O O
a O O
badly O O
followed O O
full-term O O
pregnancy O O
. O O

maternal O B-C1858460
serologies O O
were O O
not O O
done O O
. O O

the O O
birth O O
weight O O
was O O
3000g O O
. O O

the O O
APGAR O O
scoring O O
system O O
was O O
not O O
specified O O
with O O
immediate O O
scream O O
notion O O
. O O

the O O
parents O O
are O O
not O O
a O O
consanguineous O O
couple O O
. O O

its O O
symptomatology O O
dates O O
back O O
to O O
the O O
fifth O O
day O O
of O O
life O O
by O O
the O O
appearance O O
of O O
a O O
permanent O O
cholestatic O O
cutaneous O O
and O O
mucosal O O
jaundice O O
with O O
completely O O
discolored O O
stools O O
( O O
white O O
) O O
and O O
dark O B-C0426396
urine O I-C0426396
, O O
without O O
pruritus O B-C0033774
, O O
all O O
evolving O O
in O O
a O O
context O O
of O O
apyrexia O O
and O O
conservation O O
of O O
the O O
general O O
state O O
. O O

this O O
situation O O
drived O O
the O O
patient O O
to O O
the O O
prefectural O O
hospital O O
in O O
the O O
24 O O
th O O
day O O
of O O
life O O
. O O

the O O
newborn O O
was O O
after O O
transferred O O
to O O
our O O
university O O
hospital O O
centre O O
for O O
an O O
etiological O O
assessment O O
and O O
taking O O
charge O O
of O O
cholestatic O B-C0022354
jaundice O I-C0022354
. O O

clinical O O
examination O O
at O O
admission O O
showed O O
a O O
newborn O O
jaundice O O
, O O
tonic O O
, O O
reactive O O
, O O
weight O O
= O O
3700g O O
; O O
size O O
= O O
56cm O O
; O O
PC O O
= O O
37cm O O
; O O
PO O O
= O O
34cm O O
; O O
sucking O O
reflex O O
was O O
present O O
as O O
well O O
as O O
archaic O O
reflexes O O
. O O

he O O
had O O
no O B-C4231272
facial O I-C4231272
dysmorphism O I-C4231272
or O O
externalized O O
bleeding O B-C0019080
. O O

mucocutaneous O O
examination O O
found O O
three O O
punctate O O
and O O
superficial O O
cutaneous O O
angiomas O B-C1959588
in O O
the O O
neck O O
, O O
abdomen O O
and O O
right O O
lower O O
limb O O
. O O

abdominal O O
examination O O
found O O
hepatomegaly O B-C0019209
estimated O O
at O O
5cm O O
, O O
without O O
splenomegaly O B-C0038002
. O O

the O O
cardiovascular O O
examination O O
was O O
unremarkable O O
as O O
well O O
as O O
the O O
rest O O
of O O
the O O
clinical O O
examination O O
. O O

A O O
clinical O O
state O O
was O O
made O O
, O O
having O O
objectified O O
a O O
BT O O
rate O O
of O O
163.15mg O O
/ O O
l O O
; O O
BD O O
at O O
118.35mg O O
/ O O
l O O
; O O
IDB O O
at O O
44.80mg O O
/ O O
l O O
. O O

gamma-glutamyl O O
transferase O O
was O O
214 O O
( O O
unit O O
) O O
and O O
alkaline O O
phosphatase O O
300 O O
( O O
unit O O
) O O
. O O

the O O
prothrombin O O
rate O O
was O O
measured O O
and O O
returned O O
to O O
65% O O
. O O

an O O
abdominal O O
ultrasound O O
was O O
also O O
performed O O
urgently O O
after O O
a O O
strict O O
6 O O
- O O
hr O O
interval O O
to O O
find O O
biliary O B-C0005411
atresia O I-C0005411
that O O
showed O O
hepatomegaly O B-C0019209
with O O
hepatic O O
mass O O
. O O

CBEU O O
( O O
cytobacteriological O O
examination O O
of O O
urine O O
) O O
was O O
sterile O O
eliminating O O
an O O
acute O O
pyelonephritis O B-C0034186
. O O

hepatitis O O
serologies O O
( O O
A O O
, O O
B O O
, O O
C O O
) O O
were O O
negative O O
. O O

the O O
TORCH O O
serologies O O
were O O
negative O O
. O O

the O O
glycemic O O
cycle O O
in O O
search O O
of O O
hypoglycaemia O B-C0020615
was O O
normal O O
as O O
well O O
as O O
the O O
electrophoresis O O
of O O
serum O O
proteins O O
, O O
which O O
showed O O
the O O
absence O O
of O O
a O O
peak O O
of O O
alpha O O
1 O O
globulin O O
evoking O O
an O O
alpha O B-C0221757
1 O I-C0221757
antitrypsin O I-C0221757
deficiency O I-C0221757
. O O

in O O
front O O
of O O
the O O
ultrasound O O
aspect O O
, O O
an O O
abdominal O O
angio-scanner O O
was O O
performed O O
, O O
which O O
showed O O
multiple O O
vascular O B-C1402315
lesions O I-C1402315
( O O
hepatic O O
hemangiomas O B-C0018916
) O O
with O O
dilation O O
of O O
the O O
hepatic O O
vein O O
, O O
inferior O O
vena O O
cava O O
and O O
left O O
atrium O O
. O O

trans-fantanellar O O
ultrasound O O
, O O
cervical O O
ultrasound O O
and O O
reno-vesical O O
ultrasound O O
were O O
performed O O
as O O
part O O
of O O
the O O
search O O
for O O
other O O
locations O O
and O O
returned O O
without O O
abnormality O O
. O O

cardiac O O
ultrasound O O
showed O O
a O O
dilated O B-C0344911
left O I-C0344911
ventricle O I-C0344911
with O O
retained O O
function O O
, O O
grade O O
II O O
mitral O B-C0026266
insufficiency O I-C0026266
and O O
sub-systemic O O
pulmonary O B-C0020542
hypertension O I-C0020542
. O O

therapeutically O O
, O O
vitamin O O
K1 O O
was O O
injected O O
urgently O O
at O O
the O O
dose O O
of O O
2mg O O
/ O O
kg O O
to O O
prevent O O
bleeding O B-C0019080
accidents O O
due O O
to O O
malabsorption O B-C3714745
of O O
this O O
fat-soluble O O
vitamin O O
. O O

A O O
high-calorie O O
and O O
high-triglyceride O O
diet O O
was O O
introduced O O
in O O
the O O
absence O O
of O O
breast O O
milk O O
. O O

beta-blockers O O
were O O
started O O
( O O
propanolol O O
) O O
at O O
2mg O O
/ O O
kg O O
/ O O
day O O
twice O O
daily O O
with O O
monitoring O O
of O O
heart O O
rate O O
, O O
blood O O
pressure O O
and O O
blood O O
glucose O O
readings O O
, O O
which O O
remained O O
normal O O
. O O

attenuation O O
of O O
jaundice O O
and O O
signs O O
of O O
cholestasis O B-C0008370
marked O O
the O O
clinical O O
course O O
after O O
one O O
month O O
of O O
treatment O O
. O O

A O O
monthly O O
abdominal O O
ultrasound O O
showed O O
the O O
disappearance O O
of O O
these O O
angiomas O B-C1959588
after O O
12 O O
months O O
of O O
treatment O O
. O O

A O O
60 O O
- O O
year-old O O
man O O
, O O
with O O
no O O
medical O O
or O O
surgical O O
history O O
, O O
presented O O
to O O
the O O
emergency O O
department O O
with O O
acute O O
abdominal O B-C0000737
pain O I-C0000737
. O O

he O O
reported O O
a O O
short O O
history O O
of O O
constipation O B-C0009806
and O O
intermittent O O
bleeding O B-C0019080
through O O
the O O
rectum O O
for O O
the O O
last O O
two O O
weeks O O
. O O

on O O
physical O O
examination O O
, O O
vital O O
signs O O
were O O
normal O O
. O O

the O O
patient O O
was O O
afebrile O O
. O O

the O O
abdomen O O
was O O
distended O O
with O O
diffuse O O
tenderness O O
. O O

furthermore O O
, O O
no O O
palpable O B-C1850473
abdominal O I-C1850473
mass O I-C1850473
was O O
detected O O
. O O

rectal O O
examination O O
revealed O O
a O O
smooth O O
and O O
well-circumscribed O O
mass O O
lying O O
in O O
3cm O O
from O O
the O O
anal O O
verge O O
. O O

laboratory O O
investigations O O
on O O
admission O O
were O O
normal O O
except O O
for O O
a O O
high O O
level O O
of O O
weight O O
blood O O
cells O O
( O O
WBC O O
= O O
19000 O O
C O O
/ O O
ml O O
) O O
and O O
c-reactive O O
protein O O
( O O
CRP O O
= O O
170 O O
mg O O
/ O O
l O O
) O O
. O O

computed O O
tomography O O
scan O O
( O O
CT O O
) O O
of O O
the O O
abdomen O O
showed O O
a O O
6cm O O
soft-tissue O O
mass O O
with O O
fat O O
density O O
within O O
the O O
rectum O O
likely O O
to O O
be O O
the O O
lead O O
point O O
for O O
a O O
colorectal O O
intussusception O B-C0021933
. O O

large O O
bowel O O
loops O O
were O O
dilated O O
with O O
the O O
presence O O
of O O
parietal O O
pneumatosis O O
. O O

the O O
diagnosis O O
of O O
intussusception O B-C0021933
due O O
to O O
a O O
lipomatous O O
colonic O O
tumor O B-C0027651
complicated O O
with O O
acute O O
intestinal O B-C0021843
obstruction O I-C0021843
was O O
carried O O
out O O
. O O

given O O
the O O
presence O O
of O O
signs O O
of O O
occlusion O O
and O O
bowel O O
wall O O
compromise O O
, O O
an O O
emergency O O
laparotomy O O
was O O
performed O O
revealing O O
a O O
large O O
bowel O O
distension O O
preceding O O
a O O
colo-rectal O O
intussusception O B-C0021933
. O O

an O O
attempt O O
of O O
a O O
manual O O
desinvagination O O
was O O
unsuccessful O O
. O O

A O O
rectosigmoid O O
resection O O
including O O
the O O
lipoma O B-C0023798
and O O
the O O
invaginated O O
segment O O
of O O
the O O
colon O O
was O O
performed O O
. O O

due O O
to O O
colon O O
dilatation O O
, O O
we O O
decided O O
not O O
to O O
perform O O
an O O
anastomosis O O
and O O
hartmann's O O
procedure O O
was O O
considered O O
to O O
be O O
more O O
cautious O O
. O O

the O O
postoperative O O
recovery O O
was O O
uneventful O O
and O O
the O O
patient O O
was O O
discharged O O
on O O
the O O
fourth O O
postoperative O O
day O O
. O O

gross O O
examination O O
of O O
the O O
resected O O
specimen O O
showed O O
the O O
presence O O
of O O
a O O
round O O
pedunculated O O
colonic O O
lipoma O B-C0023798
measuring O O
6cm O O
. O O

microscopic O O
examination O O
revealed O O
fat O O
cells O O
proliferating O O
in O O
the O O
submucosal O O
layer O O
, O O
with O O
inflammatory O O
and O O
ischemic O O
changes O O
and O O
without O O
any O O
evidence O O
of O O
malignancy O B-C0006826
. O O

the O O
diagnosis O O
of O O
a O O
colonic O O
lipoma O B-C0023798
was O O
then O O
confirmed O O
. O O

A O O
19 O O
year O O
old O O
overweight O B-C0497406
female O O
student O O
, O O
ms O O
K O O
, O O
in O O
enugu O O
state O O
, O O
south O O
east O O
, O O
nigeria O O
, O O
who O O
presented O O
to O O
a O O
sick O O
bay O O
at O O
01 O O
: O O
30 O O
hours O O
with O O
a O O
3 O O
day O O
history O O
of O O
lower O B-C0024031
back O I-C0024031
pain O I-C0024031
, O O
abdominal O B-C0232487
discomfort O I-C0232487
and O O
constipation O B-C0009806
. O O

unknown O O
to O O
her O O
, O O
she O O
was O O
in O O
labor O O
. O O

she O O
had O O
reported O O
to O O
the O O
outpatient O O
department O O
of O O
a O O
hospital O O
several O O
months O O
ago O O
with O O
complains O O
of O O
malaise O B-C0231218
repeatedly O O
overtime O O
; O O
her O O
general O O
practitioner O O
( O O
GP O O
) O O
treated O O
empirically O O
for O O
malaria O O
on O O
each O O
visit O O
with O O
same O O
complaints O O
and O O
the O O
recount O O
that O O
her O O
menstruation O O
was O O
regular O O
. O O

at O O
the O O
sick O O
bay O O
the O O
GP O O
on O O
call O O
asked O O
if O O
she O O
was O O
pregnant O O
and O O
she O O
vehemently O O
said O O
no O O
, O O
recounting O O
that O O
she O O
sees O O
her O O
menstruation O O
regularly O O
. O O

abdominal O O
examination O O
however O O
, O O
revealed O O
a O O
gravid O O
uterus O O
of O O
about O O
36 O O
weeks O O
and O O
vaginal O O
examination O O
showed O O
that O O
her O O
cervix O O
was O O
fully O O
dilated O O
. O O

when O O
confronted O O
with O O
the O O
situation O O
, O O
ms O O
K O O
, O O
was O O
surprised O O
as O O
well O O
as O O
confused O O
. O O

however O O
, O O
she O O
only O O
remembered O O
having O O
unprotected O O
sexual O O
intercourse O O
many O O
months O O
ago O O
. O O

the O O
baby O O
presented O O
in O O
a O O
frank O B-C0233286
breech O I-C0233286
position O O
. O O

to O O
facilitate O O
delivery O O
a O O
pinard O O
maneuver O O
was O O
done O O
. O O

she O O
gave O O
birth O O
via O O
spontaneous O O
vaginal O O
delivery O O
to O O
a O O
live O O
female O O
baby O O
weighing O O
3 O O
kg O O
at O O
03 O O
: O O
14 O O
hours O O
. O O

labor O O
and O O
delivery O O
pain O B-C0030193
was O O
minimal O O
. O O

ms O O
K O O
was O O
in O O
absolute O O
shock O B-C0036974
, O O
she O O
refused O O
to O O
touch O O
the O O
baby O O
, O O
it O O
was O O
dramatic O O
as O O
she O O
struggled O O
to O O
accept O O
that O O
she O O
just O O
became O O
a O O
mother O O
. O O

as O O
a O O
result O O
of O O
the O O
circumstances O O
of O O
the O O
delivery O O
, O O
altered O O
judgement O O
of O O
the O O
mother O O
and O O
the O O
potential O O
neonatal O O
risk O O
; O O
the O O
GP O O
insisted O O
and O O
invited O O
the O O
parents O O
. O O

her O O
parents O O
arrived O O
at O O
8 O O
: O O
30 O O
hours O O
, O O
upon O O
sighting O O
the O O
baby O O
they O O
inquired O O
whose O O
it O O
was O O
. O O

they O O
were O O
completely O O
baffled O O
to O O
know O O
the O O
baby O O
was O O
their O O
granddaughter O O
. O O

it O O
was O O
even O O
more O O
difficult O O
for O O
the O O
sudden O O
grandmother O O
, O O
a O O
nurse O O
, O O
who O O
kept O O
wondering O O
how O O
her O O
daughter's O O
gravid O O
state O O
eluded O O
her O O
. O O

due O O
to O O
the O O
peculiarities O O
of O O
the O O
delivery O O
the O O
GP O O
at O O
the O O
sick O O
bay O O
followed O O
up O O
the O O
case O O
, O O
the O O
baby O O
was O O
christened O O
peace O O
. O O

the O O
GP O O
asked O O
why O O
the O O
name O O
peace O O
. O O

ms O O
K O O
replied O O
“ O O
the O O
birth O O
of O O
the O O
baby O O
brought O O
unresolved O O
conflict O O
between O O
her O O
family O O
and O O
the O O
male O O
partner's O O
family O O
” O O
. O O

it O O
was O O
after O O
the O O
baby O O
was O O
born O O
that O O
she O O
realized O O
the O O
reason O O
behind O O
all O O
that O O
she O O
had O O
gone O O
through O O
. O O

she O O
had O O
nausea O B-C0027497
only O O
when O O
she O O
drank O O
cold O B-C0009443
water O O
, O O
this O O
later O O
stopped O O
. O O

she O O
admitted O O
noticing O O
slight O O
increase O O
in O O
weight O O
and O O
mild O O
abdominal O O
protrusion O O
, O O
this O O
made O O
her O O
do O O
exercises O O
which O O
didn't O O
help O O
. O O

she O O
believes O O
her O O
overweight O B-C0497406
made O O
her O O
and O O
her O O
relatives O O
not O O
to O O
suspect O O
pregnancy O O
. O O

ms O O
K O O
was O O
confused O O
as O O
she O O
just O O
couldn't O O
understand O O
what O O
was O O
going O O
on O O
with O O
her O O
body O O
and O O
her O O
GP O O
, O O
who O O
always O O
treated O O
malaria O O
without O O
proper O O
investigation O O
, O O
was O O
of O O
no O O
help O O
either O O
. O O

ms O O
K O O
said O O
she O O
would O O
have O O
committed O O
suicide O B-C0038661
if O O
her O O
gravid O O
state O O
was O O
discovered O O
before O O
delivery O O
. O O

when O O
asked O O
why O O
she O O
replied O O
“ O O
how O O
on O O
earth O O
was O O
she O O
going O O
to O O
explain O O
her O O
gravid O O
state O O
to O O
her O O
parents O O
” O O
. O O

A O O
61 O O
- O O
year-old O O
man O O
with O O
no O O
preceding O O
history O O
of O O
genitourinary O O
infections O O
, O O
surgery O O
or O O
trauma O O
and O O
no O O
risk O B-C0035648
factors O I-C0035648
for O O
testicular O B-C0153594
cancer O I-C0153594
, O O
he O O
denied O O
any O O
contact O O
with O O
tuberculosis O B-C0041296
patients O O
. O O

he O O
was O O
referred O O
with O O
a O O
6 O O
- O O
month O O
history O O
of O O
right-sided O O
testicular O O
pain O B-C0030193
and O O
scrotal O O
enlargement O O
witch O O
was O O
progressive O O
, O O
without O O
extra O O
genital O O
signs O O
, O O
notably O O
no O O
respiratory O O
, O O
skin O O
or O O
eye O O
symptoms O O
and O O
no O O
fever O B-C0015967
. O O

clinical O O
examination O O
revealed O O
painful O O
and O O
non-tender O O
right O O
testicular O O
mass O O
on O O
palpation O O
with O O
no O O
signs O O
of O O
inflammation O O
at O O
this O O
level O O
. O O

scrotal O O
ultrasonography O O
showed O O
that O O
the O O
volume O O
of O O
the O O
right O O
testicle O O
is O O
23ml O O
( O O
25 O O
* O O
40 O O
* O O
44mm O O
) O O
, O O
with O O
irregular O O
contours O O
, O O
with O O
the O O
presence O O
of O O
hypoechogenic O O
and O O
heterogeneous O O
foci O O
. O O

color-doppler O O
showed O O
only O O
subtle O O
intralesional O O
vascularisation O O
. O O

laboratory O B-C0260877
examination O I-C0260877
revealed O O
a O O
white O O
blood O O
cell O O
count O O
of O O
5,780 O O
/ O O
mm O O
3 O O
, O O
lymphocytes O O
of O O
620 O O
/ O O
mm O O
3 O O
, O O
a O O
hemoglobin O O
level O O
of O O
13.3g O O
/ O O
dl O O
; O O
an O O
erythrocyte O O
sedimentation O O
rate O O
( O O
ESR O O
) O O
of O O
41 O O
mm O O
/ O O
h O O
; O O
a O O
c-reactive O O
protein O O
( O O
CRP O O
) O O
level O O
of O O
9mg O O
/ O O
dl O O
( O O
normal O O
, O O
< O O
0.8mg O O
/ O O
dl O O
) O O
; O O
serum O O
electrolyte O O
levels O O
and O O
renal O O
, O O
liver O O
function O O
test O O
results O O
, O O
were O O
in O O
the O O
normal O O
reference O O
ranges O O
. O O

the O O
24 O O
- O O
h O O
urinary O O
calcium O O
excretion O O
was O O
5.2mmol O O
/ O O
24h O O
( O O
normal O O
, O O
0 O O
- O O
7.5mmol O O
/ O O
24h O O
) O O
. O O

tumor O B-C0027651
markers O O
( O O
serum O O
α-fetoprotein O O
[ O O
AFP O O
] O O
and O O
β-human O O
chorionic O O
gonadotropin O O
[ O O
β-hcg O O
] O O
) O O
were O O
negative O O
, O O
whereas O O
lactate O O
dehydrogenase O O
( O O
LDH O O
) O O
was O O
at O O
220IU O O
/ O O
L O O
( O O
normal O O
, O O
135 O O
- O O
225IU O O
/ O O
L O O
) O O
. O O

the O O
tuberculin O O
skin O O
test O O
( O O
TST O O
) O O
was O O
also O O
negative O O
. O O

for O O
three O O
consecutive O O
days O O
, O O
mycobacteria O O
in O O
the O O
sputum O O
and O O
urine O O
were O O
negative O O
. O O

as O O
malignancy O B-C0006826
could O O
not O O
still O O
be O O
ruled O O
out O O
, O O
the O O
patient O O
underwent O O
a O O
radical O O
right O O
orchidectomy O O
. O O

histological O O
examination O O
of O O
the O O
orchidectomy O O
patch O O
showed O O
that O O
the O O
pulp O O
of O O
the O O
testes O O
as O O
well O O
as O O
the O O
siminiferous O O
tubes O O
are O O
partially O O
destroyed O O
and O O
replaced O O
by O O
granulomatous O O
folicular O O
foci O O
of O O
which O O
some O O
areas O O
consist O O
mainly O O
of O O
lymphoplasmocytes O O
, O O
polynuclear O O
neutrophils O O
and O O
eosinophils O O
accompanied O O
by O O
many O O
giant O O
multinucleated O O
cells O O
without O O
casous O O
necrosis O O
, O O
this O O
lesion O B-C0221198
does O O
not O O
invade O O
the O O
epididymis O O
. O O

chest O O
CT O O
showed O O
traction O O
bronchiectasis O B-C0006267
with O O
peripheral O O
reticulations O O
, O O
especially O O
in O O
the O O
upper O O
lobes O O
without O O
visible O O
mediastinal O O
lymphadenopathy O B-C0497156
. O O

A O O
bronchoscopy O O
was O O
performed O O
to O O
eliminate O O
multifocal O O
tuberculosis O B-C0041296
( O O
testicular O O
and O O
pulmonary O O
) O O
since O O
tuberculosis O B-C0041296
is O O
a O O
very O O
common O O
disease O O
in O O
the O O
moroccan O O
epidemiological O O
context O O
. O O

the O O
histological O O
examination O O
of O O
the O O
bronchial O O
biopsy O O
found O O
non-caseating O O
epitheloid O O
granulomas O B-C0018188
with O O
the O O
presence O O
of O O
the O O
giant O O
cells O O
containing O O
the O O
shaumann O O
bodies O O
. O O

bronchoalveolar O O
lavage O O
showed O O
lymphocytic O O
alveolitis O O
( O O
lymphocytes O O
at O O
47% O O
) O O
, O O
genexpert O O
MTB O O
/ O O
RIF O O
in O O
bronchial O O
aspiration O O
with O O
culture O O
of O O
bronchial O O
fragment O O
in O O
search O O
of O O
tuberculosis O B-C0041296
mycobacteria O O
were O O
negative O O
. O O

minor O O
salivary O O
gland O O
biopsy O O
revealed O O
no O B-C3809765
abnormalities O I-C3809765
, O O
ophthalmic O O
examination O O
is O O
normal O O
. O O

further O O
pulmonary O O
work O O
up O O
was O O
consistent O O
with O O
the O O
diagnosis O O
of O O
sarcoidosis O B-C0036202
: O O
pulmonary O O
function O O
tests O O
showed O O
a O O
slightly O O
decreased O O
total O B-C0040509
lung O I-C0040509
capacity O I-C0040509
suggesting O O
a O O
restrictive O O
lung O O
pattern O O
with O O
normal O O
diffusion O O
capacity O O
. O O

no O O
other O O
vital O O
organs O O
were O O
involved O O
and O O
the O O
patient O O
is O O
in O O
follow O O
up O O
every O O
4 O O
months O O
. O O

the O O
evolution O O
was O O
favorable O O
after O O
4 O O
months O O
, O O
the O O
patient O O
was O O
asymptomatic O O
on O O
the O O
respiratory O O
and O O
urinary O O
planes O O
, O O
with O O
a O O
testicular O O
echograhy O O
did O O
not O O
show O O
lesions O B-C0221198
on O O
the O O
left O O
testicle O O
. O O

in O O
2019 O O
, O O
a O O
66 O O
- O O
year-old O O
woman O O
from O O
luanda O O
, O O
angola O O
was O O
referred O O
to O O
our O O
service O O
. O O

apart O O
from O O
well O O
controlled O O
hypertension O B-C0020538
, O O
she O O
was O O
well O O
with O O
no O O
other O O
co-morbidities O O
. O O

chronic O O
HCV O O
infection O B-C3714514
was O O
diagnosed O O
10 O O
years O O
prior O O
, O O
following O O
routine O O
health O O
screening O O
. O O

at O O
that O O
point O O
, O O
genotype O O
analysis O O
performed O O
in O O
angola O O
reported O O
genotype O O
2a O O
infection O B-C3714514
. O O

at O O
that O O
point O O
, O O
she O O
had O O
declined O O
pegylated O O
interferon O O
and O O
ribavirin O O
treatment O O
given O O
its O O
potential O O
toxicities O O
. O O

the O O
route O O
of O O
acquisition O O
of O O
her O O
HCV O O
infection O B-C3714514
was O O
unknown O O
as O O
no O O
clear O O
identifiable O O
risk O B-C0035648
factors O I-C0035648
were O O
evident O O
. O O

her O O
ALT O O
was O O
71 O O
IU O O
/ O O
L O O
( O O
laboratory O O
normal O O
range O O
5 O O
- O O
40 O O
IU O O
/ O O
L O O
) O O
and O O
significant O O
liver O B-C0239946
fibrosis O I-C0239946
was O O
excluded O O
with O O
a O O
fibroscan O O
R O O
liver O O
stiffness O B-C0427008
measurement O O
of O O
7.6kpa O O
and O O
an O O
AST O O
to O O
platelet O O
ratio O O
index O O
( O O
APRI O O
) O O
score O O
of O O
0.2 O O
. O O

liver O O
ultrasound O O
was O O
normal O O
and O O
HCV O O
viral O B-C0376705
load O I-C0376705
was O O
9 O O
772 O O
784 O O
IU O O
/ O O
ml O O
( O O
xpert O O
, O O
cepheid O O
, O O
CA O O
, O O
USA O O
) O O
. O O

HIV O O
and O O
hbsag O O
testing O O
, O O
was O O
negative O O
. O O

we O O
did O O
baseline O O
population-based O O
sanger O O
sequencing O O
to O O
evaluate O O
for O O
RAS O O
in O O
the O O
NS3 O O
, O O
NS5A O O
and O O
NS5B O O
HCV O O
genes O O
using O O
pan O O
genotypic O O
primers O O
and O O
the O O
web-based O O
geno2pheno O O
program O O
( O O
table O O
1 O O
) O O
. O O

sequences O O
were O O
aligned O O
with O O
genbank O O
reference O O
sequences O O
using O O
bioedit O O
and O O
a O O
NS5B O O
neighbour-joining O O
phylogenetic O O
tree O O
was O O
constructed O O
in O O
mega O O
6.0 O O
with O O
1000 O O
bootstrap O O
resamplings O O
. O O

we O O
assigned O O
the O O
sequence O O
as O O
a O O
novel O O
genotype O O
7b O O
variant O O
( O O
accession O O
number O O
MT633130 O O
- O O
MT633134 O O
) O O
. O O

considering O O
the O O
presence O O
of O O
extensive O O
baseline O O
RAS O O
in O O
the O O
patient O O
, O O
a O O
DAA O O
therapy O O
regimen O O
was O O
considered O O
( O O
table O O
1 O O
) O O
. O O

the O O
only O O
available O O
data O O
on O O
treatment O O
was O O
the O O
single O O
genotype O O
7a O O
patient O O
inadvertently O O
treated O O
in O O
the O O
ASTRAL O O
- O O
1 O O
study O O
[ O O
6 O O
] O O
. O O

A O O
sofosbuvir O O
/ O O
velpatasvir O O
combination O O
was O O
considered O O
, O O
however O O
given O O
the O O
range O O
of O O
RAS O O
, O O
particularly O O
the O O
NS5A O O
93H O O
mutation O O
, O O
the O O
choice O O
of O O
velpatasvir O O
posed O O
a O O
concern O O
. O O

this O O
mutation O O
impairs O O
treatment O O
response O O
since O O
it O O
induces O O
a O O
high O O
fold O O
in O O
vitro O O
resistance O O
to O O
daclatasvir O O
and O O
velpatasvir O O
. O O

this O O
has O O
been O O
observed O O
to O O
negatively O O
influence O O
SVR O O
in O O
real O O
world O O
experience O O
with O O
DAA O O
therapy O O
, O O
mostly O O
with O O
genotype O O
3 O O
HCV O O
[ O O
10 O O
] O O
. O O

an O O
obvious O O
lack O O
of O O
data O O
of O O
the O O
NS5A O O
93H O O
RAS O O
in O O
genotype O O
7b O O
in O O
addition O O
to O O
the O O
range O O
of O O
other O O
RAS O O
present O O
, O O
influenced O O
our O O
decision O O
making O O
. O O

similarly O O
and O O
although O O
not O O
analogous O O
to O O
our O O
patient O O
, O O
data O O
observed O O
in O O
the O O
retreatment O O
MAGELLAN O O
- O O
1 O O
part O O
2 O O
study O O
suggested O O
that O O
a O O
16 O O
week O O
duration O O
of O O
treatment O O
with O O
the O O
NS3 O O
/ O O
NS5A O O
DAA O O
combination O O
of O O
glecaprevir O O
and O O
pibrentasvir O O
, O O
to O O
be O O
better O O
than O O
12 O O
weeks O O
in O O
patients O O
with O O
prior O O
DAA O O
failure O O
and O O
significant O O
RAS O O
[ O O
11 O O
] O O
. O O

given O O
this O O
, O O
we O O
elected O O
to O O
treat O O
the O O
patient O O
with O O
16 O O
weeks O O
of O O
glecaprevir O O
and O O
pibrentasvir O O
combination O O
as O O
well O O
as O O
the O O
NS5B O O
nucleotide O O
polymerase O O
inhibitor O O
sofosbuvir O O
, O O
all O O
as O O
single O O
daily O O
dosing O O
. O O

after O O
4 O O
weeks O O
on O O
therapy O O
, O O
HCV O O
viral O B-C0376705
load O I-C0376705
was O O
recorded O O
at O O
< O O
10IU O O
/ O O
ml O O
( O O
HCV O O
xpert O O
, O O
cepheid O O
, O O
CA O O
, O O
USA O O
) O O
and O O
undetected O O
at O O
the O O
end O O
of O O
treatment O O
. O O

sustained O O
virological O O
response O O
at O O
12 O O
weeks O O
post O O
end O O
of O O
treatment O O
( O O
SVR12 O O
) O O
, O O
was O O
confirmed O O
. O O

A O O
53 O O
- O O
year-old O O
woman O O
with O O
a O O
history O O
of O O
uncontrolled O O
type O B-C0011860
2 O I-C0011860
diabetes O I-C0011860
and O O
asthma O O
developed O O
a O O
nasal O O
septum O O
abscess O B-C0000833
after O O
a O O
bilateral O O
endoscopic O O
ethmoidectomy O O
performed O O
for O O
sinonasal O O
polyposis O O
. O O

she O O
was O O
then O O
treated O O
with O O
oral O O
and O O
nasal O O
corticosteroids O O
. O O

ten O O
days O O
after O O
surgery O O
, O O
she O O
developed O O
a O O
bilateral O B-C2350171
nasal O I-C2350171
obstruction O I-C2350171
with O O
fever O B-C0015967
without O O
any O O
postoperative O O
trauma O O
. O O

upon O O
physical O O
examination O O
, O O
the O O
patient O O
was O O
febrile O B-C0015967
with O O
a O O
temperature O O
of O O
37.8 O O
° O O
C O O
. O O

anterior O O
rhinoscopy O O
showed O O
a O O
bulging O O
anterior O O
nasal O O
septum O O
bilaterally O O
. O O

the O O
rest O O
of O O
physical O O
examination O O
presented O O
no O O
evidence O O
of O O
orbital O O
, O O
neurological O O
, O O
oral O O
or O O
facial O O
involvement O O
. O O

laboratory O O
tests O O
showed O O
leucocytosis O O
at O O
1520 O O
cells O O
/ O O
mm O O
3 O O
with O O
neutrophilic O O
predominance O O
at O O
1010 O O
cells O O
/ O O
mm O O
3 O O
and O O
a O O
c-reactive O O
protein O O
( O O
CRP O O
) O O
level O O
of O O
100mg O O
/ O O
l O O
. O O

the O O
computed O O
tomography O O
( O O
CT O O
) O O
scan O O
revealed O O
a O O
fluid O O
collection O O
with O O
thin O O
rim O O
enhancement O O
in O O
the O O
anterior O O
nasal O O
septum O O
without O O
complications O O
such O O
as O O
intracranial O O
, O O
facial O O
or O O
orbital O O
extensions O O
. O O

pus O O
from O O
the O O
nasal O O
septum O O
was O O
collected O O
by O O
needle O O
aspiration O O
, O O
and O O
sent O O
to O O
microbiology O O
culture O O
. O O

empirical O O
antimicrobial O O
therapy O O
with O O
intravenous O O
amoxicillin O O
/ O O
clavulanic O O
acid O O
and O O
gentamicin O O
was O O
initiated O O
. O O

final O O
cultures O O
were O O
positive O O
for O O
aspergillus O O
flavus O O
and O O
no O O
bacteria O O
were O O
detected O O
. O O

pus O O
from O O
the O O
nasal O O
septum O O
was O O
cultured O O
twice O O
and O O
the O O
results O O
were O O
similar O O
in O O
both O O
cultures O O
. O O

the O O
patient O O
was O O
tested O O
human O O
immunodeficiency O B-C0021051
virus O O
( O O
HIV O O
) O O
negative O O
. O O

operative O O
drainage O O
of O O
nasal O O
septum O O
abscess O B-C0000833
was O O
performed O O
under O O
general O O
anesthesia O B-C0278134
by O O
incision O O
, O O
debridement O O
and O O
nasal O O
packing O O
. O O

the O O
chosen O O
therapy O O
was O O
oral O O
voriconazole O O
200mg O O
twice O O
a O O
day O O
for O O
one O O
week O O
followed O O
by O O
fluconazole O O
150 O O
mg O O
daily O O
for O O
one O O
month O O
. O O

insulin O O
therapy O O
was O O
started O O
for O O
improvement O O
and O O
maintenance O O
of O O
glycemic O O
control O O
. O O

on O O
the O O
one O O
hand O O
, O O
clinical O O
and O O
biological O O
improvement O O
was O O
achieved O O
with O O
the O O
disappearance O O
of O O
clinical O O
signs O O
and O O
normalization O O
of O O
the O O
complete O O
blood O O
count O O
and O O
the O O
CRP O O
, O O
on O O
the O O
other O O
hand O O
, O O
the O O
patient O O
developed O O
a O O
saddle O B-C0264169
nose O I-C0264169
deformity O B-C0000768
one O O
month O O
after O O
surgery O O
. O O

her O O
case O O
has O O
been O O
followed O O
up O O
for O O
18 O O
months O O
and O O
there O O
has O O
not O O
been O O
any O O
recurrence O O
of O O
the O O
infection O B-C3714514
. O O

A O O
72 O O
- O O
year-old O O
former O O
“ O O
heavy O O
” O O
smoker O B-C0337664
( O O
365 O O
packs O O
/ O O
year O O
until O O
10 O O
years O O
ago O O
) O O
was O O
referred O O
to O O
our O O
service O O
, O O
presenting O O
with O O
a O O
dry O O
cough O B-C0010200
occurring O O
at O O
night O O
and O O
which O O
has O O
lasted O O
for O O
a O O
year O O
. O O

the O O
patient O O
did O O
not O O
report O O
any O O
concept O O
of O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
, O O
night O B-C0028081
sweats O I-C0028081
, O O
fever O B-C0015967
or O O
weight O B-C1262477
loss O I-C1262477
. O O

no O O
additional O O
illnesses O O
were O O
found O O
in O O
the O O
medical O O
history O O
. O O

during O O
the O O
clinical O O
pulmonary O O
examination O O
, O O
lung O O
sounds O O
were O O
normally O O
perceived O O
on O O
both O O
sides O O
. O O

lung O O
function O O
tests O O
were O O
also O O
normal O O
. O O

laboratory O O
tests O O
involving O O
white O O
blood O O
cell O O
count O O
( O O
5.31x10 O O
3 O O
/ O O
L O O
) O O
, O O
sedimentation O O
rate O O
and O O
CRP O O
were O O
normal O O
. O O

radiologically O O
; O O
an O O
irregular O O
density O O
was O O
observed O O
in O O
the O O
lower O O
segment O O
of O O
the O O
right O O
lung O O
on O O
the O O
chest O O
x-ray O O
. O O

A O O
thorax O O
CT O O
was O O
requested O O
. O O

it O O
showed O O
a O O
solid O O
mass O O
of O O
27x36 O O
mm O O
with O O
speculated O O
irregular O O
contours O O
, O O
in O O
the O O
posterior O O
basal O O
segment O O
of O O
the O O
lower O O
lobe O O
of O O
the O O
right O O
lung O O
. O O

irregularity O O
in O O
the O O
contour O O
of O O
the O O
inner O O
wall O O
of O O
the O O
adjacent O O
bronchi O O
and O O
bronchiectasis O B-C0006267
in O O
the O O
neighboring O O
areas O O
have O O
also O O
been O O
observed O O
. O O

furthermore O O
, O O
there O O
was O O
a O O
distortion O O
of O O
the O O
adjacent O O
pleura O O
. O O

ancillary O O
radiological O O
results O O
supported O O
the O O
theory O O
of O O
the O O
chronic O O
process O O
and O O
therefore O O
malignancy O B-C0006826
was O O
considered O O
. O O

due O O
to O O
the O O
suspicion O O
of O O
a O O
malignant O O
process O O
, O O
a O O
bronchoscopy O O
was O O
performed O O
and O O
a O O
PET O O
CT O O
was O O
requested O O
. O O

in O O
PET O O
CT O O
; O O
low O O
grade O O
FDG O O
( O O
fluoro O O
- O O
2 O O
- O O
deoxy O O
- O O
2 O O
- O O
d-glucose O O
) O O
uptake O O
was O O
present O O
. O O

[ O O
SUV O O
( O O
standardized O O
uptake O O
value O O
) O O
: O O
1.8 O O
] O O
. O O

in O O
bronchoscopy O O
, O O
the O O
left O O
bronchial O O
system O O
was O O
open O O
at O O
the O O
subsegmental O O
level O O
. O O

the O O
mucosa O O
of O O
the O O
right O O
lower O O
lobe O O
bronchi O O
was O O
coarse O O
and O O
irregular O O
. O O

lower O O
lobe O O
posterior O O
basal O O
segment O O
bronchus O O
( O O
RB O O
10 O O
) O O
was O O
successfully O O
reached O O
. O O

brushing O O
was O O
done O O
from O O
the O O
apical O O
region O O
of O O
this O O
area O O
. O O

broncho O O
aspiration O O
samples O O
were O O
obtained O O
and O O
sent O O
for O O
ARB O O
( O O
acid-resistant O O
bacillus O O
) O O
research O O
. O O

no O O
endobronchial O O
lesion O B-C0221198
was O O
observed O O
. O O

transbronchial O O
biopsy O O
was O O
performed O O
. O O

in O O
the O O
histopathological O O
examination O O
of O O
the O O
small O O
bronchial O O
biopsies O O
under O O
the O O
light O O
microscope O O
; O O
moderate O O
inflammation O O
composed O O
of O O
predominantly O O
lymphocytes O O
, O O
plasmocytes O O
and O O
a O O
few O O
neutrophils O O
and O O
eosinophils O O
were O O
seen O O
in O O
the O O
wall O O
of O O
one O O
bronchi O O
. O O

reactive O O
changes O O
were O O
seen O O
in O O
the O O
bronchial O O
epithelium O O
. O O

in O O
the O O
second O O
biopsy O O
; O O
there O O
was O O
a O O
patchy O O
involvement O O
composed O O
of O O
a O O
loose O O
fibroblastic O O
plug O O
filling O O
an O O
air O O
space O O
. O O

this O O
plug O O
had O O
typically O O
elongated O O
, O O
spindle O O
and O O
stellate O O
fibroblasts O O
embedded O O
in O O
a O O
pale-staining O O
matrix O O
. O O

some O O
fibrin O O
deposits O O
were O O
seen O O
around O O
. O O

final O O
interpretation O O
of O O
pathologist O O
was O O
; O O
with O O
all O O
of O O
these O O
histopathological O O
findings O O
it O O
was O O
thought O O
that O O
the O O
case O O
may O O
be O O
compatible O O
with O O
bronchiolitis O B-C0242770
obliterans O I-C0242770
organizing O I-C0242770
pneumonia O I-C0242770
( O O
or O O
if O O
the O O
case O O
is O O
idiopathic O O
; O O
cryptogenic O B-C0242770
organizing O I-C0242770
pneumonia O I-C0242770
) O O
if O O
clinical O O
and O O
radiological O O
findings O O
support O O
it O O
. O O

there O O
was O O
significant O O
regression O B-C1836830
in O O
the O O
lesion O B-C0221198
on O O
2 O O
- O O
month O O
follow-up O O
radiographs O O
without O O
any O O
treatment O O
. O O

no O O
predisposing O O
factor O O
to O O
explain O O
the O O
patient's O O
clinic O O
was O O
detected O O
. O O

organizing O B-C0264383
pneumonia O I-C0264383
diagnosis O O
was O O
evaluated O O
as O O
cryptogenic O O
. O O

pathology O O
, O O
clinical O O
and O O
radiological O O
findings O O
were O O
in O O
favor O O
of O O
the O O
COP O O
. O O

A O O
36 O O
- O O
year-old O O
woman O O
, O O
active O O
smoker O B-C0337664
with O O
history O O
of O O
an O O
untreated O O
dyslipidemia O B-C0242339
, O O
was O O
admitted O O
to O O
our O O
department O O
for O O
a O O
chest O B-C0008031
pain O I-C0008031
radiating O O
in O O
hemi-belt O O
, O O
in O O
the O O
two O O
upper O O
limbs O O
and O O
sometimes O O
in O O
the O O
neck O O
, O O
occurring O O
at O O
rest O O
, O O
with O O
an O O
intermittent O O
character O O
and O O
associated O O
with O O
nausea O B-C0027497
, O O
palpitations O B-C0030252
, O O
dyspnea O B-C0013404
and O O
dry O O
cough O B-C0010200
, O O
without O O
notion O O
of O O
fever O B-C0015967
or O O
recent O O
flu O B-C0021400
syndrome O O
. O O

the O O
clinical O O
examination O O
being O O
without O O
abnormalities O O
, O O
an O O
electrocardigram O O
was O O
performed O O
and O O
objectified O O
diffuse O O
microvoltage O O
and O O
fragmentation O O
of O O
the O O
QRS O O
complex O O
in O O
DIII O O
and O O
avf O O
leads O O
with O O
negative O O
T O O
wave O O
in O O
avl O O
lead O O
. O O

the O O
troponin O O
level O O
was O O
up O O
to O O
8 O O
times O O
the O O
normal O O
value O O
. O O

at O O
this O O
step O O
, O O
the O O
patient O O
is O O
diagnosed O O
as O O
a O O
non O B-C4255010
ST O I-C4255010
elevation O I-C4255010
myocardial O I-C4255010
infarction O I-C4255010
( O O
NSTEMI O O
) O O
. O O

at O O
transthoracic O O
echography O O
( O O
TTE O O
) O O
, O O
the O O
left O O
ventricle O O
( O O
LV O O
) O O
was O O
undilated O O
, O O
non-hypertrophied O O
with O O
latero-apical O O
dyskinesia O B-C0013384
, O O
and O O
LV O O
ejection O O
fraction O O
( O O
LVEF O O
) O O
at O O
50 O O
- O O
55% O O
, O O
minimal O O
central O O
mitral O B-C0026266
regurgitation O I-C0026266
on O O
normal O O
mitral O O
valves O O
, O O
normal O O
right O O
cavities O O
, O O
and O O
there O O
was O O
no O O
pericardial O B-C0031039
effusion O I-C0031039
. O O

coronary O O
angiography O O
demonstrated O O
an O O
aspect O O
evoking O O
a O O
spontaneous O O
dissection O O
of O O
the O O
distal O O
left O O
anterior O O
descending O O
artery O O
( O O
LAD O O
) O O
going O O
back O O
to O O
the O O
left O O
main O O
trunk O O
as O O
well O O
as O O
to O O
the O O
left O O
circumflex O O
artery O O
( O O
LCX O O
) O O
. O O

the O O
flow O O
on O O
the O O
LVA O O
was O O
thrombolysis O O
in O O
myocardial O B-C0027051
infarction O I-C0027051
( O O
TIMI O O
) O O
grade O O
2 O O
- O O
3 O O
and O O
slowed O O
down O O
at O O
the O O
level O O
of O O
the O O
distal O O
circumflex O O
. O O

the O O
dissection O O
was O O
aggravated O O
upon O O
injection O O
into O O
the O O
left O O
main O O
trunk O O
with O O
extensive O O
dissection O O
of O O
the O O
entire O O
left O O
coronary O O
. O O

the O O
dissection O O
was O O
occlusive O O
on O O
the O O
LCX O O
and O O
the O O
flow O O
was O O
correct O O
on O O
the O O
LAD O O
. O O

after O O
a O O
team O O
consultation O O
between O O
intensive O O
care O O
cardiologists O O
and O O
cardiac O O
surgeon O O
, O O
and O O
considering O O
clinical O O
and O O
hemodynamic O O
stability O O
, O O
we O O
decided O O
to O O
give O O
medical O O
treatment O O
with O O
a O O
single O O
antiplatelet O O
agent O O
without O O
anticoagulant O O
treatment O O
because O O
of O O
the O O
major O O
risk O O
of O O
worsening O O
the O O
extension O O
of O O
the O O
dissection O O
by O O
stenting O O
. O O

urgent O O
surgical O O
revascularization O O
does O O
not O O
appear O O
to O O
be O O
desirable O O
in O O
this O O
context O O
of O O
spontaneous O O
coronary O O
dissection O O
either O O
. O O

we O O
decided O O
to O O
respect O O
the O O
dissection O O
, O O
to O O
treat O O
with O O
only O O
aspirin O O
and O O
to O O
keep O O
the O O
patient O O
at O O
the O O
intensive O O
care O O
unit O O
. O O

the O O
outcome O O
was O O
favorable O O
, O O
with O O
progressive O O
pain O B-C0030193
relief O O
and O O
a O O
stable O O
hemodynamic O O
state O O
. O O

there O O
was O O
a O O
clear O O
elevation O O
of O O
troponin O O
and O O
creatine O O
phosphokinase O O
( O O
CPK O O
) O O
levels O O
, O O
an O O
inflammatory O O
syndrome O O
with O O
considerable O O
elevation O O
of O O
c-reactive O O
protein O O
and O O
white O O
blood O O
cells O O
, O O
without O O
evidence O O
of O O
bacterial O B-C0004623
infection O I-C0004623
, O O
probably O O
related O O
to O O
myocardial O B-C1442837
necrosis O I-C1442837
or O O
viral O B-C0042769
disease O I-C0042769
, O O
gradually O O
regressive O O
during O O
hospitalization O O
. O O

on O O
the O O
rhythmic O O
level O O
, O O
there O O
was O O
an O O
initial O O
ventricular O O
hyperexcitability O B-C0856984
, O O
leading O O
to O O
the O O
introduction O O
of O O
beta-blockers O O
with O O
favorable O O
course O O
. O O

the O O
level O O
of O O
low-density O O
lipoprotein O O
( O O
LDL O O
) O O
cholesterol O O
in O O
the O O
blood O O
was O O
1.80g O O
/ O O
dl O O
and O O
atorvastatin O O
was O O
introduced O O
. O O

discharge O O
treatment O O
included O O
aspirin O O
75mg O O
, O O
atorvastatin O O
40mg O O
and O O
bisoprolol O O
5mg O O
, O O
and O O
smoking O O
was O O
stopped O O
. O O

computed O O
tomography-coronary O O
angiography O O
( O O
CTCA O O
) O O
realised O O
after O O
2 O O
months O O
to O O
assess O O
healing O O
showed O O
a O O
non-calcified O O
coronary O O
network O O
and O O
a O O
complete O O
resolution O O
of O O
the O O
dissection O O
. O O

A O O
25 O O
- O O
year O O
female O O
patient O O
visited O O
our O O
prosthetic O O
office O O
with O O
deficiencies O O
of O O
both O O
hands O O
due O O
to O O
autoimmune O B-C0004364
disease O I-C0004364
. O O

the O O
amputations O O
were O O
performed O O
in O O
2015 O O
. O O

after O O
the O O
examination O O
of O O
both O O
hands O O
, O O
it O O
was O O
revealed O O
that O O
in O O
the O O
right O O
hand O O
; O O
the O O
metacarpal O O
of O O
the O O
index O O
finger O O
, O O
the O O
distal O O
phalanges O O
of O O
the O O
second O O
and O O
fourth O O
fingers O O
were O O
amputated O O
; O O
and O O
in O O
the O O
left O O
hand O O
; O O
the O O
metacarpals O O
of O O
the O O
thumb O O
and O O
of O O
the O O
second O O
fingers O O
and O O
the O O
proximal O O
phalange O O
of O O
the O O
third O O
finger O O
were O O
amputated O O
. O O

it O O
was O O
also O O
noticed O O
that O O
there O O
was O O
a O O
flexum O O
of O O
the O O
proximal O O
phalange O O
of O O
the O O
stump O O
of O O
the O O
third O O
finger O O
. O O

since O O
the O O
amputations O O
, O O
the O O
patient O O
has O O
never O O
worn O O
any O O
prosthesis O O
. O O

the O O
subject O O
has O O
requested O O
finger O O
prostheses O O
to O O
improve O O
the O O
quality O B-C0518214
of O I-C0518214
life O I-C0518214
. O O

the O O
case O O
was O O
discussed O O
and O O
with O O
the O O
consent O O
for O O
the O O
patient's O O
rehabilitation O O
of O O
fingers O O
, O O
silicone O O
prostheses O O
was O O
planned O O
for O O
the O O
first O O
stage O O
of O O
the O O
treatment O O
. O O

the O O
measurements O O
were O O
taken O O
by O O
a O O
certified O O
prosthetist O O
. O O

the O O
manufacturing O O
of O O
the O O
prosthesis O O
consisted O O
of O O
the O O
following O O
steps O O
: O O
the O O
impression O O
taking O O
, O O
the O O
wax O O
pattern O O
and O O
the O O
laboratory O O
works O O
as O O
described O O
in O O
former O O
studies O O
[ O O
9 O O
, O O
10 O O
] O O
. O O

the O O
case O O
described O O
here O O
presented O O
with O O
multiple O O
amputations O O
of O O
both O O
hands O O
which O O
present O O
the O O
amputation O O
of O O
the O O
distal O O
phalange O O
of O O
the O O
second O O
finger O O
as O O
well O O
. O O

that O O
made O O
it O O
difficult O O
taking O O
the O O
impression O O
on O O
the O O
sound O O
finger O O
. O O

so O O
, O O
the O O
impression O O
was O O
done O O
on O O
the O O
contralateral O O
finger O O
of O O
the O O
patient O O
. O O

the O O
impressions O O
were O O
taking O O
with O O
hydrophilic O O
vinyl-polysiloxane O O
impression O O
material O O
. O O

the O O
finger O O
was O O
in O O
relax O O
position O O
while O O
taking O O
the O O
pattern O O
. O O

two O O
layers O O
of O O
the O O
impression O O
material O O
were O O
wrapped O O
on O O
the O O
fingers O O
for O O
about O O
10 O O
minutes O O
and O O
the O O
negative O O
molds O O
were O O
taken O O
off O O
after O O
the O O
setting O O
was O O
done O O
. O O

then O O
the O O
liquid O O
wax O O
was O O
poured O O
into O O
the O O
impression O O
mold O O
to O O
retrieve O O
the O O
positive O O
replica O O
of O O
the O O
hand O O
. O O

then O O
another O O
impression O O
was O O
taken O O
from O O
the O O
wax O O
mold O O
to O O
create O O
the O O
final O O
mold O O
in O O
which O O
the O O
silicone O O
solution O O
was O O
inserted O O
. O O

to O O
ensure O O
a O O
total O O
suspension O O
of O O
the O O
prosthesis O O
, O O
a O O
suspension O O
cavity O O
was O O
created O O
in O O
the O O
mold O O
using O O
a O O
pin O O
made O O
with O O
cast O O
following O O
technique O O
described O O
in O O
the O O
former O O
study O O
[ O O
10 O O
] O O
. O O

in O O
order O O
to O O
match O O
the O O
patient's O O
skin O O
colour O O
, O O
the O O
artist's O O
oil O O
colours O O
were O O
used O O
to O O
mix O O
with O O
the O O
silicone O O
solution O O
. O O

to O O
ensure O O
total O O
aesthetics O O
, O O
the O O
nail O O
part O O
was O O
first O O
packed O O
then O O
the O O
dorsal O O
and O O
palmar O O
aspects O O
were O O
mixed O O
and O O
packed O O
separately O O
in O O
the O O
mold O O
. O O

due O O
to O O
unavailability O O
of O O
electric O O
oven O O
to O O
heat O B-C0221500
the O O
silicone O O
solution O O
, O O
the O O
mold O O
was O O
closed O O
and O O
heated O O
using O O
a O O
kitchen O O
gas O O
stove O O
for O O
about O O
an O O
hour O O
. O O

in O O
order O O
to O O
have O O
all O O
the O O
surface O O
of O O
the O O
cast O O
with O O
the O O
average O O
temperature O O
, O O
the O O
surfaces O O
of O O
the O O
cast O O
mold O O
were O O
turned O O
periodically O O
on O O
the O O
stove O O
gas O O
. O O

the O O
finished O O
prosthesis O O
was O O
then O O
retrieved O O
from O O
the O O
mold O O
and O O
excess O O
silicone O O
flesh O O
was O O
trimmed O O
from O O
the O O
margins O O
. O O

the O O
prostheses O O
were O O
tried O O
on O O
the O O
patient O O
after O O
she O O
was O O
educated O O
on O O
how O O
to O O
take O O
care O O
of O O
the O O
prosthesis O O
. O O

through O O
the O O
technique O O
described O O
above O O
, O O
good O O
suspension O O
and O O
real O O
looking O O
finger O O
prosthesis O O
as O O
patient's O O
skin O O
colour O O
was O O
manufactured O O
. O O

the O O
subject O O
was O O
able O O
to O O
don O O
the O O
prosthesis O O
on O O
her O O
own O O
and O O
had O O
no O O
pain O B-C0030193
when O O
wearing O O
it O O
and O O
was O O
able O O
to O O
grab O O
an O O
object O O
. O O

the O O
patient O O
was O O
satisfied O O
with O O
the O O
final O O
aspect O O
of O O
the O O
prosthesis O O
. O O

LA O O
is O O
an O O
8 O O
- O O
year-old O O
who O O
had O O
an O O
open O O
trauma O O
of O O
the O O
left O O
elbow O O
with O O
pus O O
15 O O
days O O
before O O
he O O
consulted O O
the O O
pediatric O O
emergency O O
department O O
for O O
a O O
generalized O O
scarlatiniform O O
erythema O O
evolving O O
towards O O
flaking O O
with O O
a O O
fever O B-C0015967
of O O
39 O O
o O O
C O O
. O O

clinical O O
examination O O
has O O
found O O
a O O
drowsy O B-C0013144
child O O
, O O
tachycardia O O
at O O
130 O O
beats O O
per O O
minute O O
, O O
polypnea O O
at O O
44 O O
cycles O O
per O O
minute O O
, O O
hypotension O B-C0020649
at O O
90 O O
/ O O
56mmhg O O
with O O
an O O
extended O O
capillary O O
refill O O
time O O
( O O
CRT O O
) O O
which O O
required O O
his O O
admission O O
to O O
intensive O O
care O O
initially O O
. O O

the O O
biological O O
assessment O O
had O O
shown O O
an O O
inflammatory O O
syndrome O O
: O O
C O O
reactive O O
protein O O
( O O
CRP O O
) O O
at O O
175.85mg O O
/ O O
L O O
; O O
to O O
the O O
blood O O
count O O
: O O
leukocytosis O B-C0023518
at O O
37.270g O O
/ O O
L O O
with O O
a O O
neutrophil O O
predominance O O
at O O
26.540g O O
/ O O
L O O
, O O
thrombocytopenia O B-C0040034
at O O
83g O O
/ O O
L O O
and O O
a O O
lymphocyte O O
count O O
at O O
4.83G O O
/ O O
L O O
. O O

the O O
blood O O
ionogram O O
identified O O
hyponatremia O B-C0020625
at O O
122mmol O O
/ O O
L O O
, O O
hypokalemia O B-C0020621
at O O
3.4mmol O O
/ O O
L O O
and O O
hypo-albuminemia O O
at O O
23.4g O O
/ O O
L O O
. O O

two O O
blood O O
cultures O O
were O O
performed O O
with O O
isolation O B-C0260397
of O O
a O O
methicillin-sensitive O O
coagulase O O
negative O O
staphylococcus O O
A O O
. O O

the O O
patient O O
received O O
amoxicillin-clavulanic O O
acid O O
intravenously O O
for O O
21 O O
days O O
combined O O
with O O
gentamycin O O
for O O
48 O O
hours O O
. O O

the O O
evolution O O
a O O
week O O
later O O
was O O
marked O O
by O O
the O O
appearance O O
of O O
a O O
painful O O
inflammatory O O
swelling O B-C0038999
associated O O
with O O
spasticity O B-C0026838
of O O
both O O
arms O O
and O O
legs O O
with O O
functional O O
impotence O B-C0242350
of O O
the O O
two O O
lower O O
limbs O O
and O O
a O O
walk O O
on O O
tiptoes O O
. O O

the O O
patient O O
was O O
transferred O O
to O O
our O O
department O O
after O O
a O O
stay O O
in O O
intensive O O
care O O
for O O
etiological O O
assessment O O
. O O

an O O
x-ray O O
of O O
the O O
pelvis O O
and O O
both O O
elbows O O
were O O
done O O
which O O
were O O
found O O
to O O
be O O
normal O O
with O O
a O O
creatine O O
phosphokinase O O
( O O
CPK O O
) O O
level O O
at O O
37IU O O
/ O O
L O O
. O O

an O O
ultrasound O O
of O O
4 O O
limbs O O
was O O
performed O O
objectifying O O
abscesses O B-C0000833
of O O
soft O O
tissues O O
, O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
of O O
the O O
two O O
legs O O
revealed O O
the O O
presence O O
of O O
multiple O O
multiloculated O O
formations O O
with O O
T2 O O
hyperintense O O
signal O O
on O O
the O O
posterior O O
and O O
the O O
right O O
antero-external O O
compartment O O
of O O
both O O
legs O O
measuring O O
for O O
the O O
largest O O
200 O O
X O O
9 O O
X O O
8mm O O
, O O
associated O O
with O O
T2 O O
hyperintense O O
signal O O
and O O
edematous O O
calcaneus O O
on O O
short-ti O O
inversion O O
recovery O O
( O O
STIR O O
) O O
images O O
suggesting O O
bilateral O O
pyomyositis O B-C1704275
. O O

indeed O O
, O O
the O O
delay O O
between O O
first O O
signs O O
and O O
diagnosis O O
was O O
2 O O
months O O
. O O

intravenous O O
antibiotic O O
therapy O O
was O O
started O O
with O O
amoxicillin-clavulanic O O
acid O O
for O O
4 O O
weeks O O
then O O
15 O O
days O O
orally O O
, O O
for O O
a O O
total O O
duration O O
of O O
6 O O
weeks O O
, O O
associated O O
with O O
motor O O
physiotherapy O O
. O O

the O O
patient O O
had O O
after O O
20 O O
days O O
of O O
evolution O O
a O O
drainage O O
of O O
abscesses O B-C0000833
by O O
the O O
team O O
of O O
orthopedic O O
surgeons O O
of O O
our O O
university O O
hospital O O
, O O
however O O
, O O
the O O
puncture O O
was O O
white O O
; O O
complemented O O
by O O
an O O
incision O O
which O O
did O O
not O O
objectify O O
pus O O
with O O
a O O
sterile O O
bacteriological O O
study O O
. O O

fever O B-C0015967
disappeared O O
after O O
72 O O
hours O O
; O O
the O O
child O O
gradually O O
resumed O O
walking O O
during O O
his O O
hospitalization O O
with O O
a O O
complete O O
regression O B-C1836830
of O O
the O O
symptomatology O O
after O O
6 O O
weeks O O
. O O

regarding O O
the O O
search O O
for O O
an O O
underlying O O
cause O O
, O O
the O O
HIV O O
serology O O
was O O
negative O O
, O O
the O O
fasting O B-C0015663
blood O O
sugar O O
was O O
0.92g O O
/ O O
dl O O
, O O
the O O
lactate O O
- O O
ammonia O O
level O O
were O O
normal O O
and O O
the O O
dihydrorhodamine O O
123 O O
test O O
( O O
DHR O O
) O O
for O O
a O O
chronic O O
septic O O
granulomatosis O B-C0521173
was O O
normal O O
. O O

however O O
, O O
the O O
assessment O O
of O O
immunoglobulins O O
, O O
lymphocyte O O
subpopulations O O
and O O
vaccine O O
antibodies O O
was O O
not O O
carried O O
out O O
. O O

A O O
50 O O
- O O
year-old O O
non-smoker O O
woman O O
followed O O
for O O
bipolar O B-C0005586
disorder O I-C0005586
treated O O
with O O
depakote O O
and O O
prazepam O O
for O O
7 O O
months O O
was O O
, O O
a O O
month O O
ago O O
, O O
diagnosed O O
with O O
organizing O B-C0264383
pneumonia O I-C0264383
. O O

the O O
diagnosis O O
was O O
based O O
on O O
the O O
presence O O
of O O
a O O
dry O O
cough O B-C0010200
with O O
stage O O
2 O O
dyspnea O B-C0231807
on O I-C0231807
exertion O I-C0231807
and O O
unexplained O O
weight O B-C1262477
loss O I-C1262477
. O O

chest O O
computed O O
tomography O O
( O O
CT O O
) O O
scan O O
showed O O
bilateral O O
and O O
peripheral O O
alveolar O O
condensations O O
with O O
2 O O
left O O
posterior O O
basal O O
air O O
cysts O B-C0010709
. O O

laboratory O O
tests O O
did O O
not O O
objectify O O
inflammatory O O
syndrome O O
. O O

A O O
compete O O
blood O O
count O O
revealed O O
lymphopenia O O
. O O

serum O O
protein O O
electrophoresis O O
, O O
liver O O
and O O
renal O O
function O O
tests O O
were O O
unremarkable O O
. O O

lactate O O
dehydrogenase O O
test O O
and O O
calcium O O
levels O O
were O O
normal O O
. O O

immunological O O
assessment O O
and O O
the O O
infectious O B-C0009450
disease O I-C0009450
tests O O
were O O
negative O O
. O O

no O O
significant O O
improvement O O
was O O
noted O O
after O O
antibiotherapy O O
with O O
levofloxacin O O
. O O

divalproex O O
sodium O O
induced O O
organizing O B-C0264383
pneumonia O I-C0264383
was O O
suspected O O
and O O
the O O
treatment O O
was O O
stopped O O
. O O

in O O
the O O
presence O O
of O O
severe O O
restriction O O
in O O
spirometry O O
and O O
hypoxemia O B-C0700292
on O O
exertion O O
, O O
steroids O O
were O O
prescribed O O
. O O

bronchoalveolar O O
lavage O O
was O O
not O O
carried O O
out O O
due O O
to O O
significant O O
respiratory O O
repercussions O O
. O O

A O O
slight O O
improvement O O
was O O
noted O O
under O O
corticotherapy O O
. O O

one O O
month O O
later O O
, O O
she O O
presented O O
with O O
sudden O O
chest O B-C0008031
pain O I-C0008031
and O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
due O O
to O O
SBSP O O
. O O

immediately O O
after O O
diagnosis O O
, O O
bilateral O O
chest O O
tubes O O
were O O
inserted O O
. O O

the O O
right O O
one O O
was O O
removed O O
after O O
24 O O
hours O O
and O O
the O O
left O O
one O O
after O O
48 O O
hours O O
when O O
no O O
air O O
leak O O
was O O
evident O O
. O O

A O O
scan-guided O O
right O O
lung O O
biopsy O O
was O O
performed O O
before O O
the O O
ablation O O
of O O
the O O
drain O O
, O O
which O O
led O O
to O O
the O O
diagnosis O O
of O O
primary O O
pulmonary O O
MALT O B-C0242647
lymphoma O I-C0242647
. O O

on O O
immunohistochemistry O O
, O O
the O O
tumor O B-C0027651
cells O O
expressed O O
CD20 O O
( O O
strong O O
membrane O O
positivity O O
) O O
. O O

they O O
were O O
immunonegative O O
for O O
CD3 O O
, O O
CD5 O O
, O O
CD10 O O
, O O
CD23 O O
and O O
cyclin O O
D1 O O
. O O

left O O
pneumothorax O B-C0032326
recurred O O
7 O O
days O O
after O O
. O O

left O O
chest O O
tube O O
was O O
inserted O O
followed O O
by O O
pleurodesis O O
by O O
left O O
pleural O O
abrasion O B-C1302752
with O O
partial O O
thoracoscopic O O
pleurectomy O O
. O O

the O O
cervical O O
and O O
abdomino-pelvic O O
CT O O
scan O O
did O O
not O O
show O O
any O O
other O O
ganglionic O O
or O O
extra O O
ganglionic O O
lesions O B-C0221198
and O O
the O O
bone O O
marrow O O
biopsy O O
was O O
negative O O
. O O

the O O
patient O O
was O O
treated O O
with O O
R-CHOP O O
chemotherapy O O
. O O

A O O
67 O O
- O O
year-old O O
patient O O
with O O
a O O
history O O
of O O
type O B-C0011860
2 O I-C0011860
diabetes O I-C0011860
treated O O
with O O
oral O O
antidiabetics O O
, O O
a O O
cholecystectomized O O
10 O O
years O O
ago O O
, O O
obese O O
with O O
body O O
mass O O
index O O
( O O
BMI O O
) O O
at O O
34 O O
kg O O
/ O O
m² O O
, O O
no O O
history O O
of O O
alcoholism O B-C0001973
, O O
smoking O O
and O O
similar O O
symptoms O O
in O O
the O O
past O O
. O O

admitted O O
to O O
the O O
emergency O O
department O O
on O O
july O O
8 O O
th O O
for O O
febrile O B-C0015967
dyspnea O B-C0013404
, O O
myalgia O B-C0231528
, O O
arthralgia O B-C0003862
, O O
without O O
associated O O
abdominal O O
signs O O
, O O
all O O
evolving O O
for O O
10 O O
days O O
in O O
a O O
context O O
of O O
deterioration O O
of O O
the O O
general O O
condition O O
. O O

on O O
admission O O
, O O
the O O
medical O O
examination O O
revealed O O
a O O
conscious O O
( O O
GCS O O
15 O O
/ O O
15 O O
) O O
, O O
polypneic O O
( O O
26 O O
cpm O O
) O O
patient O O
with O O
an O O
oxygen O O
saturation O O
( O O
spo2 O O
) O O
of O O
85% O O
in O O
the O O
ambient O O
air O O
and O O
97% O O
when O O
wearing O O
a O O
face O O
mask O O
without O O
rebreather O O
( O O
15 O O
L O O
/ O O
min O O
) O O
, O O
blood O O
pressure O O
of O O
130 O O
/ O O
70 O O
mmhg O O
, O O
pulse O O
of O O
80 O O
bpm O O
and O O
a O O
temperature O O
of O O
37.5 O O
° O O
C O O
. O O

A O O
chest O O
scanner O O
was O O
performed O O
which O O
revealed O O
typical O O
ground O O
glass O O
opacities O O
associated O O
with O O
crazy O O
paving O O
images O O
in O O
favor O O
of O O
viral O B-C0032310
pneumonia O I-C0032310
. O O

the O O
reverse O O
transcription O O
polymerase O O
chain O O
reaction O O
( O O
rt-pcr O O
) O O
for O O
sars-cov O O
- O O
2 O O
came O O
back O O
positive O O
. O O

the O O
patient O O
was O O
transferred O O
to O O
medical O O
intensive O O
care O O
unit O O
dedicated O O
to O O
COVID O O
- O O
19 O O
. O O

the O O
biological O O
assessment O O
: O O
the O O
complete O O
blood O O
count O O
showed O O
white O O
blood O O
cells O O
at O O
5940 O O
/ O O
µl O O
, O O
neutrophils O O
at O O
4650 O O
/ O O
μl O O
, O O
lymphocyte O O
at O O
910 O O
/ O O
μl O O
, O O
hemoglobin O O
at O O
14 O O
g O O
/ O O
dl O O
, O O
platelets O O
at O O
161,000 O O
/ O O
μl O O
. O O

fibrinogen O O
at O O
7.27 O O
g O O
/ O O
L O O
, O O
CRP O O
at O O
41.3 O O
mg O O
/ O O
L O O
, O O
PCT O O
at O O
0.06 O O
ng O O
/ O O
ml O O
, O O
ferritin O O
at O O
1079.5 O O
ng O O
/ O O
L O O
, O O
calcemia O O
at O O
1.94mmol O O
/ O O
L O O
, O O
creatinine O O
at O O
6.55 O O
mg O O
/ O O
L O O
, O O
urea O O
at O O
3.3 O O
mmol O O
/ O O
l O O
, O O
ALT O O
at O O
33UI O O
/ O O
L O O
, O O
AST O O
at O O
26UI O O
/ O O
L O O
, O O
ALP O O
at O O
80 O O
UI O O
/ O O
L O O
, O O
GGT O O
at O O
35 O O
UI O O
/ O O
L O O
, O O
triglycerides O O
at O O
2.40 O O
mmol O O
/ O O
L O O
and O O
troponins O O
at O O
8.1 O O
ng O O
/ O O
L O O
. O O

the O O
electrocardiogram O O
showed O O
regular O O
sinus O O
rhythm O O
of O O
80 O O
bpm O O
, O O
QT O O
at O O
420 O O
mm O O
without O O
repolarization O O
disorders O O
. O O

the O O
echocardiography O O
did O O
not O O
show O O
any O O
abnormalities O O
. O O

undilated O O
ventricular O O
chambers O O
with O O
a O O
systolic O O
ejection O O
fraction O O
at O O
60% O O
, O O
no O O
valve O O
abnormality O O
, O O
and O O
no O O
signs O O
of O O
pulmonary O B-C0020542
hypertension O I-C0020542
or O O
acute O O
cor O B-C0034072
pulmonale O I-C0034072
. O O

therapeutic O O
management O O
included O O
, O O
oxygen O O
therapy O O
, O O
the O O
association O O
hydroxychloroquine O O
200 O O
mg O O
three O O
times O O
per O O
day O O
added O O
to O O
azithromycin O O
500 O O
mg O O
the O O
first O O
day O O
then O O
250 O O
mg O O
per O O
day O O
and O O
methylprednisolone O O
at O O
80 O O
mg O O
per O O
day O O
for O O
7 O O
days O O
, O O
vitamin O O
C O O
1 O O
gramme O O
per O O
day O O
and O O
zinc O O
90 O O
mg O O
per O O
day O O
and O O
low O O
molecular O O
weight O O
heparin O O
enoxaparin O O
100 O O
UI O O
/ O O
kg O O
/ O O
day O O
. O O

on O O
day O O
5 O O
, O O
the O O
patient O O
was O O
placed O O
on O O
assisted O O
ventilation O O
. O O

faced O O
with O O
the O O
persistence O O
of O O
a O O
fever O B-C0015967
estimated O O
at O O
40 O O
degrees O O
celsius O O
, O O
an O O
infectious O O
assessment O O
including O O
a O O
cytobacteriological O O
examination O O
of O O
the O O
urine O O
, O O
a O O
protected O O
distal O O
bronchial O O
sample O O
, O O
blood O O
cultures O O
, O O
a O O
lumbar O O
puncture O O
and O O
an O O
abdominal O O
and O O
pelvic O O
ultrasound O O
were O O
requested O O
and O O
not O O
objectifying O O
no O O
anomaly O O
. O O

on O O
the O O
13 O O
th O O
day O O
, O O
a O O
thoraco-abdomino-pelvic O O
CT O O
was O O
performed O O
objectifying O O
an O O
acute O O
stage O O
c O O
pancreatitis O B-C0030305
according O O
to O O
the O O
balthazar O O
classification O O
. O O

the O O
lipasemia O O
was O O
at O O
576 O O
UI O O
/ O O
L O O
. O O

the O O
serologys O O
( O O
HAV O O
, O O
VHB O O
, O O
VHC O O
, O O
VHD O O
, O O
VHE O O
, O O
HSV O O
, O O
VZV O O
, O O
EBV O O
, O O
CMV O O
, O O
HIV O O
) O O
were O O
carried O O
out O O
and O O
which O O
were O O
negative O O
. O O

the O O
patient O O
was O O
put O O
to O O
digestive O O
rest O O
and O O
received O O
antibiotics O O
. O O

however O O
, O O
the O O
patient O O
had O O
an O O
unfavorable O O
outcome O O
and O O
died O B-C1546956
on O O
day O O
18 O O
. O O

A O O
70 O O
year O O
old O O
man O O
of O O
indian O O
origin O O
presented O O
to O O
the O O
outpatient O O
department O O
with O O
complaints O O
of O O
pain O B-C0030193
, O O
limited O B-C0700572
mobility O I-C0700572
and O O
swelling O B-C0038999
over O O
anterior O O
aspects O O
of O O
the O O
right O O
leg O O
, O O
above O O
the O O
ankle O O
for O O
three O O
months O O
. O O

he O O
gave O O
a O O
history O O
of O O
recurrent O O
ulcer O O
over O O
the O O
same O O
region O O
. O O

there O O
was O O
no O O
history O O
of O O
loss O B-C0028643
of O I-C0028643
sensation O I-C0028643
, O O
no O O
history O O
of O O
trauma O O
, O O
no O O
comorbid O O
illness O O
, O O
no O O
history O O
of O O
fever O B-C0015967
, O O
no O O
gastrointestinal O O
/ O O
respiratory O O
symptoms O O
. O O

clinical O O
examination O O
of O O
the O O
right O O
leg O O
showed O O
a O O
well O O
demarcated O O
erythematous O O
firm O O
lesion O B-C0221198
with O O
nodular O O
surrounding O O
areas O O
and O O
accompanying O O
lymphedema O B-C0024236
of O O
the O O
distal O O
foot O O
. O O

thorough O O
clinical O O
examination O O
of O O
the O O
entire O O
body O O
revealed O O
no O O
other O O
lesion O B-C0221198
. O O

there O O
was O O
no O O
past O O
history O O
of O O
similar O O
lesions O B-C0221198
anywhere O O
in O O
the O O
body O O
. O O

no O O
other O O
skin O O
/ O O
oral O B-C0149744
lesions O I-C0149744
were O O
identified O O
. O O

additional O O
investigations O O
showed O O
he O O
was O O
not O O
immunocompromised O O
or O O
did O O
not O O
suffer O O
from O O
any O O
sexually O B-C0036916
transmitted O I-C0036916
diseases O I-C0036916
. O O

plain O O
radiograph O O
of O O
the O O
leg O O
( O O
antero O O
posterior O O
and O O
lateral O O
views O O
) O O
showed O O
a O O
lobulated O O
soft O O
tissue O O
swelling O B-C0038999
in O O
the O O
anterior O O
aspect O O
of O O
the O O
lower O O
one O O
third O O
of O O
the O O
leg O O
with O O
few O O
calcific O O
areas O O
within O O
and O O
associated O O
periosteal O B-C2674853
reaction O I-C2674853
the O O
adjacent O O
bones O O
of O O
the O O
leg O O
. O O

computerised O O
tomography O O
( O O
CT O O
) O O
of O O
the O O
same O O
patient O O
shows O O
areas O O
of O O
soft O O
tissue O O
edema O O
, O O
heterogeneous O O
linear O O
densities O O
and O O
few O O
areas O O
of O O
faint O O
calcification O O
in O O
the O O
region O O
of O O
the O O
lobulated O O
skin O O
lesion O B-C0221198
. O O

thick O O
unicortical O O
periosteal O B-C2674853
reaction O I-C2674853
of O O
the O O
tibia O O
for O O
a O O
short O O
segment O O
; O O
adjacent O O
to O O
the O O
lesion O B-C0221198
was O O
noted O O
. O O

magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
showed O O
findings O O
similar O O
to O O
the O O
CT O O
findings O O
and O O
shows O O
no O O
bone O O
marrow O O
involvement O O
. O O

the O O
lesion O B-C0221198
appeared O O
iso O O
to O O
hypo O O
intense O O
on O O
T1 O O
weighted O O
images O O
and O O
hyper O O
intense O O
on O O
T2 O O
weighted O O
images O O
and O O
was O O
located O O
within O O
the O O
skeletal O O
muscle O O
. O O

surrounding O O
perilesional O O
edema O O
was O O
noted O O
. O O

there O O
was O O
no O O
bone O O
marrow O O
involvement O O
. O O

A O O
biopsy O O
of O O
the O O
lesion O B-C0221198
was O O
performed O O
and O O
showed O O
histopathological O O
features O O
of O O
kaposi O B-C0036220
sarcoma O I-C0036220
. O O

A O O
45 O O
- O O
year-old O O
caucasian O O
male O O
patient O O
was O O
referred O O
to O O
our O O
clinic O O
of O O
endocrinology O O
, O O
because O O
of O O
an O O
incidental O B-C0743997
finding O I-C0743997
in O O
a O O
CT O O
scan O O
, O O
suggestive O O
of O O
paraganglioma O B-C0030421
, O O
performed O O
in O O
the O O
work O O
up O O
for O O
abdominal O B-C0000737
pain O I-C0000737
. O O

the O O
abdominal O O
CT O O
scan O O
revealed O O
a O O
4cm O O
nonspecific O O
retroperitoneal O O
, O O
paraaortic O O
lesion O B-C0221198
, O O
between O O
celiac O B-C0007570
trunk O O
and O O
superior O O
mesenteric O O
artery O O
, O O
suggestive O O
of O O
neuroendocrine O B-C0206754
tumor O I-C0206754
as O O
the O O
first O O
possibility O O
. O O

he O O
had O O
a O O
past O O
medical O O
history O O
of O O
smoking O O
, O O
barret's O O
esophagus O O
, O O
hiatus O B-C3489393
hernia O I-C3489393
and O O
gastroesophageal O B-C0017168
reflux O I-C0017168
disease O I-C0017168
treated O O
with O O
omeprazole O O
. O O

he O O
had O O
undergone O O
a O O
sleeve O O
gastrectomy O O
as O O
a O O
surgical O O
weight O B-C1262477
loss O I-C1262477
procedure O O
in O O
2015 O O
and O O
cholecystectomy O O
for O O
cholelithiasis O B-C0008350
in O O
2017 O O
. O O

after O O
the O O
first O O
visit O O
in O O
our O O
clinic O O
, O O
an O O
initial O O
laboratory O O
investigation O O
was O O
performed O O
for O O
the O O
suspected O O
paraganglioma O B-C0030421
( O O
references O O
values O O
in O O
parenthesis O O
) O O
: O O
glucose O O
79 O O
mg O O
/ O O
dl O O
( O O
74 O O
- O O
106 O O
) O O
; O O
creatinine O O
0.69 O O
mg O O
/ O O
dl O O
( O O
0.70 O O
- O O
1.30 O O
) O O
; O O
alanine O O
aminotransferase O O
22 O O
IU O O
/ O O
L O O
( O O
10 O O
- O O
49 O O
) O O
; O O
ferritin O O
73 O O
ng O O
/ O O
ml O O
( O O
22 O O
- O O
322 O O
) O O
; O O
enolase O O
19 O O
ng O O
/ O O
ml O O
( O O
< O O
16 O O
) O O
; O O
carcinoembryonic O O
antigen O O
2.6 O O
ng O O
/ O O
ml O O
( O O
< O O
5.0 O O
) O O
; O O
ca O O
19.9 O O
: O O
12 O O
IU O O
/ O O
ml O O
( O O
< O O
37 O O
) O O
; O O
chromogranin O O
A O O
: O O
3.3 O O
nmol O O
/ O O
l O O
( O O
0.4 O O
- O O
10.0 O O
) O O
; O O
hemoglobin O O
15.4 O O
gr O O
/ O O
dl O O
( O O
13.5 O O
- O O
17.5 O O
) O O
; O O
neutrophils O O
51.7% O O
( O O
40.0 O O
- O O
70.0 O O
) O O
; O O
lymphocytes O O
33.4% O O
( O O
22.0 O O
- O O
44.0 O O
) O O
, O O
eosinophils O O
5.3% O O
( O O
RV O O
< O O
8.0 O O
) O O
. O O

moreover O O
, O O
total O O
and O O
fractional O O
catecholamines O O
, O O
total O O
metanephrines O O
and O O
excretion O O
of O O
5 O O
- O O
oh-indolacetic O O
in O O
the O O
24 O O
- O O
hour O O
urine O O
analysis O O
were O O
normal O O
. O O

next O O
, O O
radioisotope O O
imaging O O
was O O
ordered O O
. O O

the O O
whole-body O O
scintigraphy O O
with O O
metaiodobenzylguanidine O O
didn't O O
reveal O O
any O O
clear O O
signs O O
suggesting O O
the O O
existence O O
of O O
catecholamine-producing O O
tumor O B-C0027651
. O O

the O O
whole-body O O
( O O
99m O O
) O O
tc-octreotide O O
scintigraphy O O
with O O
SPECT O O
/ O O
CT O O
showed O O
a O O
paraaortic O O
abdominal O B-C0000734
mass O I-C0000734
, O O
but O O
without O O
evidence O O
of O O
pathological O O
tumor O B-C0027651
uptake O O
. O O

after O O
multidisciplinary O O
discussion O O
, O O
it O O
was O O
decided O O
to O O
perform O O
a O O
ct-guided O O
biopsy O O
of O O
the O O
lesion O B-C0221198
. O O

microscopic O O
study O O
of O O
the O O
sample O O
demonstrated O O
no O O
atypia O O
but O O
a O O
tissue O O
with O O
fibrosis O B-C0016059
, O O
collagenization O O
and O O
presence O O
of O O
spongy-looking O O
structures O O
, O O
suggestive O O
of O O
microorganisms O O
. O O

unfortunately O O
, O O
no O O
microbiological O O
cultures O O
of O O
the O O
biopsy O O
were O O
done O O
. O O

the O O
patient O O
then O O
was O O
referred O O
to O O
the O O
department O O
of O O
infectious O B-C0009450
disease O I-C0009450
for O O
further O O
evaluation O O
. O O

during O O
the O O
focused O O
anamnesis O O
, O O
the O O
patient O O
reported O O
having O O
recently O O
made O O
several O O
business O O
travels O O
to O O
africa O O
, O O
central O O
america O O
, O O
south O O
america O O
and O O
the O O
caribbean O O
. O O

he O O
had O O
no O O
weight O B-C1262477
loss O I-C1262477
, O O
fever O B-C0015967
, O O
diarrhea O B-C0011991
, O O
or O O
skin O B-C0037284
lesions O I-C0037284
and O O
there O O
were O O
no O O
significant O O
findings O O
on O O
physical O O
examination O O
. O O

A O O
mantoux O B-C1403567
test O O
was O O
performed O O
which O O
was O O
negative O O
. O O

the O O
following O O
serological O O
studies O O
were O O
carried O O
out O O
: O O
hepatitis O B-C0019159
A O I-C0019159
virus O O
; O O
epstein-barr O O
virus O O
; O O
trypanosoma O O
cruzi O O
; O O
cytomegalovirus O O
; O O
ac O O
hbs O O
; O O
ag O O
hbs O O
; O O
ac O O
hbc O O
T O O
; O O
HIV O O
1 O O
+ O O
2 O O
; O O
toxoplasma O O
gondii O O
; O O
entamoeba O O
histolytica O O
; O O
echinococcus O O
granulosus O O
; O O
taenia O O
solium O O
( O O
igg O O
) O O
; O O
leishmania O O
spp O O
. O O
; O O
strongyloides O O
and O O
schistosoma O O
. O O

all O O
results O O
were O O
negative O O
and O O
do O O
not O O
showed O O
acute O O
infection O B-C3714514
, O O
except O O
schistosoma O O
with O O
igm O O
and O O
igg O O
positive O O
. O O

based O O
on O O
the O O
results O O
obtained O O
in O O
the O O
serological O O
tests O O
, O O
a O O
schistosoma O O
infestation O B-C0851341
( O O
schistosomiasis O B-C0036323
) O O
was O O
diagnosed O O
and O O
praziquantel O O
was O O
prescribed O O
. O O

during O O
the O O
follow-up O O
the O O
patient O O
referred O O
remission O O
of O O
the O O
abdominal O B-C0000737
pain O I-C0000737
and O O
a O O
CT O O
control O O
one O O
year O O
later O O
showed O O
a O O
shrink O O
in O O
size O O
of O O
the O O
paraaortic O O
lesion O B-C0221198
. O O

an O O
82 O O
- O O
year-old O O
female O O
patient O O
was O O
hospitalized O O
for O O
a O O
life O O
threatening O O
arrhythmia O B-C0003811
. O O

medical O O
history O O
revealed O O
hypertension O B-C0020538
and O O
a O O
complete O O
AV O B-C0004245
block O I-C0004245
treated O O
by O O
a O O
single-chamber O O
pacemaker O O
in O O
1996 O O
. O O

the O O
lead O O
was O O
changed O O
few O O
years O O
later O O
for O O
an O O
unknown O O
reason O O
. O O

ventricular O B-C0042514
tachycardia O I-C0042514
was O O
the O O
most O O
probable O O
diagnosis O O
using O O
the O O
brugada O O
and O O
vereckei O O
algorithms O O
. O O

clinical O O
exam O O
, O O
found O O
a O O
patient O O
with O O
cardiogenic O B-C0036980
shock O I-C0036980
. O O

urgent O O
electrical O O
cardioversion O O
was O O
successfully O O
made O O
, O O
and O O
the O O
patient O O
was O O
put O O
on O O
IV O O
amiodarone O O
. O O

the O O
second O O
ECG O O
showed O O
Q O O
waves O O
in O O
lead O O
DIII O O
with O O
inverted O O
T O O
waves O O
in O O
leads O O
DIII O O
and O O
avf O O
and O O
a O O
first O O
degree O O
AV O B-C0004245
block O I-C0004245
. O O

the O O
patient O O
described O O
having O O
palpitation O B-C0030252
and O O
atypical O B-C0262384
chest O I-C0262384
pain O I-C0262384
few O O
hours O O
before O O
her O O
admission O O
. O O

troponins O O
were O O
slightly O O
elevated O O
( O O
0.06ug O O
/ O O
l O O
for O O
a O O
limit O O
of O O
0.05ug O O
/ O O
l O O
) O O
without O O
any O O
other O O
biological O O
abnormalities O O
. O O

echocardiography O O
showed O O
non O O
dilated O O
left O O
chambers O O
, O O
a O O
preserved O O
LV O O
ejection O O
fraction O O
( O O
visually O O
estimated O O
at O O
50 O O
- O O
55% O O
) O O
, O O
a O O
giant O O
calcified O O
basal O O
inferior O O
left O O
ventricular O B-C0392464
aneurysm O I-C0392464
with O O
a O O
thrombus O B-C0087086
at O O
its O O
bottom O O
and O O
a O O
non-severe O O
mitral O B-C0026266
regurgitation O I-C0026266
. O O

chest O O
x-ray O O
showed O O
no O O
cardiomegaly O B-C0018800
, O O
calcification O O
at O O
the O O
bottom O O
of O O
the O O
aneurysm O B-C0002940
and O O
a O O
second O O
pacemaker O O
lead O O
, O O
cut O B-C0000925
and O O
rolled O O
up O O
in O O
the O O
right O O
ventricle O O
. O O

the O O
patient O O
was O O
transferred O O
to O O
the O O
cath O O
lab O O
. O O

coronary O O
angiography O O
revealed O O
: O O
a O O
right O O
coronary O O
artery O O
with O O
multiple O O
lesions O B-C0221198
, O O
occluded O O
at O O
its O O
middle O O
segment O O
and O O
a O O
distal O O
occlusion O O
of O O
the O O
left O O
circumflex O O
artery O O
. O O

the O O
calcifications O B-C0006663
of O O
the O O
aneurysm O B-C0002940
were O O
also O O
visible O O
. O O

cardiac O O
computerized O O
tomography O O
( O O
CT O O
) O O
scan O O
showed O O
a O O
large O O
heavily O O
calcified O O
aneurysm O B-C0002940
measuring O O
45x38mm O O
. O O

the O O
patient O O
was O O
put O O
on O O
anticoagulation O O
, O O
aspirin O O
100 O O
mg O O
/ O O
day O O
, O O
atorvastatin O O
40 O O
mg O O
/ O O
day O O
, O O
bisoprolol O O
5mg O O
daily O O
and O O
candesartan O O
16mg O O
daily O O
. O O

the O O
patient O O
had O O
no O O
impairment O O
of O O
her O O
functional O B-C0598463
status O I-C0598463
, O O
no O O
ventricular O B-C0085612
arrhythmia O I-C0085612
, O O
and O O
no O O
thromboembolic O O
arterial O O
events O O
. O O

the O O
discussion O O
was O O
about O O
whether O O
to O O
extract O O
the O O
second O O
lead O O
and O O
to O O
treat O O
the O O
aneurysm O B-C0002940
surgically O O
especially O O
with O O
a O O
euroscore O B-C4706279
II O O
of O O
7% O O
but O O
the O O
patient O O
refused O O
any O O
risky O O
intervention O O
. O O

the O O
patient O O
was O O
dischargedandno O O
events O O
were O O
noted O O
at O O
a O O
follow O O
up O O
of O O
4 O O
months O O
. O O

mrs O O
. O O

DOJ O O
is O O
a O O
30 O O
year O O
old O O
G2P1 O O
+ O O
0 O O
primary O O
school O O
teacher O O
who O O
first O O
presented O O
to O O
the O O
clinic O O
at O O
18 O O
weeks O O
of O O
gestation O O
by O O
ultrasound O O
scan O O
since O O
she O O
was O O
not O O
sure O O
of O O
her O O
LMP O O
. O O

she O O
presented O O
to O O
the O O
clinic O O
because O O
of O O
the O O
gastroenteritis O B-C0017160
in O O
pregnancy O O
and O O
was O O
managed O O
with O O
intravenous O O
fluids O O
, O O
metronidazole O O
and O O
haematinics O O
. O O

she O O
eventually O O
came O O
back O O
to O O
the O O
clinic O O
to O O
book O O
at O O
about O O
32 O O
weeks O O
of O O
gestation O O
and O O
she O O
claimed O O
she O O
has O O
not O O
had O O
any O O
antenatal O O
care O O
nor O O
medications O O
prior O O
booking O O
. O O

examination O O
revealed O O
a O O
healthy-looking O O
woman O O
with O O
symphysiofundal O O
height O O
of O O
32 O O
weeks O O
and O O
fetus O O
was O O
alive O O
. O O

ultrasound O O
scan O O
revealed O O
a O O
live O O
fetus O O
in O O
longitudinal O O
lie O O
and O O
breech O B-C0006157
presentation O I-C0006157
. O O

placental O O
was O O
antero-fundal O O
and O O
there O O
was O O
polyhydramnios O B-C0020224
( O O
AFI O O
of O O
205mm O O
) O O
. O O

there O O
was O O
gross O O
incompatibility O O
between O O
the O O
biparietal O O
diameter O O
and O O
the O O
femur O O
length O O
which O O
prompted O O
the O O
diagnosis O O
of O O
some O O
form O O
of O O
skeletal O B-C0410528
dysplasia O I-C0410528
. O O

she O O
was O O
referred O O
for O O
comprehensive O O
fetal O B-C0266647
anomaly O I-C0266647
scan O O
. O O

the O O
repeat O O
scan O O
showed O O
remarkable O O
lordosis O B-C0024003
and O O
the O O
skull O O
had O O
a O O
clover O O
leaf O O
appearance O O
. O O

all O O
the O O
long O O
bones O O
were O O
significantly O O
shortened O O
. O O

the O O
measured O O
parameters O O
showed O O
biparietal O O
diameter O O
( O O
BPD O O
) O O
to O O
be O O
78mm O O
, O O
corresponding O O
to O O
30 O O
weeks O O
4 O O
days O O
and O O
femur O O
length O O
to O O
be O O
22mm O O
, O O
corresponding O O
to O O
16 O O
weeks O O
1 O O
day O O
. O O

the O O
estimated O O
fetal O O
weight O O
was O O
834g O O
. O O

polyhydramnios O B-C0020224
was O O
still O O
present O O
and O O
single O O
pocket O O
of O O
amniotic O O
fluid O O
measured O O
10cm O O
. O O

A O O
diagnosis O O
of O O
generalized O O
skeletal O B-C0410528
dysplasia O I-C0410528
, O O
thanatophoric O B-C0039743
dysplasia O I-C0039743
was O O
made O O
. O O

based O O
on O O
the O O
ultrasound O O
scan O O
( O O
USS O O
) O O
result O O
she O O
was O O
counselled O O
for O O
termination O O
of O O
pregnancy O O
which O O
she O O
declined O O
. O O

she O O
however O O
re-presented O O
to O O
the O O
clinic O O
at O O
about O O
39 O O
weeks O O
of O O
gestation O O
with O O
a O O
satisfactory O O
state O O
of O O
health O O
. O O

abdominal O O
examination O O
showed O O
a O O
symphysiofundal O O
height O O
( O O
SFH O O
) O O
of O O
37cm O O
. O O

abdominal O O
examination O O
revealed O O
a O O
baby O O
in O O
breech O B-C0006157
presentation O I-C0006157
. O O

the O O
fetal O O
heart O O
wasnot O O
heard O O
which O O
was O O
confirmed O O
by O O
USS O O
. O O

she O O
was O O
scheduled O O
for O O
induction O O
of O O
labour O O
which O O
she O O
consented O O
to O O
. O O

cervical O O
ripening O O
with O O
foleys O O
catheter O O
was O O
done O O
followed O O
by O O
induction O O
of O O
labour O O
with O O
misoprostol O O
. O O

polyhydramnios O B-C0020224
was O O
confirmed O O
during O O
artificial O O
rupture O B-C0948106
of O I-C0948106
membranes O I-C0948106
; O O
liquor O O
was O O
pot-wine O O
coloured O O
and O O
the O O
fetus O O
was O O
eventually O O
expelled O O
by O O
breech O B-C0579079
delivery O I-C0579079
with O O
a O O
weight O O
of O O
2.9kg O O
. O O

thebaby O O
was O O
macerated O O
with O O
micromelia O B-C0025995
and O O
the O O
face O O
had O O
striking O O
odd O O
facie O O
with O O
dilated O O
sutures O O
and O O
disproportionately O O
big O O
clover-leaf O O
- O O
shaped O O
head O O
, O O
a O O
short O B-C0521525
neck O I-C0521525
and O O
mild O B-C1862375
proptosis O I-C1862375
with O O
low O B-C0239234
set O I-C0239234
ears O I-C0239234
. O O

musculoskeletal O O
system O O
in O O
addition O O
showed O O
short O O
stubby O O
spade O O
like O O
fingers O O
and O O
the O O
palate O O
was O O
high O O
arched O O
. O O

the O O
abdomen O O
was O O
distended O O
and O O
hyperaemic O O
with O O
thin O O
umbilical O O
cord O O
. O O

on O O
palpation O O
, O O
the O O
abdomen O O
was O O
soft O O
and O O
; O O
the O O
liver O O
was O O
about O O
3cm O O
enlarged O O
below O O
the O O
costal O O
region O O
. O O

the O O
male O O
genitalia O O
was O O
well O O
developed O O
. O O

the O O
parents O O
rejected O O
autopsy O O
but O O
accepted O O
that O O
the O O
baby O O
be O O
donated O O
for O O
the O O
teaching O O
of O O
students O O
. O O

A O O
complete O O
x-ray O O
of O O
the O O
body O O
of O O
the O O
baby O O
( O O
babygram O O
) O O
showedmacrocephaly O O
, O O
narrowed O O
chest O O
with O O
flattened O O
ribs O O
. O O

all O O
the O O
vertebral O O
bodies O O
were O O
reduced O O
in O O
height O O
and O O
appeared O O
widened O O
. O O

the O O
iliac O O
bones O O
were O O
hypoplastic O O
and O O
all O O
the O O
long O O
bones O O
were O O
shortened O O
but O O
straightened O O
. O O

there O O
wasassociated O O
metaphyseal O B-C1850135
flaring O I-C1850135
. O O

A O O
diagnosis O O
of O O
thanatophoric O B-C0039743
dysplasia O I-C0039743
type O O
II O O
was O O
made O O
. O O

history O O
: O O
a O O
34 O O
- O O
year-old O O
woman O O
in O O
her O O
third O O
pregnancy O O
at O O
an O O
estimated O O
gestational O O
age O O
of O O
11 O O
weeks O O
, O O
with O O
both O O
her O O
children O O
alive O O
, O O
presented O O
to O O
our O O
hospital O O
. O O

she O O
had O O
started O O
experiencing O O
mild O O
, O O
poorly O O
localised O B-C0522061
abdominal O I-C0522061
pain O I-C0522061
about O O
three O O
weeks O O
prior O O
to O O
presentation O O
and O O
the O O
day O O
before O O
presentation O O
she O O
started O O
bleeding O B-C0019080
vaginally O O
, O O
with O O
associated O O
mild O O
backache O B-C0004604
in O O
addition O O
to O O
the O O
pre-existing O O
abdominal O B-C0000737
pain O I-C0000737
. O O

the O O
bleeding O B-C0019080
was O O
light O O
and O O
she O O
did O O
not O O
develop O O
any O O
symptoms O O
for O O
significant O O
volume O O
loss O O
. O O

she O O
presented O O
to O O
her O O
gynaecologist O O
, O O
who O O
ordered O O
a O O
pelvic O O
ultrasound O O
scan O O
( O O
USS O O
) O O
as O O
part O O
of O O
the O O
evaluation O O
. O O

on O O
USS O O
, O O
an O O
HP O O
was O O
diagnosed O O
, O O
with O O
a O O
single O O
viable O O
intrauterine O O
foetus O O
and O O
a O O
demised O O
left O O
adnexal O O
foetus O O
and O O
she O O
was O O
referred O O
to O O
our O O
hospital O O
for O O
further O O
management O O
. O O

A O O
systemic O O
enquiry O O
was O O
done O O
which O O
was O O
unremarkable O O
with O O
no O O
constitutional O O
symptoms O O
. O O

she O O
did O O
not O O
have O O
any O O
significant O O
gastro-intestinal O O
and O O
genitourinary O O
symptoms O O
. O O

she O O
had O O
delivered O O
vaginally O O
in O O
her O O
two O O
previous O O
pregnancies O O
and O O
had O O
not O O
experienced O O
any O O
complications O O
. O O

she O O
was O O
HIV O B-C0481430
negative O I-C0481430
, O O
had O O
no O O
previous O O
history O O
of O O
treatment O O
for O O
sexually O B-C0036916
transmitted O I-C0036916
infections O I-C0036916
and O O
had O O
not O O
been O O
screened O O
for O O
cervical O B-C4048328
cancer O I-C4048328
before O O
. O O

she O O
did O O
not O O
have O O
any O O
significant O O
medical O O
and O O
surgical O O
history O O
. O O

she O O
was O O
of O O
sober O O
habits O O
, O O
unemployed O B-C0041674
and O O
stayed O O
with O O
her O O
partner O O
in O O
rented O O
accommodation O O
in O O
a O O
high-density O O
suburb O O
and O O
was O O
not O O
on O O
medical O O
insurance O O
. O O

physical O O
examination O O
: O O
she O O
was O O
fully O O
conscious O O
and O O
hemodynamically O O
stable O O
, O O
with O O
a O O
blood O O
pressure O O
of O O
123 O O
/ O O
87 O O
mmhg O O
and O O
a O O
pulse O O
rate O O
of O O
90 O O
beats O O
per O O
minute O O
. O O

her O O
temperature O O
was O O
36.7 O O
degrees O O
celsius O O
, O O
however O O
, O O
she O O
felt O O
hot O O
to O O
touch O O
. O O

she O O
had O O
mild O O
central O O
pallor O B-C0030232
. O O

the O O
abdominal O O
examination O O
was O O
unremarkable O O
. O O

the O O
uterus O O
was O O
not O O
palpable O O
above O O
the O O
symphysis O O
pubis O O
. O O

she O O
had O O
bilateral O O
adnexal O O
fullness O O
, O O
no O O
cervical O O
motion O O
tenderness O O
and O O
had O O
no O O
active O O
vaginal O B-C2979982
bleeding O I-C2979982
or O O
discharge O O
. O O

there O O
were O O
no O O
significant O O
findings O O
in O O
the O O
respiratory O O
, O O
cardiovascular O O
and O O
central O O
nervous O B-C0027769
systems O O
. O O

her O O
hemogram O O
revealed O O
a O O
neutrophilic O O
leucocytosis O O
of O O
18.3 O O
with O O
a O O
normocytic O O
anaemia O B-C0002871
( O O
hb O O
9.0 O O
, O O
MCV O O
83.0 O O
) O O
. O O

management O O
: O O
we O O
intended O O
to O O
take O O
the O O
patient O O
for O O
laparoscopy O O
. O O

however O O
, O O
due O O
to O O
theatre O O
constraints O O
we O O
did O O
a O O
laparotomy O O
. O O

A O O
pfannestiel O O
incision O O
was O O
fashioned O O
and O O
a O O
pyoperitoneum O O
of O O
about O O
100 O O
millilitres O O
was O O
encountered O O
on O O
entering O O
the O O
abdomen O O
. O O

we O O
then O O
did O O
a O O
midline O O
incision O O
to O O
visualise O O
all O O
quadrants O O
of O O
the O O
abdomen O O
. O O

A O O
left-sided O O
ruptured O O
fimbrial O O
ectopic O B-C0032987
pregnancy O I-C0032987
was O O
noted O O
and O O
a O O
left O O
salpingectomy O O
was O O
done O O
. O O

an O O
identifiable O O
foetus O O
was O O
noted O O
and O O
not O O
sent O O
for O O
histology O O
. O O

A O O
ruptured O O
appendix O O
with O O
a O O
well-organised O O
appendiceal O O
abscess O B-C0000833
was O O
also O O
noted O O
. O O

the O O
remnants O O
of O O
the O O
appendix O O
were O O
minimal O O
and O O
all O O
necrotic O B-C0027544
debris O I-C0027544
was O O
removed O O
. O O

the O O
rest O O
of O O
the O O
abdomen O O
was O O
normal O O
, O O
with O O
scanty O O
fibrinous O O
adhesions O O
. O O

A O O
saline O O
lavage O O
was O O
done O O
prior O O
to O O
closure O O
of O O
the O O
abdomen O O
. O O

due O O
to O O
overwhelming O O
necrosis O O
, O O
there O O
was O O
no O O
appendix O O
specimen O O
to O O
send O O
for O O
histology O O
. O O

outcome O O
: O O
post-operatively O O
, O O
the O O
patient O O
was O O
managed O O
on O O
intravenous O O
fluids O O
, O O
ceftriaxone O O
, O O
metronidazole O O
and O O
paracetamol O O
and O O
she O O
recovered O O
uneventfully O O
. O O

she O O
was O O
discharged O O
on O O
the O O
fifth O O
day O O
post O O
laparotomy O O
. O O

on O O
follow-up O O
review O O
at O O
two O O
weeks O O
patient O O
was O O
well O O
and O O
her O O
scar O B-C2004491
was O O
healing O O
well O O
. O O

the O O
pregnancy O O
continued O O
and O O
was O O
viable O O
on O O
USS O O
at O O
review O O
, O O
but O O
the O O
final O O
outcome O O
is O O
still O O
to O O
be O O
determined O O
. O O

A O O
five-year-old O O
girl O O
presented O O
to O O
the O O
pediatric O O
emergency O O
room O O
with O O
acute O O
onset O O
of O O
pain O B-C0030193
of O O
the O O
right O O
lower O O
limb O O
, O O
coldness O O
of O O
the O O
limb O O
and O O
inability O O
to O O
use O O
the O O
limb O O
. O O

the O O
patient O O
was O O
given O O
benzathine O O
penicillin O O
intramuscular O O
injection O O
on O O
the O O
same O O
limb O O
for O O
acute O O
on O O
chronic O B-C0149517
tonsillitis O I-C0149517
8 O O
hours O O
prior O O
to O O
presentation O O
. O O

the O O
right O O
lower O B-C0023222
limb O I-C0023222
pain O I-C0023222
was O O
associated O O
with O O
coldness O O
of O O
the O O
limb O O
and O O
dark O O
discoloration O O
. O O

the O O
pain O B-C0030193
and O O
discoloration O O
were O O
said O O
to O O
be O O
getting O O
worse O O
with O O
time O O
. O O

however O O
, O O
there O O
was O O
no O O
history O O
of O O
fevers O B-C0015967
, O O
trauma O O
, O O
sickle O B-C0002895
cell O I-C0002895
disease O I-C0002895
or O O
bleeding O B-C1458140
tendencies O I-C1458140
. O O

examination O O
revealed O O
swollen O O
right O O
lower O O
limb O O
with O O
dark O O
discoloration O O
from O O
the O O
toes O O
to O O
mid-thigh O O
as O O
in O O
figure O O
1 O O
. O O

the O O
leg O O
was O O
cold O B-C0009443
with O O
weak O B-C3714552
popliteal O O
and O O
dorsalis O O
pedis O O
pulses O O
compared O O
to O O
the O O
contralateral O O
limb O O
. O O

sensation O O
was O O
intact O O
and O O
power O O
was O O
zero O O
. O O

systemic O O
examination O O
was O O
unremarkable O O
. O O

A O O
diagnosis O O
of O O
compartment O B-C0009492
syndrome O I-C0009492
of O O
the O O
right O O
thigh O O
secondary O O
to O O
nicolau O B-C1142083
syndrome O I-C1142083
was O O
made O O
. O O

investigations O O
done O O
were O O
full O O
blood O O
count O O
( O O
FBC O O
) O O
, O O
urea O O
, O O
electrolytes O O
, O O
creatinine O O
, O O
liver O O
enzymes O O
, O O
INR O O
and O O
doppler O O
ultrasound O O
of O O
the O O
right O O
lower O O
limb O O
. O O

FBC O O
results O O
were O O
normal O O
. O O

urea O O
and O O
creatinine O O
were O O
elevated O O
13.5mmol O O
/ O O
l O O
and O O
242.2umol O O
/ O O
l O O
respectively O O
. O O

alanine O O
aminotransferase O O
( O O
ALT O O
) O O
and O O
aspartate O O
aminotransferase O O
( O O
AST O O
) O O
were O O
997.7U O O
/ O O
L O O
and O O
115.6IU O O
/ O O
L O O
. O O

international O O
normalization O O
ratio O O
( O O
INR O O
) O O
was O O
1.57 O O
. O O

an O O
emergency O O
fasciotomy O O
was O O
done O O
24hrs O O
after O O
presentation O O
after O O
surgeons O O
reviewed O O
the O O
patient O O
and O O
intra-op O O
findings O O
were O O
osteofascial O O
compartment O O
bulging O O
on O O
first O O
incision O O
with O O
free O O
clear O O
fluid O O
and O O
minimal O O
bleeding O B-C0019080
as O O
shown O O
in O O
figure O O
2 O O
. O O

patient O O
was O O
then O O
started O O
on O O
broad O O
spectrum O O
antibiotics O O
; O O
imipenem O O
250mg O O
thrice O O
a O O
day O O
( O O
TDS O O
) O O
IV O O
and O O
metronidazole O O
200mg O O
IV O O
and O O
analgesia O O
, O O
tramadol O O
25mg O O
twice O O
a O O
day O O
intramuscular O O
( O O
B.D O O
IM O O
) O O
. O O

the O O
acute O B-C2609414
kidney O I-C2609414
injury O I-C2609414
( O O
AKI O O
) O O
was O O
managed O O
conservatively O O
by O O
restricting O O
fluid O O
intake O O
and O O
avoiding O O
nephrotoxic O O
drugs O O
. O O

AKI O O
resolve O O
after O O
5 O O
days O O
with O O
urea O O
and O O
creatinine O O
dropping O O
to O O
3.36mmol O O
/ O O
l O O
and O O
37.26umol O O
/ O O
l O O
. O O

ALT O O
and O O
AST O O
also O O
dropped O O
to O O
64.1U O O
/ O O
L O O
and O O
180.3IU O O
/ O O
l O O
with O O
albumin O O
of O O
18.5g O O
/ O O
l O O
. O O

however O O
, O O
there O O
was O O
no O O
improvement O O
in O O
the O O
perfusion O O
of O O
the O O
right O O
leg O O
and O O
foot O O
two O O
days O O
after O O
fasciotomy O O
. O O

A O O
diagnosis O O
of O O
dry O O
gangrene O B-C0017086
was O O
made O O
and O O
patient O O
was O O
planned O O
for O O
a O O
below O O
knee O O
amputation O O
but O O
parents O O
denied O O
consent O O
. O O

the O O
parents O O
continued O O
being O O
counselled O O
on O O
the O O
need O O
for O O
an O O
amputation O O
. O O

after O O
4 O O
days O O
post O O
fasciotomy O O
, O O
patient O O
started O O
having O O
spiking O O
temperatures O O
despite O O
being O O
on O O
imipenem O O
. O O

the O O
swelling O B-C0038999
worsened O O
with O O
intense O O
pain O B-C0030193
in O O
the O O
right O O
thigh O O
and O O
right O O
thigh O O
skin O O
started O O
developing O O
blisters O B-C0005758
. O O

A O O
diagnosis O O
of O O
dry O O
gangrene O B-C0017086
with O O
superimposed O O
wet O O
gangrene O B-C0017086
was O O
made O O
13 O O
days O O
after O O
fasciotomy O O
as O O
indicated O O
in O O
figure O O
3 O O
. O O

parents O O
were O O
counselled O O
for O O
an O O
above O O
knee O O
amputation O O
but O O
consent O O
was O O
denied O O
again O O
. O O

patient O O
developed O O
convulsions O B-C0036572
which O O
were O O
attributed O O
to O O
raised O O
body O O
temperatures O O
. O O

the O O
seizures O O
were O O
controlled O O
by O O
diazepam O O
7mg O O
intravenous O O
( O O
I.V O O
) O O
stat O O
. O O

four O O
days O O
later O O
, O O
the O O
parents O O
accepted O O
for O O
an O O
above O O
knee O O
amputation O O
( O O
AKA O O
) O O
to O O
be O O
done O O
. O O

the O O
AKA O O
was O O
done O O
and O O
intra-op O O
findings O O
were O O
cooked O O
muscles O O
of O O
the O O
right O O
thigh O O
due O O
to O O
poor O O
perfusion O O
. O O

patient O O
was O O
then O O
put O O
on O O
ceftriaxone O O
, O O
metronidazole O O
and O O
tramadol O O
. O O

the O O
temperatures O O
settled O O
after O O
the O O
AKA O O
. O O

wound O O
was O O
then O O
exposed O O
after O O
24hrs O O
and O O
daily O O
cleaning O O
was O O
ordered O O
. O O

the O O
patient O O
was O O
later O O
discharge O O
and O O
she O O
is O O
currently O O
undergoing O O
occupational O O
therapy O O
sessions O O
at O O
the O O
physiotherapy O O
department O O
as O O
in O O
figure O O
4 O O
. O O

A O O
28 O O
- O O
year-old O O
woman O O
, O O
at O O
32 O O
weeks O O
of O O
pregnancy O O
, O O
without O O
significant O O
medical O O
history O O
, O O
presented O O
to O O
the O O
emergency O O
room O O
with O O
severe O O
abdominal O B-C0000737
pain O I-C0000737
in O O
the O O
right O O
flank O O
, O O
evolving O O
during O O
48 O O
hours O O
. O O

abdominal O O
palpation O O
revealed O O
tenderness O O
in O O
the O O
right O O
iliac O O
fossa O O
with O O
guarding O O
. O O

blood O O
test O O
demonstrated O O
an O O
inflammatory O O
syndrome O O
( O O
175 O O
mg O O
/ O O
l O O
of O O
c-reactive O O
protein O O
) O O
and O O
neutrophilic O O
hyperleukocytosis O O
. O O

two O O
abdominal O O
ultrasounds O O
were O O
performed O O
but O O
were O O
not O O
contributive O O
. O O

due O O
to O O
lack O O
of O O
clinical O O
improvement O O
and O O
increasing O O
inflammatory O O
parameters O O
, O O
an O O
abdominal O O
CT O O
scan O O
as O O
performed O O
and O O
showed O O
free O O
fluid O O
and O O
inflammation O O
medial O O
to O O
the O O
caecum O O
, O O
next O O
to O O
the O O
gravid O O
uterus O O
. O O

this O O
image O O
was O O
compatible O O
with O O
acute O B-C0085693
appendicitis O I-C0085693
. O O

laparoscopic O O
appendectomy O O
was O O
performed O O
. O O

conversion O O
to O O
laparotomy O O
was O O
required O O
due O O
to O O
the O O
hemodynamic O O
status O O
of O O
the O O
patient O O
. O O

an O O
inflamed O O
appendix O O
was O O
found O O
just O O
medial O O
to O O
the O O
caecum O O
with O O
necrosis O O
of O O
the O O
tip O O
and O O
a O O
macroscopically O O
healthy O O
base O O
. O O

free O O
fluid O O
was O O
present O O
in O O
the O O
right O O
iliac O O
fossa O O
. O O

the O O
postoperative O O
period O O
was O O
marked O O
by O O
ileus O B-C1258215
treated O O
by O O
a O O
nasogastric O O
tube O O
. O O

the O O
patient O O
went O O
into O O
early O O
labor O O
3 O O
days O O
after O O
surgery O O
and O O
delivered O O
a O O
healthy O O
baby O O
. O O

macroscopic O O
examination O O
of O O
the O O
appendectomy O O
specimen O O
revealed O O
a O O
7 O O
cm O O
long O O
appendage O O
with O O
a O O
maximum O O
diameter O O
of O O
3 O O
cm O O
. O O

the O O
appendiceal O O
wall O O
was O O
significantly O O
thickened O O
. O O

microscopic O O
examination O O
showed O O
a O O
proliferation O O
of O O
large O O
polygonal O O
decidual O O
cells O O
within O O
the O O
mesoappendix O O
, O O
characterized O O
by O O
abundant O O
eosinophilic O O
cytoplasm O O
and O O
nuclei O O
without O O
any O O
cytonuclear O O
atypia O O
. O O

mitotic O O
activity O O
was O O
not O O
observed O O
. O O

the O O
extensive O O
appendiceal O O
deciduosis O O
showed O O
strong O O
immunoreactivity O O
for O O
vimentin O O
, O O
without O O
expression O O
of O O
PLAP O O
, O O
broad-spectrum O O
cytokeratins O O
( O O
CK-AE1 O O
/ O O
AE3 O O
) O O
, O O
inhibin O O
, O O
CD68 O O
, O O
S100 O O
or O O
calretinin O O
. O O

the O O
differential O O
diagnosis O O
of O O
appendiceal O O
deciduosis O O
includes O O
decidualized O O
endometriosis O B-C0014175
. O O

in O O
the O O
current O O
case O O
, O O
no O O
endometrial O O
glands O O
were O O
identified O O
. O O

acute O O
inflammation O O
of O O
the O O
appendiceal O O
mucosa O O
was O O
histologically O O
confirmed O O
, O O
suggesting O O
that O O
appendiceal O O
deciduosis O O
might O O
have O O
caused O O
an O O
appendiceal O O
obstruction O O
and O O
subsequent O O
inflammation O O
. O O

A O O
66 O O
- O O
year-old O O
woman O O
went O O
to O O
the O O
breast O B-C1458155
tumor O I-C1458155
unit O O
of O O
our O O
center O O
after O O
being O O
diagnosed O O
with O O
left-sided O O
BC O O
by O O
excisional O O
biopsy O O
and O O
having O O
undergone O O
a O O
modified O O
radical O O
mastectomy O O
. O O

the O O
histopathological O O
report O O
revealed O O
a O O
moderately O O
differentiated O O
infiltrating O B-C1134719
ductal O I-C1134719
adenocarcinoma O I-C1134719
of O O
3.5 O O
x O O
1.5 O O
cm O O
in O O
diameter O O
, O O
with O O
extensive O O
angiolymphatic O O
invasion O O
and O O
surgical O O
resection O O
margins O O
free O O
of O O
neoplasia O B-C0027651
; O O
1 O O
of O O
14 O O
dissected O O
axillary O O
nodes O O
was O O
positive O O
for O O
neoplasia O B-C0027651
. O O

immunohistochemical O O
analysis O O
revealed O O
negativity O O
for O O
ER O O
, O O
PR O O
, O O
and O O
HER2 O O
, O O
being O O
classified O O
as O O
TNBC O O
. O O

initial O O
imaging O O
studies O O
did O O
not O O
reveal O O
distant O O
metastatic O B-C2939419
disease O I-C2939419
. O O

after O O
evaluating O O
the O O
case O O
by O O
a O O
multidisciplinary O O
team O O
, O O
it O O
was O O
decided O O
to O O
administer O O
adjuvant O O
treatment O O
based O O
on O O
anthracyclines O O
and O O
taxanes O O
at O O
standard O O
doses O O
, O O
as O O
well O O
as O O
radiotherapy O O
. O O

one O O
year O O
after O O
the O O
end O O
of O O
the O O
treatment O O
, O O
recurrence O O
of O O
the O O
disease O O
characterized O O
by O O
neoplastic O O
infiltration O O
of O O
the O O
femoral O O
head O O
and O O
T5 O O
and O O
T7 O O
vertebrae O O
was O O
demonstrated O O
by O O
bone O O
scan O O
, O O
as O O
well O O
as O O
a O O
metastatic O O
lesion O B-C0221198
in O O
segment O O
V O O
of O O
the O O
right O O
hepatic O O
lobe O O
of O O
2.6 O O
x O O
1.9 O O
cm O O
by O O
tomography O O
. O O

we O O
started O O
systemic O O
treatment O O
based O O
on O O
gemcitabine O O
and O O
zoledronic O O
acid O O
due O O
to O O
bone O B-C0005940
disease O I-C0005940
. O O

after O O
5 O O
cycles O O
of O O
this O O
regimen O O
, O O
a O O
disease O B-C0242656
progression O I-C0242656
characterized O O
by O O
an O O
increase O O
in O O
the O O
initial O O
target O O
hepatic O O
lesion O B-C0221198
was O O
observed O O
, O O
as O O
well O O
as O O
a O O
new O O
metastatic O O
lesion O B-C0221198
in O O
the O O
right O O
kidney O O
. O O

we O O
then O O
initiated O O
second-line O O
chemotherapy O O
with O O
capecitabine O O
at O O
a O O
standard O O
dose O O
. O O

after O O
1 O O
cycle O O
, O O
our O O
team O O
decided O O
to O O
suspend O O
this O O
drug O O
based O O
on O O
toxicity O B-C0600688
characterized O O
by O O
G3 O O
mucositis O B-C0333355
. O O

immunohistochemistry O O
was O O
requested O O
for O O
the O O
determination O O
of O O
AR O O
, O O
which O O
was O O
positive O O
without O O
specifying O O
the O O
percentage O O
of O O
AR O O
expression O O
. O O

we O O
started O O
AT O O
with O O
bicalutamide O O
at O O
a O O
dose O O
of O O
50 O O
mg O O
daily O O
, O O
achieving O O
disease O O
control O O
. O O

at O O
50 O O
months O O
from O O
the O O
start O O
of O O
this O O
treatment O O
, O O
the O O
patient O O
remains O O
in O O
stable O O
disease O O
, O O
without O O
any O O
toxicity O B-C0600688
associated O O
with O O
AT O O
. O O

A O O
72 O O
- O O
years-old O O
female O O
presented O O
with O O
fatigue O B-C0015672
, O O
iterative O O
episodes O O
of O O
fainting O B-C0039070
with O O
two O O
episodes O O
of O O
exertional O B-C0235242
syncope O I-C0235242
evolving O O
for O O
the O O
last O O
6 O O
months O O
. O O

the O O
patient O O
had O O
been O O
followed O O
for O O
idiopathic O B-C0920163
thrombocytopenia O I-C0920163
diagnosed O O
five O O
years O O
ago O O
and O O
treated O O
with O O
folic O O
acid O O
and O O
corticosteroids O O
. O O

the O O
idiopathic O O
origin O O
of O O
this O O
thrombocytopenia O B-C0040034
has O O
been O O
retained O O
after O O
having O O
carried O O
out O O
a O O
paraclinical O O
assessment O O
including O O
negative O O
viral O O
serologies O O
, O O
a O O
bone O O
marrow O O
biopsy O O
confirming O O
the O O
peripheral O O
origin O O
of O O
the O O
thrombocytopenia O B-C0040034
by O O
showing O O
increased O O
megakaryocytes O O
, O O
immunological O O
laboratory O O
tests O O
that O O
were O O
normal O O
, O O
and O O
an O O
immunoelectrophoresis O O
of O O
protein O O
that O O
was O O
unremarkable O O
. O O

no O B-C4313309
anemia O I-C4313309
, O O
negative O O
coomb's O O
test O O
, O O
normal O O
lactate O O
dehydrogenase O O
, O O
and O O
normal O O
haptoglobin O O
levels O O
were O O
noted O O
. O O

her O O
medical O O
history O O
is O O
unremarkable O O
for O O
cardiovascular O B-C0007222
disease O I-C0007222
and O O
cardiovascular O B-C0850624
risk O I-C0850624
factors O I-C0850624
. O O

on O O
physical O O
examination O O
, O O
she O O
had O O
normal O B-C2712122
blood O I-C2712122
pressure O I-C2712122
at O O
120 O O
/ O O
70mmhg O O
, O O
no O O
orthostatic O B-C0020651
hypotension O I-C0020651
, O O
her O O
heart O O
rate O O
was O O
at O O
75bpm O O
. O O

her O O
cardiac O O
auscultation O O
revealed O O
regular O O
rhythm O O
, O O
a O O
soft O O
grade O O
1 O O
/ O O
6 O O
systolic O B-C0232257
murmur O I-C0232257
at O O
the O O
apex O O
. O O

she O O
had O O
no O O
signs O O
of O O
heart O B-C0018801
failure O I-C0018801
. O O

there O O
was O O
no O O
murmur O B-C0018808
at O O
auscultation O O
of O O
carotids O O
. O O

no O B-C1856555
splenomegaly O I-C1856555
or O O
hepatomegaly O B-C0019209
was O O
noted O O
. O O

her O O
platelet O O
count O O
was O O
low O O
at O O
18,000 O O
/ O O
mm O O
3 O O
, O O
hemoglobin O O
level O O
at O O
13.2 O O
g O O
/ O O
dl O O
, O O
renal O O
and O O
hepatic O O
function O O
were O O
normal O O
. O O

c-reactive O O
protein O O
level O O
was O O
normal O O
at O O
9 O O
mg O O
/ O O
l O O
. O O

electrocardiography O O
( O O
ECG O O
) O O
showed O O
a O O
regular O O
sinus O O
rhythm O O
, O O
without O O
arrhythmia O B-C0003811
or O O
repolarization O B-C3279217
abnormalities O I-C3279217
. O O

on O O
holter O O
ECG O O
monitoring O O
, O O
short O O
bursts O O
of O O
supraventricular O O
premature O B-C0340464
beats O I-C0340464
were O O
registered O O
. O O

transthoracic O O
echocardiography O O
showed O O
an O O
oval-shaped O O
mass O O
in O O
the O O
left O O
atrium O O
. O O

the O O
mass O O
is O O
lobular O O
, O O
non-homogenous O O
, O O
appended O O
to O O
the O O
inter-atrial O O
septum O O
, O O
in O O
motion O O
, O O
pushing O O
on O O
the O O
anterior O O
mitral O O
leaflet O O
without O O
prolapsing O O
into O O
the O O
mitral O O
valve O O
. O O

there O O
was O O
mild O B-C0264765
mitral O I-C0264765
regurgitation O I-C0264765
. O O

the O O
size O O
and O O
function O O
of O O
both O O
ventricles O O
were O O
normal O O
. O O

on O O
transesophageal O O
echocardiography O O
morphological O O
features O O
of O O
the O O
mass O O
were O O
consistent O O
with O O
myxoma O B-C0027149
: O O
the O O
mass O O
measuring O O
53 O O
/ O O
32 O O
, O O
was O O
shaped O O
like O O
a O O
tennis O O
racquet O O
, O O
with O O
poorly-defined O O
edged O O
evoking O O
its O O
friable O O
aspect O O
, O O
it O O
has O O
a O O
heterogeneous O O
appearance O O
with O O
hypoechoic O O
areas O O
probably O O
related O O
to O O
focal O O
necrosis O O
, O O
it O O
is O O
attached O O
to O O
the O O
interatrial O O
septum O O
by O O
several O O
filamentous O O
attachments O O
allowing O O
its O O
high O O
mobility O O
. O O

the O O
mass O O
rests O O
on O O
the O O
anterior O O
leaflet O O
of O O
the O O
mitral O O
valve O O
, O O
which O O
throws O O
it O O
high O O
as O O
it O O
closes O O
, O O
and O O
it O O
prolapses O B-C0033377
indeed O O
sometimes O O
into O O
the O O
valve O O
presenting O O
its O O
closure O O
. O O

cardiac O O
magnetic O O
resonance O O
imaging O O
confirmed O O
the O O
echocardiographic O O
findings O O
. O O

the O O
patient O O
underwent O O
surgery O O
by O O
an O O
approach O O
using O O
median O O
sternotomy O O
and O O
cardiopulmonary O O
bypass O O
, O O
with O O
perfusion O O
of O O
platelet O O
concentrates O O
before O O
and O O
during O O
surgery O O
, O O
surgical O O
exploration O O
confirmed O O
echocardiographic O O
findings O O
and O O
macroscopic O O
aspect O O
of O O
the O O
tumor O B-C0027651
evoked O O
myxoma O B-C0027149
. O O

total O O
excision O O
of O O
tumor O B-C0027651
including O O
the O O
pedicle O O
was O O
performed O O
. O O

pathology O O
confirmed O O
the O O
diagnosis O O
of O O
cardiac O O
myxoma O B-C0027149
. O O

after O O
a O O
postoperative O O
stay O O
in O O
unit O O
care O O
and O O
careful O O
monitoring O O
of O O
bleeding O B-C0019080
, O O
the O O
patient O O
was O O
discharged O O
and O O
has O O
been O O
doing O O
well O O
. O O

two O O
weeks O O
postoperatively O O
, O O
the O O
patient O O
was O O
asymptomatic O O
, O O
with O O
a O O
normal O O
cardiovascular O O
exam O O
. O O

platelet O O
count O O
was O O
gradually O O
increased O O
to O O
reach O O
95 O O
- O O
103 O O
/ O O
µl O O
after O O
6 O O
months O O
postoperatively O O
, O O
echocardiography O O
showed O O
vacuity O O
of O O
the O O
left O O
atrium O O
, O O
with O O
normal O O
mitral O O
valve O O
leaflets O O
and O O
a O O
mild O O
regurgitation O O
. O O

female O O
patient O O
, O O
from O O
morocco O O
, O O
has O O
3 O O
years O O
, O O
non-consanguineous O O
, O O
the O O
second O O
of O O
two O O
siblings O O
, O O
was O O
referred O O
to O O
the O O
medical O O
genetic O O
department O O
of O O
the O O
mohammed O O
VI O O
university O O
hospital O O
in O O
marrakech O O
for O O
a O O
dysmorphic O O
syndrome O O
, O O
seizures O O
, O O
delayed O B-C0456070
growth O I-C0456070
, O O
hypothyroidism O B-C0020676
and O O
hypotonia O B-C0026827
. O O

the O O
parents O O
and O O
the O O
older O O
sister O O
were O O
healthy O O
, O O
38 O O
- O O
year-old O O
mother O O
and O O
40 O O
- O O
year-old O O
father O O
. O O

the O O
girl O O
was O O
resulting O O
from O O
a O O
followed O O
pregnancy O O
, O O
carried O O
to O O
term O O
, O O
without O O
notion O O
of O O
teratogenic O O
drug O O
intake O O
. O O

the O O
delivery O O
took O O
place O O
by O O
cesarean O O
section O O
( O O
oligo-amnios O O
+ O O
acute O O
fetal O O
pain O B-C0030193
) O O
, O O
with O O
intra-uterine O O
growth O B-C0151686
retardation O I-C0151686
: O O
birth O O
weight O O
= O O
1 O O
kg O O
850 O O
, O O
size O O
= O O
44 O O
cm O O
, O O
cranial O O
perimeter O O
= O O
33 O O
cm O O
and O O
neonatal O B-C2267233
hypotonia O I-C2267233
. O O

the O O
girl O O
presented O O
a O O
neonatal O O
infection O B-C3714514
, O O
developmental O B-C0424605
delay O I-C0424605
, O O
transient O B-C0271795
hypothyroidism O I-C0271795
treated O O
for O O
05 O O
months O O
with O O
the O O
notion O O
of O O
a O O
single O O
convulsive O O
attack O O
at O O
the O O
age O O
of O O
05 O O
months O O
without O O
treatment O O
. O O

the O O
clinical O O
examination O O
revealed O O
: O O
a O O
microcephaly O B-C0025958
( O O
cranial O O
perimeter O O
= O O
44 O O
cm O O
( O O
- O O
2 O O
standard O O
deviation O O
) O O
) O O
, O O
low O B-C0041667
body O I-C0041667
weight O I-C0041667
( O O
weight O O
= O O
7 O O
kg O O
( O O
- O O
3 O O
standard O O
deviation O O
) O O
) O O
, O O
short O B-C0349588
stature O I-C0349588
( O O
size O O
= O O
80 O O
cm O O
( O O
- O O
2 O O
standard O O
deviation O O
) O O
) O O
; O O
hypotonia O B-C0026827
, O O
the O O
horizontal O B-C3277019
eyebrows O I-C3277019
, O O
sunken O B-C0423224
eyes O I-C0423224
, O O
no O O
space O O
between O O
the O O
eyebrows O O
and O O
the O O
eyes O O
, O O
a O O
worried O B-C0233481
look O O
, O O
a O O
hypertelorism O B-C0020534
, O O
the O O
broad O O
root O O
of O O
the O O
nose O O
, O O
midface O B-C1853242
hypoplasia O I-C1853242
, O O
the O O
erased O O
philtrum O O
an O O
ogival O O
palate O O
, O O
brachydactyly O B-C0221357
, O O
clinodactyly O B-C4551485
of O O
the O O
fifth O O
finger O O
and O O
a O O
bilateral O O
valgus O B-C0042282
of O O
the O O
feet O O
. O O

the O O
patient O O
underwent O O
whole O O
skeleton O O
radiographs O O
showing O O
delayed O B-C0541764
bone O I-C0541764
age O I-C0541764
. O O

there O O
were O O
no O O
other O O
malformations O O
or O O
organ O O
dysfunctions O O
. O O

in O O
front O O
of O O
the O O
facial O O
dysmorphia O O
and O O
other O O
clinical O O
features O O
as O O
well O O
as O O
the O O
radiological O O
explorations O O
the O O
diagnosis O O
to O O
evoke O O
in O O
our O O
patient O O
is O O
the O O
deletion O O
syndrome O O
1p36 O O
. O O

A O O
molecular O O
cytogenetic O O
study O O
, O O
by O O
fluorescence O O
in O O
situ O O
hybridization O O
( O O
FISH O O
) O O
, O O
specific O O
locus O O
probe O O
set O O
( O O
LSI O O
p58 O O
( O O
1p36 O O
) O O
spectrum O O
orange O O
/ O O
telvysion O O
1p O O
spectrum O O
green O O
/ O O
LSI O O
1q25 O O
spectrum O O
aqua O O
) O O
was O O
performed O O
and O O
confirmed O O
the O O
presence O O
of O O
a O O
heterozygous O O
microdeletion O O
in O O
1p36 O O
: O O
ish O O
del O O
( O O
1 O O
) O O
( O O
p36p36 O O
) O O
( O O
p58 O O
- O O
/ O O
tel O O
1p O O
- O O
) O O
. O O

an O O
83 O O
- O O
year-old O O
man O O
with O O
a O O
medical O O
history O O
of O O
diabetes O B-C0011849
mellitus O I-C0011849
, O O
overt O O
cardiovascular O B-C0007222
disease O I-C0007222
, O O
a O O
10 O O
months O O
history O O
of O O
stage O O
III O O
chronic O B-C1561643
kidney O I-C1561643
disease O I-C1561643
and O O
haematuria O B-C0018965
was O O
referred O O
to O O
our O O
hospital O O
for O O
dyspnoea O B-C0013404
, O O
atypical O B-C0262384
chest O I-C0262384
pain O I-C0262384
and O O
persistent O O
light-headedness O B-C0220870
. O O

the O O
patient O O
experienced O O
a O O
syncopal O B-C0751534
episode O I-C0751534
after O O
a O O
strenuous O O
effort O O
. O O

physical O O
examination O O
revealed O O
a O O
stable O O
hemodynamic O O
status O O
, O O
a O O
pulsus O O
parvus O O
and O O
an O O
increased O O
intensity O O
of O O
pulmonic O O
component O O
of O O
the O O
second O O
heart O O
sound O O
. O O

electrocardiography O O
revealed O O
no O B-C3809765
abnormalities O I-C3809765
except O O
for O O
a O O
low O O
QRS O O
voltage O O
in O O
limb O O
leads O O
. O O

laboratory O O
findings O O
highlighted O O
a O O
normocytic O O
normochromic O O
regenerative O O
anaemia O B-C0002871
, O O
thrombocytopenia O B-C0040034
and O O
noted O O
high O O
levels O O
of O O
CA19 O O
- O O
9 O O
. O O

the O O
transthoracic O O
echocardiography O O
( O O
TTE O O
) O O
readily O O
showed O O
two O O
distinct O O
masses O O
occupying O O
the O O
right O O
ventricle O O
outflow O O
tract O O
measuring O O
respectively O O
15 O O
x O O
9 O O
mm O O
and O O
14 O O
x O O
7 O O
mm O O
, O O
and O O
a O O
large O O
well-defined O O
mass O O
( O O
22 O O
x O O
33mm O O
) O O
in O O
the O O
right O O
atrium O O
attached O O
to O O
the O O
inter O O
atrial O O
septum O O
, O O
a O O
subcostal O O
view O O
revealed O O
that O O
the O O
mass O O
seemed O O
to O O
originate O O
from O O
the O O
inferior O O
vena O O
cava O O
( O O
IVC O O
) O O
, O O
hence O O
suggestive O O
of O O
a O O
thrombus O B-C0087086
. O O

computed O O
tomography O O
scan O O
of O O
the O O
chest O O
and O O
abdomen O O
were O O
undergone O O
to O O
rule O O
out O O
any O O
primary O O
malignancy O B-C0006826
. O O

it O O
consistently O O
showed O O
that O O
the O O
mass O O
is O O
extending O O
from O O
the O O
IVC O O
to O O
the O O
right O O
atrium O O
, O O
along O O
with O O
another O O
mass O O
situated O O
in O O
the O O
right O O
ventricle O O
, O O
without O O
evidence O O
of O O
pulmonary O B-C0034065
embolism O I-C0034065
. O O

moreover O O
, O O
we O O
noted O O
a O O
dilation O O
of O O
the O O
right O O
urinary O O
tract O O
associated O O
to O O
ureteral O O
wall O O
thickening O O
highly O O
suggestive O O
of O O
a O O
tumour O B-C0027651
, O O
considering O O
the O O
history O O
of O O
haematuria O B-C0018965
and O O
the O O
presence O O
of O O
malignant O O
cells O O
in O O
urine O O
samples O O
. O O

in O O
light O O
of O O
this O O
, O O
anticoagulation O O
with O O
intravenous O O
unfractionated O O
heparin O O
was O O
initiated O O
with O O
echocardiographic O O
follow-up O O
. O O

the O O
patient O O
didn't O O
experience O O
haematuria O B-C0018965
or O O
any O O
external O O
bleeding O B-C0019080
in O O
the O O
following O O
days O O
. O O

yet O O
, O O
after O O
six O O
days O O
of O O
heparin O O
therapy O O
, O O
the O O
patient O O
presented O O
acute O B-C0264490
respiratory O I-C0264490
failure O I-C0264490
and O O
hemodynamic O B-C0948268
instability O I-C0948268
refractory O O
to O O
intensive O O
medical O O
care O O
. O O

the O O
patient O O
died O B-C1546956
shortly O O
after O O
. O O

A O O
40 O O
- O O
year-old O O
moroccan O O
patient O O
, O O
living O O
in O O
tangier O B-C0039292
province O O
, O O
without O O
any O O
medical O O
history O O
. O O

admitted O O
from O O
a O O
provincial O O
hospital O O
for O O
headache O B-C0018681
with O O
influenza-like O O
illness O O
plus O O
anosmia O B-C0003126
evolving O O
for O O
3 O O
days O O
. O O

the O O
history O O
of O O
its O O
symptoms O O
reveals O O
a O O
recent O O
flu O B-C0021400
syndrome O O
associated O O
with O O
a O O
loss O B-C0003126
of O I-C0003126
smell O I-C0003126
and O O
cough O B-C0010200
in O O
the O O
context O O
of O O
the O O
COVID O O
- O O
19 O O
epidemic O O
. O O

patient O O
suspected O O
of O O
a O O
case O O
of O O
COVID O O
- O O
19 O O
is O O
placed O O
under O O
isolation O B-C0260397
and O O
the O O
PCR O O
and O O
the O O
nasal O O
swab O O
taken O O
. O O

during O O
his O O
isolation O B-C0260397
he O O
had O O
two O O
episodes O O
of O O
convulsion O B-C4048158
with O O
vomiting O B-C0042963
. O O

after O O
stopping O O
the O O
convulsive O B-C0751494
seizures O I-C0751494
with O O
medical O O
treatment O O
, O O
he O O
was O O
evacuated O O
in O O
our O O
hospital O O
( O O
military O O
hospital O O
of O O
rabat O O
) O O
. O O

medical O O
examen O O
in O O
our O O
hospital O O
. O O

the O O
interrogation O O
found O O
a O O
progressive O O
decrease O O
in O O
progressive O O
visual O O
acuity O O
. O O

with O O
two O O
episodes O O
of O O
vomiting O B-C0042963
and O O
partial O B-C0751495
seizures O I-C0751495
with O O
recent O O
secondary O B-C2674108
generalization O I-C2674108
in O O
a O O
context O O
of O O
influenza O B-C0021400
like O O
illness O O
. O O

the O O
admission O O
clinic O O
exam O O
; O O
after O O
the O O
barrier O O
measurements O O
and O O
temperature O O
measurement O O
, O O
it O O
is O O
placed O O
in O O
isolation O B-C0260397
pending O O
the O O
result O O
of O O
the O O
COVID O O
- O O
19 O O
PCR O O
and O O
the O O
sampling O O
of O O
the O O
nasal O O
swab O O
. O O

secondary O O
after O O
the O O
negative O O
result O O
of O O
the O O
PCR O O
, O O
the O O
second O O
clinical O O
examination O O
founded O O
a O O
conscious O O
patient O O
, O O
glascow O O
coma O O
scale O O
= O O
15 O O
/ O O
15 O O
, O O
temperature O O
is O O
37.8 O O
° O O
C O O
, O O
and O O
his O O
neck O O
is O O
flexible O O
. O O

neurogically O O
standing O O
and O O
walking O O
are O O
possible O O
and O O
the O O
examen O O
of O O
muscle O O
strength O O
is O O
normal O O
to O O
the O O
4 O O
limbs O O
. O O

the O O
osteotendinous O O
reflexes O O
are O O
also O O
normal O O
and O O
the O O
cutaneo O O
plantar O O
reflexes O O
are O O
in O O
bilateral O O
flexion O O
. O O

the O O
examination O O
of O O
the O O
cranial O O
nerves O O
reveals O O
anosmia O B-C0003126
indicating O O
damage O O
to O O
the O O
first O O
pair O O
of O O
cranial O O
nerves O O
. O O

the O O
visual O O
acuity O O
was O O
preserved O O
in O O
both O O
eyes O O
. O O

the O O
visual O O
field O O
in O O
bed O O
shows O O
an O O
anomaly O O
of O O
the O O
bilateral O O
nasal O O
visual O O
field O O
. O O

the O O
fundus O O
shows O O
grade O O
1 O O
papillary O O
oedema O B-C0013604
. O O

pulmonary O O
auscultation O O
shows O O
fine O O
crackles O B-C0034642
in O O
the O O
lung O O
bases O O
in O O
a O O
eupneic O O
patient O O
with O O
98% O O
saturation O O
in O O
ambient O O
air O O
. O O

the O O
rest O O
of O O
the O O
somatic O O
examination O O
is O O
unremarkable O O
, O O
in O O
particular O O
cardiac O O
, O O
digestive O O
and O O
cutaneous O O
. O O

it's O O
a O O
case O O
of O O
anosmia O B-C0003126
plus O O
secondary O O
epilepsy O B-C0014544
associated O O
with O O
influenza-like O O
illness O O
in O O
a O O
40 O O
- O O
year-old O O
patient O O
during O O
COVID O O
- O O
19 O O
pandemic O O
. O O

the O O
biological O O
assessment O O
shows O O
a O O
protein O O
reactive O O
C O O
= O O
45 O O
with O O
11,000 O O
white O O
blood O O
cells O O
with O O
predominance O O
of O O
polynucleosis O O
. O O

the O O
chest O O
x-ray O O
is O O
normal O O
. O O

then O O
we O O
performed O O
a O O
cerebral O O
CT O O
scan O O
which O O
show O O
a O O
slightly O O
rounded O O
hyper-density O O
process O O
of O O
the O O
extra O O
axial O O
front O O
floor O O
sitting O O
at O O
the O O
olfactory O O
groove O O
area O O
with O O
significant O O
hypo-density O O
peri-lesional O O
oedema O B-C0013604
on O O
the O O
toe O O
finger O O
more O O
marked O O
on O O
the O O
right O O
and O O
hyper-osterosis O O
in O O
regard O O
of O O
the O O
lesion O B-C0221198
. O O

secondary O O
the O O
cerebral O O
MRI O O
scan O O
revelead O O
the O O
presence O O
4x4x4 O O
cm O O
well O O
enhanced O O
meningioma O B-C0025286
extra O O
axial O O
mass O O
of O O
the O O
anterior O O
skull O O
base O O
with O O
peri-tumoral O O
oedema O B-C0013604
corresponding O O
to O O
an O O
olfactory O B-C1335107
groove O I-C1335107
meningioma O I-C1335107
. O O

patient O O
was O O
prepared O O
and O O
operated O O
. O O

the O O
tumour O B-C0027651
was O O
totally O O
resected O O
through O O
a O O
left O O
fronto-lateral O O
approach O O
. O O

the O O
postoperative O O
courses O O
were O O
un-eventful O O
with O O
the O O
persistence O O
of O O
totally O O
anosmia O B-C0003126
. O O

A O O
38 O O
- O O
years-old O O
male O O
, O O
with O O
known O O
history O O
of O O
hypertension O B-C0020538
, O O
obesity O B-C0028754
and O O
gallstones O B-C0008350
, O O
presented O O
in O O
the O O
emergency O O
room O O
with O O
abdominal O B-C0000737
pain O I-C0000737
in O O
the O O
upper O O
right O O
quadrant O O
that O O
radiated O O
to O O
the O O
right O O
shoulder O O
. O O

after O O
clinical O O
, O O
laboratory O O
and O O
ultrasound O O
evaluation O O
, O O
the O O
diagnosis O O
of O O
acute O B-C0149520
cholecystitis O I-C0149520
was O O
established O O
. O O

he O O
was O O
admitted O O
for O O
a O O
laparoscopic O O
cholecystectomy O O
. O O

intraoperatively O O
, O O
an O O
acute O O
gangrenous O O
cholecystitis O B-C0008325
with O O
a O O
contained O O
perforation O O
was O O
found O O
. O O

due O O
to O O
the O O
marked O O
inflammation O O
, O O
dissection O O
of O O
the O O
hilum O O
and O O
the O O
gallbladder O O
was O O
laborious O O
and O O
gallstones O B-C0008350
leaked O O
out O O
of O O
the O O
gallbladder O O
. O O

this O O
was O O
identified O O
and O O
an O O
abundant O O
peritoneal O O
lavage O O
was O O
performed O O
as O O
well O O
as O O
an O O
attempt O O
to O O
remove O O
all O O
leaked O O
gallstones O B-C0008350
. O O

no O O
more O O
intra O O
or O O
postoperative O B-C0032787
complications O I-C0032787
were O O
recorded O O
, O O
and O O
the O O
patient O O
was O O
discharged O O
on O O
the O O
5 O O
th O O
postoperative O O
day O O
after O O
antibiotic O O
therapy O O
with O O
piperacillin O O
/ O O
tazobactam O O
, O O
completely O O
asymptomatic O O
. O O

in O O
a O O
follow-up O O
appointment O O
, O O
1 O O
month O O
after O O
surgery O O
, O O
the O O
patient O O
reported O O
new O O
onset O O
of O O
abdominal O B-C0000737
pain O I-C0000737
, O O
at O O
the O O
upper O O
right O O
quadrant O O
, O O
with O O
progressive O O
worsening O O
. O O

upon O O
observation O O
, O O
he O O
was O O
sweaty O O
, O O
with O O
pain O B-C0030193
at O O
the O O
superficial O O
and O O
deep O O
palpation O O
of O O
the O O
right O O
hypochondrium O O
. O O

for O O
that O O
reason O O
, O O
he O O
was O O
referred O O
to O O
the O O
emergency O O
room O O
. O O

due O O
to O O
the O O
recent O O
history O O
of O O
surgery O O
, O O
it O O
was O O
decided O O
to O O
perform O O
laboratory O O
and O O
imaging O O
investigation O O
. O O

the O O
blood O O
work O O
showed O O
leukocytosis O B-C0023518
without O O
neutrophilia O B-C0151683
and O O
elevated O O
PCR O O
. O O

the O O
computerized O O
tomography O O
( O O
CT O O
) O O
scan O O
revealed O O
: O O
“ O O
in O O
the O O
right O O
hypochondrium O O
, O O
at O O
the O O
transverse O O
and O O
internal O O
oblique O O
muscles O O
, O O
a O O
marked O O
thickening O O
with O O
69x31x26 O O
mm O O
, O O
with O O
a O O
poorly O O
defined O O
margin O O
and O O
with O O
densification O O
of O O
the O O
surrounding O O
fat O O
, O O
and O O
an O O
image O O
of O O
hyper-attenuation O O
with O O
9mm O O
” O O
. O O

an O O
ultrasound O O
was O O
made O O
to O O
clarify O O
these O O
findings O O
: O O
“ O O
a O O
pericentrimetric O O
calcification O O
is O O
observed O O
in O O
the O O
abdominal O O
wall O O
, O O
about O O
6 O O
cm O O
deep O O
from O O
the O O
cutaneous O O
surface O O
, O O
with O O
adjacent O O
pseudonodular O O
densification O O
” O O
. O O

these O O
findings O O
were O O
compatible O O
with O O
a O O
migrated O O
stone O O
and O O
small O O
surrounding O O
collection O O
. O O

the O O
patient O O
was O O
discharged O O
with O O
the O O
indication O O
for O O
antibiotics O O
therapy O O
( O O
amoxicillin O O
+ O O
clavulanic O O
acid O O
) O O
and O O
analgesia O O
. O O

the O O
complaints O O
disappeared O O
and O O
it O O
was O O
decided O O
to O O
keep O O
an O O
expectant O O
attitude O O
. O O

the O O
patient O O
maintained O O
regular O O
follow-up O O
and O O
reported O O
intermittent O O
pain O B-C0030193
in O O
the O O
referred O O
region O O
but O O
not O O
disabling O O
. O O

for O O
that O O
reason O O
, O O
elective O O
removal O O
of O O
the O O
gallstone O O
was O O
proposed O O
. O O

before O O
elective O O
surgery O O
, O O
he O O
returned O O
to O O
the O O
emergency O O
department O O
with O O
severe O O
abdominal O B-C0000737
pain O I-C0000737
associated O O
with O O
fever O B-C0015967
and O O
an O O
upper O O
right O O
abdominal O O
tumefaction O O
. O O

abdominal O O
exam O O
showed O O
a O O
hard O O
, O O
painful O O
mass O O
with O O
inflammatory O O
signs O O
on O O
the O O
right O O
hypochondrium O O
. O O

laboratory O O
work O O
revealed O O
leukocytosis O B-C0023518
without O O
neutrophilia O B-C0151683
and O O
a O O
new O O
ultrasound O O
and O O
CT O O
scan O O
showed O O
thickening O O
of O O
the O O
abdominal O O
wall O O
, O O
that O O
echographically O O
translated O O
a O O
hypoechoic O O
formation O O
of O O
6x5 O O
cm O O
and O O
may O O
correspond O O
to O O
an O O
abscess O B-C0000833
and O O
/ O O
or O O
phlegm O O
with O O
possible O O
liquefaction O O
. O O

also O O
, O O
a O O
prominent O O
external O O
anterior O O
parietal O O
thickening O O
measuring O O
8x6 O O
cm O O
, O O
with O O
two O O
deep O O
calcifications O B-C0006663
of O O
10 O O
and O O
8 O O
mm O O
, O O
one O O
most O O
likely O O
a O O
chondral O O
alteration O O
and O O
the O O
other O O
a O O
possible O O
gallstone O O
” O O
. O O

an O O
abscess O B-C0000833
of O O
the O O
abdominal O O
wall O O
due O O
to O O
a O O
foreign O B-C0016542
body O I-C0016542
( O O
gallstone O O
) O O
was O O
diagnosed O O
. O O

the O O
patient O O
completed O O
one O O
week O O
of O O
antibiotics O O
and O O
underwent O O
surgery O O
, O O
under O O
general O O
anesthesia O B-C0278134
. O O

at O O
that O O
time O O
, O O
there O O
was O O
no O O
evidence O O
of O O
abscess O B-C0000833
on O O
the O O
abdominal O O
wall O O
and O O
a O O
foreign O B-C0018193
body O I-C0018193
granuloma O I-C0018193
was O O
found O O
occupying O O
the O O
entire O O
abdominal O O
wall O O
, O O
with O O
a O O
pigmented O O
gallstone O O
in O O
pre-peritoneal O O
position O O
. O O

so O O
, O O
extraction O O
of O O
the O O
gallstone O O
and O O
the O O
respective O O
foreign O B-C0018193
body O I-C0018193
granuloma O I-C0018193
was O O
performed O O
, O O
which O O
was O O
later O O
confirmed O O
through O O
histopathological O O
examination O O
. O O

post-operative O O
period O O
was O O
without O O
complications O O
, O O
with O O
progressive O O
improvement O O
of O O
symptoms O O
. O O

the O O
patient O O
was O O
followed O O
for O O
a O O
year O O
, O O
remaining O O
asymptomatic O O
throughout O O
this O O
entire O O
period O O
, O O
without O O
other O O
manifestations O O
due O O
to O O
lost O O
gallstones O B-C0008350
. O O

A O O
47 O O
- O O
year-old O O
male O O
, O O
with O O
no O O
pathological O O
history O O
and O O
no O O
significant O O
cardiovascular O B-C0850624
risk O I-C0850624
factors O I-C0850624
presented O O
at O O
the O O
emergency O O
department O O
for O O
the O O
management O O
of O O
chest O B-C0008031
pain O I-C0008031
, O O
new O O
york O O
heart O O
association O O
functional O O
( O O
NYHA O O
) O O
stage O O
IV O O
dyspnea O B-C0013404
and O O
fever O B-C0015967
at O O
39 O O
° O O
C O O
. O O

at O O
the O O
admission O O
, O O
the O O
patient O O
presented O O
dyspnea O B-C0013404
associated O O
with O O
chills O B-C0085593
. O O

his O O
heart O O
sounds O O
were O O
regular O O
with O O
systolic O O
and O O
diastolic O B-C0232262
murmurs O I-C0232262
at O O
the O O
aortic O O
area O O
. O O

pleuro-pulmonary O O
auscultation O O
revealed O O
the O O
presence O O
of O O
bibasilar O O
crackles O B-C0034642
. O O

moreover O O
, O O
electrocardiogram O O
test O O
( O O
ECG O O
) O O
found O O
a O O
regular O O
sinus O O
rhythm O O
with O O
a O O
sub-shift O O
of O O
the O O
ST O O
segment O O
in O O
the O O
lateral O O
leads O O
. O O

TTE O O
found O O
a O O
preserved O O
ejection O O
fraction O O
with O O
left O B-C0149721
ventricular O I-C0149721
hypertrophy O I-C0149721
as O O
well O O
as O O
left O O
to O O
right O O
shunt O O
at O O
the O O
level O O
of O O
the O O
aortic O O
valve O O
without O O
apparent O O
origin O O
and O O
normal O O
size O O
and O O
function O O
of O O
right O O
heart O O
cavities O O
. O O

ascending O O
aorta O O
was O O
moderately O O
dilated O O
( O O
44 O O
mm O O
) O O
with O O
dry O O
pericardial O O
sac O O
. O O

TEE O O
was O O
quickly O O
performed O O
to O O
characterize O O
the O O
observed O O
shunt O O
and O O
showed O O
a O O
rupture O O
of O O
the O O
right O O
valsalva O O
sinus O O
in O O
the O O
right O O
atrium O O
with O O
a O O
channel O O
of O O
6 O O
mm O O
. O O

furthermore O O
, O O
a O O
small O O
6 O O
mm O O
vibrate O O
image O O
on O O
the O O
right O O
side O O
of O O
the O O
right O O
atrium O O
was O O
also O O
observed O O
indicating O O
the O O
presence O O
of O O
possible O O
infective O B-C1541923
endocarditis O I-C1541923
. O O

A O O
computerized O O
tomography O O
( O O
CT O O
) O O
scan O O
was O O
performed O O
and O O
showed O O
the O O
presence O O
of O O
aneurysmal O O
dilatation O O
of O O
the O O
valsalva O O
sinus O O
( O O
44 O O
mm O O
) O O
with O O
an O O
iodine O O
contrast O O
leakage O O
through O O
the O O
right O O
coronary O O
sinus O O
to O O
the O O
right O O
atrioventricular O O
junction O O
. O O

blood O O
cultures O O
, O O
serology O O
for O O
bartonella O O
, O O
brucellosis O B-C0006309
, O O
Q O B-C0034362
fever O I-C0034362
and O O
syphilis O B-C0039128
and O O
cytobacteriological O O
examination O O
of O O
the O O
urine O O
were O O
all O O
negative O O
. O O

dental O O
examination O O
found O O
multiple O O
dental O O
infectious O O
locations O O
that O O
required O O
extractions O O
. O O

the O O
optimal O O
care O O
management O O
was O O
discussed O O
with O O
a O O
multidisciplinary O O
team O O
, O O
which O O
recommended O O
intravenous O O
antibiotics O O
including O O
amoxicillin O O
, O O
cefazolin O O
and O O
gentamicin O O
for O O
14 O O
days O O
before O O
surgical O O
intervention O O
and O O
then O O
an O O
oral O O
switch O O
with O O
amoxicillin O O
andcefazolin O O
for O O
4 O O
additional O O
weeks O O
. O O

after O O
two O O
weeks O O
of O O
treatment O O
, O O
surgery O O
was O O
performed O O
using O O
a O O
vertical O O
median O O
sternotomy O O
, O O
an O O
extracorporeal O O
circulation O O
and O O
a O O
complete O O
transverse O O
aortotomy O O
until O O
the O O
sino-tubular O O
junction O O
. O O

peroperative O O
assessment O O
highlighted O O
a O O
tricuspid O O
aortic O O
valve O O
with O O
thin O O
leaflets O O
, O O
dilatation O O
of O O
the O O
right O O
valsalva O O
sinus O O
with O O
presence O O
of O O
a O O
large O O
perforation O O
( O O
about O O
1 O O
cm O O
) O O
at O O
the O O
base O O
of O O
the O O
aortic O O
annulus O O
and O O
under O O
the O O
ostium O O
of O O
right O O
coronary O O
artery O O
. O O

right O O
atriotomy O O
was O O
performed O O
in O O
order O O
to O O
assess O O
the O O
perforation O O
which O O
was O O
localized O O
near O O
to O O
the O O
tricuspid O O
ring O O
at O O
the O O
level O O
of O O
the O O
anteroseptal O O
commissure O O
. O O

after O O
trimming O O
, O O
the O O
orifice O O
was O O
closed O O
using O O
a O O
pericardial O O
patch O O
passing O O
by O O
the O O
aortic O O
way O O
. O O

vegetations O O
were O O
sent O O
to O O
bacteriological O O
analysis O O
. O O

in O O
order O O
to O O
reinforce O O
the O O
border O O
between O O
the O O
two O O
cavities O O
, O O
another O O
pericardial O O
patch O O
was O O
used O O
using O O
right O O
atrial O O
way O O
. O O

the O O
patient O O
was O O
extubated O O
six O O
hours O O
later O O
and O O
discharged O O
after O O
ten O O
postoperative O O
days O O
. O O

the O O
bacteriological O O
examination O O
of O O
the O O
vegetations O O
based O O
on O O
culture O O
and O O
polymerase O O
chain O O
reaction O O
( O O
PCR O O
) O O
was O O
negative O O
. O O

however O O
, O O
the O O
patient O O
was O O
asymptomatic O O
with O O
no O O
signs O O
of O O
recurrence O O
on O O
echocardiography O O
at O O
the O O
third O O
month O O
of O O
follow O O
up O O
. O O

A O O
28 O O
- O O
year-old O O
woman O O
who O O
, O O
a O O
month O O
before O O
admission O O
, O O
had O O
suffered O O
from O O
asthenia O B-C0004093
with O O
a O O
weight O B-C1262477
loss O I-C1262477
that O O
evolved O O
in O O
a O O
context O O
of O O
altered O O
general O O
condition O O
and O O
fever O B-C0015967
that O O
was O O
not O O
calculated O O
. O O

on O O
clinical O O
examination O O
, O O
the O O
general O O
condition O O
is O O
very O O
deteriorated O O
( O O
WHO O O
stage O O
3 O O
) O O
, O O
fever O B-C0015967
at O O
38 O O
° O O
C O O
. O O

there O O
was O O
no O O
lymph O O
node O O
hypertrophy O B-C0020564
on O O
admission O O
and O O
no O O
hepatosplenomegaly O B-C0019214
on O O
abdominal O O
examination O O
. O O

on O O
the O O
biological O O
level O O
, O O
patient O O
presents O O
a O O
microcytic O B-C5194182
anemia O I-C5194182
( O O
hemoglobin O O
: O O
8.1g O O
/ O O
dl O O
) O O
, O O
microcytic O B-C5194182
anemia O I-C5194182
( O O
mean O O
globular O O
volume O O
( O O
MGV O O
) O O
: O O
78.5 O O
fl O O
) O O
, O O
and O O
thrombocytopenia O B-C0040034
( O O
9000 O O
G O O
/ O O
l O O
) O O
, O O
leukopenia O B-C0023530
( O O
leukocytes O O
: O O
1580 O O
G O O
/ O O
l O O
) O O
, O O
neutropenia O B-C0027947
( O O
PNN O O
: O O
850 O O
G O O
/ O O
l O O
) O O
, O O
lymphopenia O O
( O O
lymphocyte O O
: O O
500 O O
G O O
/ O O
l O O
) O O
, O O
and O O
lymphocytopenia O B-C0024312
( O O
lymphocyte O O
: O O
500 O O
G O O
/ O O
l O O
) O O
. O O

A O O
syndrome O O
of O O
inflammation O O
( O O
sedimentation O O
rate O O
( O O
SV O O
) O O
: O O
49 O O
mm O O
in O O
the O O
first O O
hour O O
, O O
fibrinogen O O
: O O
5.1 O O
g O O
/ O O
l O O
, O O
CRP O O
: O O
86 O O
mg O O
/ O O
l O O
) O O
, O O
as O O
well O O
as O O
liver O O
cytolysis O O
( O O
ASAT O O
: O O
348UI O O
/ O O
L O O
, O O
ALAT O O
: O O
49UI O O
/ O O
L O O
, O O
GGT O O
: O O
96UI O O
/ O O
L O O
, O O
alkaline O O
phosphatases O O
: O O
158UI O O
/ O O
L O O
, O O
total O O
bilirubin O O
: O O
59 O O
mg O O
/ O O
l O O
) O O
. O O

lactate O O
dehydrogenase O O
( O O
LDH O O
) O O
is O O
1234UI O O
/ O O
L O O
, O O
triglycerides O O
5.72 O O
mmol O O
/ O O
l O O
( O O
N O O
: O O
0.35 O O
- O O
1.7 O O
) O O
and O O
ferritinemia O O
2017 O O
g O O
/ O O
l O O
( O O
N O O
: O O
30 O O
- O O
400 O O
) O O
. O O

infectious O O
balance O O
is O O
negative O O
( O O
blood O O
cultures O O
, O O
serology O O
of O O
atypical O O
germs O O
, O O
PCR O O
of O O
herpes O B-C0019340
viridae O O
, O O
herpes O B-C0019348
simplex O I-C0019348
virus O O
1 O O
( O O
HSV1 O O
) O O
, O O
herpes O B-C0019348
simplex O I-C0019348
virus O O
2 O O
( O O
HSV2 O O
) O O
, O O
parvovirus O B-C0276275
, O O
varicella O B-C0008049
zoster O B-C0019360
virus O O
( O O
VZV O O
) O O
, O O
cytomegalovirus O O
( O O
CMV O O
) O O
, O O
epstein-barr O O
virus O O
( O O
EBV O O
) O O
, O O
human O O
herpesvirus O O
( O O
HHV6 O O
) O O
and O O
( O O
HHV8 O O
) O O
, O O
sputum O O
stain O O
for O O
koch O O
bacillus O O
( O O
BK O O
) O O
and O O
gene-expert O O
are O O
negatives O O
, O O
coprocultures O O
and O O
PCR O O
of O O
gastrointestinal O O
tract O O
are O O
negatives O O
) O O
. O O

the O O
myelogram O O
is O O
rich O O
with O O
the O O
presentation O O
of O O
very O O
many O O
images O O
of O O
hemophagocytosis O B-C0876991
, O O
compatible O O
with O O
MAS O O
. O O

an O O
axillary O O
lymphadenopathy O B-C0497156
developed O O
one O O
week O O
after O O
the O O
patient's O O
admission O O
, O O
1 O O
cm O O
x O O
1 O O
cm O O
in O O
diameter O O
, O O
mobile O O
, O O
solid O O
, O O
painful O O
; O O
removal O O
of O O
the O O
lymphadenopathy O B-C0497156
is O O
carried O O
out O O
as O O
an O O
emergency O O
procedure O O
. O O

the O O
anatomopathological O O
study O O
revealed O O
a O O
modified O O
and O O
infiltrated O O
architecture O O
of O O
an O O
essentially O O
mononuclear O O
inflammatory O O
element O O
arranged O O
in O O
layers O O
with O O
a O O
few O O
giant O O
cells O O
and O O
fibrosis O B-C0016059
of O O
the O O
lymph O O
node O O
pulp O O
scattered O O
with O O
rare O O
cells O O
with O O
enlarged O O
nuclei O O
with O O
a O O
prominent O O
nucleolus O O
and O O
a O O
clear O O
cytoplasm O O
that O O
is O O
fairly O O
abundant O O
and O O
poorly O O
limited O O
in O O
favor O O
of O O
scleroderodular O O
LH O O
. O O

the O O
immunohistochemical O O
study O O
found O O
positive O O
anti-cd O O
30 O O
antibodies O O
, O O
anti O O
MUM1 O O
positive O O
, O O
anti O O
CD15 O O
negative O O
and O O
anti O O
PAX O O
5 O O
inconclusive O O
antibodies O O
. O O

this O O
result O O
is O O
compatible O O
with O O
LH O O
bone O O
marrow O O
infiltration O O
. O O

the O O
diagnosis O O
of O O
stage O O
ivb O O
scleroderodular O O
LH O O
is O O
retained O O
. O O

for O O
extension O O
assessment O O
and O O
given O O
the O O
limited O O
resources O O
available O O
in O O
our O O
context O O
for O O
a O O
PET O O
scan O O
, O O
a O O
cervico-thoraco-abdomino-pelvic O O
CT O O
scan O O
shows O O
mediastinal O O
and O O
left O O
axillary O O
lymph O O
node O O
involvement O O
associated O O
with O O
homogenous O O
hepato-splenomegaly O O
and O O
multiple O O
effusions O O
. O O

hepatitis O B-C0019163
B O I-C0019163
virus O O
( O O
HBV O O
) O O
, O O
hepatitis O B-C0019196
C O I-C0019196
virus O O
( O O
HCV O O
) O O
and O O
the O O
human O O
immunodeficiency O B-C0021051
virus O O
( O O
HIV O O
) O O
viral O O
serology O O
are O O
negative O O
and O O
the O O
echocardiography O O
shows O O
an O O
ejection O O
fraction O O
of O O
75% O O
. O O

patient O O
receives O O
4 O O
courses O O
of O O
dexamethazone O O
40 O O
mg O O
/ O O
day O O
then O O
ABVD O O
( O O
doxorubicin O O
25 O O
mg O O
/ O O
m O O
2 O O
/ O O
d O O
, O O
vinblastine O O
6 O O
mg O O
/ O O
m O O
2 O O
/ O O
d O O
, O O
bleomycin O O
10 O O
mg O O
/ O O
m O O
2 O O
/ O O
d O O
, O O
dacarbazine O O
375 O O
mg O O
/ O O
m O O
2 O O
/ O O
d O O
on O O
aay O O
1 O O
and O O
day O O
15 O O
) O O
for O O
8 O O
courses O O
of O O
treatment O O
with O O
a O O
partial O O
remission O O
then O O
ICE O O
second O O
ligne O O
protocol O O
( O O
etoposide O O
100 O O
mg O O
/ O O
m O O
2 O O
/ O O
d O O
IV O O
day O O
1 O O
to O O
day O O
3 O O
, O O
holoxan O O
5g O O
/ O O
m O O
2 O O
/ O O
d O O
to O O
day O O
2 O O
, O O
mesna O O
6g O O
/ O O
m O O
2 O O
to O O
day O O
2 O O
, O O
carboplatin O O
formula O O
AUC O O
5 O O
to O O
day O O
2 O O
for O O
4 O O
cures O O
with O O
good O O
evolution O O
. O O

45 O O
years O O
old O O
female O O
patient O O
who O O
presented O O
with O O
a O O
vulvar O O
ulcer O O
for O O
one O O
year O O
without O O
other O O
symptoms O O
. O O

she O O
was O O
HIV O O
infected O O
with O O
CD4 O O
+ O O
of O O
291 O O
cells O O
/ O O
μl O O
on O O
highly O O
active O O
retroviral O O
treatment O O
. O O

she O O
was O O
previously O O
treated O O
for O O
pulmonary O B-C0041327
tuberculosis O I-C0041327
for O O
six O O
months O O
. O O

she O O
had O O
no O O
other O O
co-morbidities O O
or O O
family O B-C0241889
history O I-C0241889
of O O
malignancy O B-C0006826
. O O

on O O
examination O O
, O O
she O O
had O O
good O O
performance O O
score O O
. O O

the O O
abdomen O O
was O O
soft O O
with O O
right O O
inguinal O O
lymphadenopathy O B-C0497156
. O O

per O O
vaginal O O
examination O O
revealed O O
an O O
ulcerated O O
nodule O B-C0028259
on O O
the O O
right O O
labia O O
majora O O
extending O O
from O O
the O O
right O O
labia O O
minora O O
into O O
the O O
right O O
lower O O
2 O O
/ O O
3 O O
of O O
the O O
vagina O O
. O O

this O O
lesion O B-C0221198
was O O
close O O
to O O
the O O
anal O O
sphincter O O
, O O
but O O
did O O
not O O
involve O O
the O O
pelvic O O
bone O O
. O O

it O O
was O O
draining O O
foul O O
smelling O O
dark O O
discharge O O
. O O

she O O
did O O
not O O
have O O
pigmented O O
lesion O B-C0221198
/ O O
nevus O B-C0027960
on O O
any O O
part O O
of O O
the O O
body O O
. O O

A O O
biopsy O O
of O O
the O O
ulcer O O
showed O O
malignant O B-C0025202
melanoma O I-C0025202
. O O

the O O
patient O O
was O O
counselled O O
about O O
the O O
disease O O
and O O
the O O
prognosis O O
thereof O O
. O O

she O O
was O O
further O O
investigated O O
for O O
extent O O
of O O
the O O
disease O O
and O O
possible O O
metastasis O B-C0027627
. O O

the O O
chest O O
x-ray O O
was O O
unremarkable O O
. O O

the O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
revealed O O
a O O
vulvovaginal O O
tumour O B-C0027651
which O O
pushed O O
the O O
uterus O O
superiorly O O
. O O

it O O
did O O
not O O
show O O
bladder O O
or O O
rectal O O
involvement O O
. O O

computed O O
tomography O O
( O O
CT O O
) O O
showed O O
pelvic O O
lymph O O
nodes O O
metastasis O B-C0027627
. O O

the O O
full O O
blood O O
count O O
showed O O
hemoglobin O O
of O O
9.2 O O
g O O
/ O O
dl O O
while O O
the O O
rest O O
of O O
the O O
blood O O
investigation O O
was O O
unremarkable O O
. O O

she O O
was O O
offered O O
pelvic O O
exenteration O O
but O O
declined O O
. O O

A O O
hemivulvectomy O O
and O O
vaginectomy O O
with O O
inguinofemoral O O
and O O
pelvic O O
lymphadenectomy O O
was O O
performed O O
. O O

an O O
ulcerated O O
, O O
multinodular O O
and O O
rubbery O O
tumour O B-C0027651
measuring O O
90x50x25mm O O
was O O
received O O
with O O
pelvic O O
and O O
inguinal O O
lymph O O
nodes O O
for O O
histopathological O O
assessment O O
. O O

microscopy O O
showed O O
a O O
malignant O O
nodular O B-C0334424
melanoma O I-C0334424
evidenced O O
by O O
an O O
ulcerated O O
tumour O B-C0027651
arranged O O
in O O
a O O
nodular O O
pattern O O
without O O
epithelial O O
component O O
. O O

the O O
tumour O B-C0027651
cells O O
had O O
pleomorphic O O
and O O
vesicular O O
nuclei O O
with O O
prominent O O
inclusion-like O O
nucleoli O O
. O O

intracytoplasmic O O
melanin O O
pigment O O
was O O
not O O
seen O O
. O O

the O O
tumour O B-C0027651
corresponded O O
to O O
clark O O
level O O
V O O
and O O
breslow O O
stage O O
V O O
. O O

there O O
was O O
no O O
brisk O O
intratumoural O O
lymphocytic O B-C0333386
infiltrate O I-C0333386
. O O

the O O
mitotic O O
count O O
was O O
15 O O
per O O
square O O
millimeter O O
. O O

the O O
tumour O B-C0027651
cells O O
were O O
immunoreactive O O
for O O
melanin O O
A O O
, O O
HMB45 O O
and O O
S O O
- O O
100 O O
protein O O
. O O

molecular O O
studies O O
confirmed O O
a O O
BRAF O O
pv600e O O
mutation O O
. O O

the O O
tumour O B-C0027651
was O O
present O O
at O O
the O O
vaginal O O
resection O O
margin O O
and O O
1mm O O
from O O
the O O
closest O O
soft O O
tissue O O
excision O O
margins O O
. O O

only O O
3 O O
of O O
the O O
17 O O
inguinofemoral O O
lymph O O
nodes O O
showed O O
metastatic O O
diseases O O
. O O

post-surgically O O
, O O
she O O
presented O O
with O O
recto-vaginal O O
fistula O B-C0016169
after O O
23 O O
days O O
. O O

A O O
diverting O O
colostomy O O
was O O
performed O O
and O O
discharged O O
to O O
home O O
. O O

she O O
came O O
back O O
after O O
a O O
month O O
to O O
the O O
gynaecology O O
clinic O O
with O O
shortness O B-C0013404
of O I-C0013404
breath O I-C0013404
, O O
weakness O B-C3714552
and O O
pain O B-C0030193
of O O
the O O
lower O O
limbs O O
. O O

per O O
vaginal O O
examination O O
revealed O O
bleeding O B-C0019080
and O O
non-healing O O
operation O O
side O O
and O O
a O O
well O O
colostomy O O
. O O

although O O
the O O
biopsy O O
was O O
not O O
done O O
at O O
this O O
stage O O
, O O
a O O
clinical O O
diagnosis O O
of O O
local O O
recurrence O O
was O O
made O O
. O O

A O O
CXR O O
at O O
this O O
point O O
showed O O
upper O O
lobes O O
nodules O O
and O O
left O O
pleural O B-C0032227
effusion O I-C0032227
in O O
keeping O O
with O O
lung O O
metastasis O B-C0027627
. O O

she O O
was O O
referred O O
to O O
radiation O O
oncology O O
where O O
she O O
received O O
palliation O O
radiotherapy O O
of O O
8 O O
grays O O
and O O
one O O
fraction O O
of O O
radiation O O
. O O

she O O
was O O
discharged O O
from O O
oncology O O
due O O
to O O
poor O O
treatment O O
response O O
. O O

she O O
was O O
eventually O O
discharged O O
home O O
for O O
palliation O O
care O O
and O O
has O O
since O O
been O O
lost O B-C1302313
to O I-C1302313
follow-up O I-C1302313
clinic O O
. O O

A O O
14 O O
- O O
year-old O O
teenager O O
with O O
no O O
particular O O
pathological O O
history O O
, O O
apart O O
from O O
moderate O B-C0694533
obesity O I-C0694533
with O O
a O O
body O O
mass O O
index O O
( O O
BMI O O
) O O
of O O
31 O O
kg O O
/ O O
m O O
2 O O
, O O
was O O
admitted O O
for O O
a O O
class O O
IV O O
dyspnea O B-C0013404
according O O
to O O
the O O
new O O
york O O
heart O O
association O O
( O O
NYHA O O
\ O O
) O O
classification O O
with O O
sudden O O
chest O B-C0008031
pain O I-C0008031
. O O

the O O
symptomatology O O
started O O
3 O O
weeks O O
before O O
admission O O
, O O
with O O
an O O
influenza O B-C0021400
syndrome O O
and O O
a O O
dry O O
cough O B-C0010200
complicated O O
by O O
an O O
effort O O
dyspnea O B-C0013404
. O O

it O O
should O O
be O O
noted O O
that O O
her O O
parents O O
were O O
undergoing O O
COVID O O
- O O
19 O O
treatment O O
. O O

the O O
patient O O
consulted O O
a O O
general O O
practitioner O O
, O O
who O O
prescribed O O
treatment O O
with O O
antibiotics O O
, O O
oral O O
corticosteroids O O
and O O
inhaled O O
bronchodilators O O
. O O

the O O
evolution O O
was O O
characterized O O
by O O
a O O
progressive O O
worsening O O
of O O
dyspnea O B-C0013404
and O O
the O O
appearance O O
of O O
palpitations O B-C0030252
and O O
chest O B-C0008031
pain O I-C0008031
. O O

the O O
clinical O O
examination O O
showed O O
a O O
pale O O
, O O
anxious O O
, O O
apyretic O O
patient O O
, O O
with O O
tachycardia O O
at O O
125 O O
beats O O
per O O
minute O O
( O O
BPM O O
) O O
, O O
a O O
blood O O
pressure O O
at O O
110 O O
/ O O
70 O O
mmhg O O
and O O
an O O
arterial O O
saturation O O
in O O
ambient O O
air O O
at O O
90% O O
. O O

auscultation O O
found O O
regular O O
tachycardia O O
with O O
no O O
audible O O
murmur O B-C0018808
, O O
no O O
signs O O
of O O
right O O
or O O
left O O
heart O B-C0018801
failure O I-C0018801
, O O
no O O
sign O O
of O O
deep O B-C0149871
vein O I-C0149871
thrombosis O I-C0149871
. O O

the O O
initial O O
biological O O
assessment O O
noted O O
a O O
normal O O
blood O O
count O O
and O O
hemostasis O O
, O O
d-dimer O O
level O O
was O O
very O O
high O O
at O O
3520 O O
ngfeu O O
/ O O
ml O O
and O O
an O O
inflammatory O O
syndrome O O
with O O
a O O
sedimentation O O
rate O O
at O O
28 O O
mm O O
and O O
c-reactive O O
protein O O
at O O
26 O O
mg O O
/ O O
l O O
, O O
with O O
negative O O
procalcitonin O O
was O O
found O O
( O O
table O O
1 O O
) O O
. O O

echocardiography O O
found O O
signs O O
of O O
an O O
acute O O
pulmonary O O
heart O O
with O O
a O O
very O O
dilated O O
right O O
ventricle O O
. O O

it O O
showed O O
a O O
mass O O
on O O
its O O
side O O
wall O O
, O O
a O O
pulmonary O B-C0020542
hypertension O I-C0020542
at O O
50 O O
mmhg O O
, O O
with O O
a O O
paradoxical O O
septum O O
. O O

the O O
systolic O O
function O O
of O O
the O O
right O O
and O O
left O O
ventricle O O
was O O
preserved O O
. O O

the O O
computed O O
tomography O O
( O O
CT O O
) O O
angiogram O O
of O O
the O O
chest O O
showed O O
a O O
bilateral O O
massive O O
pulmonary O B-C0034065
embolism O I-C0034065
without O O
parenchymal O O
lesions O B-C0221198
. O O

the O O
cardiac O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
confirmed O O
the O O
thrombotic O O
nature O O
of O O
the O O
mass O O
and O O
eliminated O O
its O O
tissue O O
character O O
. O O

the O O
systolic O O
function O O
of O O
the O O
right O O
ventricle O O
was O O
preserved O O
. O O

the O O
patient O O
was O O
hospitalized O O
in O O
an O O
intensive O O
care O O
unit O O
. O O

anticoagulation O O
with O O
unfractionated O O
heparin O O
was O O
started O O
as O O
continuous O O
infusion O O
to O O
target O O
an O O
APTT O O
of O O
2 O O
to O O
3 O O
times O O
control O O
. O O

thrombolysis O O
was O O
not O O
administered O O
as O O
her O O
hemodynamic O O
status O O
was O O
stable O O
. O O

as O O
part O O
of O O
the O O
etiological O O
assessment O O
of O O
her O O
pulmonary O B-C0034065
embolism O I-C0034065
, O O
a O O
venous O O
doppler O O
of O O
the O O
lower O O
limbs O O
with O O
an O O
abdominal O O
ultrasound O O
was O O
normal O O
. O O

biological O O
assessment O O
for O O
thrombophilia O B-C0398623
( O O
C O O
protein O O
, O O
S O O
protein O O
, O O
antithrombin O O
) O O
or O O
autoimmune O B-C0004364
disease O I-C0004364
( O O
anti-cardiolipin O O
antibody O O
immunoglobulin O O
M O O
( O O
igm O O
) O O
and O O
immunoglobulin O O
G O O
( O O
igg O O
) O O
, O O
anti-nuclear O O
antibody O O
, O O
anti-dna O O
antibody O O
) O O
was O O
negative O O
as O O
well O O
. O O

sars-cov O O
- O O
2 O O
nasopharyngeal O O
polymerase O O
chain O O
reaction O O
( O O
PCR O O
) O O
was O O
negative O O
but O O
sars-cov O O
- O O
2 O O
antibody O O
was O O
positive O O
( O O
igg O O
) O O
. O O

clinical O O
improvement O O
with O O
regression O B-C1836830
of O O
acute O O
pulmonary O B-C0034072
heart O I-C0034072
disease O I-C0034072
, O O
pulmonary O B-C0020542
hypertension O I-C0020542
and O O
right O O
ventricular O O
mass O O
was O O
noted O O
. O O

the O O
patient O O
was O O
discharged O O
on O O
antivitamin O O
K O O
and O O
aspirin O O
at O O
anticoagulant O O
dose O O
. O O

after O O
two O O
months O O
, O O
there O O
was O O
a O O
clear O O
clinical O O
improvement O O
with O O
disappearance O O
of O O
the O O
mass O O
in O O
the O O
right O O
ventricle O O
. O O

A O O
44 O O
- O O
year-old O O
algerian O O
woman O O
, O O
without O O
any O O
personal O O
medical O O
or O O
trauma O O
history O O
, O O
nor O O
under O O
any O O
medical O O
treatment O O
, O O
was O O
referred O O
to O O
our O O
hepatobiliary O O
surgery O O
department O O
for O O
management O O
of O O
a O O
sub-capsular O O
hematoma O B-C0018944
of O O
the O O
right O O
liver O O
developing O O
in O O
a O O
context O O
of O O
fever O B-C0015967
and O O
body O O
aches O B-C0234238
dating O O
back O O
for O O
more O O
than O O
10 O O
days O O
. O O

when O O
questioning O O
the O O
patient O O
, O O
she O O
describes O O
that O O
the O O
onset O O
of O O
her O O
illness O O
was O O
marked O O
by O O
the O O
appearance O O
of O O
fever O B-C0015967
and O O
aches O B-C0234238
followed O O
few O O
days O O
later O O
by O O
severe O O
pain O B-C0030193
in O O
the O O
right O O
hypochondrium O O
. O O

the O O
patient O O
, O O
however O O
, O O
did O O
not O O
report O O
any O O
particular O O
respiratory O O
signs O O
neither O O
notion O O
of O O
trauma O O
or O O
fall O B-C0085639
. O O

on O O
the O O
day O O
of O O
her O O
admission O O
, O O
the O O
patient O O
was O O
in O O
general O O
condition O O
scored O O
WHO O O
2 O O
, O O
the O O
blood O O
pressure O O
was O O
132 O O
/ O O
80 O O
mm O O
hg O O
with O O
a O O
heartbeat O O
rate O O
of O O
105 O O
beats O O
/ O O
min O O
, O O
and O O
her O O
temperature O O
was O O
38.9 O O
° O O
C O O
. O O

on O O
physical O O
examination O O
, O O
palpation O O
of O O
the O O
right O O
hypochondrium O O
was O O
very O O
painful O O
, O O
the O O
remainder O O
of O O
the O O
physical O O
examination O O
was O O
normal O O
. O O

blood O O
laboratory O O
tests O O
found O O
: O O
blood O O
hemoglobin O O
at O O
10.1 O O
g O O
/ O O
dl O O
, O O
hyper O O
leukocytosis O B-C0023518
at O O
13,370 O O
elm O O
/ O O
ml O O
with O O
a O O
predominance O O
of O O
polynuclear O O
cells O O
( O O
8300 O O
elm O O
/ O O
ml O O
) O O
, O O
without O O
lymphopenia O O
( O O
3400 O O
elm O O
/ O O
ml O O
) O O
, O O
a O O
platelet O O
count O O
at O O
276,000 O O
elm O O
/ O O
ml O O
, O O
hepatic O O
transaminases O O
were O O
slightly O O
elevated O O
with O O
aspartate O O
aminotransferase O O
( O O
AST O O
) O O
at O O
76 O O
IU O O
/ O O
ml O O
and O O
alanine O O
aminotransferase O O
( O O
ALT O O
) O O
at O O
72 O O
IU O O
/ O O
ml O O
, O O
normal O O
hemostasis O O
with O O
a O O
prothrombin O O
ratio O O
of O O
87% O O
, O O
KCT O O
= O O
32.1 O O
' O O
' O O
( O O
t O O
= O O
30 O O
' O O
' O O
) O O
and O O
an O O
international O O
normalized O O
ratio O O
of O O
1.10 O O
. O O

an O O
abdominal O O
computerized O O
tomography O O
( O O
ct-scan O O
) O O
performed O O
before O O
admission O O
( O O
9 O O
days O O
before O O
) O O
confirmed O O
the O O
presence O O
of O O
a O O
giant O O
sub-capsular O O
hepatic O O
hematoma O B-C0018944
, O O
developed O O
at O O
the O O
expense O O
of O O
segments O O
VI O O
, O O
VII O O
, O O
and O O
VIII O O
of O O
136 O O
x O O
80 O O
mm O O
in O O
diameter O O
. O O

an O O
abdominal O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
was O O
done O O
urgently O O
on O O
the O O
day O O
of O O
admission O O
to O O
our O O
department O O
and O O
confirmed O O
that O O
it O O
was O O
a O O
giant O O
sub-capsular O O
hematoma O B-C0018944
of O O
the O O
liver O O
at O O
a O O
phase O O
of O O
resorption O O
without O O
any O O
traumatic O O
or O O
hepatic O O
tumour O B-C0027651
pathology O O
that O O
could O O
explain O O
this O O
spontaneous O B-C0746649
bleeding O I-C0746649
. O O

we O O
performed O O
ultrasound-guided O O
drainage O O
( O O
G10 O O
diameter O O
nephrostomy O O
drain O O
) O O
of O O
the O O
hematoma O B-C0018944
under O O
local O O
anaesthesia O B-C0278134
; O O
the O O
drain O O
returned O O
800 O O
ml O O
of O O
sequestered O O
blood O O
upon O O
placement O O
, O O
and O O
the O O
bacteriological O O
study O O
of O O
the O O
collected O O
fluid O O
showed O O
no O O
bacterial O O
contamination O O
. O O

on O O
the O O
first O O
day O O
after O O
drainage O O
, O O
an O O
abdominal O O
ct-scan O O
was O O
performed O O
to O O
check O O
the O O
position O O
of O O
the O O
drain O O
and O O
consider O O
its O O
mobilization O O
; O O
this O O
time O O
radiological O O
signs O O
in O O
lung O O
cuts O O
were O O
compatible O O
with O O
a O O
sars-cov O O
- O O
2 O O
infection O B-C3714514
. O O

the O O
thoracic O B-C0729233
ct-scan O O
showed O O
lesions O B-C0221198
compatible O O
with O O
a O O
sars-cov O O
- O O
2 O O
infection O B-C3714514
( O O
ground O O
glass O O
opacities O O
with O O
moderate O O
pulmonary O O
involvement O O
estimated O O
between O O
15 O O
and O O
20% O O
as O O
shown O O
in O O
. O O

after O O
review O O
of O O
the O O
old O O
radiological O O
examinations O O
of O O
the O O
abdomen O O
, O O
the O O
same O O
images O O
were O O
found O O
in O O
the O O
pulmonary O O
bases O O
but O O
not O O
reported O O
. O O

A O O
nasopharyngeal O O
sample O O
was O O
sent O O
for O O
reverse O O
transcription-polymerase O O
chain O O
reaction O O
( O O
RT-PCR O O
) O O
, O O
the O O
result O O
was O O
positive O O
for O O
gene O O
N O O
and O O
gene O O
E O O
and O O
confirmed O O
the O O
presence O O
of O O
a O O
sars-cov O O
- O O
2 O O
infection O B-C3714514
. O O

following O O
the O O
algerian O O
national O O
protocol O O
, O O
we O O
prescribed O O
azithromycin O O
500mg O O
on O O
the O O
first O O
day O O
then O O
250 O O
mg O O
for O O
the O O
next O O
4 O O
days O O
and O O
hydroxychloroquine O O
200 O O
mg O O
3 O O
/ O O
day O O
for O O
10 O O
days O O
. O O

the O O
outcomes O O
were O O
simple O O
with O O
drying O O
up O O
on O O
day O O
02 O O
; O O
the O O
patient O O
became O O
afebrile O O
on O O
day O O
03 O O
with O O
an O O
improvement O O
of O O
its O O
general O O
condition O O
after O O
removal O O
of O O
the O O
drain O O
. O O

she O O
was O O
discharged O O
on O O
day O O
07 O O
with O O
prescription O O
of O O
home O O
confinement O O
for O O
14 O O
days O O
. O O

A O O
40 O O
- O O
year-old O O
married O O
woman O O
( O O
the O O
probands O O
: O O
II3 O O
) O O
, O O
non-consanguineous O O
, O O
mother O O
of O O
five O O
children O O
. O O

her O O
family O B-C0241889
history O I-C0241889
was O O
remarkable O O
; O O
two O O
of O O
her O O
children O O
were O O
diagnosed O O
with O O
spinocerebellar O B-C0087012
ataxia O I-C0087012
. O O

in O O
2011 O O
, O O
the O O
patient O O
developed O O
a O O
progressive O B-C0393525
cerebellar O I-C0393525
ataxia O I-C0393525
associated O O
with O O
coordination O O
disorder O O
and O O
a O O
significant O O
decrease O O
in O O
visual O O
acuity O O
; O O
in O O
the O O
clinical O O
findings O O
, O O
the O O
patient O O
presented O O
an O O
ataxia O B-C0004134
, O O
impaired O B-C0520966
coordination O I-C0520966
with O O
vivid O O
and O O
diffuse O O
osteotendinous O O
reflexes O O
, O O
a O O
negative O O
babinski O B-C0034935
sign O I-C0034935
and O O
a O O
positive O O
hoffman's O O
sign O O
. O O

in O O
contrast O O
, O O
muscle O O
tone O O
, O O
deep O O
sensitivity O O
and O O
thermo-pain O O
were O O
normal O O
. O O

the O O
patient O O
did O O
not O O
present O O
hollow O O
feet O O
or O O
scoliosis O B-C0036439
. O O

the O O
ophthalmologic O O
examination O O
revealed O O
a O O
decrease O O
in O O
visual O O
acuity O O
with O O
significant O O
macular O O
damage O O
and O O
a O O
bilateral O O
optic O B-C0029124
atrophy O I-C0029124
. O O

the O O
routine O O
laboratory O O
testing O O
and O O
brain O O
CT O O
and O O
MRI O O
detected O O
isolated O O
pontocerebellar O B-C1853766
atrophy O I-C1853766
. O O

the O O
daughter O O
III1 O O
was O O
symptomatic O O
up O O
to O O
19 O O
- O O
years-old O O
, O O
with O O
a O O
progressive O B-C0393525
ataxia O I-C0393525
and O O
an O O
ophthalmoplegia O B-C0029089
. O O

the O O
neurological O O
examination O O
revealed O O
a O O
vivid O O
and O O
diffuse O O
osteotendinous O O
reflexes O O
. O O

also O O
, O O
the O O
son O O
III2 O O
was O O
symptomatic O O
up O O
to O O
17 O O
years O O
old O O
with O O
a O O
progressive O B-C0393525
ataxia O I-C0393525
, O O
ophtalmoparesia O O
and O O
coordination O O
disorder O O
. O O

the O O
clinical O O
data O O
including O O
spinocerebellar O B-C0087012
ataxia O I-C0087012
, O O
maculopathy O B-C0024437
, O O
optic O B-C0029124
atrophy O I-C0029124
and O O
the O O
autosomal O O
dominant O O
inheritance O O
manner O O
have O O
supported O O
the O O
clinical O O
diagnosis O O
of O O
SCA7 O O
. O O

all O O
family O O
members O O
included O O
in O O
this O O
report O O
case O O
signed O O
a O O
written O O
informed O O
consent O O
before O O
DNA O O
extraxtion O O
. O O

we O O
conducted O O
genomic O O
DNA O O
purification O O
from O O
peripheral O O
blood O O
samples O O
in O O
our O O
genetic O O
department O O
in O O
the O O
clinical O O
research O O
center O O
, O O
mohammed O O
VI O O
university O O
hospital O O
of O O
marrakech O O
. O O

we O O
amplified O O
the O O
CAG O O
repeat O O
region O O
in O O
the O O
ATXN7 O O
gene O O
using O O
a O O
fluorescent O O
PCR O O
amplification O O
with O O
primers O O
surrounding O O
the O O
repeated O O
region O O
of O O
interest O O
followed O O
by O O
capillary O O
electrophoresis O O
. O O

the O O
fragments O O
analysis O O
, O O
revealed O O
the O O
presence O O
of O O
a O O
heterozygote O O
allele O O
with O O
pathological O O
expansion O O
of O O
the O O
CAG O O
triplet O O
of O O
the O O
tested O O
locus O O
, O O
which O O
confirmed O O
the O O
diagnosis O O
of O O
spinocerebellar O B-C0752125
ataxia O I-C0752125
type O I-C0752125
7 O I-C0752125
in O O
our O O
patient O O
( O O
the O O
probands O O
: O O
II3 O O
) O O
. O O

A O O
72 O O
- O O
year-old O O
woman O O
was O O
consulted O O
to O O
the O O
wahidin O O
sudirohusodo O O
hospotal O O
, O O
makassar O O
, O O
south O O
sulawesi O O
, O O
indonesia O O
, O O
with O O
a O O
chief O O
complaint O O
of O O
blackish O O
red O O
spots O O
on O O
the O O
posterior O O
trunk O O
since O O
one O O
day O O
before O O
admission O O
. O O

the O O
initial O O
lesion O B-C0221198
was O O
unknown O O
. O O

complaints O O
of O O
itching O B-C0033774
is O O
unknown O O
due O O
to O O
patient's O O
decreased O O
of O O
consciousness O O
state O O
. O O

the O O
patient O O
had O O
a O O
long O O
history O O
of O O
immobilize O O
for O O
14 O O
days O O
. O O

history O O
of O O
similar O O
complaint O O
from O O
the O O
family O O
was O O
denied O O
. O O

history O O
of O O
diabetes O B-C0011849
mellitus O I-C0011849
was O O
absent O O
. O O

patient O O
had O O
a O O
history O O
of O O
syphilis O B-C0039128
with O O
HIV O B-C0019693
infection O I-C0019693
and O O
got O O
therapy O O
of O O
intramuscular O O
injection O O
2.4 O O
million O O
unit O O
of O O
benzathine O O
penicillin O O
G O O
for O O
three O O
consecutive O O
weeks O O
. O O

he O O
was O O
also O O
treated O O
with O O
antiretroviral O O
therapy O O
( O O
ART O O
) O O
with O O
tenofovir O O
300mg O O
, O O
lamivudine O O
300mg O O
, O O
and O O
efavirenz O O
600mg O O
. O O

physical O O
examination O O
showed O O
blood O O
pressure O O
of O O
100 O O
/ O O
80 O O
mmhg O O
, O O
heart O O
rate O O
of O O
80 O O
beats O O
per O O
minute O O
, O O
respiratory O O
rate O O
of O O
18 O O
beats O O
per O O
minute O O
, O O
and O O
temperature O O
36.5 O O
° O O
C O O
. O O

laboratory O O
blood O O
tests O O
were O O
within O O
normal O O
limits O O
. O O

neurologic O O
examination O O
showed O O
decreased O O
awareness O O
and O O
lateralization O O
of O O
both O O
sides O O
. O O

dermatological O O
examination O O
of O O
the O O
posterior O O
trunk O O
region O O
found O O
hyperpigmented O B-C1842774
macules O I-C1842774
accompanied O O
by O O
crust O O
, O O
squama O O
and O O
erythematous O O
macules O O
. O O

based O O
on O O
the O O
history O O
taking O O
and O O
physical O O
examination O O
, O O
the O O
patient O O
was O O
diagnosed O O
with O O
sepsis O B-C0243026
, O O
suspected O O
meningoencephalitis O B-C0025309
, O O
hypoalbuminemia O B-C0239981
, O O
community-acquired O O
pneumonia O B-C0032285
, O O
and O O
cutaneous O B-C0006846
candidiasis O I-C0006846
. O O

the O O
patient O O
was O O
given O O
citicoline O O
500mg O O
/ O O
12 O O
hours O O
/ O O
IV O O
, O O
omeprazole O O
40mg O O
/ O O
12 O O
hours O O
/ O O
IV O O
, O O
ceftriaxone O O
2gr O O
/ O O
12 O O
hours O O
/ O O
IV O O
, O O
vancomycin O O
1gr O O
/ O O
12 O O
hours O O
/ O O
IV O O
, O O
vitamin O O
B O O
complex O O
1gr O O
/ O O
24 O O
hours O O
/ O O
intravenously O O
, O O
acetazolamide O O
250mg O O
/ O O
12 O O
hours O O
/ O O
nasogastric O O
tube O O
, O O
and O O
paracetamol O O
1gr O O
/ O O
8 O O
hours O O
/ O O
intravenously O O
. O O

topical O O
fusidic O O
acid O O
cream O O
was O O
also O O
applied O O
on O O
ulcerative O O
lesions O B-C0221198
to O O
avoid O O
bacterial O O
superinfection O B-C0038826
. O O

for O O
the O O
cutaneous O B-C0006846
candidiasis O I-C0006846
, O O
patient O O
was O O
treated O O
with O O
miconazole O O
cream O O
twice O O
daily O O
in O O
the O O
morning O O
and O O
evening O O
and O O
fusidic O O
acid O O
cream O O
for O O
14 O O
days O O
. O O

direct O O
microscopic O O
examination O O
using O O
10% O O
potassium O O
hydroxide O O
( O O
KOH O O
) O O
and O O
culture O O
were O O
done O O
to O O
for O O
further O O
investigation O O
on O O
the O O
causative O O
agent O O
. O O

direct O O
microscopic O O
of O O
the O O
skin O O
scrapings O O
on O O
the O O
back O O
using O O
10% O O
KOH O O
showed O O
clustered O O
spores O O
and O O
pseudohyphae O O
. O O

culture O O
in O O
sabouraud O O
dextrose O O
agar O O
( O O
SDA O O
) O O
media O O
added O O
with O O
chloramphenicol O O
incubated O O
at O O
25 O O
° O O
- O O
30 O O
° O O
C O O
showed O O
mucoid O O
brownish O O
white O O
colonies O O
with O O
smooth O O
surfaces O O
on O O
the O O
third O O
day O O
, O O
typical O O
of O O
the O O
fungus O O
candida O O
sp O O
. O O

one O O
week O O
later O O
, O O
gram O O
staining O O
was O O
carried O O
out O O
and O O
positive O O
purple O O
color O O
mildews O O
were O O
obtained O O
. O O

there O O
were O O
yeast O O
cells O O
and O O
budding O O
spores O O
which O O
were O O
consistent O O
with O O
candida O O
species O O
. O O

further O O
examination O O
was O O
carried O O
out O O
using O O
carbohydrate O O
fermentation O O
to O O
determine O O
the O O
type O O
of O O
candida O O
which O O
showed O O
a O O
change O O
in O O
color O O
from O O
purple O O
to O O
orange O O
in O O
glucose O O
, O O
sucrose O O
, O O
and O O
lactose O O
and O O
gas O O
formed O O
in O O
each O O
of O O
the O O
reagents O O
. O O

the O O
findings O O
from O O
carbohydrate O O
fermentation O O
test O O
supported O O
candida O O
kefyr O O
as O O
the O O
causative O O
agent O O
( O O
table O O
1 O O
) O O
. O O

data O O
from O O
the O O
history O O
taking O O
, O O
physical O O
examination O O
, O O
and O O
supporting O O
examinations O O
concluded O O
a O O
diagnosis O O
of O O
cutaneous O B-C0006846
candidiasis O I-C0006846
caused O O
by O O
candida O O
kefyr O O
. O O

on O O
the O O
fifth O O
day O O
of O O
treatment O O
the O O
lesion O B-C0221198
showed O O
marked O O
improvement O O
. O O

fusidic O O
acid O O
was O O
dropped O O
and O O
only O O
miconazole O O
was O O
continued O O
. O O

the O O
patient O O
was O O
eventually O O
discharged O O
from O O
the O O
neurology O O
department O O
on O O
the O O
sixth O O
day O O
. O O

we O O
report O O
the O O
case O O
of O O
a O O
38 O O
- O O
year-old O O
obese O O
female O O
with O O
a O O
body O O
mass O O
index O O
( O O
BMI O O
) O O
of O O
35 O O
, O O
with O O
no O O
known O O
comorbidity O B-C0009488
. O O

she O O
reported O O
diarrhea O B-C0011991
accompanied O O
by O O
fever O B-C0015967
three O O
weeks O O
before O O
, O O
which O O
revealed O O
a O O
COVID O O
- O O
19 O O
infection O B-C3714514
, O O
for O O
which O O
she O O
was O O
treated O O
at O O
home O O
without O O
complications O O
. O O

she O O
went O O
to O O
the O O
emergency O O
room O O
on O O
the O O
seventeenth O O
day O O
after O O
the O O
onset O O
of O O
symptoms O O
, O O
with O O
sudden O O
onset O O
dyspnea O B-C0013404
. O O

the O O
physical O O
examination O O
revealed O O
: O O
glasgow O O
coma O O
scale O O
15 O O
/ O O
15 O O
; O O
blood O O
pressure O O
: O O
127 O O
/ O O
80mmhg O O
; O O
heart O O
rate O O
: O O
100 O O
beats O O
/ O O
min O O
; O O
respiratory O O
rate O O
: O O
30 O O
cycles O O
/ O O
min O O
; O O
87% O O
sao O O
2 O O
in O O
ambient O O
air O O
; O O
crackling O O
and O O
wheezing O B-C0043144
rales O B-C0034642
at O O
the O O
base O O
of O O
the O O
left O O
lung O O
. O O

cardiovascular O O
examination O O
was O O
normal O O
, O O
there O O
was O O
no O O
evidence O O
of O O
deep O B-C0149871
vein O I-C0149871
thrombosis O I-C0149871
. O O

given O O
the O O
epidemiological O O
context O O
, O O
we O O
performed O O
two O O
RT-PCR O O
tests O O
on O O
the O O
first O O
and O O
the O O
second O O
day O O
, O O
all O O
were O O
negative O O
. O O

the O O
anti-sars-cov O O
- O O
2 O O
igg O O
fraction O O
of O O
the O O
serological O O
test O O
was O O
positive O O
. O O

the O O
chest O O
x-ray O O
found O O
left O O
middle O O
arch O O
of O O
the O O
heart O O
convex O O
, O O
right O O
basal O O
pulmonary O O
opacity O O
, O O
bilateral O O
interstitial O O
syndrome O O
. O O

the O O
chest O O
computed O O
tomography O O
with O O
and O O
without O O
injection O O
of O O
contrast O O
product O O
found O O
multifocal O O
ground O O
glass O O
foci O O
( O O
10 O O
- O O
25% O O
impairment O O
) O O
of O O
the O O
two O O
pulmonary O O
hemi O O
fields O O
located O O
under O O
pleural O O
with O O
segmental O O
and O O
sub-segmental O O
left O O
pulmonary O B-C0034065
embolism O I-C0034065
. O O

the O O
biological O O
assessment O O
found O O
white O O
blood O O
cells O O
: O O
13780 O O
/ O O
UL O O
( O O
N O O
≤ O O
10000 O O
) O O
with O O
polynuclear O O
neutrophils O O
at O O
10930 O O
/ O O
UL O O
( O O
N O O
≤ O O
7000 O O
) O O
; O O
C O O
reactive O O
protein O O
: O O
40 O O
( O O
N O O
≤ O O
6 O O
) O O
, O O
troponin O O
: O O
60ng O O
/ O O
L O O
( O O
N O O
≤ O O
14 O O
) O O
, O O
d.dimers O O
: O O
1000ug O O
/ O O
ml O O
( O O
< O O
0.5 O O
) O O
; O O
creatinine O O
: O O
9mg O O
/ O O
L O O
( O O
6 O O
- O O
13 O O
) O O
, O O
antithrombin O O
, O O
protein O O
S O O
, O O
protein O O
C O O
, O O
factor O O
V O O
leiden O O
, O O
all O O
were O O
normal O O
. O O

the O O
electrocardiogram O O
found O O
a O O
sinus O B-C0039239
tachycardia O I-C0039239
with O O
incomplete O B-C0262525
right O I-C0262525
bundle O I-C0262525
branch O I-C0262525
block O I-C0262525
, O O
anteroseptoapical O O
and O O
inferior O O
negative O O
T O O
wave O O
, O O
S1Q3 O O
aspect O O
. O O

the O O
transthoracic O O
ultrasound O O
showed O O
an O O
acute O O
pulmonary O O
heart O O
without O O
right O O
ventricule O O
dysfonction O O
, O O
pulmonary O B-C0020542
hypertension O I-C0020542
at O O
54 O O
mmhg O O
with O O
dilated O O
lower O O
vein O O
cave O O
. O O

we O O
retained O O
the O O
diagnosis O O
of O O
pulmonary O B-C0034065
embolism O I-C0034065
at O O
low O O
intermediate O O
risk O O
on O O
recovered O O
COVID O O
- O O
19 O O
infection O B-C3714514
. O O

the O O
patient O O
received O O
curative O O
dose O O
of O O
low O O
molecular O O
weight O O
heparin O O
( O O
LMWH O O
) O O
followed O O
by O O
acenocoumarol O O
, O O
oxygen O O
therapy O O
( O O
3L O O
/ O O
min O O
) O O
. O O

the O O
clinical O O
outcome O O
was O O
favorable O O
after O O
eight O O
days O O
of O O
hospitalization O O
. O O

we O O
report O O
the O O
case O O
of O O
a O O
61 O O
- O O
year-old O O
man O O
who O O
presented O O
with O O
a O O
3 O O
- O O
month O O
history O O
of O O
atraumatic O O
right O O
knee O B-C0231749
pain O I-C0231749
localized O O
to O O
the O O
suprapatellar O O
region O O
. O O

pre-operative O O
magnetic O O
resonance O O
imaging O O
confirmed O O
the O O
presence O O
of O O
loose O O
bodies O O
at O O
the O O
suprapatellar O O
region O O
behind O O
the O O
complete O O
septum O O
. O O

loose O O
bodies O O
were O O
concealed O O
in O O
a O O
sealed O O
suprapatellar O O
pouch O O
and O O
could O O
not O O
be O O
detected O O
by O O
routine O O
arthroscopic O O
examination O O
of O O
the O O
knee O O
cavity O O
. O O

the O O
suprapatellar O O
plica O O
was O O
punctured O O
and O O
loose O O
bodies O O
trapped O O
within O O
the O O
enclosed O O
suprapatellar O O
compartment O O
were O O
arthroscopically O O
removed O O
. O O

histological O O
examination O O
of O O
the O O
loose O O
bodies O O
confirmed O O
the O O
diagnosis O O
of O O
osteochondromatosis O B-C0206641
. O O

the O O
patient O O
postoperatively O O
experienced O O
complete O O
relief O O
of O O
knee O B-C0231749
pain O I-C0231749
. O O

A O O
21 O O
# O O
years O O
old O O
male O O
mexican O O
with O O
human O O
immunodeficiency O B-C0021051
virus O O
( O O
HIV O O
) O O
, O O
late O O
presenter O O
; O O
who O O
developed O O
cytomegalovirus O O
( O O
CMV O O
) O O
infection O B-C3714514
and O O
a O O
disseminated O O
histoplasmosis-related O O
HLS O O
, O O
as O O
part O O
of O O
an O O
immune O B-C1619738
reconstitution O I-C1619738
inflammatory O I-C1619738
syndrome O I-C1619738
( O O
IRIS O O
) O O
. O O

the O O
patient O O
required O O
a O O
long O O
course O O
of O O
corticotherapy O O
, O O
intravenous O O
immunoglobulin O O
and O O
massive O O
transfusions O O
( O O
more O O
than O O
10 O O
units O O
in O O
24 O O
# O O
h O O
, O O
and O O
a O O
total O O
of O O
83 O O
units O O
) O O
, O O
besides O O
amphotericin-b O O
and O O
ganciclovir O O
treatment O O
. O O

an O O
academic O O
research O O
institute O O
of O O
immunology O O
aided O O
in O O
the O O
accurate O O
diagnosis O O
of O O
HLS O O
with O O
the O O
implementation O O
of O O
tests O O
not O O
available O O
within O O
the O O
hospital O O
, O O
thus O O
improving O O
the O O
care O O
provided O O
to O O
the O O
patient O O
. O O

the O O
patient O O
recovered O O
, O O
was O O
discharged O O
, O O
and O O
continue O O
to O O
improve O O
. O O

A O O
37 O O
- O O
year-old O O
man O O
was O O
admitted O O
to O O
our O O
hospital O O
with O O
frequency O O
, O O
urgency O O
and O O
odynuria O O
for O O
3 O O
months O O
. O O

he O O
received O O
open O O
right O O
inguinal O B-C0019294
hernia O I-C0019294
repair O O
in O O
september O O
2014 O O
, O O
and O O
right O O
laparoscopic O O
hernioplasty O O
for O O
recurrence O O
of O O
the O O
inguinal O B-C0019294
hernia O I-C0019294
in O O
may O O
2015 O O
. O O

in O O
february O O
2019 O O
, O O
he O O
underwent O O
a O O
day-case O O
transurethral O O
cystoscopic O O
operation O O
for O O
urethral O O
and O O
bladder O B-C0005683
stones O I-C0005683
. O O

cystoscopy O O
revealed O O
the O O
existence O O
of O O
bladder O B-C0005683
stones O I-C0005683
and O O
part O O
of O O
the O O
eroded O O
mesh O O
on O O
the O O
right O O
anterior O O
wall O O
, O O
for O O
which O O
an O O
open O O
partial O O
cystectomy O O
was O O
performed O O
. O O

the O O
patient O O
was O O
followed O O
up O O
for O O
3 O O
months O O
postoperatively O O
, O O
during O O
which O O
no O O
further O O
mesh O O
erosion O O
or O O
stone O O
recurrence O O
was O O
detected O O
by O O
cystoscopy O O
. O O

A O O
78 O O
- O O
year-old O O
male O O
known O O
to O O
have O O
a O O
left O O
sided O O
inguinal O B-C0019294
hernia O I-C0019294
presented O O
to O O
the O O
emergency O O
department O O
with O O
two O O
weeks O O
of O O
intermittent O O
suprapubic O O
tenderness O O
, O O
dysuria O B-C0013428
, O O
frequency O O
, O O
urgency O O
, O O
frothy O O
urine O O
as O O
well O O
as O O
nausea O B-C0027498
and O I-C0027498
vomiting O I-C0027498
. O O

workup O O
on O O
admission O O
revealed O O
an O O
elevated O O
creatinine O O
of O O
2.8 O O
mg O O
/ O O
dl O O
. O O

CT O O
imaging O O
revealed O O
duplicated O O
left O O
sided O O
ureters O O
with O O
left O O
inguinal O B-C0019294
hernia O I-C0019294
containing O O
the O O
ureters O O
. O O

there O O
was O O
cystic O O
ureteral O B-C3809360
dilation O I-C3809360
within O O
the O O
herniation O O
sac O O
as O O
well O O
as O O
moderate O O
left O O
hydroureteronephrosis O B-C0268804
. O O

patient O O
had O O
an O O
elective O O
inguinal O B-C0019294
hernia O I-C0019294
repair O O
with O O
left O O
ureteral O O
stent O O
placement O O
. O O

following O O
the O O
surgery O O
, O O
he O O
had O O
recovery O O
of O O
kidney O O
function O O
to O O
the O O
previous O O
baseline O O
serum O O
creatinine O O
of O O
1.5 O O
mg O O
/ O O
dl O O
. O O

A O O
45 O O
- O O
year-old O O
male O O
presented O O
with O O
a O O
left O O
SSS O O
and O O
a O O
bilateral O O
concha O O
bullosa O O
. O O

he O O
developed O O
a O O
contralateral O O
SSS O O
two O O
years O O
after O O
an O O
endoscopic O O
uncinectomy O O
and O O
re-ventilation O O
of O O
the O O
diseased O O
maxillary O O
sinus O O
. O O

this O O
case O O
is O O
the O O
second O O
reported O O
in O O
literature O O
with O O
a O O
metachronous O O
presentation O O
. O O

A O O
pure O O
endoscopic O O
approach O O
has O O
led O O
to O O
the O O
resolution O O
of O O
symptomatology O O
and O O
the O O
full O O
restoration O O
of O O
the O O
ventilation O O
of O O
the O O
maxillary O O
sinuses O B-C0016169
. O O

the O O
key O O
role O O
of O O
the O O
uncinate O O
process O O
in O O
the O O
genesis O O
of O O
the O O
pathology O O
has O O
been O O
well O O
demonstrated O O
by O O
the O O
onset O O
of O O
a O O
contralateral O O
SSS O O
in O O
a O O
normally O O
developed O O
maxillary O O
sinus O O
thanks O O
to O O
a O O
complete O O
radiological O O
follow-up O O
. O O

the O O
patient O O
was O O
a O O
45 O O
- O O
year-old O O
female O O
who O O
presented O O
to O O
the O O
ED O O
with O O
a O O
three-day O O
history O O
of O O
sore O B-C0242429
throat O I-C0242429
that O O
was O O
exacerbated O O
by O O
eating O O
and O O
drinking O O
. O O

the O O
patient O O
was O O
not O O
on O O
any O O
prescription O O
medications O O
, O O
but O O
tried O O
over-the-counter O O
medications O O
for O O
the O O
sore O B-C0242429
throat O I-C0242429
without O O
any O O
improvement O O
in O O
symptoms O O
. O O

review O O
of O O
systems O O
was O O
positive O O
for O O
sore O B-C0242429
throat O I-C0242429
, O O
fevers O B-C0015967
, O O
and O O
chills O B-C0085593
. O O

physical O O
examination O O
of O O
her O O
oropharynx O O
revealed O O
mildly O O
dry O O
mucous O O
membranes O O
with O O
confluent O O
plaques O O
and O O
white O O
patchy O O
ulcerative O O
appearance O O
involving O O
the O O
tongue O O
, O O
tonsils O O
, O O
hard O O
palate O O
, O O
and O O
soft O O
palate O O
. O O

rapid O O
streptococcal O O
antigen O O
, O O
mononucleosis O B-C0021345
spot O O
test O O
, O O
and O O
KOH O O
test O O
were O O
performed O O
and O O
found O O
to O O
be O O
negative O O
. O O

A O O
30 O O
- O O
year-old O O
male O O
presented O O
with O O
a O O
right O O
pneumo-haemothorax O O
due O O
to O O
active O O
bleeding O B-C0019080
revealed O O
at O O
contrast-enhanced O O
CT O O
, O O
as O O
a O O
consequence O O
of O O
a O O
fall O B-C0085639
occurred O O
in O O
the O O
previous O O
week O O
. O O

the O O
patient O O
was O O
treated O O
with O O
endovascular O O
embolisation O O
in O O
an O O
angiographic O O
room O O
with O O
coils O O
placement O O
, O O
since O O
the O O
right O O
thyrocervical O O
artery O O
was O O
found O O
to O O
be O O
supplying O O
the O O
pneumo-haemothorax O O
. O O

A O O
radiculo-medullary O O
branch O O
rose O O
from O O
the O O
thyrocervical O O
trunk O O
, O O
impeding O O
the O O
proximal O O
embolization O O
with O O
microparticles O O
and O O
needing O O
selective O O
isolation O B-C0260397
of O O
the O O
bleeding O B-C0019080
artery O O
with O O
the O O
catheter O O
to O O
avoid O O
spinal O B-C0037929
cord O I-C0037929
injuries O I-C0037929
. O O

the O O
treatment O O
had O O
a O O
successful O O
result O O
and O O
the O O
following O O
CT O O
control O O
showed O O
signs O O
of O O
recovering O O
, O O
without O O
any O O
complication O O
. O O

A O O
37 O O
- O O
year-old O O
patient O O
was O O
admitted O O
to O O
the O O
emergency O O
department O O
with O O
acute O O
abdominal O B-C0000737
pain O I-C0000737
. O O

following O O
explorative O O
laparoscopy O O
, O O
locally O O
advanced O O
diffuse O O
gastric O B-C0024623
cancer O I-C0024623
was O O
diagnosed O O
. O O

the O O
indication O O
for O O
genetic O O
testing O O
of O O
CDH1 O O
was O O
given O O
due O O
to O O
the O O
patient's O O
young O O
age O O
. O O

A O O
germline O O
mutation O O
in O O
CDH1 O O
was O O
identified O O
in O O
the O O
index O O
patient O O
. O O

as O O
a O O
result O O
, O O
several O O
family O O
members O O
underwent O O
genetic O O
testing O O
. O O

the O O
patient's O O
father O O
, O O
brother O O
and O O
one O O
aunt O O
were O O
identified O O
as O O
carriers O O
of O O
the O O
familial O O
CDH1 O O
mutation O O
and O O
subsequently O O
received O O
gastrectomy O O
. O O

in O O
both O O
the O O
father O O
and O O
the O O
aunt O O
, O O
histology O O
of O O
the O O
surgical O O
specimen O O
revealed O O
a O O
diffuse O O
growing O O
adenocarcinoma O B-C0001418
after O O
an O O
unremarkable O O
preoperative O O
gastroscopy O O
. O O

A O O
22 O O
- O O
year-old O O
chinese O O
man O O
presented O O
a O O
combination O O
of O O
kissing O O
molars O O
, O O
maxillary O O
bilateral O O
supernumerary O B-C0040457
teeth O I-C0040457
and O O
macrodontia O B-C0266036
. O O

radiographically O O
, O O
two O O
maxillary O O
bilateral O O
distomolars O O
located O O
at O O
the O O
buccal O O
side O O
of O O
adjacent O O
third O O
molars O O
. O O

one O O
mandibular O O
distomolar O B-C0162475
with O O
the O O
adjacent O O
third O O
molar O O
was O O
contacted O O
by O O
occlusal O O
surfaces O O
while O O
roots O O
were O O
pointed O O
oppositely O O
, O O
which O O
could O O
be O O
diagnosed O O
as O O
KM O O
. O O

furthermore O O
, O O
the O O
left O O
mandibular O O
third O O
molar O O
can O O
be O O
inferred O O
to O O
be O O
a O O
macrodontia O B-C0266036
, O O
characterized O O
by O O
a O O
large O O
crown O O
and O O
tapering O O
root O O
. O O

after O O
a O O
thorough O O
investigation O O
, O O
we O O
excluded O O
the O O
possibilities O O
of O O
systemic O O
diseases O O
and O O
genetic O O
inheritance O O
. O O

however O O
, O O
the O O
etiology O O
of O O
this O O
rare O O
combination O O
deserves O O
to O O
be O O
further O O
explored O O
. O O

we O O
report O O
on O O
a O O
case O O
of O O
giant O O
paraesophageal O O
HH O O
in O O
a O O
middle-aged O O
male O O
patient O O
with O O
reflux O B-C0232483
symptoms O O
and O O
severe O O
anemia O B-C0002871
. O O

after O O
performing O O
a O O
series O O
of O O
tests O O
and O O
diagnostic O O
approaches O O
, O O
results O O
showed O O
a O O
complete O O
intrathoracic O B-C2673583
stomach O I-C2673583
associated O O
with O O
severe O O
iron O B-C0162316
deficiency O I-C0162316
anemia O I-C0162316
. O O

the O O
patient O O
underwent O O
successful O O
laparoscopic O O
hernia O B-C0019270
repair O O
with O O
mesh O O
reinforcement O O
and O O
nissen O O
fundoplication O O
. O O

postoperatively O O
, O O
reflux O B-C0232483
symptoms O O
were O O
markedly O O
relieved O O
, O O
and O O
the O O
imaging O O
study O O
showed O O
complete O O
reduction O O
of O O
the O O
hernia O B-C0019270
sac O O
. O O

more O O
importantly O O
, O O
anemia O B-C0002871
was O O
resolved O O
, O O
and O O
hemoglobin O O
, O O
serum O O
iron O O
and O O
ferritin O O
level O O
were O O
returned O O
to O O
the O O
normal O O
range O O
. O O

the O O
patient O O
kept O O
regular O O
follow-up O O
appointments O O
and O O
remained O O
in O O
a O O
satisfactory O O
condition O O
. O O

we O O
report O O
two O O
patients O O
with O O
dysphagia O B-C0011168
due O O
to O O
LMS O O
and O O
propose O O
a O O
novel O O
technique O O
named O O
hyoid-complex O O
elevation O O
and O O
stimulation O O
technique O O
( O O
known O O
as O O
HEST O O
) O O
. O O

the O O
two O O
patients O O
had O O
no O O
other O O
functional O O
incapacity O O
back O O
into O O
life O O
, O O
but O O
nasogastric O O
feeding O O
was O O
the O O
only O O
possible O O
way O O
for O O
nutrition O O
because O O
of O O
severe O O
aspirations O O
. O O

swallowing O O
function O O
was O O
evaluated O O
by O O
functional O O
oral O O
intake O O
scale O O
, O O
modified O O
water O O
swallow O O
test O O
, O O
surface O O
electromyographic O O
signal O O
associated O O
with O O
video O O
fluorography O O
swallowing O O
study O O
to O O
assess O O
the O O
situation O O
of O O
aspiration O O
, O O
pharyngeal O O
residue O O
, O O
pharyngeal O O
peristalsis O O
, O O
upper O O
esophageal O O
opening O O
and O O
the O O
ability O O
of O O
deglutition O O
. O O

both O O
patients O O
were O O
treated O O
with O O
the O O
HEST O O
method O O
for O O
dysphagia O B-C0011168
and O O
recovered O O
quickly O O
. O O

A O O
49 O O
- O O
year-old O O
woman O O
presented O O
with O O
neck O B-C0007859
pain O I-C0007859
lasting O O
for O O
several O O
months O O
and O O
second O O
and O O
third O O
finger O O
radiating O B-C0234254
pain O I-C0234254
. O O

severe O O
cervical O O
herniated O O
intervertebral O O
disc O O
findings O O
could O O
be O O
identified O O
at O O
C6 O O
- O O
7 O O
level O O
on O O
c-spine O O
MRI O O
. O O

ACDF O O
C6 O O
- O O
7 O O
surgery O O
was O O
performed O O
. O O

immediately O O
after O O
the O O
operation O O
, O O
physical O O
examination O O
revealed O O
paraplegia O B-C0030486
and O O
emergency O O
MRI O O
was O O
performed O O
. O O

on O O
MR O O
images O O
, O O
T2 O O
high O O
signal O O
myelopathy O B-C0037928
suspected O O
as O O
reperfusion O B-C0035126
injury O I-C0035126
at O O
C6 O O
- O O
7 O O
level O O
, O O
and O O
emergency O O
surgery O O
was O O
performed O O
under O O
diagnosis O O
of O O
white O O
cord O O
syndrome O O
. O O

after O O
the O O
emergency O O
operation O O
, O O
the O O
paraplegic O O
problem O O
was O O
gradually O O
resolved O O
. O O

before O O
discharge O O
, O O
motor O O
power O O
and O O
sensory O O
deficit O O
of O O
bilateral O O
lower O O
extremity O O
were O O
fully O O
recovered O O
. O O

the O O
case O O
of O O
an O O
84 O O
- O O
year-old O O
woman O O
who O O
sustained O O
a O O
periprosthetic O O
tibial O B-C0040185
fracture O I-C0040185
10 O O
years O O
after O O
a O O
TKA O O
is O O
presented O O
. O O

this O O
patient O O
had O O
multiple O O
risk O B-C0035648
factors O I-C0035648
. O O

the O O
fracture O O
was O O
not O O
deemed O O
amenable O O
to O O
conventional O O
treatment O O
because O O
the O O
bone O O
fragment O O
was O O
too O O
small O O
. O O

this O O
patient O O
underwent O O
fixation O O
of O O
her O O
tibial O B-C0040185
fracture O I-C0040185
above O O
the O O
TKA O O
using O O
a O O
five-ring O O
ilizarov O O
external O O
fixator O O
. O O

this O O
allowed O O
immediate O O
full O O
weight-bearing O O
. O O

the O O
fixator O O
was O O
removed O O
at O O
12 O O
weeks O O
, O O
at O O
which O O
time O O
the O O
fracture O O
was O O
solidly O O
healed O O
. O O

at O O
the O O
most O O
recent O O
follow-up O O
, O O
2 O O
years O O
from O O
injury O B-C3263723
, O O
she O O
was O O
fully O O
weight-bearing O O
without O O
walking O O
aids O O
and O O
had O O
a O O
knee O O
range O O
of O O
motion O O
( O O
ROM O O
) O O
of O O
0 O O
- O O
110 O O
° O O
. O O

data O O
were O O
collected O O
by O O
historical O O
review O O
, O O
clinical O O
examination O O
, O O
laboratory O O
investigations O O
, O O
imaging O O
examination O O
, O O
and O O
by O O
histopathological O O
study O O
of O O
the O O
excised O O
surgical O O
specimen O O
. O O

it O O
is O O
the O O
case O O
of O O
a O O
25 O O
- O O
year-old O O
woman O O
who O O
was O O
third O O
gravida O O
and O O
third O O
para O O
with O O
unknown O O
pathological O O
history O O
. O O

after O O
she O O
had O O
given O O
birth O O
through O O
vagina O O
, O O
a O O
giant O O
ovarian O B-C0029927
cyst O I-C0029927
, O O
unknown O O
during O O
pregnancy O O
, O O
was O O
diagnosed O O
. O O

A O O
left O O
oophorectomy O O
carrying O O
the O O
cyst O B-C0010709
was O O
performed O O
after O O
laparotomy O O
in O O
yalgado O O
ouedraogo O O
university O O
hospital O O
center O O
of O O
ouagadougou O O
( O O
burkina O O
faso O O
) O O
. O O

the O O
cyst O B-C0010709
was O O
42 O O
cm O O
long O O
and O O
weighed O O
19.7 O O
kg O O
. O O

the O O
histology O O
of O O
the O O
operative O O
specimen O O
revealed O O
serous O B-C0206709
cystadenoma O I-C0206709
of O O
the O O
ovary O O
. O O

the O O
postoperative O O
course O O
was O O
uneventful O O
. O O

A O O
60 O O
- O O
year-old O O
male O O
patient O O
presented O O
to O O
the O O
department O O
of O O
general O O
surgery O O
of O O
PLA O O
strategic O O
support O O
force O O
characteristic O O
medical O O
center O O
with O O
the O O
chief O O
complaint O O
of O O
a O O
mass O O
in O O
the O O
perianal O O
region O O
gradually O O
expanding O O
for O O
more O O
than O O
30 O O
years O O
and O O
perianal O O
discomfort O B-C2364135
upon O O
sitting O O
for O O
a O O
preceding O O
period O O
of O O
2 O O
mo O O
. O O

physical O O
examination O O
revealed O O
a O O
painless O O
mass O O
in O O
the O O
left O O
perianal O O
region O O
. O O

contrast-enhanced O O
CT O O
was O O
used O O
for O O
preoperative O O
diagnosis O O
. O O

the O O
patient O O
was O O
treated O O
by O O
total O O
mass O O
excision O O
under O O
epidural O O
anesthesia O B-C0278134
. O O

postoperative O O
pathological O O
examination O O
revealed O O
the O O
presence O O
of O O
a O O
perianal O O
epidermoid O B-C0014511
cyst O I-C0014511
. O O

the O O
patient O O
showed O O
a O O
satisfactory O O
recovery O O
during O O
the O O
6 O O
- O O
month O O
follow-up O O
period O O
. O O

patient O O
A O O
was O O
91 O O
# O O
years O O
old O O
with O O
known O O
pulmonary O B-C0020542
hypertension O I-C0020542
and O O
right O O
ventricular O O
systolic O B-C0749225
dysfunction O I-C0749225
who O O
presented O O
in O O
septic O B-C0036983
shock O I-C0036983
requiring O O
vasopressor O O
support O O
. O O

hepatic O O
and O O
portal O O
vein O O
dopplers O O
were O O
consistent O O
with O O
right O B-C0235527
heart O I-C0235527
failure O I-C0235527
and O O
significant O O
venous O B-C0042484
congestion O I-C0042484
, O O
therefore O O
, O O
diuresis O O
was O O
initiated O O
which O O
resulted O O
in O O
portal O O
flow O O
normalization O O
, O O
renal O O
recovery O O
, O O
and O O
cessation O O
of O O
vasopressor O O
support O O
. O O

patient O O
B O O
was O O
82 O O
# O O
years O O
old O O
with O O
severe O O
idiopathic O B-C1800706
pulmonary O I-C1800706
fibrosis O I-C1800706
on O O
home O O
oxygen O O
who O O
presented O O
in O O
decompensated O O
right O B-C0235527
heart O I-C0235527
failure O I-C0235527
. O O

despite O O
aggressive O O
diuresis O O
, O O
a O O
negative O O
fluid O O
balance O O
was O O
not O O
achieved O O
. O O

the O O
patient O O
continued O O
to O O
deteriorate O O
and O O
prior O O
to O O
their O O
death O O
portal O O
vein O O
, O O
doppler O O
showed O O
significant O O
flow O O
reversal O O
. O O

A O O
27 O O
- O O
year-old O O
man O O
visited O O
the O O
emergency O O
department O O
with O O
a O O
self-inflicted O O
abdominal O O
stab O B-C0043255
wound O I-C0043255
. O O

injuries O B-C0497561
to O O
the O O
colon O O
and O O
ileum O O
were O O
detected O O
, O O
but O O
an O O
injury O B-C3263723
to O O
the O O
second O O
portion O O
of O O
the O O
duodenum O O
was O O
missed O O
. O O

on O O
the O O
day O O
following O O
admission O O
to O O
our O O
institution O O
, O O
the O O
patient O O
became O O
hemodynamically O O
unstable O O
with O O
massive O O
hematochezia O B-C0018932
, O O
although O O
there O O
was O O
no O O
evidence O O
of O O
bleeding O B-C0019080
in O O
the O O
levin O O
tube O O
or O O
jackson-pratt O O
drain O O
. O O

we O O
thus O O
performed O O
an O O
upper O O
gastrointestinal O O
endoscopy O O
and O O
discovered O O
a O O
missed O O
duodenal O O
injury O B-C3263723
that O O
was O O
actively O O
bleeding O B-C0019080
. O O

an O O
endoscopic O O
band O O
ligation O O
was O O
performed O O
for O O
hemostasis O O
and O O
closure O O
of O O
the O O
perforation O O
. O O

the O O
patient O O
was O O
subsequently O O
discharged O O
without O O
any O O
complications O O
. O O

from O O
april O O
2017 O O
to O O
october O O
2018 O O
, O O
five O O
female O O
patients O O
were O O
diagnosed O O
with O O
hypertension O B-C0020538
due O O
to O O
takayasu O B-C0039263
arteritis O I-C0039263
by O O
computed O O
tomography O O
angiography O O
( O O
CTA O O
) O O
and O O
laboratory O O
tests O O
. O O

four O O
patients O O
had O O
a O O
complaint O O
of O O
headache O B-C0018681
with O O
or O O
without O O
dizziness O B-C0012833
, O O
and O O
one O O
patient O O
showed O O
no O O
symptom O O
. O O

there O O
was O O
no O O
significant O O
family O O
or O O
past O O
history O O
of O O
hypertension O B-C0020538
or O O
kidney O B-C0022658
disease O I-C0022658
, O O
and O O
the O O
physical O O
examinations O O
were O O
almost O O
normal O O
on O O
admission O O
. O O

we O O
performed O O
a O O
treatment O O
by O O
drug O O
coated O O
balloon O O
angioplasty O O
. O O

blood O O
pressure O O
decreased O O
dramatically O O
in O O
all O O
patients O O
after O O
balloon O O
angioplasty O O
, O O
and O O
the O O
patency O O
of O O
treated O O
renal O O
artery O O
was O O
demonstrated O O
with O O
CTA O O
over O O
5 O O
months O O
after O O
the O O
angioplasty O O
procedure O O
. O O

A O O
43 O O
- O O
year-old O O
woman O O
was O O
referred O O
with O O
complaints O O
of O O
deteriorating O O
dyspnea O B-C0013404
and O O
orthopnea O B-C0085619
. O O

chest O O
computed O O
tomography O O
revealed O O
right O O
massive O O
pleural O B-C0032227
effusion O I-C0032227
and O O
pericardial O B-C0031039
effusion O I-C0031039
. O O

echocardiography O O
demonstrated O O
collapse O O
of O O
both O O
the O O
right O O
atrium O O
and O O
right O O
ventricle O O
due O O
to O O
cardiac O B-C0007177
tamponade O I-C0007177
. O O

semi-rigid O O
thoracoscopic O O
pleural O O
biopsy O O
and O O
pericardio-pleural O O
fenestration O O
were O O
successfully O O
performed O O
under O O
local O O
anesthesia O B-C0278134
via O O
a O O
single O O
trocar O O
, O O
because O O
surgical O O
procedures O O
under O O
general O O
anesthesia O B-C0278134
with O O
single-lung O O
ventilation O O
might O O
have O O
been O O
intolerable O O
for O O
the O O
patient O O
. O O

adequate O O
biopsy O O
specimens O O
of O O
pleura O O
and O O
pericardium O O
and O O
immediate O O
relief O O
of O O
serious O O
symptoms O O
were O O
obtained O O
without O O
perioperative O O
complications O O
. O O

no O O
recurrence O O
of O O
pleural O O
or O O
pericardial O B-C0031039
effusion O I-C0031039
was O O
observed O O
for O O
3 O O
months O O
postoperatively O O
. O O

we O O
report O O
our O O
observations O O
of O O
three O O
unrelated O O
moroccan O O
patients O O
referred O O
to O O
our O O
genetics O O
department O O
for O O
molecular O O
diagnosis O O
of O O
epilepsy O B-C0014544
: O O
a O O
4 O O
- O O
year-old O O
moroccan O O
boy O O
, O O
a O O
3 O O
- O O
year-old O O
moroccan O O
girl O O
, O O
and O O
a O O
7 O O
- O O
year-old O O
moroccan O O
boy O O
. O O

due O O
to O O
the O O
heterogeneity O O
and O O
complexity O O
of O O
epilepsy O B-C0014544
, O O
we O O
performed O O
clinical O O
exome O O
sequencing O O
followed O O
by O O
targeted O O
analysis O O
of O O
936 O O
epilepsy O B-C0014544
genes O O
. O O

A O O
total O O
of O O
three O O
mutations O O
were O O
identified O O
in O O
known O O
epilepsy O B-C0014544
genes O O
( O O
SCN1A O O
, O O
SCN2A O O
) O O
. O O

by O O
clinical O O
exome O O
sequencing O O
, O O
we O O
identified O O
two O O
novel O O
mutations O O
: O O
c O O
.4973C O O
> O O
A O O
( O O
p.thr1658lys O O
) O O
in O O
SCN1A O O
gene O O
and O O
c O O
.1283A O O
> O O
G O O
( O O
p.tyr428cys O O
) O O
in O O
the O O
SCN2A O O
gene O O
, O O
whereas O O
the O O
third O O
mutation O O
c O O
.3295G O O
> O O
T O O
( O O
p.glu1099 O O
* O O
) O O
was O O
already O O
described O O
in O O
patients O O
with O O
dravet O B-C0751122
syndrome O I-C0751122
. O O

A O O
78 O O
- O O
year-old O O
man O O
with O O
squamous O B-C0149782
cell O I-C0149782
lung O I-C0149782
carcinoma O I-C0149782
in O O
IPF O O
underwent O O
second-line O O
treatment O O
with O O
pembrolizumab O O
. O O

he O O
was O O
diagnosed O O
as O O
having O O
pembrolizumab-induced O O
pneumonitis O B-C3714636
after O O
two O O
cycles O O
. O O

he O O
was O O
administered O O
prednisolone O O
( O O
PSL O O
) O O
and O O
then O O
improved O O
immediately O O
. O O

thereafter O O
, O O
his O O
lung O B-C0242379
cancer O I-C0242379
lesion O B-C0221198
enlarged O O
despite O O
treatment O O
with O O
TS O O
- O O
1 O O
. O O

atezolizumab O O
was O O
then O O
administered O O
as O O
4th-line O O
chemotherapy O O
, O O
but O O
he O O
immediately O O
developed O O
atezolizumab-induced O O
pneumonitis O B-C3714636
after O O
1 O O
cycle O O
. O O

the O O
re-escalated O O
dosage O O
of O O
PSL O O
improved O O
the O O
pneumonitis O B-C3714636
, O O
and O O
then O O
nintedanib O O
was O O
started O O
as O O
additional O O
therapy O O
. O O

under O O
careful O O
observation O O
with O O
nintedanib O O
, O O
atezolizumab O O
was O O
re-administered O O
on O O
day O O
1 O O
of O O
an O O
every O O
- O O
21 O O
- O O
day O O
cycle O O
. O O

after O O
three O O
cycles O O
, O O
it O O
remained O O
stable O O
without O O
exacerbation O O
of O O
drug-induced O O
pneumonitis O B-C3714636
. O O

A O O
29 O O
- O O
year-old O O
primigravida O O
japanese O O
woman O O
presented O O
to O O
our O O
hospital O O
at O O
40 O O
weeks O O
and O O
1 O O
day O O
of O O
gestation O O
with O O
marked O O
vaginal O B-C2979982
bleeding O I-C2979982
. O O

since O O
admission O O
, O O
fetal O B-C0018811
heart O I-C0018811
rate O I-C0018811
tracing O O
consistently O O
demonstrated O O
a O O
sawtooth-like O O
pattern O O
. O O

there O O
were O O
3 O O
- O O
4 O O
oscillations O O
per O O
minute O O
, O O
and O O
their O O
amplitude O O
was O O
30 O O
- O O
40 O O
beats O O
per O O
minute O O
. O O

an O O
emergency O O
cesarean O O
section O O
was O O
performed O O
because O O
of O O
non-reassuring O O
fetal O O
status O O
. O O

evidence O O
of O O
placental O B-C0000832
abruption O I-C0000832
was O O
not O O
observed O O
. O O

the O O
newborn O O
was O O
a O O
male O O
weighing O O
2936 O O
g O O
, O O
with O O
an O O
apgar O O
score O O
of O O
1 O O
and O O
3 O O
at O O
1 O O
minute O O
and O O
5 O O
minutes O O
, O O
respectively O O
. O O

the O O
infant O O
received O O
brain O O
cooling O O
, O O
but O O
was O O
discharged O O
uneventfully O O
. O O

A O O
follow-up O O
examination O O
at O O
age O O
3 O O
years O O
demonstrated O O
no O O
developmental O O
restriction O O
. O O

A O O
68 O O
- O O
year-old O O
female O O
was O O
diagnosed O O
with O O
stage O O
IV O O
non-small O O
cell O O
lung O B-C0152013
adenocarcinoma O I-C0152013
and O O
was O O
started O O
on O O
pembrolizumab O O
. O O

the O O
patient O O
developed O O
sudden O O
onset O O
numbness O B-C0028643
and O O
discoloration O O
of O O
fingertips O O
bilaterally O O
at O O
week O O
25 O O
after O O
initiation O O
of O O
ICI O O
treatment O O
. O O

extensive O O
workup O O
to O O
rule O O
out O O
hypercoagulable O O
, O O
autoimmune O O
and O O
vascular O B-C0042373
disease O I-C0042373
was O O
unremarkable O O
except O O
for O O
mild O O
elevation O O
of O O
ANA O O
and O O
ESR O O
. O O

the O O
symptoms O O
quickly O O
progressed O O
into O O
dry O O
gangrene O B-C0017086
within O O
four O O
weeks O O
and O O
did O O
not O O
respond O O
to O O
medical O O
or O O
surgical O O
treatment O O
. O O

pembrolizumab O O
was O O
subsequently O O
discontinued O O
due O O
to O O
progression O O
of O O
metastatic O B-C2939419
disease O I-C2939419
. O O

the O O
patient O O
refused O O
further O O
interventions O O
and O O
transitioned O O
to O O
hospice O B-C0869461
care O I-C0869461
where O O
she O O
expired O O
after O O
two O O
months O O
. O O

the O O
patient O O
underwent O O
hysteroscopic O O
surgery O O
, O O
which O O
successfully O O
resolved O O
the O O
isthmocele O O
as O O
well O O
as O O
the O O
hydrometra O B-C0948277
. O O

afterward O O
, O O
two O O
high-quality O O
, O O
euploid O O
embryos O O
, O O
determined O O
by O O
morphological O O
assessment O O
and O O
pre-implantation O O
genetic O O
diagnostic O O
testing O O
, O O
were O O
transferred O O
. O O

this O O
resulted O O
in O O
uterine O O
pregnancy O O
, O O
as O O
determined O O
by O O
serum O O
β-human O O
chorionic O O
gonadotropin O O
levels O O
on O O
day O O
14 O O
( O O
180 O O
mu O O
/ O O
ml O O
) O O
and O O
ultrasound-confirmed O O
presence O O
of O O
a O O
gestational O O
sac O O
with O O
a O O
positive O O
embryocardia O O
at O O
week O O
6 O O
. O O

the O O
pregnancy O O
reached O O
36 O O
wk O O
without O O
any O O
complications O O
, O O
and O O
the O O
product O O
was O O
born O O
in O O
good O O
health O O
. O O

we O O
report O O
a O O
successful O O
isthmocele O O
treatment O O
in O O
a O O
patient O O
with O O
secondary O O
infertility O B-C0021359
, O O
in O O
which O O
the O O
isthmocele O O
was O O
the O O
cause O O
of O O
persistent O O
hydrometra O B-C0948277
. O O

in O O
this O O
report O O
, O O
an O O
unusual O O
complication O O
of O O
radial O O
access O O
angiography O O
was O O
encountered O O
. O O

shortly O O
after O O
the O O
procedure O O
, O O
the O O
patient's O O
right O O
arm O O
began O O
to O O
swell O O
and O O
a O O
pulsating O O
mass O O
grew O O
over O O
the O O
medial O O
aspect O O
of O O
the O O
arm O O
. O O

right O O
brachial O O
artery O O
angiography O O
was O O
performed O O
immediately O O
for O O
rolling O O
out O O
brachial O O
artery O O
perforation O O
. O O

there O O
was O O
no O O
evidence O O
of O O
extravasation O O
in O O
brachial O O
angiography O O
. O O

surprisingly O O
, O O
the O O
mass O O
began O O
to O O
disappear O O
after O O
some O O
active O O
flexion O O
and O O
extension O O
at O O
elbow O O
joint O O
. O O

the O O
same O O
problem O O
occurred O O
again O O
after O O
percutaneous O O
coronary O O
intervention O O
( O O
PCI O O
) O O
on O O
left O O
anterior O O
descending O O
artery O O
( O O
LAD O O
) O O
in O O
this O O
case O O
2 O O
days O O
later O O
and O O
was O O
resolved O O
by O O
the O O
same O O
maneuver O O
. O O

in O O
case O O
1 O O
, O O
a O O
46 O O
- O O
year-old O O
man O O
complained O O
of O O
painless O O
swelling O B-C0038999
of O O
the O O
right O O
maxilla O O
for O O
3 O O
years O O
, O O
with O O
a O O
1 O O
- O O
mo O O
history O O
of O O
hemorrhinia O O
in O O
the O O
right O O
nasal O O
cavity O O
. O O

in O O
case O O
2 O O
, O O
a O O
72 O O
- O O
year-old O O
man O O
was O O
referred O O
to O O
our O O
hospital O O
with O O
a O O
chief O O
complaint O O
of O O
painful O O
swelling O B-C0038999
of O O
the O O
right O O
mandible O O
. O O

initially O O
, O O
the O O
preliminary O O
diagnoses O O
were O O
ameloblastomas O B-C0002448
. O O

thus O O
, O O
the O O
two O O
patients O O
underwent O O
resection O O
of O O
the O O
tumor O B-C0027651
under O O
general O O
anesthesia O B-C0278134
. O O

finally O O
, O O
immunohistochemical O O
examination O O
confirmed O O
the O O
diagnosis O O
of O O
GCOC O O
. O O

the O O
patient O O
in O O
case O O
1 O O
was O O
followed O O
for O O
2 O O
years O O
, O O
with O O
no O O
evidence O O
of O O
recurrence O O
. O O

however O O
, O O
the O O
patient O O
in O O
case O O
2 O O
was O O
lost O B-C1302313
to O I-C1302313
follow-up O I-C1302313
. O O

A O O
37 O O
- O O
year-old O O
man O O
was O O
admitted O O
with O O
a O O
headache O B-C0018681
, O O
nausea O B-C0027497
, O O
vomiting O B-C0042963
, O O
fever O B-C0015967
, O O
and O O
numbness O B-C0028643
of O O
the O O
left O O
cheek O O
and O O
upper O O
limb O O
for O O
10 O O
# O O
days O O
. O O

cerebral O O
magnetic O O
resonance O O
imaging O O
( O O
MRI O O
) O O
shows O O
the O O
lesion O B-C0221198
in O O
his O O
right O O
frontal O O
lobe O O
. O O

blood O O
gas O O
analysis O O
indicated O O
lower O O
blood O O
oxygen O O
saturation O O
level O O
, O O
and O O
blood O O
routine O O
test O O
showed O O
hemoglobin O O
elevation O O
. O O

craniotomy O O
for O O
the O O
lesion O B-C0221198
and O O
decompressive O O
craniotomy O O
were O O
performed O O
. O O

brain O B-C0006105
abscess O I-C0006105
was O O
confirmed O O
by O O
pathology O O
examination O O
. O O

the O O
chest O O
computed O O
tomography O O
angiography O O
( O O
CTA O O
) O O
revealed O O
a O O
pulmonary O O
arteriovenous O B-C0003855
fistula O I-C0003855
( O O
PAVF O O
) O O
in O O
his O O
right O O
lower O O
lung O O
. O O

after O O
1 O O
# O O
month O O
, O O
embolization O O
of O O
PAVF O O
was O O
performed O O
. O O

anoxic O O
symptom O O
improved O O
after O O
surgery O O
. O O

cranioplasty O O
was O O
performed O O
after O O
7 O O
# O O
months O O
. O O

we O O
report O O
the O O
cases O O
of O O
18 O O
- O O
months-old O O
twin O O
girls O O
living O O
at O O
the O O
german-swiss O O
border O O
, O O
who O O
developed O O
visceral O B-C0023290
leishmaniasis O I-C0023290
7 O O
and O O
15 O O
# O O
months O O
after O O
travelling O O
to O O
tuscany O O
. O O

they O O
presented O O
with O O
fever O B-C0015970
of O I-C0015970
unknown O I-C0015970
origin O I-C0015970
and O O
pancytopenia O B-C0030312
. O O

both O O
had O O
splenomegaly O B-C0038002
and O O
in O O
the O O
first O O
case O O
haemophagocytic O O
lymphohistiocytosis O B-C0877564
or O O
leukaemia O B-C0023418
was O O
initially O O
included O O
in O O
the O O
differential O O
diagnosis O O
. O O

diagnosis O O
of O O
visceral O B-C0023290
leishmaniasis O I-C0023290
was O O
confirmed O O
by O O
presence O O
of O O
intracytoplasmic O O
localised O O
leishmania O O
parasites O O
on O O
bone O O
marrow O O
aspirate O O
and O O
/ O O
or O O
positive O O
leishmania O O
serology O O
. O O

both O O
girls O O
responded O O
well O O
to O O
treatment O O
with O O
liposomal O O
amphotericin O O
B O O
. O O

the O O
mother O O
and O O
two O O
older O O
siblings O O
remained O O
uninfected O O
, O O
while O O
the O O
father O O
was O O
diagnosed O O
to O O
be O O
an O O
asymptomatic O O
carrier O O
. O O

this O O
case O O
presents O O
a O O
female O O
patient O O
with O O
a O O
complaint O O
of O O
posterior-region O O
pain O B-C0030193
of O O
her O O
left O O
knee O O
post O O
direct O O
trauma O O
post O O
fall O B-C0085639
. O O

this O O
was O O
directly O O
followed O O
by O O
knee O O
joint O O
blockage O O
for O O
1 O O
- O O
week O O
duration O O
before O O
presentation O O
to O O
the O O
hospital O O
. O O

on O O
MRI O O
, O O
she O O
was O O
found O O
to O O
have O O
a O O
multiloculated O O
hemosiderin-containing O O
structure O O
of O O
synovial O O
origin O O
within O O
the O O
femoral O O
notch O O
, O O
extending O O
beyond O O
the O O
joint O O
capsule O O
displacing O O
the O O
popliteal O O
vessels O O
. O O

the O O
patient O O
underwent O O
arthroscopic O O
resection O O
of O O
the O O
lesion O B-C0221198
, O O
which O O
was O O
found O O
to O O
be O O
pigmented O B-C0039106
villonodular O I-C0039106
synovitis O I-C0039106
on O O
anatomopathological O O
examination O O
. O O

on O O
6 O O
- O O
month O O
follow-up O O
, O O
the O O
patient O O
showed O O
good O O
clinical O O
evolution O O
with O O
the O O
absence O O
of O O
symptoms O O
and O O
back-to-normal O O
daily O O
activities O O
. O O

A O O
54 O O
- O O
year-old O O
man O O
was O O
referred O O
to O O
our O O
hospital O O
for O O
further O O
evaluation O O
of O O
a O O
liver O B-C0577053
lesion O I-C0577053
. O O

the O O
patient O O
was O O
asymptomatic O O
and O O
had O O
a O O
history O O
of O O
emergent O O
splenectomy O O
after O O
a O O
high-altitude O O
falling O B-C0000921
accident O O
. O O

abdominal O O
contrast-enhanced O O
computed O O
tomography O O
revealed O O
a O O
4.5 O O
× O O
3.3 O O
# O O
cm O O
lesion O B-C0221198
that O O
was O O
located O O
in O O
segment O O
IV O O
of O O
the O O
left O O
liver O O
lobe O O
. O O

the O O
lesion O B-C0221198
had O O
an O O
inhomogeneous O O
enhancement O O
during O O
the O O
arterial O O
phase O O
and O O
diminished O O
enhancement O O
during O O
the O O
portal O O
and O O
equilibrium O O
phases O O
. O O

similar O O
radiological O O
features O O
were O O
also O O
observed O O
on O O
a O O
contrast O O
magnetic O O
resonance O O
imaging O O
scan O O
. O O

partial O O
hepatectomy O O
was O O
performed O O
with O O
the O O
suspicion O O
of O O
hepatocellular O B-C2239176
carcinoma O I-C2239176
. O O

pathological O O
examination O O
of O O
the O O
liver O O
specimen O O
revealed O O
intrahepatic O O
splenosis O B-C0206369
. O O

A O O
45 O O
- O O
year-old O O
woman O O
with O O
a O O
two-year O O
history O O
of O O
ovarian O O
endometriosis O B-C0014175
confirmed O O
by O O
ultrasound O O
underwent O O
oophorectomy O O
. O O

on O O
microscopic O O
examination O O
, O O
a O O
focus O O
of O O
malignant O O
stratified O O
epithelium O O
, O O
initially O O
interpreted O O
as O O
transitional O B-C0007138
cell O I-C0007138
carcinoma O I-C0007138
, O O
was O O
identified O O
within O O
the O O
endometriotic O O
cyst O B-C0010709
wall O O
. O O

examination O O
of O O
the O O
hysterectomy O O
specimen O O
revealed O O
superficially O O
invasive O O
squamous O B-C0007137
carcinoma O I-C0007137
of O O
the O O
cervix O O
. O O

in O O
addition O O
, O O
two O O
triploid O B-C0333693
, O O
CD45 O O
- O O
negative O O
cells O O
were O O
detected O O
during O O
the O O
analysis O O
of O O
the O O
peripheral O O
blood O O
for O O
circulating O O
tumor O B-C0027651
cells O O
( O O
CTC O O
) O O
. O O

high-risk O O
HPV O O
was O O
detected O O
on O O
the O O
sections O O
of O O
endometriosis O B-C0014175
containing O O
cancerous O O
area O O
by O O
using O O
hybrid O O
capture O O
2 O O
assay O O
, O O
supporting O O
the O O
diagnosis O O
of O O
metastatic O O
squamous O B-C0007137
cell O I-C0007137
carcinoma O I-C0007137
originating O O
from O O
the O O
uterine O O
cervix O O
. O O

A O O
33 O O
- O O
year-old O O
woman O O
with O O
a O O
history O O
of O O
poorly O O
controlled O O
epilepsy O B-C0014544
presented O O
with O O
generalized O B-C0494475
tonic-clonic O I-C0494475
seizures O I-C0494475
, O O
followed O O
by O O
recurrent O O
focal O B-C0751495
seizures O I-C0751495
that O O
evolved O O
into O O
NCSE O O
. O O

this O O
immediately O O
recurred O O
within O O
24 O O
# O O
h O O
of O O
a O O
prior O O
episode O O
of O O
NCSE O O
that O O
was O O
treated O O
with O O
IV O O
ketamine O O
. O O

considering O O
her O O
previous O O
response O O
, O O
she O O
was O O
started O O
again O O
on O O
an O O
IV O O
ketamine O O
infusion O O
, O O
which O O
successfully O O
terminated O O
NCSE O O
. O O

this O O
time O O
, O O
enteral O O
ketamine O O
was O O
gradually O O
introduced O O
while O O
weaning O B-C0043084
off O O
the O O
IV O O
formulation O O
. O O

treatment O O
with O O
enteral O O
ketamine O O
was O O
continued O O
for O O
6 O O
# O O
months O O
and O O
then O O
tapered O O
off O O
. O O

there O O
was O O
no O O
recurrence O O
of O O
NCSE O O
or O O
seizures O O
and O O
no O O
adverse O O
events O O
noted O O
during O O
the O O
course O O
of O O
treatment O O
. O O

we O O
present O O
a O O
case O O
of O O
29 O O
- O O
year-old O O
woman O O
with O O
epidermolysis O B-C0014527
bullosa O I-C0014527
caused O O
by O O
laminin O O
5 O O
gene O O
mutation O O
. O O

the O O
patient O O
suffered O O
from O O
additional O O
conditions O O
: O O
blindness O B-C0456909
, O O
complete O O
bilateral O B-C0452138
sensorineural O I-C0452138
deafness O I-C0452138
and O O
oesophageal O O
stenosis O O
. O O

when O O
end O B-C0022661
stage O I-C0022661
renal O I-C0022661
disease O I-C0022661
was O O
diagnosed O O
, O O
the O O
problem O O
of O O
renal O O
replacement O O
therapy O O
had O O
to O O
be O O
faced O O
. O O

there O O
have O O
been O O
few O O
reports O O
concerning O O
ESRD O O
in O O
this O O
specific O O
group O O
of O O
patients O O
in O O
the O O
available O O
literature O O
. O O

in O O
most O O
of O O
them O O
the O O
prognosis O O
was O O
very O O
poor O O
. O O

nevertheless O O
, O O
we O O
were O O
very O O
determined O O
to O O
overcome O O
all O O
the O O
difficulties O O
. O O

special O O
procedures O O
and O O
cooperation O O
with O O
the O O
patient's O O
family O O
allowed O O
us O O
to O O
consider O O
kidney O O
transplantation O O
as O O
a O O
treatment O O
option O O
. O O

we O O
have O O
included O O
five O O
cases O O
which O O
were O O
diagnosed O O
in O O
our O O
department O O
as O O
we O O
believe O O
that O O
publication O O
of O O
these O O
new O O
cases O O
is O O
relevant O O
for O O
the O O
improved O O
understanding O O
of O O
these O O
specific O O
tumors O O
. O O

four O O
of O O
our O O
five O O
patients O O
were O O
males O O
, O O
mean O O
age O O
was O O
24 O O
# O O
years O O
. O O

there O O
was O O
wide O O
variation O O
in O O
the O O
location O O
of O O
these O O
tumors O O
. O O

mean O O
size O O
of O O
excised O O
tumors O O
was O O
5.5 O O
# O O
cms O O
in O O
the O O
greatest O O
dimensions O O
. O O

three O O
out O O
of O O
five O O
cases O O
represented O O
hybrid O O
schwannoma O B-C0027809
/ O O
perineurioma O B-C0751691
histologically O O
. O O

no O O
significant O O
nuclear O O
atypia O O
, O O
mitotic O O
activity O O
or O O
necrosis O O
seen O O
. O O

all O O
five O O
cases O O
were O O
completely O O
excised O O
. O O

all O O
five O O
patients O O
are O O
alive O O
and O O
well O O
at O O
the O O
time O O
of O O
writing O O
with O O
no O O
recurrence O O
. O O

we O O
report O O
the O O
case O O
of O O
a O O
81 O O
year O O
old O O
female O O
with O O
flank O B-C0016199
pain O I-C0016199
who O O
was O O
found O O
to O O
have O O
idiopathic O O
diaphragmatic O B-C0019284
hernia O I-C0019284
with O O
incarcerated O O
proximal O O
ureter O O
. O O

she O O
had O O
no O O
prior O O
injury O B-C3263723
or O O
surgery O O
that O O
explained O O
her O O
clinical O O
presentation O O
. O O

she O O
was O O
initially O O
observed O O
and O O
then O O
managed O O
conservatively O O
with O O
ureteral O O
stent O O
exchanges O O
. O O

ultimately O O
she O O
underwent O O
open O O
surgical O O
repair O O
of O O
her O O
diaphragmatic O B-C0019284
hernia O I-C0019284
, O O
reduction O O
, O O
resection O O
and O O
anastomosis O O
of O O
redundant O O
proximal O O
incarcerated O O
ureteral O O
segment O O
, O O
and O O
nephropexy O O
for O O
a O O
hypermobile O O
right O O
renal O O
unit O O
. O O

this O O
case O O
report O O
illustrates O O
the O O
pre O O
- O O
and O O
post-operative O O
imaging O O
studies O O
of O O
a O O
very O O
rare O O
intrathoracic O O
ureteral O O
herniation O O
as O O
well O O
as O O
surgical O O
approach O O
to O O
repair O O
. O O

we O O
describe O O
the O O
case O O
of O O
a O O
woman O O
who O O
developed O O
a O O
severe O O
secondary O O
addiction O O
to O O
opioids O O
in O O
the O O
context O O
of O O
lombo-sciatic O O
pain O B-C0030193
. O O

she O O
presented O O
a O O
severe O O
opioid O B-C0524662
addiction O I-C0524662
, O O
and O O
her O O
physicians O O
refused O O
to O O
prescribe O O
such O O
high O O
doses O O
of O O
opioid O O
treatment O O
( O O
oxycontin O O
® O O
extended-release O O
120 O O
# O O
mg O O
daily O O
, O O
oxycodone O O
60 O O
# O O
mg O O
daily O O
, O O
and O O
acetaminophen O O
/ O O
codeine O O
300 O O
# O O
mg O O
/ O O
25 O O
# O O
mg O O
6 O O
times O O
per O O
day O O
) O O
. O O

to O O
assist O O
her O O
with O O
her O O
opioid O O
withdrawal O B-C2825032
which O O
risked O O
increasing O O
her O O
existing O O
pain O B-C0030193
, O O
she O O
received O O
1 O O
# O O
mg O O
/ O O
kg O O
ketamine O O
oral O O
solution O O
, O O
and O O
two O O
days O O
after O O
ketamine O O
initiation O O
her O O
opioid O O
treatment O O
was O O
gradually O O
reduced O O
. O O

the O O
patient O O
dramatically O O
reduced O O
the O O
dosage O O
of O O
opioid O O
painkillers O O
and O O
ketamine O O
was O O
withdrawn O O
without O O
any O O
withdrawal O B-C0087169
symptoms O I-C0087169
. O O

A O O
23 O O
years O O
old O O
male O O
patient O O
admitted O O
with O O
h O O
/ O O
o O O
dysuria O B-C0013428
, O O
pyuria O B-C0034359
and O O
loss O B-C1971624
of O I-C1971624
appetite O I-C1971624
since O O
3 O O
months O O
. O O

he O O
was O O
a O O
known O O
case O O
of O O
chronic O B-C0022661
renal O I-C0022661
failure O I-C0022661
and O O
reflux O B-C0232483
nephropathy O B-C0022658
. O O

on O O
investigating O O
, O O
patient's O O
renal O O
parameters O O
were O O
high O O
and O O
he O O
was O O
started O O
with O O
haemodialysis O O
. O O

the O O
next O O
day O O
patient O O
had O O
c O O
/ O O
o O O
bilateral O B-C4011879
hip O I-C4011879
pain O I-C4011879
and O O
inability O O
to O O
move O O
bilateral O O
lower O O
limbs O O
following O O
an O O
episode O O
of O O
seizure O O
. O O

radiograph O O
of O O
pelvis O O
showed O O
vertical O O
sub O O
capital O O
fractures O B-C0016658
of O O
bilateral O O
neck O O
of O O
femur O O
. O O

in O O
this O O
patient O O
, O O
considering O O
his O O
age O O
, O O
general O O
condition O O
& O O
prognosis O O
, O O
an O O
elective O O
surgery O O
in O O
the O O
form O O
of O O
bilateral O O
uncemented O O
modular O O
bipolar O O
hemiarthroplasty O O
was O O
done O O
. O O

case O O
presentation O O
1 O O
: O O
A O O
4 O O
year-old O O
right-hand O O
dominant O O
girl O O
sustained O O
a O O
hyper-extension O O
injury O B-C3263723
to O O
her O O
right O O
thumb O O
while O O
on O O
holiday O O
abroad O O
. O O

she O O
was O O
told O O
she O O
has O O
" O O
sprained O O
" O O
her O O
thumb O O
. O O

on O O
review O O
in O O
fracture O O
clinic O O
10 O O
days O O
later O O
, O O
the O O
MCPJ O O
of O O
her O O
thumb O O
remained O O
swollen O O
and O O
bruised O O
. O O

radiographs O O
showed O O
a O O
dorsally O O
dislocated O O
MCPJ O O
of O O
the O O
right O O
thumb O O
. O O

case O O
presentation O O
2 O O
: O O
A O O
four-year O O
old O O
right-hand O O
dominant O O
boy O O
presented O O
to O O
fracture O O
clinic O O
after O O
being O O
referred O O
from O O
A O O
& O O
E O O
with O O
a O O
left O O
' O O
thumb O O
injury O B-C3263723
' O O
- O O
his O O
thumb O O
had O O
accidentally O O
been O O
jammed O O
in O O
a O O
door O O
1 O O
week O O
previously O O
. O O

radiographs O O
were O O
reviewed O O
and O O
repeated O O
, O O
confirming O O
a O O
MCPJ O O
dislocation O B-C0012691
. O O

we O O
here O O
report O O
the O O
clinical O O
findings O O
of O O
an O O
infant O O
suffering O O
from O O
TSC O O
complicated O O
with O O
dilated O B-C0007193
cardiomyopathy O I-C0007193
( O O
DCM O O
) O O
after O O
the O O
regression O B-C1836830
of O O
cardiac O O
rhabdomyomas O B-C0035411
. O O

although O O
his O O
tumors O O
improved O O
spontaneously O O
, O O
tachycardia O O
and O O
irregular O O
heart O O
rate O O
due O O
to O O
frequent O O
premature O O
ventricular O O
and O O
supraventricular O O
contractions O O
persisted O O
from O O
the O O
newborn O O
period O O
and O O
were O O
refractory O O
to O O
several O O
medications O O
. O O

his O O
cardiomyopathy O B-C0878544
was O O
suspected O O
to O O
have O O
been O O
induced O O
by O O
the O O
tachycardia O O
or O O
arrhythmia O B-C0003811
. O O

we O O
found O O
carvedilol O O
therapy O O
to O O
be O O
safe O O
and O O
highly O O
effective O O
in O O
treating O O
the O O
cardiomyopathy O B-C0878544
. O O

to O O
our O O
knowledge O O
, O O
this O O
is O O
the O O
first O O
case O O
report O O
of O O
TSC O O
with O O
DCM O O
after O O
regression O B-C1836830
of O O
cardiac O B-C0018809
tumors O I-C0018809
and O O
its O O
successful O O
treatment O O
. O O

A O O
24 O O
year O O
old O O
asian O O
female O O
presented O O
to O O
the O O
surgical O O
clinic O O
with O O
a O O
goitre O B-C0018021
of O O
eight O O
months O O
duration O O
and O O
recent O O
onset O O
of O O
altered O O
bowel O O
habits O O
with O O
features O O
of O O
anaemia O B-C0002871
. O O

she O O
was O O
previously O O
healthy O O
and O O
there O O
was O O
no O O
family O B-C0241889
history O I-C0241889
of O O
adenomatous O O
polyposis O O
, O O
colorectal O B-C0009402
carcinoma O I-C0009402
or O O
thyroid O B-C0040136
neoplasms O I-C0040136
. O O

colonoscopy O O
revealed O O
large O O
bowel O O
polyposis O O
and O O
fine O O
needle O O
aspiration O O
of O O
thyroid O O
revealed O O
a O O
smear O O
suspicious O O
for O O
malignancy O B-C0006826
. O O

she O O
underwent O O
total O O
thyroidectomy O O
which O O
revealed O O
CMV O O
PTC O O
. O O

histology O O
was O O
characterized O O
by O O
a O O
prominent O O
cribriform O O
pattern O O
of O O
growth O O
with O O
interspersed O O
cell O O
clusters O O
arranged O O
as O O
morules O O
along O O
with O O
papillary O O
structures O O
which O O
are O O
the O O
key O O
features O O
of O O
this O O
subtype O O
. O O

A O O
62 O O
- O O
year-old O O
sri O O
lankan O O
male O O
was O O
admitted O O
to O O
our O O
medical O O
unit O O
following O O
four O O
repeated O O
generalized O O
tonic-clonic O O
convulsions O B-C0036572
, O O
each O O
lasting O O
for O O
several O O
minutes O O
. O O

following O O
the O O
second O O
seizure O O
he O O
reported O O
an O O
inability O O
to O O
move O O
both O O
upper O O
arms O O
due O O
to O O
intense O O
pain O B-C0030193
. O O

there O O
was O O
no O O
history O O
of O O
fall O B-C0085639
during O O
the O O
episodes O O
of O O
convulsions O B-C0036572
however O O
but O O
the O O
bystanders O O
have O O
forcibly O O
restrained O O
his O O
movements O O
during O O
the O O
tonic-clonic O O
convulsions O B-C0036572
. O O

clinical O O
examination O O
revealed O O
severely O O
restricted O O
range O O
of O O
movement O O
in O O
both O O
shoulders O O
, O O
with O O
associated O O
swelling O B-C0038999
and O O
bruising O O
of O O
the O O
shoulder O O
joints O O
and O O
upper O O
arms O O
. O O

radiographs O O
of O O
the O O
shoulders O O
confirmed O O
fractures O B-C0016658
at O O
the O O
level O O
of O O
surgical O O
neck O O
with O O
posterior O O
dislocation O B-C0012691
. O O

A O O
72 O O
- O O
year-old O O
japanese O O
male O O
PD O O
patient O O
developed O O
jaundice O O
and O O
was O O
diagnosed O O
with O O
cholangiocarcinoma O O
. O O

pancreaticoduodenectomy O O
was O O
performed O O
and O O
part O O
of O O
the O O
stomach O O
, O O
total O O
duodenum O O
, O O
and O O
part O O
of O O
the O O
jejunum O O
were O O
resected O O
. O O

the O O
patient O O
had O O
been O O
treated O O
with O O
LD O O
, O O
and O O
his O O
pharmacokinetics O O
was O O
checked O O
twice O O
at O O
the O O
age O O
of O O
68 O O
years O O
. O O

because O O
LD O O
is O O
absorbed O O
in O O
the O O
duodenum O O
and O O
jejunum O O
, O O
we O O
checked O O
his O O
pharmacokinetics O O
again O O
after O O
the O O
operation O O
. O O

the O O
results O O
before O O
the O O
operation O O
were O O
almost O O
similar O O
; O O
however O O
, O O
in O O
comparison O O
, O O
the O O
area O O
under O O
the O O
curve O O
and O O
peak O O
drug O O
concentration O O
was O O
reduced O O
, O O
and O O
the O O
time-to-peak O O
drug O O
concentration O O
and O O
elimination O O
halftime O O
were O O
elongated O O
after O O
the O O
operation O O
. O O

A O O
previously O O
healthy O O
4 O O
- O O
year-old O O
boy O O
presented O O
with O O
a O O
2 O O
- O O
day O O
history O O
of O O
vomiting O B-C0042963
, O O
diarrhoea O B-C0011991
, O O
and O O
fever O B-C0015967
, O O
complicated O O
by O O
reduced O O
level O O
of O O
consciousness O O
. O O

magnetic O O
resonance O O
imaging O O
of O O
the O O
brain O O
showed O O
a O O
marked O O
hyperintensity O O
in O O
the O O
splenium O O
of O O
the O O
corpus O O
callosum O O
on O O
T2 O O
and O O
diffusion-weighted O O
images O O
. O O

rotavirus O O
genome O O
was O O
detected O O
by O O
polymerase O O
chain O O
reaction O O
in O O
a O O
stool O O
specimen O O
, O O
but O O
not O O
in O O
the O O
cerebrospinal O O
fluid O O
. O O

the O O
genotype O O
was O O
identified O O
as O O
G1P8 O O
. O O

his O O
clinical O O
condition O B-C3242272
improved O I-C3242272
with O O
gradual O O
resolution O O
of O O
his O O
symptoms O O
. O O

no O O
neurological O O
complications O O
were O O
evident O O
upon O O
discharge O O
and O O
the O O
patient O O
had O O
no O O
recurring O O
symptoms O O
or O O
significant O O
residual O O
defects O O
when O O
followed O O
up O O
2 O O
months O O
later O O
. O O

A O O
26 O O
- O O
year-old O O
moroccan O O
man O O
, O O
without O O
a O O
medical O O
or O O
surgical O O
history O O
, O O
presented O O
with O O
a O O
four-month O O
history O O
of O O
chest O O
distress O O
, O O
dyspnea O B-C0013404
, O O
and O O
a O O
frequent O O
dry O O
cough O B-C0010200
for O O
the O O
previous O O
month O O
. O O

A O O
computed O O
tomographic O O
scan O O
of O O
the O O
chest O O
revealed O O
a O O
bulky O O
mediastinal O O
mass O O
, O O
which O O
was O O
biopsied O O
. O O

histologically O O
, O O
the O O
tumoral O O
mass O O
proved O O
to O O
be O O
a O O
yolk O B-C0014145
sac O I-C0014145
tumor O I-C0014145
. O O

the O O
serum O O
level O O
of O O
alpha-fetoprotein O O
of O O
this O O
patient O O
was O O
elevated O O
to O O
19052 O O
# O O
ng O O
/ O O
ml O O
. O O

after O O
4 O O
courses O O
of O O
preoperative O O
chemotherapy O O
, O O
the O O
patient O O
underwent O O
a O O
surgical O O
resection O O
of O O
the O O
tumor O B-C0027651
, O O
with O O
a O O
complete O O
pathologic O O
response O O
. O O

at O O
the O O
time O O
of O O
writing O O
, O O
the O O
patient O O
is O O
alive O O
with O O
complete O O
remission O O
without O O
any O O
evidence O O
of O O
recurrence O O
. O O

A O O
60 O O
- O O
year-old O O
woman O O
presented O O
with O O
symptoms O B-C0037088
and O I-C0037088
signs O I-C0037088
of O O
CS O O
. O O

adrenal O O
CS O O
was O O
confirmed O O
by O O
standard O O
biochemical O O
evaluation O O
. O O

imaging O O
revealed O O
a O O
right O O
adrenal O O
lesion O B-C0221198
( O O
diameter O O
3.5 O O
# O O
cm O O
) O O
and O O
multiple O B-C0748164
pulmonary O I-C0748164
nodules O I-C0748164
, O O
suggesting O O
a O O
cortisol-secreting O O
adrenal O B-C0206686
carcinoma O I-C0206686
with O O
pulmonary O O
metastases O B-C0027627
. O O

the O O
patient O O
underwent O O
right O O
adrenalectomy O O
with O O
a O O
pathohistological O O
diagnosis O O
of O O
an O O
adrenal O B-C0206667
adenoma O I-C0206667
. O O

subsequent O O
thoracoscopic O O
wedge O O
resection O O
of O O
one O O
lung O B-C0577916
lesion O I-C0577916
revealed O O
pulmonary O O
KS O O
with O O
positive O O
immunostaining O O
for O O
human O O
herpes O B-C0019340
virus O O
8 O O
( O O
HHV O O
- O O
8 O O
) O O
. O O

hiv-serology O O
was O O
negative O O
. O O

hydrocortisone O O
replacement O O
was O O
initiated O O
for O O
secondary O O
adrenal O B-C0001623
insufficiency O I-C0001623
after O O
surgery O O
. O O

post-operative O O
follow O O
up O O
imaging O O
showed O O
complete O O
remission O O
of O O
all O O
ks-related O O
pulmonary O O
nodules O O
solely O O
after O O
resolution O O
of O O
hypercortisolism O B-C0010481
. O O

A O O
33 O O
- O O
year-old O O
man O O
of O O
libyan O O
origin O O
with O O
no O O
significant O O
past O O
medical O O
history O O
underwent O O
an O O
ajmaline O O
provocation O O
test O O
for O O
investigation O O
of O O
suspected O O
brugada O B-C1142166
syndrome O I-C1142166
. O O

three O O
weeks O O
later O O
, O O
he O O
presented O O
with O O
painless O O
cholestatic O B-C0022354
jaundice O I-C0022354
which O O
peaked O O
in O O
severity O O
at O O
eleven O O
weeks O O
after O O
the O O
test O O
. O O

blood O O
tests O O
confirmed O O
no O O
evidence O O
of O O
autoimmune O O
or O O
viral O O
liver O B-C0023895
disease O I-C0023895
, O O
whilst O O
imaging O O
confirmed O O
the O O
absence O O
of O O
biliary O O
tract O O
obstruction O O
. O O

A O O
liver O O
biopsy O O
demonstrated O O
centrilobular O O
cholestasis O B-C0008370
and O O
focal O O
rosetting O O
of O O
hepatocytes O O
, O O
consistent O O
with O O
a O O
cholestatic O O
drug O B-C0041755
reaction O I-C0041755
. O O

over O O
the O O
course O O
of O O
the O O
next O O
few O O
months O O
, O O
he O O
began O O
to O O
improve O O
clinically O O
and O O
biochemically O O
, O O
with O O
complete O O
resolution O O
by O O
one O O
year O O
post-exposure O O
. O O

an O O
11 O O
and O O
1 O O
/ O O
2 O O
- O O
year-old O O
caucasian O O
southeast O O
european O O
female O O
patient O O
with O O
earlier O O
established O O
diagnoses O O
of O O
growth O B-C0271561
hormone O I-C0271561
deficiency O I-C0271561
, O O
diabetes O B-C0011848
insipidus O I-C0011848
, O O
seizures O O
, O O
mental O B-C0025362
retardation O I-C0025362
, O O
optic O B-C0029124
nerve O I-C0029124
atrophy O I-C0029124
and O O
right O O
ptosis O B-C0033377
, O O
was O O
directed O O
to O O
us O O
for O O
consultative O O
examination O O
. O O

the O O
girl O O
of O O
short O B-C0349588
stature O I-C0349588
and O O
low O B-C0041667
weight O I-C0041667
for O O
her O O
age O O
had O O
bilateral O O
optic O B-C0338502
nerve O I-C0338502
hypoplasia O I-C0338502
, O O
poor O B-C0042798
vision O I-C0042798
, O O
nystagmus O B-C0028738
and O O
right O O
eye O O
oculomotor O O
palsy O O
. O O

electroencephalogram O O
revealed O O
epileptic O O
changes O O
. O O

magnetic O O
resonance O O
imaging O O
showed O O
an O O
empty O B-C0014008
sella O I-C0014008
syndrome O I-C0014008
, O O
partial O O
hypoplasia O B-C0344482
of O I-C0344482
corpus O I-C0344482
callosum O I-C0344482
, O O
cavum O O
of O O
pellucid O O
septum O O
and O O
diffuse O O
polymicrogyria O B-C0266464
of O O
the O O
left O O
temporal O O
lobe O O
. O O

we O O
found O O
all O O
elements O O
of O O
septo-optic O B-C0338503
dysplasia O I-C0338503
plus O O
syndrome O O
with O O
right O O
oculomotor O O
nerve O O
involvement O O
. O O

we O O
report O O
the O O
case O O
of O O
a O O
64 O O
- O O
year-old O O
female O O
patient O O
with O O
a O O
history O O
of O O
long-term O O
NSAID O O
use O O
, O O
who O O
was O O
hospitalized O O
with O O
septic O B-C0036983
shock O I-C0036983
caused O O
by O O
klebsiella O O
pneumoniae O O
bacteremia O B-C0004610
. O O

computed O O
tomography O O
revealed O O
multiple O O
renal O O
and O O
splenic O O
abscesses O B-C0000833
with O O
diffuse O O
colon O O
wall O O
thickening O O
. O O

A O O
colonoscopy O O
confirmed O O
colitis O B-C0009319
with O O
diffuse O O
ulcers O B-C0041582
. O O

nsaids O O
were O O
discontinued O O
after O O
this O O
hospitalization O O
. O O

the O O
abscesses O B-C0000833
improved O O
after O O
antibiotic O O
treatment O O
. O O

A O O
short O O
course O O
of O O
balsalazide O O
treatment O O
was O O
given O O
under O O
the O O
suspicion O O
of O O
ulcerative O B-C0009324
colitis O I-C0009324
. O O

balsalazide O O
was O O
discontinued O O
four O O
months O O
later O O
due O O
to O O
a O O
non-compatible O O
clinical O O
course O O
. O O

A O O
follow-up O O
colonoscopy O O
two O O
years O O
later O O
revealed O O
a O O
normal O O
colon O O
mucosa O O
, O O
and O O
nsaid-induced O O
colitis O B-C0009319
was O O
diagnosed O O
. O O

A O O
22 O O
- O O
years-old O O
female O O
nurse O O
with O O
a O O
body O O
mass O O
index O O
18 O O
suffered O O
from O O
myalgias O B-C0231528
, O O
vomiting O B-C0042963
and O O
diarrhea O B-C0011991
. O O

blood O O
tests O O
revealed O O
hypokalemia O B-C0020621
with O O
a O O
lowest O O
value O O
of O O
1.1 O O
mmol O O
/ O O
l O O
, O O
moderate O O
hyponatremia O B-C0020625
, O O
metabolic O B-C0220983
alkalosis O I-C0220983
, O O
mild O O
renal O B-C1565489
insufficiency O I-C1565489
and O O
creatinphosphokinase-elevation O O
. O O

since O O
hypokalemia O B-C0020621
and O O
alkalosis O B-C0002063
were O O
unexplained O O
, O O
she O O
was O O
asked O O
for O O
diuretic-intake O O
. O O

she O O
confessed O O
that O O
she O O
has O O
taken O O
250 O O
mg O O
furosemide O O
/ O O
day O O
for O O
the O O
last O O
4 O O
months O O
to O O
improve O O
the O O
shape O O
of O O
her O O
muscles O O
. O O

furosemide O O
tablets O O
were O O
given O O
to O O
her O O
by O O
a O O
physician O O
attending O O
the O O
gym O O
where O O
she O O
exercised O O
. O O

after O O
electrolyte O O
substitution O O
, O O
laboratory O O
abnormalities O O
regressed O O
and O O
no O O
cardiac O O
arrests O O
were O O
observed O O
. O O

psychiatric O O
investigation O O
diagnosed O O
an O O
adjustment O B-C0001546
disorder O I-C0001546
. O O

we O O
report O O
a O O
case O O
of O O
anti-epileptic-induced O O
drug O B-C3541994
reaction O I-C3541994
with O I-C3541994
eosinophilia O I-C3541994
and O I-C3541994
systemic O I-C3541994
symptoms O I-C3541994
syndrome O I-C3541994
in O O
an O O
18 O O
- O O
year-old O O
african-american O O
man O O
who O O
presented O O
with O O
a O O
five-day O O
history O O
of O O
rash O B-C0015230
, O O
periorbital O O
and O O
upper O O
extremity O O
edema O O
, O O
hepatitis O O
and O O
fever O B-C0015967
. O O

laboratory O O
findings O O
revealed O O
an O O
atypical O B-C1839973
lymphocytosis O I-C1839973
, O O
eosinophilia O B-C0014457
, O O
and O O
elevated O B-C0859350
serum O I-C0859350
transaminases O I-C0859350
. O O

no O O
drug O B-C0013182
allergies O I-C0013182
were O O
reported O O
at O O
the O O
time O O
of O O
presentation O O
, O O
but O O
phenytoin O O
and O O
levetiracetam O O
therapy O O
had O O
been O O
initiated O O
five O O
weeks O O
prior O O
to O O
hospital O O
admission O O
for O O
new-onset O O
seizures O O
. O O

both O O
medications O O
were O O
discontinued O O
on O O
hospital O O
admission O O
, O O
and O O
after O O
three O O
days O O
of O O
high-dose O O
corticosteroid O O
therapy O O
the O O
patient O O
experienced O O
resolution O O
of O O
both O O
his O O
symptoms O O
and O O
laboratory O O
markers O O
of O O
inflammation O O
. O O

we O O
present O O
the O O
clinical O O
case O O
of O O
a O O
41 O O
- O O
year-old O O
caucasian O O
man O O
undergoing O O
chronic O O
hemodialysis O O
, O O
who O O
had O O
a O O
parathyroidectomy O O
to O O
treat O O
severe O O
secondary O B-C0020503
hyperparathyroidism O I-C0020503
resistant O O
to O O
cinacalcet O O
treatment O O
. O O

preoperatively O O
, O O
24 O O
months O O
after O O
high-dose O O
cinacalcet O O
hydrochloride O O
, O O
we O O
observed O O
a O O
persistently O O
elevated O O
intact O O
parathyroid O O
hormone O O
serum O O
level O O
, O O
and O O
detected O O
clear O O
parathyroid O O
gland O O
hyperplasia O B-C0020507
regression O B-C1836830
on O O
ultrasound O O
. O O

we O O
performed O O
a O O
three-gland O O
parathyroidectomy O O
, O O
which O O
was O O
assumed O O
to O O
be O O
total O O
, O O
associated O O
with O O
a O O
hemithyroidectomy O O
. O O

our O O
patient O O
then O O
entered O O
a O O
hypoparathyroid O O
state O O
. O O

A O O
histopathological O O
examination O O
showed O O
that O O
the O O
removed O O
parathyroid O O
glands O O
were O O
of O O
small O O
size O O
, O O
with O O
a O O
total O O
weight O O
of O O
1g O O
, O O
associated O O
with O O
a O O
multifocal O O
small O O
papillary O B-C0238463
thyroid O I-C0238463
cancer O I-C0238463
. O O

A O O
46 O O
- O O
year-old O O
african-american O O
woman O O
presented O O
to O O
the O O
university O O
emergency O O
department O O
complaining O O
of O O
urinary O B-C0042029
tract O I-C0042029
infection O I-C0042029
symptoms O O
and O O
severe O O
abdominal O B-C0000737
pain O I-C0000737
. O O

diagnostic O O
imaging O O
by O O
transvaginal O O
ultrasound O O
and O O
computed O O
tomography O O
revealed O O
a O O
massive O O
peripherally-enhancing O O
, O O
low-attenuating O O
fluid O O
collection O O
within O O
her O O
pelvis O O
. O O

the O O
patient's O O
abdominopelvic O O
abscess O B-C0000833
was O O
drained O O
by O O
ultrasound-guided O O
drainage O O
and O O
this O O
yielded O O
a O O
septic O O
aspirate O O
that O O
was O O
culture O O
positive O O
for O O
abundant O O
S O O
. O O
agalactiae O O
. O O

A O O
recent O O
history O O
of O O
urinary O B-C0042029
tract O I-C0042029
infection O I-C0042029
symptoms O O
in O O
the O O
patient O O
suggested O O
that O O
her O O
abscess O B-C0000833
developed O O
secondary O O
to O O
cystitis O B-C0010692
. O O

complete O O
resolution O O
of O O
the O O
abscess O B-C0000833
as O O
a O O
favorable O O
outcome O O
was O O
achieved O O
in O O
this O O
case O O
following O O
surgical O O
drainage O O
and O O
appropriate O O
antimicrobial O O
therapy O O
. O O

A O O
27 O O
- O O
year-old O O
caucasian O O
woman O O
with O O
known O O
adult O O
still's O B-C0087031
disease O I-C0087031
was O O
admitted O O
to O O
our O O
hospital O O
for O O
community-acquired O O
pneumonia O B-C0032285
, O O
due O O
to O O
legionella O O
infection O B-C3714514
, O O
with O O
acute O B-C0022660
renal O I-C0022660
failure O I-C0022660
. O O

although O O
her O O
respiratory O O
symptoms O O
responded O O
well O O
to O O
antibiotic O O
treatment O O
, O O
her O O
renal O O
function O O
worsened O O
, O O
with O O
severe O O
proteinuria O B-C0033687
and O O
edema O O
. O O

A O O
renal O O
biopsy O O
showed O O
extracapillary O O
and O O
endocapillary O O
proliferative O O
glomerulonephritis O B-C0017658
with O O
accompanying O O
chronic O O
and O O
acute O O
interstitial O B-C0027707
nephritis O I-C0027707
. O O

this O O
was O O
consistent O O
with O O
a O O
post-infection O O
immunocomplex O O
glomerulonephritis O B-C0017658
. O O

after O O
initiation O O
of O O
steroid O O
therapy O O
, O O
her O O
renal O O
function O O
improved O O
. O O

additionally O O
, O O
therapy O O
with O O
diuretics O O
and O O
an O O
angiotensin-converting O O
enzyme O O
inhibitor O O
was O O
initiated O O
because O O
of O O
persistent O O
proteinuria O B-C0033687
. O O

under O O
this O O
treatment O O
regimen O O
, O O
her O O
severe O O
edema O O
and O O
proteinuria O B-C0033687
disappeared O O
. O O

A O O
67 O O
- O O
year-old O O
aboriginal O O
woman O O
with O O
severe O O
chronic O B-C0024117
obstructive O I-C0024117
pulmonary O I-C0024117
disease O I-C0024117
and O O
hypercapnic O B-C0398353
respiratory O I-C0398353
failure O I-C0398353
underwent O O
right O O
trans-tibial O O
( O O
below O O
the O O
knee O O
) O O
amputation O O
for O O
severe O O
foot O O
gangrene O B-C0017086
. O O

an O O
aggressive O O
rehabilitation O O
program O O
of O O
conditioning O O
exercises O O
and O O
gait O B-C0016928
training O O
utilizing O O
oxygen O O
therapy O O
was O O
initiated O O
. O O

she O O
was O O
custom-fitted O O
with O O
a O O
right O O
trans-tibial O O
prosthesis O O
. O O

A O O
rehabilitation O O
program O O
improved O O
her O O
strength O O
, O O
endurance O O
and O O
stump O O
contracture O B-C0009917
, O O
and O O
she O O
was O O
able O O
to O O
walk O O
for O O
short O O
distances O O
with O O
the O O
prosthesis O O
. O O

the O O
motion O O
analysis O O
studies O O
showed O O
a O O
cadence O O
of O O
73.5 O O
steps O O
per O O
minute O O
, O O
a O O
velocity O O
of O O
0.29 O O
meters O O
per O O
second O O
and O O
no O O
difference O O
in O O
right O O
and O O
left O O
step O O
time O O
and O O
step O O
length O O
. O O

A O O
34 O O
- O O
year-old O O
chinese O O
woman O O
was O O
admitted O O
to O O
our O O
intensive O O
care O O
unit O O
due O O
to O O
hypertriglyceridemia O B-C0020557
and O O
severe O O
acute O B-C0001339
pancreatitis O I-C0001339
. O O

as O O
she O O
suffered O O
from O O
acute O B-C0035222
respiratory O I-C0035222
distress O I-C0035222
syndrome O I-C0035222
and O O
required O O
mechanical O B-C4760388
ventilation O I-C4760388
, O O
a O O
nasojejunal O O
feeding O O
tube O O
was O O
placed O O
by O O
transnasal O O
endoscopic O O
technique O O
. O O

the O O
procedure O O
took O O
place O O
at O O
her O O
bedside O O
. O O

half O O
a O O
month O O
later O O
, O O
she O O
had O O
a O O
high O O
fever O B-C0015967
and O O
abdominal O B-C0000731
distension O I-C0000731
. O O

an O O
abdominal O O
radiography O O
was O O
performed O O
and O O
showed O O
that O O
the O O
nasojejunal O O
feeding O O
tube O O
was O O
kinking O O
on O O
the O O
third O O
portion O O
of O O
the O O
duodenum O O
and O O
the O O
tip O O
of O O
the O O
nasojejunal O O
feeding O O
tube O O
was O O
inserted O O
into O O
the O O
right O O
retroperitoneum O O
on O O
the O O
second O O
portion O O
of O O
the O O
duodenum O O
. O O

48 O O
- O O
year-old O O
turkish O O
female O O
presented O O
to O O
the O O
department O O
with O O
fever O B-C0015967
, O O
weakness O B-C3714552
and O O
pain O B-C0030193
in O O
the O O
bilateral O O
pelvic O O
region O O
. O O

in O O
contrast O O
abdominal O O
magnetic O O
resonance O O
, O O
a O O
collection O O
compatible O O
with O O
the O O
hyperintense O O
abscess O B-C0000833
was O O
observed O O
in O O
the O O
right O O
and O O
left O O
ilipsoas O O
muscles O O
. O O

it O O
was O O
decided O O
to O O
simultaneously O O
drain O O
both O O
abscesses O B-C0000833
of O O
the O O
case O O
who O O
had O O
been O O
using O O
oral O O
and O O
intravenous O O
broad-spectrum O O
antibiotics O O
for O O
two O O
months O O
. O O

no O O
factors O O
were O O
detected O O
in O O
the O O
microbiological O O
reviews O O
made O O
on O O
the O O
abscess O B-C0000833
fluid O O
of O O
the O O
operated O O
case O O
. O O

the O O
case O O
was O O
also O O
examined O O
in O O
terms O O
of O O
tuberculosis O B-C0041296
and O O
crohn's O B-C0010346
disease O I-C0010346
and O O
no O O
findings O O
were O O
encountered O O
to O O
rise O O
suspicions O O
of O O
such O O
diseases O O
. O O

we O O
report O O
a O O
patient O O
in O O
whom O O
with O O
local O O
recurrence O O
of O O
esophageal O B-C0152018
carcinoma O I-C0152018
an O O
esophagotracheal O B-C0040588
fistula O I-C0040588
occurred O O
. O O

initially O O
the O O
patient O O
had O O
undergone O O
esophageal O O
resection O O
with O O
interposition O O
of O O
a O O
gastric O O
tube O O
. O O

due O O
to O O
complete O O
obstruction O O
of O O
the O O
lumen O O
by O O
recurrent O O
tumor O B-C0027651
conventional O O
transoral O O
stent O O
placement O O
failed O O
. O O

for O O
retrograde O O
dilatation O O
a O O
laparotomy O O
was O O
performed O O
. O O

via O O
a O O
duodenal O O
incision O O
endoscopic O O
access O O
to O O
the O O
gastric O O
tube O O
was O O
achieved O O
. O O

using O O
a O O
guidewire O O
the O O
esophageal O O
obstruction O O
was O O
traversed O O
and O O
dilated O O
. O O

then O O
it O O
was O O
possible O O
to O O
place O O
an O O
esophageal O O
stent O O
via O O
an O O
antegrade O O
approach O O
. O O

